UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-K
(Mark
One)
☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the fiscal year ended December 31, 2023
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the transition period from to
CATCHA
INVESTMENT CORP
(Exact
name of registrant as specified in its charter)
Cayman Islands | | 98-1574476 |
(State or Other Jurisdiction of Incorporation or Organization) | | (IRS Employer Identification Number) |
| |
3 Raffles Place #06-01, Bharat Building, Singapore | | 048617 |
(Address of Principal Executive Offices) | | (Zip Code) |
+65-6325-2788
(Registrant
Telephone Number, Including Area Code)
Level
42, Suntec Tower Three
8
Temasek Blvd Singapore
(Former
name or former address, if changed since last report)
001-40061
(Commission File Number)
Securities
registered pursuant to Section 12(b) of the Act:
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Class A ordinary shares, par value $0.0001 per share | | CHAA | | NYSE American LLC |
Securities
registered pursuant to Section 12(g) of the Act: None
Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒
Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act. Yes ☐
No ☒
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit and such files). Yes ☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer”, “smaller
reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | | Accelerated filer | ☐ |
Non-accelerated filer | ☒ | | Smaller reporting company | ☒ |
| | | Emerging growth company | ☒ |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report. ☐
If
securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in the filing reflect the correction of an error to previously issued financial statements. ☐
Indicate
by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐
The
aggregate market value of the Registrant’s Class A ordinary shares outstanding, other than shares held by persons who may be deemed
affiliates of the Registrant, computed by reference to the closing price for the Class A ordinary shares as of the last business day
of the Registrant’s most recently completed second fiscal quarter ($10.48 as of June
30, 2023), as reported on the New York Stock Exchange, was $23,211,722.
As of June 17, 2024, 8,715,232 shares of Class A ordinary shares
(including 7,350,350 shares that were converted from Class B ordinary shares), par value $0.0001, and 149,650 shares of Class B ordinary
shares, par value $0.0001, were issued and outstanding.
Documents
Incorporated by Reference: None.
TABLE
OF CONTENTS
CERTAIN
TERMS
Unless
otherwise stated in this Annual Report on Form 10-K (this “Report”), or the context otherwise requires, references to:
|
● |
“amended and restated memorandum and articles of association” are to the third amended and restated memorandum and articles of association, adopted by special resolution on February 5, 2021, effective as of February 11, 2021, as amended by special resolutions on February 14, 2023, February 16, 2024 and May 15, 2024; |
| ● | “Catcha,”
“we,” “us,” “our,” “company,” or “our
company” are to Catcha Investment Corp, a Cayman Islands exempted company. |
| ● | “Companies
Act” are to the Companies Act (2020 Revision) of the Cayman Islands as the same may
be amended from time to time; |
| ● | “equity-linked
securities” are to any debt or equity securities that are convertible, exercisable
or exchangeable for our Class A ordinary shares issued in a financing transaction in connection
with our initial business combination, including but not limited to a private placement of
equity or debt; |
| ● | “founder
shares” are to our Class B ordinary shares issued to our sponsor in a private placement
prior to our initial public offering and the Class A ordinary shares that will be issued
upon the automatic conversion of the Class B ordinary shares at the time of our initial business
combination or earlier at the option of the holders thereof (for the avoidance of doubt,
such Class A ordinary shares will not be “public shares”); |
| ● | “initial
shareholders” are to holders of our founder shares prior to our initial public offering; |
| ● | “letter
agreement” refers to the letter agreement, dated February 11, 2021, by and among the
company, Catcha Holdings LLC, and each director and executive officer of the Company; |
| ● | “management”
or our “management team” are to our officers and directors; |
| ● | “ordinary
shares” are to our Class A ordinary shares and our Class B ordinary shares; |
| ● | “private
placement warrants” are to the warrants issued to our sponsor in a private placement
simultaneously with the closing of our initial public offering and upon conversion of working
capital loans, if any; “public shares” are to our Class A ordinary shares sold
as part of the units in our initial public offering (whether they are purchased in our initial
public offering or thereafter in the open market); |
| ● | “public
shareholders” are to the holders of our public shares, including our sponsor and management
team to the extent our sponsor and/or members of our management team purchase public shares,
provided that our sponsor’s and each member of our management team’s status as
a “public shareholder” will only exist with respect to such public shares; |
| ● | “sponsor”
are to Catcha Holdings LLC, a Cayman Islands limited liability company; and |
| ● | “warrants”
or “public warrants” are to warrants sold as part of the units in our initial
public offering (whether they are purchased in our initial public offering or thereafter
in the open market); |
CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS
This
Report includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities
Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking
statements can be identified by the use of forward-looking terminology, including the words “anticipate,” “believe,”
“continue,” “could,” “estimate,” “expect,” “intends,” “may,”
“might,” “plan,” “possible,” “potential,” “predict,” “project,”
“should,” “would” or, in each case, their negative or other variations or comparable terminology. There can be
no assurance that actual results will not materially differ from expectations. Such statements include, but are not limited to, any statements
relating to our ability to consummate any acquisition or other business combination and any other statements that are not statements
of current or historical facts.
The
forward-looking statements contained in this Report are based on our current expectations and beliefs concerning future developments
and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated.
These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions
that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements.
These risks and uncertainties include, but are not limited to, the following risks, uncertainties and other factors:
| ● | our
ability to complete our initial business combination with Crown
(defined below); |
| ● | our
expectations around the performance of Crown or any other prospective target business or
businesses; |
| ● | our
success in retaining or recruiting, or changes required in, our officers, key employees or
directors following our initial business combination; |
| ● | our
officers and directors allocating their time to other businesses and potentially having conflicts
of interest with our business or in approving our initial business combination; |
| ● | our
potential ability to obtain additional financing to complete our initial business combination; |
| ● | our
public securities’ potential liquidity and trading; |
| ● | our
ability to maintain the listing of our Class A ordinary shares on the NYSE American; |
| ● | the
amount of redemptions made by public shareholders; |
| ● | the
lack of a market for our securities; |
| ● | the
use of proceeds not held in the trust account or available to us from interest income on
the trust account balance; |
| ● | the
trust account not being subject to claims of third parties; or |
| ● | our
financial performance following our initial public offering. |
Should
one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in
material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities
laws. These risks and others described under “Risk Factors” may not be exhaustive.
By
their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that
may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and that
our actual results of operations, financial condition and liquidity, and developments in the industry in which we operate may differ
materially from those made in or suggested by the forward-looking statements contained in this Report. In addition, even if our results
of operations, financial condition and liquidity, and developments in the industry in which we operate are consistent with the forward-looking
statements contained in this Report, those results or developments may not be indicative of results or developments in subsequent periods.
SUMMARY
OF RISK FACTORS
The
following is a summary of the principal risks described below in Part I, Item 1A “Risk Factors” in this Report. We believe
that the risks described in the “Risk Factors” section are material to investors, but other factors not presently known to
us or that we currently believe are immaterial may also adversely affect us. The following summary should not be considered an exhaustive
summary of the material risks facing us, and it should be read in conjunction with the “Risk Factors” section and the other
information contained in this Report:
| ● | Past
performance of our management team, Catcha Group (“Catcha Group”), or their respective
affiliates may not be indicative of future performance of an investment in us. |
| ● | Our
shareholders may not be afforded an opportunity to vote on our proposed initial business
combination, which means we may complete our initial business combination even though a majority
of our shareholders do not support such a combination. |
| ● | Your
only opportunity to affect the investment decision regarding a potential business combination
may be limited to the exercise of your right to redeem your shares from us for cash. |
| ● | If
we seek shareholder approval of our initial business combination, our initial shareholders
have agreed to vote in favor of such initial business combination, regardless of how our
public shareholders vote. |
| ● | The
ability of our public shareholders to redeem their shares for cash may make our financial
condition unattractive to potential business combination targets, which may make it difficult
for us to enter into a business combination with a target. |
| ● | The
ability of our public shareholders to exercise redemption rights with respect to a large
number of our shares may not allow us to complete the most desirable business combination
or optimize our capital structure. |
| ● | The
requirement that we consummate an initial business combination within 42 months after the
closing of our initial public offering may give potential target businesses leverage over
us in negotiating a business combination and may limit the time we have in which to conduct
due diligence on potential business combination targets, in particular as we approach our
dissolution deadline, which could undermine our ability to complete our initial business
combination on terms that would produce value for our shareholders. |
| ● | We
may not be able to consummate an initial business combination, in which case we would cease
all operations except for the purpose of winding up and we would redeem our public shares
and liquidate. |
| ● | If
the net proceeds of our initial offering and the sale of the private placement warrants not
being held in the trust account are insufficient to allow us to operate following the closing
of our initial public offering, it could limit the amount available to fund our search for
a target business or businesses and our ability to complete our initial business combination,
and we will depend on loans from our sponsor, its affiliates or members of our management
team to fund our search and to complete our initial business combination. |
| ● | Our
management concluded that there is substantial doubt about our ability to continue as a “going
concern.” |
| ● | We
may be unable to obtain additional financing to complete our initial business combination
or to fund the operations and growth of a target business, which could compel us to restructure
or abandon a particular business combination. If we have not consummated our initial business
combination within the required time period, our public shareholders may receive only approximately
$10.00 per public share, or less in certain circumstances, on the liquidation of our trust
account and our warrants will expire worthless. |
| ● | NYSE
American may delist our securities from trading on its exchange, which could limit investors’
ability to make transactions in our securities and subject us to additional trading restrictions. |
PART
I
Item
1. Business
Introduction
We
are a blank check company incorporated on December 17, 2020 as a Cayman Islands exempted company and formed for the purpose of effecting
a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses,
which we refer to throughout this Report as our initial business combination. We have not selected any specific business combination
target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business
combination target with respect to an initial business combination with us.
While
we may pursue an acquisition or a business combination target in any business, industry, or geography, we focus our search on a target
with operations or prospective operations in the technology, digital media, financial technology, or digital services sectors, which
we refer to as the “new economy sectors”, across Asia Pacific.
Our
team combines global industry knowledge with deep on-the-ground experience gained from a long history of operating and investing in new
economy sectors in Asia. We believe that through their reputation and deep network of contacts, our team affords us with differentiated
access to a wide range of investment opportunities in this space.
Our
Sponsor
Founded
in 1999 and led by Patrick Grove and Luke Elliott, our sponsor, Catcha Group, is one of the earliest and most established internet-focused
investment groups in Southeast Asia and Australia. Headquartered in Singapore and Malaysia and with over 20 years of operating experience,
Catcha Group has a strong focus and deep local understanding of the region. Since its inception, Catcha Group has made over 50 investments
globally which are held directly or indirectly, and brought six digital business from their early stages to a public listing or sale,
with an aggregate valuation of over $1 billion. These include iProperty Group, which was acquired by REA Group Limited in 2016, iCar
Asia, which was acquired by Carsome in 2022, as well as Frontier Digital Ventures, which is listed on the Australian Securities Exchange.
Business
Combination Agreement
Proposed
Business Combination
On August 3, 2023, we entered into a
Business Combination Agreement (as amended on October 2, 2023, January 31, 2024, February 16, 2024 May 21, 2024 and June 11, 2024,
the “Business Combination Agreement” and the transactions contemplated therein, collectively, the “Business
Combination”) with Crown LNG Holding AS, a private limited liability company incorporated under the laws of Norway
(“Crown”), Crown LNG Holdings Limited, a private limited company incorporated under the laws of Jersey, Channel Islands
(“PubCo”), and CGT Merge II Limited, a Cayman Islands exempted company limited by shares (“Merger Sub”).
Pursuant to the Business Combination Agreement, Merger Sub will merge with and into Catcha (the “Merger”), with Catcha
surviving as the surviving company and becoming a wholly owned subsidiary of PubCo.
In
connection with the Merger, each (a) of our issued and outstanding Class A ordinary share will be converted into the right to receive
one newly issued ordinary share, no par value, of PubCo (together, the “PubCo ordinary shares” and each individually, a “PubCo
ordinary share”), (b) of our issued and outstanding Class B ordinary share will be converted into the right to receive one newly
issued PubCo ordinary share, and (c) of our outstanding and unexercised public and private placement warrant shall be converted into
a warrant to purchase a PubCo ordinary share (together, the “PubCo warrants” and each individually, a “PubCo warrant”).
Following
the Merger, subject to the terms and procedures set forth under the Business Combination Agreement, the Crown shareholders will transfer
to PubCo, and PubCo will acquire from the Crown shareholders, all of the ordinary shares of Crown held by the shareholders in exchange
for the issuance of PubCo ordinary shares (the “Exchange”). In
consideration for such transfer, PubCo shall issue to each of the Crown shareholders its pro rata share of the exchange consideration,
which is a number of newly issued PubCo ordinary shares equal to (a) a transaction value of $600 million divided by (b) a
per share price of $10.00.
The
terms of the Business Combination Agreement, which contains customary representations and warranties, covenants, closing conditions and
other terms relating to the mergers and the other transactions contemplated thereby, are summarized below.
Representations,
Warranties and Covenants
The
parties to the Business Combination Agreement have agreed to customary representations and warranties for transactions of this type,
which will not survive the closing. No party will have any liabilities to such other parties, other than claims for fraud, with respect
to the making of its applicable representations and warranties. In addition, the parties agreed to be bound by certain covenants generally
customary for transactions of this type, including, among others, covenants with respect to the conduct of business of Crown (including
its subsidiaries) and Catcha during the period between execution of the Business Combination Agreement and the closing and a covenant
by Crown to deliver to Catcha the draft financial statements no later than 15 days after the date of the Business Combination Agreement.
Each of the parties has agreed to use its commercially reasonable efforts to cause the Business Combination to be consummated after the
date of the execution of the Business Combination Agreement in the most expeditious manner practicable.
Conditions
to Closing
Under
the Business Combination Agreement, the obligations of the parties (or, in some cases, some of the parties) to consummate the
Business Combination are subject to the satisfaction or waiver of certain regulatory or other customary closing conditions of the
respective parties, including, without limitation: (i) the completion of the KGLNG Transaction and the GBTron Transaction (each as
described in the Business Combination Agreement); (ii) the approval and adoption of the Business Combination Agreement and the
transactions contemplated thereby and certain other matters by the requisite vote of Catcha’s shareholders; (iii) the
execution of the Registration Rights Agreement and the Lock-Up Agreement (each as described below); (iv) the effectiveness of the
proxy statement / registration statement; (v) the approval of the listing of the shares of PubCo ordinary shares on the New York
Stock Exchange (the “NYSE”) or Nasdaq Stock Market LLC
(“Nasdaq”) or another national securities exchange acceptable to Crown; and (vi) Catcha having net tangible
assets of at least $5,000,001.
Termination
The Business Combination
Agreement may be terminated under certain customary circumstances at any time prior to the closing, including, without limitation, (i)
upon the mutual written consent of Catcha and Crown, (ii) by either Catcha or Crown, if any of the conditions to the closing has not
been satisfied or waived by June 28, 2024, (iii) by Catcha, on the one hand, or Crown, on the other hand, as a result of certain material
breaches by the counterparties to the Business Combination Agreement that remain uncured after any applicable cure period, (iv) by either
Catcha or Crown, if a governmental authority of competent jurisdiction shall have issued an order or taken any other action permanently
prohibiting the transactions contemplated by the Business Combination Agreement, (v) by Catcha, on the one hand, or Crown, on the other
hand, as a result of the failure by the counterparties to obtain approvals required for the Business Combination, (vi) by Catcha, if
there has been a material adverse effect on Crown and its subsidiaries taken as a whole, and (vii) by Crown in the event that prior
to June 28, 2024, the parties do not receive notice from NASDAQ, NYSE American, or another national securities exchange acceptable to
Crown, that the post-business combination public company common stock shall be approved for listing upon the closing of the Business
Combination.
In addition, the non-solicitation
provisions of the Business Combination Agreement were amended to expire on May 31, 2024, unless Crown has received notice that the post-business
combination public company ordinary shares shall be approved for listing upon the closing of the Business Combination on Nasdaq, NYSE
American or another national securities exchange acceptable to Crown.
Other
Agreements
The
Business Combination Agreement contemplates the execution of various additional agreements and instruments, including, among others,
as follows:
Registration
Rights Agreement
The
Business Combination Agreement contemplates that, as a condition to the closing, Catcha, Crown, PubCo, certain Crown shareholders, Catcha’s
directors and officers and our sponsor will enter into the Registration Rights Agreement pursuant to which, among other things,
PubCo will provide certain registration rights for the PubCo ordinary shares and PubCo warrants held by the applicable parties to the
Registration Rights Agreement. In particular, PubCo shall file, in no event later than sixty (60) days after the closing, a registration
statement for a shelf registration covering the resale of all registrable securities of the applicable holders. The holders are entitled
to make up to three demands for shelf takedowns within any 12-month period, after the shelf has been declared effective. In
addition, the holders have certain piggyback registration rights with respect to registration statements filed in connection with any
PubCo’s registered offering of equity securities after the Business Combination, subject to certain exceptions.
Lock-Up Agreement
The
Business Combination Agreement contemplates that, as a condition to the closing, Catcha, Crown, PubCo, certain Crown shareholders, our
sponsor, and Crown’s and Catcha’s directors and officers will enter into the Lock-Up Agreement pursuant to which,
among other things, the applicable parties will agree not to transfer, sell, assign or otherwise dispose of any PubCo’s equity
securities held by such persons for 12 months following the closing, in each case subject to certain exceptions.
Exchange
and Support Agreement
Concurrently
with the execution of the Business Combination Agreement, Catcha, PubCo, Crown and certain Crown shareholders entered into the Exchange
and Support Agreement, pursuant to which, such Crown shareholders agreed to (i) exchange all of their Crown shares for PubCo ordinary
shares as part of the Exchange, (ii) to vote their Crown shares in favor of the transactions contemplated by the Business Combination
Agreement and (iii) to provide a power of attorney to Crown to take certain actions in connection with the transactions contemplated
by the Business Combination Agreement on behalf of such Crown shareholders. The Crown Shareholders that are party to the Exchange and
Support Agreement are expected to represent approximately 90% of issued and outstanding Crown shares immediately before the closing.
Shareholder Approval
On June 12, 2024, Catcha held an extraordinary general meeting of shareholders
pursuant to which the shareholders of record as of January 16, 2024 approved Catcha’s previously proposed Business Combination with
Crown.
Our
Competitive Advantages
Our
Operating Excellence
Our
team has a rich operating track record with demonstrated ability to launch, operate, and scale digital business, creating significant
value for our stakeholders. We believe the collective experience of our team positions us uniquely to assess promising candidates and
support companies to achieve their long-term objectives.
For
example, in 2007, Catcha Group founded iProperty, an online real estate portal with presence across Southeast Asia, and exited in 2016
at a valuation of A $751 million, which was one of the largest exits in the region at the time. Leveraging insights from its experience
with iProperty, Catcha Group founded Frontier Digital Ventures to establish leading online classifieds businesses in the other emerging
markets across the world. Today, Frontier Digital Ventures has invested in a portfolio of online classifieds assets worth over US$750
million comprising of real estate, automotive and general classifieds platforms across Asia Pacific, Central and South America, and MENA.
Catcha Group also founded iFlix in 2015, a video-on-demand platform focused on emerging markets in Asia and was acquired by Tencent Group
in 2020. Another Catcha Group company, iCar Asia, has grown to become a leading online automotive-focused portal in Southeast Asia, and
was acquired by Carsome for approximately $200 million.
Our
Sourcing Network
Our
team has a rich and long track record as entrepreneurs, operators and investors providing them with deep understanding of the entrepreneurial
journey. Our team is regarded as thought leaders and mentors with a long history of successfully helping other founders and businesses
in the region develop and scale their businesses.
Our
team has developed a large and deep network within the technology and digital ecosystem globally and across Asia Pacific, including strong
relationships with many leading founders, executives, and investors. For example, Wild Digital Conference, which is a regional premier
technology-focused conference organized by Catcha Group since 2015, saw participation from over 2,600 attendees in 2021.
Additionally,
we leverage the extensive global network brought by members of our Board of Directors and Advisors. Their deep experience and reputation
helps to position us well to source attractive prospects.
Our
transaction experience
Our
team includes seasoned dealmakers with experience in investments with a wide range of sizes and structures, across multiple macroeconomic
and industry cycles. Catcha Group has invested in over 50 new economy companies, held either directly or indirectly and has conducted
over 70 corporate transactions including mergers and acquisitions, initial public offerings and capital raisings over the last 20 years.
Our
commitment to supporting our business combination partner
Our
team is committed to ensuring the longer term success of the business combination partner we identify and pursue, and intend to bring
our unique expertise to drive efficiencies following a business combination to steer our partner through their short-term and long-term
challenges.
Our
rich transaction and operating experience makes us well-suited to guide our partner through variety of macroeconomic and industry cycles
as they build and scale their business, and help them assess potential strategic opportunities as the technology and competitive landscape
continue to change. Our team is committed to leveraging its large network globally to help our partner companies find the best available
talent and operate with excellence.
Having
brought several companies public and with a successful track record as operators of public companies, our sponsor is well-positioned
to lead our partner on their journey to public capital markets and guide them through the potential opportunities and challenges as a
newly publicly listed company.
Our
Management Team, Directors, and Advisors
Our
officers, directors, and advisors consist of seasoned investors and industry executives with an extensive track record of identifying,
investing in, building, operating, and advising leading businesses. In particular, the team possesses a deep understanding of the technology
space and market opportunities globally and in our focus region. We believe our management team, together with the support of our advisors
and directors, is well-positioned to identify and access a differentiated range of investment opportunities in the new economy sectors
by capitalizing on their reputation and deep network of relationships.
Our
management team and board of directors comprises of Patrick Grove, chairman of our board of directors and chief executive officer since
our inception, Luke Elliott, director and president since our inception, Wai Kit Wong, chief financial officer, James A. Graf, independent
director, Rick Hess, independent director, and Yaniv Ghitis, independent director. For more information on the experience and background
of our team and directors, see “Item 10. Directors, Executive Officers, and Corporate Governance.”
Our
Business Strategy
While
we may pursue an acquisition or a business combination target in any business, industry, or geography, we have focused our search on
a target with operations or prospective operations in the technology, digital media sectors, financial technology, or digital services,
which we refer to as the “new economy sectors,” across Asia Pacific. We believe that Asia Pacific will continue to enjoy
an outsized growth trajectory, particularly in the new economy sectors, and that this will result in opportunities for attractive risk-adjusted
returns from our initial business combination. We’ve focused on companies that complement the experience of our management team
and that can benefit from the management team’s operational expertise. Our selection process has leveraged our management team’s
and our sponsor’s broad and deep network of relationships, industry expertise, and proven deal-sourcing capabilities, providing
us with a strong pipeline of potential targets. Our management and sponsor have experience in:
| ● | investing
and building businesses in the new economy sectors; |
| ● | managing
and operating companies, setting and changing strategies, and identifying, mentoring and
recruiting top-notch talent; |
| ● | developing
and growing companies, both organically and inorganically, and expanding the product ranges
and geographic footprints of portfolio businesses; |
| ● | executing
merger and acquisition strategies to accelerate growth and create integrated value chains; |
| ● | sourcing,
structuring, acquiring and selling businesses in various markets; |
| ● | partnering
with other industry-leading companies to increase sales and improve the competitive position
of companies; |
| ● | fostering
relationships with users, sellers, capital providers and target management teams; and |
| ● | accessing
the capital markets across various business cycles, including financing businesses and assisting
companies with the transition to public ownership. |
Business
Combination Criteria
Consistent
with our business strategy, we have focused on businesses with:
| ● | Operations
or prospects in new economy sectors in Southeast Asia and Australia. Based upon our management
team’s experience, we have increased access to investment opportunities and a competitive
advantage in our ability to negotiate a business combination with potential targets in Southeast
Asia and Australia’s new economy sectors. Our management team’s extensive experience
and network of contacts provides them with an opportunity to source a target, evaluate a
target, consummate a business combination with the target and help grow the target’s
business. |
| ● | Strong
management team and culture. We intend to acquire one or more businesses that have strong
management teams with a proven track record of driving growth, building long-term competitive
advantage and making sound strategic decisions, as well as operating with a transparent corporate
culture anchored in strong values. |
| ● | Large
addressable markets. We intend to invest in one or more businesses that address a large
market that creates the opportunity for attractive long-term growth prospects. |
| ● | Scalability.
We seek to invest in one or more businesses that will be able to significantly scale
their operations to take advantage of their opportunities. We intend to leverage our experience
in scaling businesses in order to help accelerate growth. |
| ● | Sound
fundamentals with the potential to further improve their performance under our ownership.
We believe our management team’s experience in our target sectors as well as their
network of industry contacts will create opportunities to enhance the revenue and operational
efficiencies of the target business, and potentially generate higher returns for our investors. |
| ● | Market
leadership. We intend to seek one or more targets that have a leading presence across
an industry or segment or have leading technology or product capabilities. |
| ● | Appropriate
valuations. We are a disciplined and valuation-centric investor that will invest on terms
that we believe are attractive relative to market comparables and intrinsic value that provide
significant upside potential. |
| ● | Opportunities
for inorganic growth. We seek companies that can serve as a platform for future synergistic
acquisitions, and can benefit from the public currency afforded by access to equity capital
markets. |
We
used these criteria and guidelines in evaluating acquisition opportunities, though we may decide to consummate our initial business combination
with a target business that does not meet these criteria and guidelines.
Our
Business Combination Process
In
evaluating Crown and other prospective target businesses, we conducted a thorough due diligence review that encompassed, among other
things, meetings with incumbent management and employees, document reviews, interviews of customers and suppliers, inspection of facilities,
as well as reviewing financial and other information that were made available to us. We also utilized our operational and capital allocation
experience.
Our
acquisition criteria, due diligence processes, and value creation methods are not exhaustive. Any evaluation relating to the merits of
a particular initial business combination may be based, to the extent relevant, on these general guidelines as well as other considerations,
factors and criteria that our management may deem relevant. In the event that we decide to enter into our initial business combination
with a target business that does not meet the above criteria and guidelines, we will disclose that the target business does not meet
the above criteria in our shareholder communications related to our initial business combination, which, as discussed in this Report,
would be in the form of tender offer documents or proxy solicitation materials that we would file with the SEC.
Initial
Business Combination
The
rules of the NYSE require that our initial business combination must be with one or more operating businesses or assets with a fair market
value equal to at least 80% of the net assets held in the trust account (net of amounts disbursed to management for working capital purposes,
if permitted, and excluding the amount of any deferred underwriting discount held in trust). We refer to this as the “80% of net
assets test.” If our board of directors is not able to independently determine the fair market value of the target business or
businesses, we will obtain an opinion from an independent investment banking firm or another independent entity that commonly renders
valuation opinions with respect to the satisfaction of such criteria. We do not currently intend to purchase multiple businesses in unrelated
industries in conjunction with our initial business combination, although there is no assurance that will be the case. Additionally,
pursuant to NYSE rules, any initial business combination must be approved by a majority of our independent directors.
Unless
we complete our initial business combination with an affiliated entity, or our board of directors cannot independently determine the
fair market value of the target business or businesses, we are not required to obtain an opinion from an independent investment banking
firm, another independent firm that commonly renders valuation opinions for the type of company we are seeking to acquire or from an
independent accounting firm that the price we are paying for a target is fair to our company from a financial point of view. If no opinion
is obtained, our shareholders will be relying on the business judgment of our board of directors, which will have significant discretion
in choosing the standard used to establish the fair market value of the target or targets, and different methods of valuation may vary
greatly in outcome from one another. Such standards used will be disclosed in our tender offer documents or proxy solicitation materials,
as applicable, related to our initial business combination.
We
anticipate structuring our initial business combination so that the post-transaction company in which our public shareholders own shares
will own or acquire 100% of the equity interests or assets of the target business or businesses. We may, however, structure our initial
business combination such that the post-transaction company owns or acquires less than 100% of such interests or assets of the target
business in order to meet certain objectives of the target management team or shareholders or for other reasons. However, we will only
complete such business combination if the post-transaction company owns or acquires 50% or more of the issued and outstanding voting
securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register
as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). Even if the
post-transaction company owns or acquires 50% or more of the voting securities of the target, our shareholders prior to the business
combination may collectively own a minority interest in the post-transaction company, depending on valuations ascribed to the target
and us in the business combination transaction. For example, we could pursue a transaction in which we issue a substantial number of
new shares in exchange for all of the issued and outstanding capital stock, shares, and/or other equity interests of a target. In this
case, we would acquire a 100% controlling interest in the target. However, as a result of the issuance of a substantial number of new
shares, our shareholders immediately prior to our initial business combination could own less than a majority of our issued and outstanding
shares subsequent to our initial business combination. If less than 100% of the equity interests or assets of a target business or businesses
are owned or acquired by the post-transaction company, the portion of such business or businesses that is owned or acquired is what will
be valued for purposes of the 80% of net assets test. If our initial business combination involves more than one target business, the
80% of net assets test will be based on the aggregate value of all of the target businesses. We intend to satisfy the 80% requirement
even if our securities are not listed on the NYSE at the time of our initial business combination.
We
filed a Registration Statement on Form 8-A with the SEC to voluntarily register our securities under Section 12 of the Exchange Act.
As a result, we are subject to the rules and regulations promulgated under the Exchange Act. We have no current intention of filing a
Form 15 to suspend our reporting or other obligations under the Exchange Act prior or subsequent to the consummation of our initial business
combination.
Status
as a Public Company
We
believe our structure makes us an attractive business combination partner to target businesses. As an existing public company, we offer
a target business an alternative to the traditional initial public offering through a merger or other business combination with us. In
a business combination transaction with us, the owners of the target business may, for example, exchange their shares of stock, shares
or other equity interests in the target business for our Class A ordinary shares (or shares of a new holding company) or for a combination
of our Class A ordinary shares and cash, allowing us to tailor the consideration to the specific needs of the sellers. We believe target
businesses will find this method to be a more expeditious and cost effective method to becoming a public company than the typical initial
public offering. The typical initial public offering process takes a significantly longer period of time than the typical business combination
transaction process, and there are significant expenses in the initial public offering process, including underwriting discounts and
commissions, that may not be present to the same extent in connection with a business combination with us.
Furthermore,
once a proposed business combination is completed, the target business will have effectively become public, whereas an initial public
offering is always subject to the underwriters’ ability to complete the offering, as well as general market conditions, which could
delay or prevent the offering from occurring or have negative valuation consequences. Once public, we believe the target business would
then have greater access to capital, an additional means of providing management incentives consistent with shareholders’ interests
and the ability to use its shares as currency for acquisitions. Being a public company can offer further benefits by augmenting a company’s
profile among potential new customers and vendors and aid in attracting talented employees.
While
we believe that our structure and our management team’s backgrounds makes us an attractive business partner, some potential target
businesses may view our status as a blank check company, such as our lack of an operating history and our ability to seek shareholder
approval of any proposed initial business combination, negatively.
Lack
of Business Diversification
For
an indefinite period of time after the completion of our initial business combination, the prospects for our success may depend entirely
on the future performance of a single business. Unlike other entities that have the resources to complete business combinations with
multiple entities in one or several industries, it is probable that we will not have the resources to diversify our operations and mitigate
the risks of being in a single line of business. By completing our initial business combination with only a single entity, our lack of
diversification may:
| ● | subject
us to negative economic, competitive and regulatory developments, any or all of which may
have a substantial adverse impact on the particular industry in which we operate after our
initial business combination; and |
| ● | cause
us to depend on the marketing and sale of a single product or limited number of products
or services. |
Limited
Ability to Evaluate the Target’s Management Team
Although
we intend to closely scrutinize the management of Crown or any other prospective target business when evaluating the desirability of
effecting our initial business combination with that business, our assessment of the target business’s management may not prove
to be correct. In addition, the future management may not have the necessary skills, qualifications or abilities to manage a public company.
Furthermore, the future role of members of our management team, if any, in the target business cannot presently be stated with any certainty.
The determination as to whether any of the members of our management team will remain with the combined company will be made at the time
of our initial business combination. While it is possible that one or more of our directors will remain associated in some capacity with
us following our initial business combination, it is unlikely that any of them will devote their full efforts to our affairs subsequent
to our initial business combination. Moreover, we cannot assure you that members of our management team will have significant experience
or knowledge relating to the operations of the particular target business.
We
cannot assure you that any of our key personnel will remain in senior management or advisory positions with the combined company. The
determination as to whether any of our key personnel will remain with the combined company will be made at the time of our initial business
combination.
Following
a business combination, we may seek to recruit additional managers to supplement the incumbent management of the target business. We
cannot assure you that we will have the ability to recruit additional managers, or that additional managers will have the requisite skills,
knowledge, or experience necessary to enhance the incumbent management.
Shareholders
May Not Have the Ability to Approve Our Initial Business Combination
We may conduct redemptions without a shareholder
vote pursuant to the tender offer rules of the SEC, subject to the provisions of our third amended and restated memorandum and articles
of association. However, we will seek shareholder approval if it is required by applicable law or stock exchange listing requirement,
or we may decide to seek shareholder approval for business or other reasons.
Under
NYSE listing rules, shareholder approval would typically be required for our initial business combination if, for example:
| ● | we
issue ordinary shares that will be equal to or in excess of 20% of the number of our ordinary
shares then-outstanding (other than in a public offering); |
| ● | any
of our officers, directors or substantial security holders (as defined by the NYSE rules)
has a 5% or greater interest, directly or indirectly, in the target business or assets to
be acquired or otherwise, and the present or potential issuance of ordinary shares could
result in an increase in issued and outstanding ordinary shares or voting power of 1% or
more (or 5% or more if the related party involved is classified as such solely because such
person is a substantial security holder); or |
| ● | the
issuance or potential issuance of ordinary shares will result in our undergoing a change
of control. |
The
decision as to whether we will seek shareholder approval of a proposed business combination in those instances in which shareholder approval
is not required by law will be made by us, solely in our discretion, and will be based on business and reasons, which include a variety
of factors, including, but not limited to:
| ● | the
timing of the transaction, including in the event we determine shareholder approval would
require additional time and there is either not enough time to seek shareholder approval
or doing so would place the company at a disadvantage in the transaction or result in other
additional burdens on the company; |
| ● | the
expected cost of holding a shareholder vote; |
| ● | the
risk that the shareholders would fail to approve the proposed business combination; |
| ● | other
time and budget constraints of the company; and |
| ● | additional
legal complexities of a proposed business combination that would be time-consuming and burdensome
to present to shareholders. |
Permitted
Purchases and Other Transactions with Respect to Our Securities
If
we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business
combination pursuant to the tender offer rules, our sponsor, officers, directors, advisors or their affiliates may purchase public shares
or warrants in privately negotiated transactions or in the open market either prior to or following the completion of our initial business
combination. Additionally, at any time at or prior to our initial business combination, subject to applicable securities laws (including
with respect to material non-public information), our sponsor, officers, directors, advisors or their affiliates may enter into transactions
with investors and others to provide them with incentives to acquire public shares, vote their public shares in favor of our initial
business combination or not redeem their public shares. However, they have no current commitments, plans, or intentions to engage in
such transactions and have not formulated any terms or conditions for any such transactions. None of the funds in the trust account will
be used to purchase public shares or warrants in such transactions. If they engage in such transactions, they will be restricted from
making any such purchases when they are in possession of any material non-public information not disclosed to the seller or if such purchases
are prohibited by Regulation M under the Exchange Act.
In
the event that our sponsor, officers, directors, advisors, or their affiliates purchase public shares in privately negotiated transactions
from public shareholders who have already elected to exercise their redemption rights or submitted a proxy to vote against our initial
business combination, such selling shareholders would be required to revoke their prior elections to redeem their shares and any proxy
to vote against our initial business combination. We do not currently anticipate that such purchases, if any, would constitute a tender
offer subject to the tender offer rules under the Exchange Act or a going-private transaction subject to the going-private rules under
the Exchange Act; however, if the purchasers determine at the time of any such purchases that the purchases are subject to such rules,
the purchasers will be required to comply with such rules.
The
purpose of any such transaction could be to (i) vote in favor of the business combination and thereby increase the likelihood of obtaining
shareholder approval of the business combination, (ii) reduce the number of public warrants outstanding or vote such warrants on any
matters submitted to the warrant holders for approval in connection with our initial business combination, or (iii) satisfy a closing
condition in an agreement with a target that requires us to have a minimum net worth or a certain amount of cash at the closing of our
initial business combination, where it appears that such requirement would otherwise not be met. Any such purchases of our securities
may result in the completion of our initial business combination that may not otherwise have been possible.
In
addition, if such purchases are made, the public “float” of our Class A ordinary shares or public warrants may be reduced
and the number of beneficial holders of our securities may be reduced, which may make it difficult to maintain or obtain the quotation,
listing or trading of our securities on a national securities exchange.
Our
sponsor, officers, directors and/or their affiliates may identify the shareholders with whom they may pursue privately negotiated transactions
by either the shareholders contacting us directly or by our receipt of redemption requests submitted by shareholders (in the case of
Class A ordinary shares) following our mailing of tender offer or proxy materials in connection with our initial business combination.
To the extent that our sponsor, officers, directors, advisors or their affiliates enter into a private transaction, they would identify
and contact only potential selling or redeeming shareholders who have expressed their election to redeem their shares for a pro rata
share of the trust account or vote against our initial business combination, whether or not such shareholder has already submitted a
proxy with respect to our initial business combination, but only if such shares have not already been voted at the general meeting related
to our initial business combination. Our sponsor, officers, directors, advisors, or their affiliates will select which shareholders to
purchase shares from based on the negotiated price and number of shares and any other factors that they may deem relevant, and will be
restricted from purchasing shares if such purchases do not comply with Regulation M under the Exchange Act and the other federal securities
laws.
Our
sponsor, officers, directors and/or their affiliates will be restricted from making purchases of shares if the purchases would violate
Section 9(a)(2) or Rule 10b-5 of the Exchange Act. We expect any such purchases would be reported by such person pursuant to Section
13 and Section 16 of the Exchange Act to the extent such purchasers are subject to such reporting requirements.
Redemption
Rights for Public Shareholders upon the Completion of Our Initial Business Combination
We will provide our public shareholders with the
opportunity to redeem all or a portion of their Class A ordinary shares upon the completion of our initial business combination at a per-share
price, payable in cash, equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to
the consummation of the initial business combination, including interest earned on the funds held in the trust account and not previously
released to us to pay our income taxes, if any, divided by the number of then-outstanding public shares, subject to the limitations described
herein. The amount in the trust account is initially anticipated to be $10.00 per public share. The per-share amount we will distribute
to investors who properly redeem their shares will not be reduced by the deferred underwriting commissions we will pay to the underwriters.
The redemption rights will include the requirement that a beneficial holder must identify itself in order to validly redeem its shares.
There were no redemption rights upon the completion of our initial business combination with respect to our warrants. Further, we will
not proceed with redeeming our public shares, even if a public shareholder has properly elected to redeem its shares, if a business combination
does not close. Our sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed to
waive their redemption rights with respect to any founder shares and public shares held by them in connection with (i) the completion
of our initial business combination and (ii) a shareholder vote to approve an amendment to our third amended and restated memorandum and
articles of association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares
the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if
we do not complete our initial business combination within 42 months from the closing of our initial public offering or during any extension
period or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares.
Limitations
on Redemptions
Our third amended and restated memorandum and
articles of association provides that in no event will we redeem our public shares in an amount that would cause our net tangible assets
to be less than $5,000,001 (so that we do not then become subject to the SEC’s “penny stock” rules). However, the proposed
business combination may require: (i) cash consideration to be paid to the target or its owners, (ii) cash to be transferred to the target
for working capital or other general corporate purposes, or (iii) the retention of cash to satisfy other conditions in accordance with
the terms of the proposed business combination. In the event the aggregate cash consideration we would be required to pay for all Class
A ordinary shares that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to the terms
of the proposed business combination exceed the aggregate amount of cash available to us, we will not complete the business combination
or redeem any shares, and all Class A ordinary shares submitted for redemption will be returned to the holders thereof.
Manner
of Conducting Redemptions
We will provide our public shareholders with the
opportunity to redeem all or a portion of their Class A ordinary shares upon the completion of our initial business combination either
(i) in connection with a general meeting called to approve the business combination or (ii) by means of a tender offer. The decision as
to whether we will seek shareholder approval of a proposed business combination or conduct a tender offer will be made by us, solely in
our discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction
would require us to seek shareholder approval under applicable law or stock exchange listing requirement or whether we were deemed to
be a foreign private issuer (which would require a tender offer rather than seeking shareholder approval under SEC rules). Asset acquisitions
and share purchases would not typically require shareholder approval while direct mergers with our company where we do not survive and
any transactions where we issue more than 20% of our issued and outstanding ordinary shares or seek to amend our third amended and restated
memorandum and articles of association would typically require shareholder approval. We currently intend to conduct redemptions in connection
with a shareholder vote unless shareholder approval is not required by applicable law or stock exchange listing requirement or we choose
to conduct redemptions pursuant to the tender offer rules of the SEC for business or other reasons. So long as we obtain and maintain
a listing for our securities on NYSE, we will be required to comply with the NYSE rules.
If we held a shareholder vote to approve our initial business combination,
we will, pursuant to our third amended and restated memorandum and articles of association:
| ● | conduct
the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the
Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender
offer rules; and |
| ● | file
proxy materials with the SEC. |
In
the event that we seek shareholder approval of our initial business combination, we will distribute proxy materials and, in connection
therewith, provide our public shareholders with the redemption rights described above upon the completion of our initial business combination.
If we seek shareholder approval, we will complete
our initial business combination only if we obtain the approval of an ordinary resolution under Cayman Islands law, which requires the
affirmative vote of a majority of the ordinary shares represented in person or by proxy and entitled to vote thereon and who vote at a
general meeting. In such case, our initial shareholders have agreed to vote their founder shares and public shares in favor of our initial
business combination. As a result, as of June 10, 2024, in addition to the founder shares, we would need none (assuming only the minimum
number of shares representing a quorum are voted), of the public shares sold in our initial public offering to be voted in favor of an
initial business combination in order to have our initial business combination approved. On June 12, 2024, such shareholder approval was
obtained at an extraordinary general meeting of shareholders to approve our initial business combination. Each public shareholder may
elect to redeem their public shares irrespective of whether they vote for or against the proposed transaction or vote at all. In addition,
our sponsor, officers and directors entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption
rights with respect to any founder shares and public shares held by them in connection with (i) the completion of a business combination
and (ii) a shareholder vote to approve an amendment to our third amended and restated memorandum and articles of association (A) that
would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares
redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial
business combination within 24 months from the closing of our initial public offering or during any extension period or (B) with respect
to any other provision relating to the rights of holders of our Class A ordinary shares.
If we conduct redemptions pursuant to the tender
offer rules of the SEC, we will, pursuant to our third amended and restated memorandum and articles of association:
| ● | conduct
the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate
issuer tender offers; and |
| ● | file
tender offer documents with the SEC prior to completing our initial business combination,
which contain substantially the same financial and other information about the initial business
combination and the redemption rights as is required under Regulation 14A of the Exchange
Act, which regulates the solicitation of proxies. |
Upon
the public announcement of our initial business combination, if we elect to conduct redemptions pursuant to the tender offer rules, we,
and our sponsor, will terminate any plan established in accordance with Rule 10b5-1 to purchase Class A ordinary shares in the open market,
in order to comply with Rule 14e-5 under the Exchange Act.
In
the event we conduct redemptions pursuant to the tender offer rules, our offer to redeem will remain open for at least 20 business days,
in accordance with Rule 14e-1(a) under the Exchange Act, and we will not be permitted to complete our initial business combination until
the expiration of the tender offer period. In addition, the tender offer will be conditioned on public shareholders not tendering more
than the number of public shares we are permitted to redeem. If public shareholders tender more shares than we have offered to purchase,
we will withdraw the tender offer and not complete such initial business combination.
Shareholder
Approval
On June 12, 2024, Catcha held an extraordinary general meeting of shareholders
pursuant to which the shareholders of record as of January 16, 2024 approved Catcha’s previously proposed Business Combination with
Crown..
Limitation
on Redemption upon the Completion of Our Initial Business Combination If We Seek Shareholder Approval
If we seek shareholder approval of our initial
business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer
rules, then, pursuant to our third amended and restated memorandum and articles of association, a public shareholder, together with any
affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined
under Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the
shares sold in our initial public offering without our prior consent. We believe this restriction will discourage shareholders from accumulating
large blocks of shares, and subsequent attempts by such holders to use their ability to exercise their redemption rights against a proposed
business combination as a means to force us or our management to purchase their shares at a significant premium to the then-current market
price or on other undesirable terms. Absent this provision, a public shareholder holding more than an aggregate of 15% of the shares sold
in our initial public offering could threaten to exercise its redemption rights if such holder’s shares are not purchased by us,
our sponsor or our management at a premium to the then-current market price or on other undesirable terms. By limiting our shareholders’
ability to redeem no more than 15% of the shares sold in our initial public offering without our prior consent, we believe we will limit
the ability of a small group of shareholders to unreasonably attempt to block our ability to complete our initial business combination,
particularly in connection with a business combination with a target that requires as a closing condition that we have a minimum net worth
or a certain amount of cash.
However,
we would not be restricting our shareholders’ ability to vote all of their shares (including Excess Shares, as defined below) for
or against our initial business combination.
Tendering
Share Certificates in Connection with a Tender Offer or Redemption Rights
Public
shareholders seeking to exercise their redemption rights, whether they are record holders or hold their shares in “street name,”
will be required to either tender their certificates (if any) to our transfer agent prior to the date set forth in the proxy solicitation
or tender offer materials, as applicable, mailed to such holders, or to deliver their shares to the transfer agent electronically using
The Depository Trust Company’s DWAC (Deposit/ Withdrawal At Custodian) System, at the holder’s option, in each case up to
two business days prior to the initially scheduled vote to approve the business combination. The proxy solicitation or tender offer materials,
as applicable, that we will furnish to holders of our public shares in connection with our initial business combination will indicate
the applicable delivery requirements, which will include the requirement that a beneficial holder must identify itself in order to validly
redeem its shares. Accordingly, a public shareholder would have from the time we send out our tender offer materials until the close
of the tender offer period, or up to two business days prior to the initially scheduled vote on the proposal to approve the business
combination if we distribute proxy materials, as applicable, to tender its shares if it wishes to seek to exercise its redemption rights.
Given the relatively short period in which to exercise redemption rights, it is advisable for shareholders to use electronic delivery
of their public shares.
There
is a nominal cost associated with the above-referenced tendering process and the act of certificating the shares or delivering them through
the DWAC System. The transfer agent will typically charge the tendering broker a fee of approximately $80.00 and it would be up to the
broker whether or not to pass this cost on to the redeeming holder. However, this fee would be incurred regardless of whether or not
we require holders seeking to exercise redemption rights to tender their shares. The need to deliver shares is a requirement of exercising
redemption rights regardless of the timing of when such delivery must be effectuated.
The
foregoing is different from the procedures used by many blank check companies. In order to perfect redemption rights in connection with
their business combinations, many blank check companies would distribute proxy materials for the shareholders’ vote on an initial
business combination, and a holder could simply vote against a proposed business combination and check a box on the proxy card indicating
such holder was seeking to exercise his or her redemption rights. After the business combination was approved, the company would contact
such shareholder to arrange for him or her to deliver his or her certificate to verify ownership. As a result, the shareholder then had
an “option window” after the completion of the business combination during which he or she could monitor the price of the
company’s shares in the market. If the price rose above the redemption price, he or she could sell his or her shares in the open
market before actually delivering his or her shares to the company for cancellation. As a result, the redemption rights, to which shareholders
were aware they needed to commit before the general meeting, would become “option” rights surviving past the completion of
the business combination until the redeeming holder delivered its certificate. The requirement for physical or electronic delivery prior
to the meeting ensures that a redeeming shareholder’s election to redeem is irrevocable once the business combination is approved.
Any
request to redeem such shares, once made, may be withdrawn at any time up to two business days prior to the initially scheduled vote
on the proposal to approve the business combination, unless otherwise agreed to by us. Furthermore, if a holder of a public share delivered
its certificate in connection with an election of redemption rights and subsequently decides prior to the applicable date not to elect
to exercise such rights, such holder may simply request that the transfer agent return the certificate (physically or electronically).
It is anticipated that the funds to be distributed to holders of our public shares electing to redeem their shares will be distributed
promptly after the completion of our initial business combination.
If
our initial business combination is not approved or completed for any reason, then our public shareholders who elected to exercise their
redemption rights would not be entitled to redeem their shares for the applicable pro rata share of the trust account. In such case,
we will promptly return any certificates delivered by public holders who elected to redeem their shares.
Redemption
of Public Shares and Liquidation if no Initial Business Combination
Our
third amended and restated memorandum and articles of association provides that we have until 42 months
after the closing of our initial public offering to consummate an initial business combination. If we have not consummated an initial
business combination within 42 months from our initial public offering, we will: (i) cease all operations except for the purpose of winding
up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price,
payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the
trust account and not previously released to us to pay our income taxes, if any divided by the number of the then-outstanding public shares,
which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further
liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of
our remaining shareholders and our board of directors, liquidate and dissolve, subject, in each case to our obligations under Cayman Islands
law to provide for claims of creditors and the requirements of other applicable law. There are no redemption rights or liquidating distributions
with respect to our warrants, which will expire worthless if we fail to consummate an initial business combination within 42 month from
the closing of our initial public offering. Our third amended and restated memorandum and articles of association provides that, if we
wind up for any other reason prior to the consummation of our initial business combination, we will follow the foregoing procedures with
respect to the liquidation of the trust account as promptly as reasonably possible but not more than ten business days thereafter, subject
to applicable Cayman Islands law.
Our sponsor, officers and directors entered into
a letter agreement with us, pursuant to which they have agreed to waive their rights to liquidating distributions from the trust account
with respect to any founder shares they hold if we fail to consummate an initial business combination within 42 months from the closing
of our initial public offering or during any extension period (although they will be entitled to liquidating distributions from the trust
account with respect to any public shares they hold if we fail to complete our initial business combination within the prescribed time
frame).
Our sponsor, officers and directors have agreed,
pursuant to a letter agreement with us, that they will not propose any amendment to our third amended and restated memorandum and articles
of association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right
to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not
complete our initial business combination within 42 months from the closing of our initial public offering or during any extension period
or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares, unless we provide our public
shareholders with the opportunity to redeem their public shares upon approval of any such amendment at a per-share price, payable in cash,
equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and
not previously released to us to pay our income taxes, if any, divided by the number of the then-outstanding public shares, subject to
the limitations set forth in “Limitations on redemptions.” However, we may not redeem our public shares in an amount that
would cause our net tangible assets to be less than $5,000,001 (so that we do not then become subject to the SEC’s “penny
stock” rules). If this optional redemption right is exercised with respect to an excessive number of public shares such that we
cannot satisfy the net tangible asset requirement, we would not proceed with the amendment or the related redemption of our public shares
at such time. This redemption right shall apply in the event of the approval of any such amendment, whether proposed by our sponsor, officer,
director or any other person.
On February 14, 2023, we held an extraordinary general meeting of shareholders
(the “First Extraordinary General Meeting”), where the shareholders approved a proposal (the “Trust Amendment Proposal”)
to amend our investment management trust agreement, dated as of February 11, 2021 (the “IMTA”), by and between us and Continental
Stock Transfer & Trust Company (“CST”), to extend the date by which the we have to consummate a business combination from
February 17, 2023 to February 17, 2024 or such earlier date as is determined by our board of directors (such date, the “Extended
Date”). Following such approval by our shareholders, we and CST entered into the Amendment No. 1 to the IMTA on February 14, 2023
(the “IMTA Amendment No. 1”).
At
the First Extraordinary General Meeting, our shareholders also approved an amendment to the Company’s amended and restated memorandum
and articles of association to extend the date by which the Company has to consummate a business combination from February 17, 2023 to
the Extended Date.
In
connection with the votes taken at the First Extraordinary General Meeting, holders of 27,785,141
of our Class A ordinary shares properly exercised their right to redeem their shares for cash at a redemption price of approximately
$10.18 per share, for an aggregate redemption amount of $282,903,643.31. The funds were redeemed from the Trust Account on February 23,
2023.
On
February 16, 2024, we held another extraordinary general meeting of shareholders (the “Second Extraordinary General Meeting”),
at which the shareholders approved to extend the date by which the Company has to consummate the Business Combination from February 17,
2024 up to three times by one month each to March 17, 2024, April 17, 2024, or May 17, 2024, subject to that our sponsor, or one or more
of its affiliates, members or third-party designees (the “Lender”), will deposit into the Trust Account for each month $0.03
for each then-outstanding ordinary share issued in the Company’s initial public offering that is not redeemed, in exchange for
one or more non-interest bearing, unsecured promissory notes issued by the Company to the Lender. At the Second Extraordinary General
Meeting, our shareholders approved a proposal to approve a special resolution to amend our amended and restated memorandum and articles
of association to provide our board of directors the ability to extend the date by which we must (1) consummate an initial business combination,
(2) cease our operations except for the purpose of winding up if we fail to complete such business combination, and (3) redeem all of
our Class A ordinary shares included as part of the units sold in our initial public offering that was consummated on February 17, 2021
from February 17, 2024 up to three times by one month each to March 17, 2024, April 17, 2024, or May 17, 2024. In addition, our shareholders
approved a proposal to approve a special resolution to amend the Trust Agreement to extend the date on which Continental must liquidate
the Trust Account if Catcha has not completed its initial business combination, up to three times for one month each from February 17,
2024 to March 17, 2024, April 17, 2024, or May 17, 2024.
In
connection with the votes taken at the Second Extraordinary General Meeting on February 16, 2024, holders of an
additional 641,303 of our Class A ordinary shares properly exercised their right to redeem their shares for cash at a redemption
price of approximately $11.29 per share, for an aggregate redemption amount of $7,241,004. The funds were redeemed from the Trust
Account on February 23, 2024.
In connection with the votes taken at the Third
Extraordinary General Meeting on May 15, 2024, holders of 208,674 of our Class A ordinary shares properly exercised their right to redeem
their shares for cash at a redemption price of approximately $11.52 per share, for an aggregate redemption amount of $2,403,928. The funds
were redeemed from the Trust Account on May 20, 2024.
On May 15, 2024, we held another extraordinary
general meeting of shareholders (the “Third Extraordinary General Meeting”), at which the shareholders approved to extend
the date by which the Company has to consummate the Business Combination from May 17, 2024 up to three times by one month each to June
17, 2024, July 17, 2024, or August 17, 2024, subject to that our sponsor, or one or more of its affiliates, members or third-party designees
(the “Lender”), will deposit into the Trust Account for each month $0.03 for each then-outstanding ordinary share issued
in the Company’s initial public offering that is not redeemed, in exchange for one or more non-interest bearing, unsecured promissory
notes issued by the Company to the Lender. At the Third Extraordinary General Meeting, our shareholders approved a proposal to approve
a special resolution to amend our amended and restated memorandum and articles of association to provide our board of directors the ability
to extend the date by which we must (1) consummate an initial business combination, (2) cease our operations except for the purpose of
winding up if we fail to complete such business combination, and (3) redeem all of our Class A ordinary shares included as part of the
units sold in our initial public offering that was consummated on February 17, 2021 from May 17, 2024 up to three times by one month
each to June 17, 2024, July 17, 2024, or August 17, 2024. In addition, our shareholders approved
a proposal to approve a special resolution to amend the Trust Agreement to extend the date on which Continental must liquidate the Trust
Account if Catcha has not completed its initial business combination, up to three times for one month each from June 17, 2024, July 17,
2024, or August 17, 2024.
On June 12, 2024, Catcha held an
extraordinary general meeting of shareholders (the “Fourth Extraordinary General Meeting”) pursuant to which the
shareholders of record as of January 16, 2024 approved Catcha’s previously proposed Business Combination with Crown. In
connection with the votes taken at this Extraordinary General Meeting, Catcha has received elections from certain holders of our
Class A ordinary shares to exercise their right to redeem their shares for cash. As of the date of these financial statements, such
elections are still within the time frame when such requests can be rescinded; thus the final redemption payout has not yet been
determined.
We
expect that all costs and expenses associated with implementing our plan of dissolution, as well as payments to any creditors, will be
funded from amounts held outside the trust account, although we cannot assure you that there will be sufficient funds for such purpose.
If
we were to expend all of the net proceeds of our initial public offering and the sale of the private placement warrants, other than the
proceeds deposited in the trust account, and without taking into account interest, if any, earned on the trust account, the per-share
redemption amount received by shareholders upon our dissolution would be $10.00. The proceeds deposited in the trust account could, however,
become subject to the claims of our creditors, which would have higher priority than the claims of our public shareholders. We cannot
assure you that the actual per-share redemption amount received by shareholders will not be less than $10.00. While we intend to pay
such amounts, if any, we cannot assure you that we will have funds sufficient to pay or provide for all creditors’ claims.
Although
we will seek to have all vendors, service providers, prospective target businesses and other entities (other than our Independent Registered
Public Accounting Firm) with which we do business execute agreements with us waiving any right, title, interest or claim of any kind
in or to any monies held in the trust account for the benefit of our public shareholders, there is no guarantee that they will execute
such agreements or even if they execute such agreements that they would be prevented from bringing claims against the trust account including,
but not limited to, fraudulent inducement, breach of fiduciary responsibility or other similar claims, as well as claims challenging
the enforceability of the waiver, in each case in order to gain an advantage with respect to a claim against our assets, including the
funds held in the trust account. If any third-party refuses to execute an agreement waiving such claims to the monies held in the trust
account, our management will perform an analysis of the alternatives available to it and will only enter into an agreement with a third-party
that has not executed a waiver if management believes that such third-party’s engagement would be significantly more beneficial
to us than any alternative. Examples of possible instances where we may engage a third-party that refuses to execute a waiver include
the engagement of a third-party consultant whose particular expertise or skills are believed by management to be significantly superior
to those of other consultants that would agree to execute a waiver or in cases where management is unable to find a service provider
willing to execute a waiver. In addition, there is no guarantee that such entities will agree to waive any claims they may have in the
future as a result of, or arising out of, any negotiations, contracts or agreements with us and will not seek recourse against the trust
account for any reason. In order to protect the amounts held in the trust account, our sponsor has agreed that it will be liable to us
if and to the extent any claims by a third-party for services rendered or products sold to us (other than our independent registered
public accounting firm), or a prospective target business with which we have discussed entering into a transaction agreement, reduce
the amounts in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held
in the trust account as of the date of the liquidation of the trust account if less than $10.00 per public share due to reductions in
the value of the trust assets, in each case net of the interest that may be withdrawn to pay our tax obligations, provided that such
liability will not apply to any claims by a third-party or prospective target business that executed a waiver of any and all rights to
seek access to the trust account nor will it apply to any claims under our indemnity of the underwriters of our initial public offering
against certain liabilities, including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable
against a third-party, our sponsor will not be responsible to the extent of any liability for such third-party claims. However, we have
not asked our sponsor to reserve for such indemnification obligations nor have we independently verified whether our sponsor has sufficient
funds to satisfy its indemnity obligations, and we believe that our sponsor’s only assets are securities of our company. Therefore,
we cannot assure you that our sponsor would be able to satisfy those obligations. None of our officers or directors will indemnify us
for claims by third parties including, without limitation, claims by vendors and prospective target businesses.
In
the event that the proceeds in the trust account are reduced below the lesser of (i) $10.00 per public share and (ii) the actual amount
per public share held in the trust account as of the date of the liquidation of the trust account if less than $10.00 per public share
due to reductions in the value of the trust assets, in each case net of the amount of interest that may be withdrawn to pay our income
tax obligations, and our sponsor asserts that it is unable to satisfy its indemnification obligations or that it has no indemnification
obligations related to a particular claim, our independent directors would determine whether to take legal action against our sponsor
to enforce its indemnification obligations. While we currently expect that our independent directors would take legal action on our behalf
against our sponsor to enforce its indemnification obligations to us, it is possible that our independent directors in exercising their
business judgment may choose not to do so in any particular instance. Accordingly, we cannot assure you that due to claims of creditors
the actual value of the per-share redemption price will not be less than $10.00 per public share.
We
will seek to reduce the possibility that our sponsor will have to indemnify the trust account due to claims of creditors by endeavoring
to have all vendors, service providers, prospective target businesses or other entities with which we do business execute agreements
with us waiving any right, title, interest or claim of any kind in or to monies held in the trust account. Our sponsor will also not
be liable as to any claims under our indemnity of the underwriters of our initial public offering against certain liabilities, including
liabilities under the Securities Act. We will have access to up to $1,000,000 of the proceeds held in the trust account. In the event
that we liquidate and it is subsequently determined that the reserve for claims and liabilities is insufficient, shareholders who received
funds from our trust account could be liable for claims made by creditors, however such liability will not be greater than the amount
of funds from our trust account received by any such shareholder.
If
we file a bankruptcy or winding-up petition or an involuntary bankruptcy or winding-up petition is filed against us that is not dismissed,
the proceeds held in the trust account could be subject to applicable bankruptcy or insolvency law and may be included in our bankruptcy
estate and subject to the claims of third parties with priority over the claims of our shareholders. To the extent any bankruptcy claims
deplete the trust account, we cannot assure you that we will be able to return $10.00 per public share to our public shareholders. Additionally,
if we file a bankruptcy or winding-up petition or an involuntary bankruptcy or winding-up petition is filed against us that is not dismissed,
any distributions received by shareholders could be viewed under applicable debtor/creditor and/or bankruptcy or insolvency laws as either
a “preferential transfer” or a “fraudulent conveyance.” As a result, a bankruptcy or insolvency court could seek
to recover some or all amounts received by our shareholders. Furthermore, our board of directors may be viewed as having breached its
fiduciary duty to our creditors and/or may have acted in bad faith, and thereby exposing itself and our company to claims of punitive
damages, by paying public shareholders from the trust account prior to addressing the claims of creditors. We cannot assure you that
claims will not be brought against us for these reasons.
Our public shareholders are entitled to
receive funds from the trust account only (i) in the event of the redemption of our public shares if we do not complete our initial
business combination within 42 months from the closing of our initial public offering, (ii) in connection with a shareholder vote to
amend our third amended and restated memorandum and articles of association (A) to modify the substance or timing of our obligation
to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business
combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the
closing of our initial public offering or during any extension period or (B) with respect to any other provision relating to the
rights of holders of our Class A ordinary shares, or (iii) if they redeem their respective shares for cash upon the completion of
the initial business combination. Public shareholders who redeem their Class A ordinary shares in connection with a shareholder vote
described in clause (ii) in the preceding sentence shall not be entitled to funds from the trust account upon the subsequent
completion of an initial business combination or liquidation if we have not consummated an initial business combination within 24
months from the closing of our initial public offering or during any extension period, with respect to such Class A ordinary shares
so redeemed. In no other circumstances will a shareholder have any right or interest of any kind to or in the trust account. In the
event we seek shareholder approval in connection with our initial business combination, a shareholder’s voting in connection
with the business combination alone will not result in a shareholder’s redeeming its shares to us for an applicable pro rata
share of the trust account. Such shareholder must have also exercised its redemption rights described above. These provisions of our
third amended and restated memorandum and articles of association, like all provisions of our third amended and restated memorandum
and articles of association, may be amended with a shareholder vote.
Competition
In
identifying, evaluating, and selecting a target business for our initial business combination, we may encounter intense competition from
other entities having a business objective similar to ours, including other blank check companies, private equity groups and leveraged
buyout funds, public companies, and operating businesses seeking strategic acquisitions. Many of these entities are well established
and have extensive experience in identifying and effecting business combinations directly or through affiliates. Moreover, many of these
competitors possess greater financial, technical, human, and other resources than us. Our ability to acquire larger target businesses
is limited by our available financial resources. This inherent limitation gives others an advantage in pursuing the acquisition of a
target business. Furthermore, our obligation to pay cash in connection with our public shareholders who exercise their redemption rights
may reduce the resources available to us for our initial business combination and our outstanding warrants, and the future dilution they
potentially represent may not be viewed favorably by certain target businesses. Either of these factors may place us at a competitive
disadvantage in successfully negotiating an initial business combination.
Facilities
We
currently maintain our executive offices at 3 Raffles Place #06-01, Bharat Building, Singapore 048617. The cost for our use of this space
is included in the $10,000 per month fee we pay to an affiliate of our sponsor for office space and administrative and support services.
We consider our current office space adequate for our current operations.
Employees
We
currently have four executive officers. These individuals are not obligated to devote any specific number of hours to our matters but
they intend to devote as much of their time as they deem necessary to our affairs until we have completed our initial business combination.
The amount of time they will devote in any time period will vary based on whether a target business has been selected for our initial
business combination and the stage of the business combination process we are in.
Periodic
Reporting and Financial Information
Our
units, Class A ordinary shares, and warrants are registered under the Exchange Act and have reporting obligations, including the requirement
that we file annual, quarterly, and current reports with the SEC. In accordance with the requirements of the Exchange Act, our annual
reports will contain financial statements audited and reported on by our independent registered public accountants.
We have already evaluated our internal control
procedures for the fiscal year ended December 31, 2023 as required by the Sarbanes-Oxley Act of 2002 (“Sarbanes-Oxley Act”).
Refer to the discussion below under “Item 9A. Controls and Procedures.” Only in the event we are deemed to be a large
accelerated filer or an accelerated filer and no longer qualify as an emerging growth company will we be required to comply with the independent
registered public accounting firm attestation requirement on our internal control over financial reporting. A target business may not
be in compliance with the provisions of the Sarbanes-Oxley Act regarding the adequacy of their internal controls. The development of the
internal controls of any such entity to achieve compliance with the Sarbanes-Oxley Act may increase the time and costs necessary to complete
any such acquisition.
Prior
to the date of this Report, we filed a Registration Statement on Form 8-A with the SEC to voluntarily register our securities under Section
12 of the Exchange Act. As a result, we are subject to the rules and regulations promulgated under the Exchange Act. We have no current
intention of filing a Form 15 to suspend our reporting or other obligations under the Exchange Act prior or subsequent to the consummation
of our initial business combination.
We
are a Cayman Islands exempted company. Exempted companies are Cayman Islands companies conducting business mainly outside the Cayman
Islands and, as such, are exempted from complying with certain provisions of the Companies Act. As an exempted company, we have applied
for and received a tax exemption undertaking from the Cayman Islands government that, in accordance with the Tax Concessions Law of the
Cayman Islands, for a period of 20 years from the date of the undertaking, no law which is enacted in the Cayman Islands imposing any
tax to be levied on profits, income, gains or appreciations shall apply to us or our operations and, in addition, that no tax to be levied
on profits, income, gains or appreciations or which is in the nature of estate duty or inheritance tax will be payable (i) on or in respect
of our shares, debentures or other obligations or (ii) by way of the withholding in whole or in part of any relevant payment as defined
in the Tax Concessions Law.
We
are an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act. As such,
we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies
that are not “emerging growth companies,” including, but not limited to, not being required to comply with the auditor attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic
reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and
shareholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive
as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.
In
addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended
transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other
words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise
apply to private companies. We intend to take advantage of the benefits of this extended transition period.
We
will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of
the completion of our initial public offering, (b) in which we have total annual gross revenue of at least $1.235 billion, or (c) in
which we are deemed to be a large accelerated filer, which means the market value of our Class A ordinary shares that are held by non-affiliates
equals or exceeds $700 million as of the prior June 30, and (2) the date on which we have issued more than $1.0 billion in non-convertible
debt securities during the prior three-year period.
Additionally,
we are a “smaller reporting company” as defined in Rule 10(f)(1) of Regulation S-K. Smaller reporting companies may take
advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements.
We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our Class A ordinary
shares held by non-affiliates equals or exceeds $250 million as of the prior June 30 and (2) our annual revenues exceeded $100 million
during such completed fiscal year and the market value of our Class A ordinary shares held by non-affiliates equals or exceeds $700 million
as of the prior June 30. To the extent we take advantage of such reduced disclosure obligations, it may also make comparison of our financial
statements with other public companies difficult or impossible.
Available
Information
Our
website address is https://www.catchagroup.com/. In addition to the information about us and our business contained in this Report,
information about us can be found on our website. The information on our website is not a part of this Report and is included herein
as an inactive textual reference only.
Our
Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports (including
exhibits) filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act are available free of charge through our website
at https://www.catchagroup.com/chaa/ as soon as reasonably practicable after they are electronically filed with or furnished to the SEC.
Additionally, the SEC maintains an internet site that contains reports, proxy and information statements and other information. The address
of the SEC’s website is www.sec.gov.
Item
1A. Risk Factors
You
should consider carefully all of the risks described below, together with the other information contained in this Report, including the
financial statements. If any of the following risks occur, our business, financial condition or results of operation may be materially
and adversely affected. The risks described below are not necessarily exhaustive and you are encouraged to perform your own investigation
with respect to us and our business.
Risks
Relating to our Search for, and Consummation of or Inability to Consummate, a Business Combination
Our
shareholders may not be afforded an opportunity to vote on our proposed initial business combination, which means we may complete our
initial business combination even though a majority of our shareholders do not support such a combination.
We
may choose not to hold a shareholder vote before we complete our initial business combination if the business combination would not require
shareholder approval under applicable law or stock exchange listing requirement. For instance, if we were seeking to acquire a target
business where the consideration we were paying in the transaction was all cash, we would typically not be required to seek shareholder
approval to complete such a transaction. Except for as required by applicable law or stock exchange listing requirement, the decision
as to whether we will seek shareholder approval of a proposed business combination or will allow shareholders to sell their shares to
us in a tender offer will be made by us, solely in our discretion, and will be based on a variety of factors, such as the timing of the
transaction and whether the terms of the transaction would otherwise require us to seek shareholder approval. Accordingly, we may complete
our initial business combination even if holders of a majority of our issued and outstanding ordinary shares do not approve of the business
combination we complete.
Your
only opportunity to affect the investment decision regarding a potential business combination may be limited to the exercise of your
right to redeem your shares from us for cash.
At
the time of your investment in us, you will not be provided with an opportunity to evaluate the specific merits or risks of any target
businesses. Since our board of directors may complete a business combination without seeking shareholder approval, public shareholders
may not have the right or opportunity to vote on the business combination, unless we seek such shareholder approval. Accordingly, your
only opportunity to affect the investment decision regarding a potential business combination may be limited to exercising your redemption
rights within the period of time (which will be at least 20 business days) set forth in our tender offer documents mailed to our public
shareholders in which we describe our initial business combination.
If
we seek shareholder approval of our initial business combination, our initial shareholders have agreed to vote in favor of such initial
business combination, regardless of how our public shareholders vote.
Our initial shareholders owned, on an
as-converted basis, 20% of our outstanding ordinary shares immediately following the completion of our initial public offering. As of June 12, 2024, our initial shareholders own approximately 84%
of our outstanding ordinary shares. Our
initial shareholders also may from time to time purchase Class A ordinary shares prior to our initial business combination. Our
third amended and restated memorandum and articles of association provides that, if we seek shareholder approval, we will complete
our initial business combination only if we obtain the approval of an ordinary resolution under Cayman Islands law, which requires
the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the company. As a result, in
addition to the shares held by our Sponsor, we would need no other shares in order
to have our initial business combination approved. Accordingly, if we seek shareholder approval of our initial business combination,
the agreement by our initial shareholders to vote in favor of our initial business combination will increase the likelihood that we
will receive the requisite shareholder approval for such initial business combination.
You
will not have any rights or interests in funds from the trust account, except under certain limited circumstances. Therefore, to liquidate
your investment, you may be forced to sell your public shares or warrants, potentially at a loss.
Our public shareholders are entitled to receive
funds from the trust account only upon the earliest to occur of: (i) our completion of an initial business combination, and then only
in connection with those Class A ordinary shares that such shareholder properly elected to redeem, subject to the limitations described
herein, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend our third amended and
restated memorandum and articles of association (A) to modify the substance or timing of our obligation to provide holders of our Class
A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our
public shares if we do not complete our initial business combination within 42 months from the closing of our initial public offering
or during any extension period or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares,
and (iii) the redemption of our public shares if we have not consummated an initial business combination within 42 months from the closing
of our initial public offering, subject to applicable law and as further described herein. Public shareholders who redeem their Class
A ordinary shares in connection with a shareholder vote described in clause (ii) in the preceding sentence shall not be entitled to funds
from the trust account upon the subsequent completion of an initial business combination or liquidation if we have not consummated an
initial business combination within 42 months from the closing of our initial public offering, with respect to such Class A ordinary shares
so redeemed. In no other circumstances will a public shareholder have any right or interest of any kind in the trust account. Holders
of warrants do not have any right to the proceeds held in the trust account with respect to the warrants. Accordingly, to liquidate your
investment, you may be forced to sell your public shares or warrants, potentially at a loss.
The
ability of our public shareholders to redeem their shares for cash may make our financial condition unattractive to potential business
combination targets, which may make it difficult for us to enter into a business combination with a target.
We
may seek to enter into a business combination transaction agreement with a prospective target that requires as a closing condition that
we have a minimum net worth or a certain amount of cash. If too many public shareholders exercise their redemption rights, we would not
be able to meet such closing condition and, as a result, would not be able to proceed with the business combination. Furthermore, in
no event will we redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001 (so that we
do not then become subject to the SEC’s “penny stock” rules). Consequently, if accepting all properly submitted redemption
requests would cause our net tangible assets to be less than $5,000,001 or such greater amount necessary to satisfy a closing condition
as described above, we would not proceed with such redemption and the related business combination and may instead search for an alternate
business combination. Prospective targets will be aware of these risks and, thus, may be reluctant to enter into a business combination
transaction with us.
The
ability of our public shareholders to exercise redemption rights with respect to a large number of our shares may not allow us to complete
the most desirable business combination or optimize our capital structure.
At
the time we enter into an agreement for our initial business combination, we will not know how many shareholders may exercise their redemption
rights, and therefore will need to structure the transaction based on our expectations as to the number of shares that will be submitted
for redemption. If a large number of shares are submitted for redemption, we may need to restructure the transaction to reserve a greater
portion of the cash in the trust account or arrange for additional third-party financing. Raising additional third-party financing may
involve dilutive equity issuances or the incurrence of indebtedness at higher than desirable levels. The above considerations may limit
our ability to complete the most desirable business combination available to us or optimize our capital structure. The amount of the
deferred underwriting commissions payable to the underwriters will not be adjusted for any shares that are redeemed in connection with
an initial business combination. The per-share amount we will distribute to shareholders who properly exercise their redemption rights
will not be reduced by the deferred underwriting commissions and after such redemptions, the amount held in trust will continue to reflect
our obligation to pay the entire deferred underwriting commissions.
The
ability of our public shareholders to exercise redemption rights with respect to a large number of our shares could increase the probability
that our initial business combination would be unsuccessful and that you would have to wait for liquidation in order to redeem your shares.
If
our initial business combination agreement requires us to use a portion of the cash in the trust account to pay the purchase price, or
requires us to have a minimum amount of cash at closing, the probability that our initial business combination would be unsuccessful
is increased. If our initial business combination is unsuccessful, you would not receive your pro rata portion of the funds in the trust
account until we liquidate the trust account. If you are in need of immediate liquidity, you could attempt to sell your shares in the
open market; however, at such time our shares may trade at a discount to the pro rata amount per share in the trust account. In either
situation, you may suffer a material loss on your investment or lose the benefit of funds expected in connection with our redemption
until we liquidate or you are able to sell your shares in the open market.
The requirement that we consummate an initial
business combination within 42 months after the closing of our initial public offering may give potential target businesses leverage over
us in negotiating a business combination and may limit the time we have in which to conduct due diligence on potential business combination
targets, in particular as we approach our dissolution deadline, which could undermine our ability to complete our initial business combination
on terms that would produce value for our shareholders.
Any potential target business with which we enter
into negotiations concerning a business combination will be aware that we must consummate an initial business combination within 42 months
from the closing of our initial public offering unless we obtain the required shareholder vote for any Extension Period. Consequently,
such target business may obtain leverage over us in negotiating a business combination, knowing that if we do not complete our initial
business combination with that particular target business, we may be unable to complete our initial business combination with any target
business. This risk will increase as we get closer to the timeframe described above. In addition, we may have limited time to conduct
due diligence and may enter into our initial business combination on terms that we would have rejected upon a more comprehensive investigation.
We
may not be able to consummate an initial business combination, in which case we would cease all operations except for the purpose of
winding up and we would redeem our public shares and liquidate.
We may not be able to find a suitable target business
and consummate an initial business combination. Our ability to complete our initial business combination may be negatively impacted by
general market conditions, volatility in the capital and debt markets and the other risks described herein. For example, the outbreak
of COVID-19 continues to grow both in the U.S. and globally and, while the extent of the impact of the outbreak on us will depend on future
developments, it could limit our ability to complete our initial business combination, including, as a result of increased market volatility,
decreased market liquidity and third-party financing being unavailable on terms acceptable to us or at all. Additionally, the outbreak
of COVID-19 may negatively impact businesses we may seek to acquire. If we have not consummated an initial business combination within
such applicable time period, we will: (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible
but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate
amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released
to us to pay our income taxes, if any, divided by the number of the then-outstanding public shares, which redemption will completely extinguish
public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii)
as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors,
liquidate and dissolve, subject, in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements
of other applicable law. Our third amended and restated memorandum and articles of association provides that, if we wind up for any other
reason prior to the consummation of our initial business combination, we will follow the foregoing procedures with respect to the liquidation
of the trust account as promptly as reasonably possible but not more than ten business days thereafter, subject to applicable Cayman Islands
law. In either such case, our public shareholders may receive only the cash available in trust on the redemption of their shares, and
our warrants will expire worthless.
If we have not consummated an initial business
combination within 42 months from the closing of our initial public offering, our public shareholders may be forced to wait beyond such
period before redemption from our trust account.
If we have not consummated an initial business
combination within 42 months from the closing of our initial public offering, the proceeds then on deposit in the trust account, including
interest earned on the funds held in the trust account and not previously released to us to pay our income taxes, if any, will be used
to fund the redemption of our public shares, as further described herein. Any redemption of public shareholders from the trust account
will be effected automatically by function of our third amended and restated memorandum and articles of association prior to any voluntary
winding up. If we are required to wind up, liquidate the trust account and distribute such amount therein, pro rata, to our public shareholders,
as part of any liquidation process, such winding up, liquidation and distribution must comply with the applicable provisions of the Companies
Act. In that case, investors may be forced to wait beyond 42 months from the closing of our initial public offering before the redemption
proceeds of our trust account become available to them and they receive the return of their pro rata portion of the proceeds from our
trust account. We have no obligation to return funds to investors prior to the date of our redemption or liquidation unless, prior thereto,
we consummate our initial business combination or amend certain provisions of our third amended and restated memorandum and articles of
association, and only then in cases where investors have sought to redeem their Class A ordinary shares. Only upon our redemption or any
liquidation will public shareholders be entitled to distributions if we do not complete our initial business combination and do not amend
certain provisions of our third amended and restated memorandum and articles of association. Our third amended and restated memorandum
and articles of association provides that, if we wind up for any other reason prior to the consummation of our initial business combination,
we will follow the foregoing procedures with respect to the liquidation of the trust account as promptly as reasonably possible but not
more than ten business days thereafter, subject to applicable Cayman Islands law.
If
we seek shareholder approval of our initial business combination, our sponsor, officers, directors, advisors and their affiliates may
elect to purchase public shares or warrants, which may influence a vote on a proposed business combination and reduce the public “float”
of our Class A ordinary shares or public warrants.
If
we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business
combination pursuant to the tender offer rules, our sponsor, officers, directors, advisors or their affiliates may purchase public shares
or warrants in privately negotiated transactions or in the open market either prior to or following the completion of our initial business
combination, although they are under no obligation to do so. However, they have no current commitments, plans or intentions to engage
in such transactions and have not formulated any terms or conditions for any such transactions. None of the funds in the trust account
will be used to purchase public shares or warrants in such transactions.
In the event that our sponsor, officers, directors,
advisors or their affiliates purchase public shares or warrants in privately negotiated transactions from public shareholders who have
already elected to exercise their redemption rights, such selling shareholders would be required to revoke their prior elections to redeem
their shares. The purpose of any such transaction could be to (1) vote in favor of the business combination and thereby increase the likelihood
of obtaining shareholder approval of the business combination, (2) reduce the number of public warrants outstanding or vote such warrants
on any matters submitted to the warrant holders for approval in connection with our initial business combination or (3) satisfy a closing
condition in an agreement with a target that requires us to have a minimum net worth or a certain amount of cash at the closing of our
initial business combination, where it appears that such requirement would otherwise not be met. Any such purchases of our securities
may result in the completion of our initial business combination that may not otherwise have been possible. In addition, if such purchases
are made, the public “float” of our Class A ordinary shares or public warrants may be reduced and the number of beneficial
holders of our securities may be reduced, which may make it difficult to maintain or obtain the quotation, listing or trading of our securities
on a national securities exchange. Any such purchases will be reported pursuant to Section 13 and Section 16 of the Exchange Act to the
extent such purchasers are subject to such reporting requirements.
If
a shareholder fails to receive notice of our offer to redeem our public shares in connection with our initial business combination, or
fails to comply with the procedures for tendering its shares, such shares may not be redeemed.
We
will comply with the proxy rules or tender offer rules, as applicable, when conducting redemptions in connection with our initial business
combination. Despite our compliance with these rules, if a shareholder fails to receive our proxy solicitation or tender offer materials,
as applicable, such shareholder may not become aware of the opportunity to redeem its shares. In addition, the proxy solicitation or
tender offer materials, as applicable, that we will furnish to holders of our public shares in connection with our initial business combination
will describe the various procedures that must be complied with in order to validly redeem or tender public shares. In the event that
a shareholder fails to comply with these procedures, its shares may not be redeemed.
As
the number of special purpose acquisition companies evaluating targets increases, attractive targets may become scarcer and there may
be more competition for attractive targets. This could increase the cost of our initial business combination and could even result in
our inability to find a target or to consummate an initial business combination.
In
recent years, the number of special purpose acquisition companies that have been formed has increased substantially. Many potential targets
for special purpose acquisition companies have already entered into an initial business combination, and there are still many special
purpose acquisition companies preparing for an initial public offering, as well as many such companies currently in registration. As
a result, at times, fewer attractive targets may be available to consummate an initial business combination.
In
addition, because there are more special purpose acquisition companies seeking to enter into an initial business combination with available
targets, the competition for available targets with attractive fundamentals or business models may increase, which could cause targets
companies to demand improved financial terms. Attractive deals could also become scarcer for other reasons, such as economic or industry
sector downturns, geopolitical tensions, or increases in the cost of additional capital needed to close business combinations or operate
targets post-business combination. This could increase the cost of, delay or otherwise complicate or frustrate our ability to find and
consummate an initial business combination, and may result in our inability to consummate an initial business combination on terms favorable
to our investors altogether.
Because
of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us to complete
our initial business combination. If we have not consummated our initial business combination within the required time period, our public
shareholders may receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our trust
account and our warrants will expire worthless.
We
expect to encounter intense competition from other entities having a business objective similar to ours, including private investors
(which may be individuals or investment partnerships), other blank check companies and other entities, domestic and international, competing
for the types of businesses we intend to acquire. Many of these individuals and entities are well established and have extensive experience
in identifying and effecting, directly or indirectly, acquisitions of companies operating in or providing services to various industries.
Many of these competitors possess greater technical, human, and other resources or more local industry knowledge than we do and our financial
resources will be relatively limited when contrasted with those of many of these competitors. While we believe there are numerous target
businesses we could potentially acquire with the net proceeds of our initial public offering and the sale of the private placement warrants,
our ability to compete with respect to the acquisition of certain target businesses that are sizable is limited by our available financial
resources. This inherent competitive limitation gives others an advantage in pursuing the acquisition of certain target businesses. Furthermore,
we are obligated to offer holders of our public shares the right to redeem their shares for cash at the time of our initial business
combination in conjunction with a shareholder vote or via a tender offer. Target companies will be aware that this may reduce the resources
available to us for our initial business combination. Any of these obligations may place us at a competitive disadvantage in successfully
negotiating a business combination. If we have not consummated our initial business combination within the required time period, our
public shareholders may receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our
trust account and our warrants will expire worthless.
If
the net proceeds of our initial offering and the sale of the private placement warrants not being held in the trust account are insufficient
to allow us to operate following the closing of our initial public offering, it could limit the amount available to fund our search for
a target business or businesses and our ability to complete our initial business combination, and we will depend on loans from our sponsor,
its affiliates or members of our management team to fund our search and to complete our initial business combination.
As of December 31, 2023, we had $30,850 available
to us outside of the trust account to fund our working capital requirements. We believe that the funds available to us outside of the
trust account, together with funds available from loans from our sponsor, its affiliates or members of our management team, will be sufficient
to allow us to operate for 42 months following the closing of our initial public offering; however, we cannot assure you that our estimate
is accurate, and our sponsor, its affiliates or members of our management team are under no obligation to advance funds to us in such
circumstances. Of the funds available to us, we expect to use a portion of the funds to pay fees to consultants to assist us with our
search for a target business. We could also use a portion of the funds as a down payment or to fund a “no-shop” provision
(a provision in letters of intent designed to keep target businesses from “shopping” around for transactions with other companies
or investors on terms more favorable to such target businesses) with respect to a particular proposed business combination, although we
do not have any current intention to do so. If we entered into a letter of intent where we paid for the right to receive exclusivity from
a target business and were subsequently required to forfeit such funds (whether as a result of our breach or otherwise), we might not
have sufficient funds to continue searching for, or conduct due diligence with respect to, a target business.
If
we are required to seek additional capital, we would need to borrow funds from our sponsor, its affiliates, members of our management
team or other third parties to operate or may be forced to liquidate. Neither our sponsor, members of our management team nor their affiliates
is under any obligation to us in such circumstances. Any such advances may be repaid only from funds held outside the trust account or
from funds released to us upon the completion of our initial business combination.
If
we have not consummated our initial business combination within the required time period because we do not have sufficient funds available
to us, we will be forced to cease operations and liquidate the trust account. Consequently, our public shareholders may only receive
an estimated $10.00 per public share, or possibly less, on our redemption of our public shares, and our warrants will expire worthless.
Our
management concluded that there is substantial doubt about our ability to continue as a “going concern.”
We
have incurred and expect to continue to incur significant costs in pursuit of our acquisition plans. If the estimate of the costs of
identifying a target business, undertaking in-depth due diligence and negotiating a business combination are less than the actual amount
necessary to do so, we may have insufficient funds available to operate the business prior to our business combination. Moreover, we
will need to raise additional capital through loans from our sponsor, officers, directors, or third parties. None of our sponsor, officers
or directors are under any obligation to advance funds to, or to invest in us. We cannot provide any assurance that new financing will
be available to us on commercially acceptable terms, if at all. These conditions raise substantial doubt about our ability to continue
as a going concern for a period of time within one year after the date that the financial statements are issued.
In addition, if we are not able to
consummate a business combination before June 17, 2024, or, if our Sponsor deposits additional funds into the Trust Account for one
or two additional one-month extensions, July 17, 2024 or August 17, 2024, as applicable, we will commence an automatic winding up,
dissolution and liquidation. Management has determined that the automatic liquidation, should a business combination not occur, and
potential subsequent dissolution also raises substantial doubt about our ability to continue as a going concern. The financial
statements contained elsewhere in this Annual Report do not include any adjustments that might result from our inability to
consummate a business combination or our inability to continue as a going concern.
We
may seek business combination opportunities with a high degree of complexity that require significant operational improvements, which
could delay or prevent us from achieving our desired results.
We
may seek business combination opportunities with large, highly complex companies that we believe would benefit from operational improvements.
While we intend to implement such improvements, to the extent that our efforts are delayed or we are unable to achieve the desired improvements,
the business combination may not be as successful as we anticipate.
To
the extent we complete our initial business combination with a large complex business or entity with a complex operating structure, we
may also be affected by numerous risks inherent in the operations of the business with which we combine, which could delay or prevent
us from implementing our strategy. Although our management team will endeavor to evaluate the risks inherent in a particular target business
and its operations, we may not be able to properly ascertain or assess all of the significant risk factors until we complete our business
combination. If we are not able to achieve our desired operational improvements, or if the improvements take longer to implement than
anticipated, we may not achieve the gains that we anticipate. Furthermore, some of these risks and complexities may be outside of our
control and leave us with no ability to control or reduce the chances that those risks and complexities will adversely impact a target
business. Such combination may not be as successful as a combination with a smaller, less complex organization.
Our
shareholders may be held liable for claims by third parties against us to the extent of distributions received by them upon redemption
of their shares.
If
we are forced to enter into an insolvent liquidation, any distributions received by shareholders could be viewed as an unlawful payment
if it was proved that immediately following the date on which the distribution was made, we were unable to pay our debts as they fall
due in the ordinary course of business. As a result, a liquidator could seek to recover some or all amounts received by our shareholders.
Furthermore, our directors may be viewed as having breached their fiduciary duties to us or our creditors and/or may have acted in bad
faith, thereby exposing themselves and our company to claims, by paying public shareholders from the trust account prior to addressing
the claims of creditors. We cannot assure you that claims will not be brought against us for these reasons. We and our officers and directors
who knowingly and willfully authorized or permitted any distribution to be paid out of our share premium account while we were unable
to pay our debts as they fall due in the ordinary course of business would be guilty of an offence and may be liable for a fine of $18,293
and imprisonment for five years in the Cayman Islands.
We
may not hold an annual general meeting until after the consummation of our initial business combination.
In
accordance with the NYSE corporate governance requirements, we are not required to hold an annual general meeting until one year after
our first fiscal year end following our listing on NYSE. There is no requirement under the Companies Act for us to hold annual or extraordinary
general meetings to appoint directors. Until we hold an annual general meeting, public shareholders may not be afforded the opportunity
to appoint directors and to discuss company affairs with management. Our board of directors is divided into three classes with only one
class of directors being appointed in each year and each class (except for those directors appointed prior to our first annual general
meeting) serving a three-year term.
We
may seek acquisition opportunities in industries or sectors that may or may not be outside of our management’s area of expertise.
We
will consider a business combination outside of our management’s area of expertise if a business combination target is presented
to us and we determine that such candidate offers an attractive acquisition opportunity for our company. Although our management will
endeavor to evaluate the risks inherent in any particular business combination target, we cannot assure you that we will adequately ascertain
or assess all of the significant risk factors. In the event we elect to pursue an acquisition outside of the areas of our management’s
expertise, our management’s expertise may not be directly applicable to its evaluation or operation, and the information contained
in this Report regarding the areas of our management’s expertise would not be relevant to an understanding of the business that
we elect to acquire. As a result, our management may not be able to adequately ascertain or assess all of the significant risk factors.
Accordingly, any holders who choose to retain their securities following the business combination could suffer a reduction in the value
of their securities. Such holders are unlikely to have a remedy for such reduction in value.
Unlike
some other similarly structured blank check companies, our sponsor will receive additional Class A ordinary shares if we issue shares
to consummate an initial business combination.
The
founder shares will automatically convert into Class A ordinary shares (which such Class A ordinary shares delivered upon conversion
will not have redemption rights or be entitled to liquidating distributions from the trust account if we do not consummate an initial
business combination) at the time of our initial business combination or earlier at the option of the holders thereof at a ratio such
that the number of Class A ordinary shares issuable upon conversion of all founder shares will equal, in the aggregate, on an as-converted
basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon the completion of our initial public offering,
plus (ii) the total number of Class A ordinary shares issued, deemed issued or issuable upon conversion or exercise of any equity-linked
securities or rights issued or deemed issued by the company in connection with or in relation to the consummation of the initial business
combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares
issued, deemed issued or to be issued to any seller in the initial business combination and any private placement warrants issued to
our sponsor, its affiliates or any members of our management team upon conversion of working capital loans, unless the holders of a majority
of the then-outstanding Class B ordinary shares agree to waive such adjustment with respect to such issuance or deemed issuance at the
time thereof. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one-to-one. This
is different than some other similarly structured blank check companies in which initial shareholders will only be issued an aggregate
of 20% of the total number of shares to be outstanding prior to the initial business combination.
We
do not have a specified maximum redemption threshold. The absence of such a redemption threshold may make it possible for us to complete
our initial business combination with which a substantial majority of our shareholders do not agree.
Our third amended and restated memorandum and articles of association
provides a specified maximum redemption threshold, except that in no event will we redeem our public shares in an amount that would cause
our net tangible assets to be less than $5,000,001 (so that we do not then become subject to the SEC’s “penny stock”
rules). As a result, we may be able to complete our initial business combination even though a substantial majority of our public shareholders
do not agree with the transaction and have redeemed their shares or, if we seek shareholder approval of our initial business combination
and do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, have entered into
privately negotiated agreements to sell their shares to our sponsor, officers, directors, advisors or their affiliates. In the event the
aggregate cash consideration we would be required to pay for all Class A ordinary shares that are validly submitted for redemption plus
any amount required to satisfy cash conditions pursuant to the terms of the proposed business combination exceed the aggregate amount
of cash available to us, we will not complete the business combination or redeem any shares, all Class A ordinary shares submitted for
redemption will be returned to the holders thereof, and we instead may search for an alternate business combination. In connection with
the votes taken at the First, Second and Third Extraordinary General Meetings, the holders of an aggregate of 28,635,118 Class A ordinary
shares properly exercised their right to redeem their shares for cash. The balance in the Trust Account was approximately $15.79 million
as of June 11, 2024.
In order to effectuate an initial business
combination, blank check companies have, in the recent past, amended various provisions of their charters and other governing instruments,
including their warrant agreements. We cannot assure you that we will not seek to amend our third amended and restated memorandum and
articles of association or governing instruments in a manner that will make it easier for us to complete our initial business combination
that our shareholders may not support.
In order to effectuate a business combination,
blank check companies have, in the recent past, amended various provisions of their charters and governing instruments, including their
warrant agreements. For example, blank check companies have amended the definition of business combination, increased redemption thresholds,
extended the time to consummate an initial business combination and, with respect to their warrants, amended their warrant agreements
to require the warrants to be exchanged for cash and/or other securities. Amending our third amended and restated memorandum and articles
of association requires at least a special resolution of our shareholders as a matter of Cayman Islands law, meaning the approval of holders
of at least two-thirds of our ordinary shares who attend and vote at a general meeting of the company, and amending our warrant agreement
will require a vote of holders of at least 50% of the public warrants and, solely with respect to any amendment to the terms of the private
placement warrants or any provision of the warrant agreement with respect to the private placement warrants, 50% of the number of the
then outstanding private placement warrants. In addition, our third amended and restated memorandum and articles of association requires
us to provide our public shareholders with the opportunity to redeem their public shares for cash if we propose an amendment to our third
amended and restated memorandum and articles of association (A) that would modify the substance or timing of our obligation to provide
holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or
to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of our initial
public offering or during any extension period or (B) with respect to any other provision relating to the rights of holders of our Class
A ordinary shares. To the extent any of such amendments would be deemed to fundamentally change the nature of any of the securities offered
through our initial public offering, we would register, or seek an exemption from registration for, the affected securities.
Our
sponsor controls a substantial interest in us and thus may exert a substantial influence on actions requiring a shareholder vote, potentially
in a manner that you do not support.
Our
initial shareholders own approximately 84% of our issued and outstanding ordinary shares. Accordingly, they may exert a substantial
influence on actions requiring a shareholder vote, potentially in a manner that you do not support, including amendments to our
third amended and restated memorandum and articles of association. If our sponsor purchases any units in our initial public offering
or if our sponsor purchases any additional Class A ordinary shares in the aftermarket or in privately negotiated transactions, this
would increase its control. Neither our sponsor nor, to our knowledge, any of our officers or directors, have any current intention
to purchase additional securities, other than as disclosed in this Report. Factors that would be considered in making such
additional purchases would include consideration of the current trading price of our Class A ordinary shares. In addition, our board
of directors, whose members were elected by our sponsor, is divided into three classes, each of which generally serves for a term of
three years with only one class of directors being appointed in each year. We may not hold an annual general meeting to appoint new
directors prior to the completion of our initial business combination, in which case all of the current directors will continue in
office until at least the completion of the business combination. If there is an annual general meeting, as a consequence of our
“staggered” board of directors, only a minority of the board of directors will be considered for election and our
sponsor, because of its ownership position, will control the outcome, as only holders of our Class B ordinary shares have the right
to vote on the appointment of directors and to remove directors prior to our initial business combination. Accordingly, our sponsor
will continue to exert control at least until the completion of our initial business combination. In addition, we have agreed not to
enter into a definitive agreement regarding an initial business combination without the prior consent of our sponsor.
After
our initial business combination, it is possible that a majority of our officers and directors will live outside the U.S. and all of
our assets will be located outside the U.S.; therefore, investors may not be able to enforce federal securities laws or their other legal
rights.
It
is possible that after our initial business combination, a majority of our officers and directors will reside outside of the U.S. and
all of our assets will be located outside of the U.S. As a result, it may be difficult, or in some cases not possible, for investors
in the U.S. to enforce their legal rights, to effect service of process upon all of our officers or directors or to enforce judgments
of United States courts predicated upon civil liabilities and criminal penalties on our officers and directors under U.S. laws.
You
will not be entitled to protections normally afforded to investors of many other blank check companies.
Since
the net proceeds of our initial public offering and the sale of the private placement warrants are intended to be used to complete an
initial business combination with a target business that has not been selected, we may be deemed to be a “blank check” company
under the U.S. securities laws. However, because we have net tangible assets in excess of $5,000,001 upon the completion of our initial
public offering and the sale of the private placement warrants and we filed a Current Report on Form 8-K, including an audited balance
sheet demonstrating this fact, we are exempt from rules promulgated by the SEC to protect investors in blank check companies, such as
Rule 419. Accordingly, investors will not be afforded the benefits or protections of those rules. Among other things, this means that
since our units were immediately tradable, we have a longer period of time to complete our initial business combination than do companies
subject to Rule 419. Moreover, if our initial public offering were subject to Rule 419, that rule would have prohibited the release of
any interest earned on funds held in the trust account to us unless and until the funds in the trust account were released to us in connection
with our completion of an initial business combination.
Subsequent
to our completion of our initial business combination, we may be required to take write-downs or write-offs or incur restructuring, impairment
or other charges that could have a significant negative effect on our financial condition, results of operations and the price of our
securities, which could cause you to lose some or all of your investment.
Even
if we conduct extensive due diligence on a target business with which we combine, we cannot assure you that this diligence will identify
all material issues with a particular target business, that it would be possible to uncover all material issues through a customary amount
of due diligence, or that factors outside of the target business and outside of our control will not later arise. As a result of these
factors, we may be forced to later write-down or write-off assets, restructure our operations, or incur impairment or other charges that
could result in our reporting losses. Even if our due diligence successfully identifies certain risks, unexpected risks may arise and
previously known risks may materialize in a manner not consistent with our preliminary risk analysis. Even though these charges may be
non-cash items and may not have an immediate impact on our liquidity, the fact that we report charges of this nature could contribute
to negative market perceptions about us or our securities. In addition, charges of this nature may cause us to violate net worth or other
covenants to which we may be subject as a result of assuming pre-existing debt held by a target business or by virtue of our obtaining
post-combination debt financing. Accordingly, any holders who choose to retain their securities following the business combination could
suffer a reduction in the value of their securities. Such holders are unlikely to have a remedy for such reduction in value, unless they
are able to successfully claim that the reduction was due to the breach by our officers or directors of a duty of care or other fiduciary
duty owed to such holders, or if they are able to successfully bring a private claim under the securities laws that the tender offer
materials or proxy statement related to our initial business combination contained an actionable material misstatement or material omission.
If
third parties bring claims against us, the proceeds held in the trust account could be reduced and the per-share redemption amount received
by shareholders may be less than $10.00 per public share.
Our
placing of funds in the trust account may not protect those funds from third-party claims against us. Although we will seek to have all
vendors, service providers, prospective target businesses and other entities with which we do business execute agreements with us waiving
any right, title, interest or claim of any kind in or to any monies held in the trust account for the benefit of our public shareholders,
such parties may not execute such agreements, or even if they execute such agreements, they may not be prevented from bringing claims
against the trust account, including, but not limited to, fraudulent inducement, breach of fiduciary responsibility or other similar
claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain advantage with respect to a claim
against our assets, including the funds held in the trust account. If any third-party refuses to execute an agreement waiving such claims
to the monies held in the trust account, our management will perform an analysis of the alternatives available to it and will only enter
into an agreement with a third-party that has not executed a waiver if management believes that such third-party’s engagement would
be significantly more beneficial to us than any alternative.
Examples of possible instances where we may engage
a third-party that refuses to execute a waiver include the engagement of a third-party consultant whose particular expertise or skills
are believed by management to be significantly superior to those of other consultants that would agree to execute a waiver or in cases
where management is unable to find a service provider willing to execute a waiver. In addition, there is no guarantee that such entities
will agree to waive any claims they may have in the future as a result of, or arising out of, any negotiations, contracts or agreements
with us and will not seek recourse against the trust account for any reason. Upon redemption of our public shares, if we have not consummated
an initial business combination within 42 months from the closing of our initial public offering, or upon the exercise of a redemption
right in connection with our initial business combination, we will be required to provide for payment of claims of creditors that were
not waived that may be brought against us within the ten years following redemption. Accordingly, the per-share redemption amount received
by public shareholders could be less than the $10.00 per public share initially held in the trust account, due to claims of such creditors.
Pursuant to a letter agreement, our sponsor has agreed that it will be liable to us if and to the extent any claims by a third-party (other
than our independent registered public accounting firm) for services rendered or products sold to us, or a prospective target business
with which we have discussed entering into a transaction agreement, reduce the amounts in the trust account to below the lesser of (i)
$10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the
trust account if less than $10.00 per public share due to reductions in the value of the trust assets, in each case net of the interest
that may be withdrawn to pay our tax obligations, provided that such liability will not apply to any claims by a third-party or prospective
target business that executed a waiver of any and all rights to seek access to the trust account nor will it apply to any claims under
our indemnity of the underwriters of our initial public offering against certain liabilities, including liabilities under the Securities
Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, our sponsor will not be responsible
to the extent of any liability for such third-party claims.
However,
we have not asked our sponsor to reserve for such indemnification obligations nor have we independently verified whether our sponsor
has sufficient funds to satisfy its indemnity obligations, and we believe that our sponsor’s only assets are securities of our
company. Therefore, we cannot assure you that our sponsor would be able to satisfy those obligations. As a result, if any such claims
were successfully made against the trust account, the funds available for our initial business combination and redemptions could be reduced
to less than $10.00 per public share. In such event, we may not be able to complete our initial business combination, and you would receive
such lesser amount per share in connection with any redemption of your public shares. None of our officers or directors will indemnify
us for claims by third parties including, without limitation, claims by vendors and prospective target businesses.
Our
directors may decide not to enforce the indemnification obligations of our sponsor, resulting in a reduction in the amount of funds in
the trust account available for distribution to our public shareholders.
In
the event that the proceeds in the trust account are reduced below the lesser of (i) $10.00 per public share and (ii) the actual amount
per public share held in the trust account as of the date of the liquidation of the trust account if less than $10.00 per public share
due to reductions in the value of the trust assets, in each case net of the interest that may be withdrawn to pay our tax obligations,
and our sponsor asserts that it is unable to satisfy its obligations or that it has no indemnification obligations related to a particular
claim, our independent directors would determine whether to take legal action against our sponsor to enforce its indemnification obligations.
While we currently expect that our independent directors would take legal action on our behalf against our sponsor to enforce its indemnification
obligations to us, it is possible that our independent directors in exercising their business judgment and subject to their fiduciary
duties may choose not to do so in any particular instance. If our independent directors choose not to enforce these indemnification obligations,
the amount of funds in the trust account available for distribution to our public shareholders may be reduced below $10.00 per public
share.
If,
after we distribute the proceeds in the trust account to our public shareholders, we file a bankruptcy or winding-up petition or an involuntary
bankruptcy or winding-up petition is filed against us that is not dismissed, a bankruptcy or insolvency court may seek to recover such
proceeds, and the members of our board of directors may be viewed as having breached their fiduciary duties to our creditors, thereby
exposing the members of our board of directors and us to claims of punitive damages.
If,
after we distribute the proceeds in the trust account to our public shareholders, we file a bankruptcy or winding-up petition or an involuntary
bankruptcy or winding-up petition is filed against us that is not dismissed, any distributions received by shareholders could be viewed
under applicable debtor/creditor and/or bankruptcy or insolvency laws as either a “preferential transfer” or a “fraudulent
conveyance.” As a result, a bankruptcy or insolvency court could seek to recover some or all amounts received by our shareholders.
In addition, our board of directors may be viewed as having breached its fiduciary duty to our creditors and/or having acted in bad faith,
thereby exposing itself and us to claims of punitive damages, by paying public shareholders from the trust account prior to addressing
the claims of creditors.
If,
before distributing the proceeds in the trust account to our public shareholders, we file a bankruptcy or winding-up petition or an involuntary
bankruptcy or winding-up petition is filed against us that is not dismissed, the claims of creditors in such proceeding may have priority
over the claims of our shareholders and the per-share amount that would otherwise be received by our shareholders in connection with
our liquidation may be reduced.
If,
before distributing the proceeds in the trust account to our public shareholders, we file a bankruptcy or winding-up petition or an involuntary
bankruptcy or winding-up petition is filed against us that is not dismissed, the proceeds held in the trust account could be subject
to applicable bankruptcy or insolvency law, and may be included in our bankruptcy estate and subject to the claims of third parties with
priority over the claims of our shareholders. To the extent any bankruptcy claims deplete the trust account, the per-share amount that
would otherwise be received by our shareholders in connection with our liquidation may be reduced.
Because
we are neither limited to evaluating a target business in a particular industry sector nor have we selected any specific target businesses
with which to pursue our initial business combination, you will be unable to ascertain the merits or risks of any particular target business’s
operations.
We may pursue business combination opportunities
in any sector, except that we are not, under our third amended and restated memorandum and articles of association, permitted to effectuate
our initial business combination solely with another blank check company or similar company with nominal operations. Because we have not
yet selected any specific target business with respect to a business combination, there is no basis to evaluate the possible merits or
risks of any particular target business’s operations, results of operations, cash flows, liquidity, financial condition or prospects.
To the extent we complete our initial business combination, we may be affected by numerous risks inherent in the business operations with
which we combine. For example, if we combine with a financially unstable business or an entity lacking an established record of sales
or earnings, we may be affected by the risks inherent in the business and operations of a financially unstable or a development stage
entity. Although our officers and directors will endeavor to evaluate the risks inherent in a particular target business, we cannot assure
you that we will properly ascertain or assess all of the significant risk factors or that we will have adequate time to complete due diligence.
Furthermore, some of these risks may be outside of our control and leave us with no ability to control or reduce the chances that those
risks will adversely impact a target business. We also cannot assure you that an investment in our units will ultimately prove to be more
favorable to investors than a direct investment, if such opportunity were available, in a business combination target. Accordingly, any
holders who choose to retain their securities following the business combination could suffer a reduction in the value of their securities.
Such holders are unlikely to have a remedy for such reduction in value.
Although
we have identified general criteria and guidelines that we believe are important in evaluating prospective target businesses, we may
enter into our initial business combination with a target that does not meet such criteria and guidelines, and, as a result, the target
business with which we enter into our initial business combination may not have attributes entirely consistent with our general criteria
and guidelines.
Although
we have identified general criteria and guidelines for evaluating prospective target businesses, it is possible that a target business
with which we enter into our initial business combination will not have all of these positive attributes. If we complete our initial
business combination with a target that does not meet some or all of these guidelines, such combination may not be as successful as a
combination with a business that does meet all of our general criteria and guidelines. In addition, if we announce a prospective business
combination with a target that does not meet our general criteria and guidelines, a greater number of shareholders may exercise their
redemption rights, which may make it difficult for us to meet any closing condition with a target business that requires us to have a
minimum net worth or a certain amount of cash. In addition, if shareholder approval of the transaction is required by applicable law
or stock exchange listing requirements, or we decide to obtain shareholder approval for business or other reasons, it may be more difficult
for us to attain shareholder approval of our initial business combination if the target business does not meet our general criteria and
guidelines. If we have not consummated our initial business combination within the required time period, our public shareholders may
receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our trust account and our
warrants will expire worthless.
We
are not required to obtain an opinion from an investment banking firm or another independent entity, and consequently, you may have no
assurance from an independent source that the price we are paying for the business is fair to our shareholders from a financial point
of view.
Unless
we complete our initial business combination with an affiliated entity, we are not required to obtain an opinion from an independent
investment banking firm that is a member of FINRA or another independent entity that commonly renders valuation opinions that the price
we are paying is fair to our shareholders from a financial point of view. If no opinion is obtained, our shareholders will be relying
on the judgment of our board of directors, who will determine fair market value based on standards generally accepted by the financial
community. Such standards used will be disclosed in our proxy solicitation or tender offer materials, as applicable, related to our initial
business combination.
We may issue additional Class A ordinary
shares or preference shares to complete our initial business combination or under an employee incentive plan after the completion of our
initial business combination. We may also issue Class A ordinary shares upon the conversion of the founder shares at a ratio greater than
one-to-one at the time of our initial business combination as a result of the anti-dilution provisions contained in our third amended
and restated memorandum and articles of association. Any such issuances would dilute the interest of our shareholders and likely present
other risks.
Our third amended and restated memorandum
and articles of association authorizes the issuance of up to 500,000,000 Class A ordinary shares, par value $0.0001 per share,
50,000,000 Class B ordinary shares, par value $0.0001 per share, and 5,000,000 preference shares, par value $0.0001 per share. As of
December 31, 2023, there are 497,785,141 and 42,500,000 authorized but unissued share of our Class A ordinary shares and Class B
ordinary shares, which amount does not take into account shares reserved for issuance upon exercise of outstanding warrants or
shares issuable upon conversion of the Class B ordinary shares, if any. The Class B ordinary shares will automatically convert into
Class A ordinary shares (which such Class A ordinary shares delivered upon conversion will not have redemption rights or be entitled
to liquidating distributions from the trust account if we do not consummate an initial business combination) at the time of our
initial business combination or earlier at the option of the holders thereof as described herein and in our third amended and
restated memorandum and articles of association. There are no preference shares issued and outstanding.
We may issue a substantial number of additional
Class A ordinary shares or preference shares to complete our initial business combination or under an employee incentive plan after the
completion of our initial business combination. We may also issue Class A ordinary shares in connection with our redeeming the warrants
or upon conversion of the Class B ordinary shares at a ratio greater than one-to-one at the time of our initial business combination as
a result of the anti-dilution provisions as set forth herein. However, our third amended and restated memorandum and articles of association
provides, among other things, that prior to or in connection with our initial business combination, we may not issue additional shares
that would entitle the holders thereof to (i) receive funds from the trust account or (ii) vote on any initial business combination or
on any other proposal presented to shareholders prior to or in connection with the completion of an initial business combination. These
provisions of our third amended and restated memorandum and articles of association, like all provisions of our third amended and restated
memorandum and articles of association, may be amended with a shareholder vote. The issuance of additional ordinary or preference shares:
| ● | may
significantly dilute the equity interest of investors in our initial public offering, which
dilution would increase if the anti-dilution provisions in the Class B ordinary shares resulted
in the issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion
of the Class B ordinary shares; |
| ● | may
subordinate the rights of holders of Class A ordinary shares if preference shares are issued
with rights senior to those afforded our Class A ordinary shares; |
| ● | could
cause a change in control if a substantial number of Class A ordinary shares are issued,
which may affect, among other things, our ability to use our net operating loss carry forwards,
if any, and could result in the resignation or removal of our present officers and directors; |
| ● | may
have the effect of delaying or preventing a change of control of us by diluting the share
ownership or voting rights of a person seeking to obtain control of us; |
| ● | may
adversely affect prevailing market prices for our units, Class A ordinary shares and/or warrants;
and |
| ● | may
not result in adjustment to the exercise price of our warrants. |
Resources
could be wasted in researching acquisitions that are not completed, which could materially adversely affect subsequent attempts to locate
and acquire or merge with another business. If we have not consummated our initial business combination within the required time period,
our public shareholders may receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation
of our trust account and our warrants will expire worthless.
We
anticipate that the investigation of each specific target business and the negotiation, drafting and execution of relevant agreements,
disclosure documents, and other instruments will require substantial management time and attention and substantial costs for accountants,
attorneys and others. If we decide not to complete a specific initial business combination, the costs incurred up to that point for the
proposed transaction likely would not be recoverable. Furthermore, if we reach an agreement relating to a specific target business, we
may fail to complete our initial business combination for any number of reasons including those beyond our control. Any such event will
result in a loss to us of the related costs incurred, which could materially adversely affect subsequent attempts to locate and acquire
or merge with another business. If we have not consummated our initial business combination within the required time period, our public
shareholders may receive only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our trust
account and our warrants will expire worthless.
Compliance
obligations under the Sarbanes-Oxley Act may make it more difficult for us to effectuate a business combination, require substantial
financial and management resources and increase the time and costs of completing an acquisition.
Section 404 of the Sarbanes-Oxley Act requires
that we evaluate and report on our system of internal controls beginning with our Annual Report on Form 10-K for the year ending December
31, 2023. Only in the event we are deemed to be a large accelerated filer or an accelerated filer and no longer qualify as an emerging
growth company will we be required to comply with the independent registered public accounting firm attestation requirement on our internal
control over financial reporting. The fact that we are a blank check company makes compliance with the requirements of the Sarbanes-Oxley
Act particularly burdensome on us as compared to other public companies because a target business with which we seek to complete our initial
business combination may not be in compliance with the provisions of the Sarbanes-Oxley Act regarding the adequacy of its internal controls.
The development of the internal control of any such entity to achieve compliance with the Sarbanes-Oxley Act may increase the time and
costs necessary to complete any such acquisition.
We
may have a limited ability to assess the management of a prospective target business and, as a result, may affect our initial business
combination with a target business whose management may not have the skills, qualifications, or abilities to manage a public company.
When
evaluating the desirability of effecting our initial business combination with a prospective target business, our ability to assess the
target business’s management may be limited due to a lack of time, resources, or information. Our assessment of the capabilities
of the target business’s management, therefore, may prove to be incorrect and such management may lack the skills, qualifications
or abilities we suspected. Should the target business’s management not possess the skills, qualifications, or abilities necessary
to manage a public company, the operations and profitability of the post-combination business may be negatively impacted. Accordingly,
any holders who choose to retain their securities following the business combination could suffer a reduction in the value of their securities.
Such holders are unlikely to have a remedy for such reduction in value.
We
may issue notes or other debt securities, or otherwise incur substantial debt, to complete a business combination, which may adversely
affect our leverage and financial condition and thus negatively impact the value of our shareholders’ investment in us.
Although
we have no commitments as of the date of this Report to issue any notes or other debt securities, or to otherwise incur outstanding debt
following our initial public offering, we may choose to incur substantial debt to complete our initial business combination. We and our
officers and directors have agreed that we will not incur any indebtedness unless we have obtained from the lender a waiver of any right,
title, interest, or claim of any kind in or to the monies held in the trust account. As such, no issuance of debt will affect the per-share
amount available for redemption from the trust account. Nevertheless, the incurrence of debt could have a variety of negative effects,
including:
| ● | default
and foreclosure on our assets if our operating revenues after an initial business combination
are insufficient to repay our debt obligations; |
| ● | acceleration
of our obligations to repay the indebtedness even if we make all principal and interest payments
when due if we breach certain covenants that require the maintenance of certain financial
ratios or reserves without a waiver or renegotiation of that covenant; |
| ● | our
immediate payment of all principal and accrued interest, if any, if the debt is payable on
demand; |
| ● | our
inability to obtain necessary additional financing if the debt contains covenants restricting
our ability to obtain such financing while the debt is outstanding; |
| ● | our
inability to pay dividends on our Class A ordinary shares; |
| ● | using
a substantial portion of our cash flow to pay principal and interest on our debt, which will
reduce the funds available for dividends on our Class A ordinary shares if declared, expenses,
capital expenditures, acquisitions and other general corporate purposes; |
| ● | limitations
on our flexibility in planning for and reacting to changes in our business and in the industry
in which we operate; |
| ● | increased
vulnerability to adverse changes in general economic, industry and competitive conditions
and adverse changes in government regulation; and |
| ● | limitations
on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions,
debt service requirements, execution of our strategy and other purposes and other disadvantages
compared to our competitors who have less debt. |
We
may only be able to complete one business combination with the proceeds of our initial public offering and the sale of the private placement
warrants, which will cause us to be solely dependent on a single business that may have a limited number of products or services. This
lack of diversification may negatively impact our operations and profitability.
The
net proceeds from our initial public offering and the sale of the private placement warrants provided us $300,000,000 that we may use
to complete our initial business combination.
We
may effectuate our initial business combination with a single-target business or multiple-target businesses simultaneously or within
a short period of time. However, we may not be able to effectuate our initial business combination with more than one target business
because of various factors, including the existence of complex accounting issues and the requirement that we prepare and file pro forma
financial statements with the SEC that present operating results and the financial condition of several target businesses as if they
had been operated on a combined basis. By completing our initial business combination with only a single entity, our lack of diversification
may subject us to numerous economic, competitive, and regulatory developments. Further, we would not be able to diversify our operations
or benefit from the possible spreading of risks or offsetting of losses, unlike other entities that may have the resources to complete
several business combinations in different industries or different areas of a single industry. Accordingly, the prospects for our success
may be:
| ● | solely
dependent upon the performance of a single business, property or asset; or |
| ● | dependent
upon the development or market acceptance of a single or limited number of products, processes
or services. |
This
lack of diversification may subject us to numerous economic, competitive and regulatory risks, any or all of which may have a substantial
adverse impact upon the particular industry in which we may operate subsequent to our initial business combination.
We may attempt to
simultaneously complete business combinations with multiple prospective targets, which may hinder our ability to complete our initial
business combination and give rise to increased costs and risks that could negatively impact our operations and profitability.
If we determine to simultaneously acquire several
businesses that are owned by different sellers, we will need for each of such sellers to agree that our purchase of its business is contingent
on the simultaneous closings of the other business combinations, which may make it more difficult for us, and delay our ability to complete
our initial business combination. With multiple business combinations, we could also face additional risks, including additional burdens
and costs with respect to possible multiple negotiations and due diligence (if there are multiple sellers) and the additional risks associated
with the subsequent assimilation of the operations and services or products of the acquired companies in a single operating business.
If we are unable to adequately address these risks, it could negatively impact our profitability and results of operations.
We may attempt to
complete our initial business combination with a private company about which little information is available, which may result in a business
combination with a company that is not as profitable as we suspected, if at all.
In pursuing our acquisition strategy, we may seek
to effectuate our initial business combination with a privately held company. Very little public information generally exists about private
companies, and we could be required to make our decision on whether to pursue a potential initial business combination on the basis of
limited information, which may result in a business combination with a company that is not as profitable as we suspected, if at all.
Because we must
furnish our shareholders with target business financial statements, we may lose the ability to complete an otherwise advantageous initial
business combination with some prospective target businesses.
The federal proxy rules require that a proxy statement
with respect to a vote on a business combination meeting certain financial significance tests include historical and/or pro forma financial
statement disclosure in periodic reports. We will include the same financial statement disclosure in connection with our tender offer
documents, whether or not they are required under the tender offer rules. These financial statements may be required to be prepared in
accordance with, or be reconciled to, US GAAP or international financial reporting standards as issued by the International Accounting
Standards Board, or IFRS, depending on the circumstances and the historical financial statements may be required to be audited in accordance
with the standards of the Public Company Accounting Oversight Board (United States), or PCAOB. These financial statement requirements
may limit the pool of potential target businesses we may acquire because some targets may be unable to provide such statements in time
for us to disclose such statements in accordance with federal proxy rules and complete our initial business combination within the prescribed
timeframe.
If we are deemed
to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements and our
activities may be restricted, which may make it difficult for us to complete our initial business combination.
If we are deemed to be an investment company under
the Investment Company Act, our activities may be restricted, including:
| ● | restrictions on the nature of our investments; and |
| ● | restrictions on the issuance of securities, |
each of which may make it difficult for us to
complete our initial business combination. In addition, we may be subject to burdensome requirements, including:
| ● | registration as an investment company with the SEC; |
| ● | adoption of a specific form of corporate structure; and |
| ● | reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations that
we are currently not subject to. |
In order not to be regulated as an investment
company under the Investment Company Act, unless we can qualify for an exclusion, we must ensure that we are engaged primarily in a business
other than investing, reinvesting or trading of securities and that our activities do not include investing, reinvesting, owning, holding
or trading “investment securities” constituting more than 40% of our assets (exclusive of U.S. government securities and cash
items) on an unconsolidated basis. Our business is to identify and complete a business combination and thereafter to operate the post-transaction
business or assets for the long term. We do not plan to buy businesses or assets with a view to resale or profit from their resale. We
do not plan to buy unrelated businesses or assets or to be a passive investor.
We do not believe that our principal activities
subjects us to the Investment Company Act. To this end, the proceeds held in the trust account may only be invested in United States “government
securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money
market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act that invest only in direct U.S. government
treasury obligations. Pursuant to the trust agreement, the trustee is not permitted to invest in other securities or assets. By restricting
the investment of the proceeds to these instruments, and by having a business plan targeted at acquiring and growing businesses for the
long term (rather than buying and selling businesses in the manner of a merchant bank or private equity fund), we intend to avoid being
deemed an “investment company” within the meaning of the Investment Company Act.
An investment in our securities is not intended
for persons who are seeking a return on investments in government securities or investment securities. The trust account is intended as
a holding place for funds pending the earliest to occur of either: (i) the completion of our initial business combination; (ii) the redemption
of any public shares properly tendered in connection with a shareholder vote to amend our third amended and restated memorandum and articles
of association (A) to modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to
have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete
our initial business combination within 24 months from the closing of our initial public offering or during any extension period or (B)
with respect to any other provision relating to the rights of holders of our Class A ordinary shares; or (iii) absent our completing an
initial business combination within 24 months from the closing of our initial public offering or during any extension period, our return
of the funds held in the trust account to our public shareholders as part of our redemption of the public shares. If we do not invest
the proceeds as discussed above, we may be deemed to be subject to the Investment Company Act. If we were deemed to be subject to the
Investment Company Act, compliance with these additional regulatory burdens would require additional expenses for which we have not allotted
funds and may hinder our ability to complete a business combination. If we have not consummated our initial business combination within
the required time period, our public shareholders may receive only approximately $10.00 per public share, or less in certain circumstances,
on the liquidation of our trust account and our warrants will expire worthless.
The provisions of our third amended and
restated memorandum and articles of association that relate to the rights of holders of our Class A ordinary shares (and corresponding
provisions of the trust agreement governing the release of funds from our trust account) may be amended with the approval of a special
resolution, which requires the approval of the holders of at least two-thirds of our ordinary shares who attend and vote at a general
meeting of the company, which is a lower amendment threshold than that of some other blank check companies. It may be easier for us, therefore,
to amend our third amended and restated memorandum and articles of association to facilitate the completion of an initial business combination
that some of our shareholders may not support.
Some other blank check companies have a provision
in their charter that prohibits the amendment of certain of its provisions, including those that relate to the rights of a company’s
shareholders, without approval by a certain percentage of the company’s shareholders. In those companies, amendment of these provisions
typically requires approval by between 90% and 100% of the company’s shareholders. Our third amended and restated memorandum and
articles of association provides that any of its provisions related to the rights of holders of our Class A ordinary shares (including
the requirement to deposit proceeds of our initial public offering and the placement of warrants into the trust account and not release
such amounts except in specified circumstances, and to provide redemption rights to public shareholders as described herein) may be amended
if approved by special resolution, meaning holders of at least two-thirds of our ordinary shares who attend and vote at a general meeting
of the company, and corresponding provisions of the trust agreement governing the release of funds from our trust account may be amended
if approved by holders of at least 65% of our ordinary shares participated in the vote, provided that the provisions of our third amended
and restated memorandum and articles of association governing the appointment or removal of directors prior to our initial business combination
may only be amended by a special resolution passed by not less than two-thirds of our ordinary shares who attend and vote at our general
meeting. Our initial shareholders and their
permitted transferees, if any, who collectively beneficially own, 84% of our ordinary shares, will participate
in any vote to amend our third amended and restated memorandum and articles of association and/or trust agreement and will have the discretion
to vote in any manner they choose. As a result, we may be able to amend the provisions of our third amended and restated memorandum and
articles of association that govern our pre-business combination behavior more easily than some other blank check companies, and this
may increase our ability to complete a business combination with which you do not agree. Our shareholders may pursue remedies against
us for any breach of our third amended and restated memorandum and articles of association.
Our sponsor, officers and directors have agreed,
pursuant to a letter agreement with us, that they will not propose any amendment to our third amended and restated memorandum and articles
of association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right
to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not
complete our initial business combination within 24 months from the closing of our initial public offering or during any extension period
or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares, unless we provide our public
shareholders with the opportunity to redeem their Class A ordinary shares upon approval of any such amendment at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust
account and not previously released to us to pay our income taxes, if any, divided by the number of the then-outstanding public shares,
subject to the limitations described herein. Our shareholders are not parties to, or third-party beneficiaries of, these agreements and,
as a result, will not have the ability to pursue remedies against our sponsor, executive officers or directors for any breach of these
agreements. As a result, in the event of a breach, our shareholders would need to pursue a shareholder derivative action, subject to applicable
law.
We may be unable
to obtain additional financing to complete our initial business combination or to fund the operations and growth of a target business,
which could compel us to restructure or abandon a particular business combination. If we have not consummated our initial business combination
within the required time period, our public shareholders may receive only approximately $10.00 per public share, or less in certain circumstances,
on the liquidation of our trust account and our warrants will expire worthless.
Although we believe that the net proceeds of our
initial public offering and the sale of the private placement warrants is sufficient to allow us to complete our initial business combination,
because we have not yet selected any prospective target business we cannot ascertain the capital requirements for any particular transaction.
If the net proceeds of our initial public offering and the sale of the private placement warrants prove to be insufficient, either because
of the size of our initial business combination, the depletion of the available net proceeds in search of a target business, the obligation
to redeem for cash a significant number of shares from shareholders who elect redemption in connection with our initial business combination
or the terms of negotiated transactions to purchase shares in connection with our initial business combination, we may be required to
seek additional financing or to abandon the proposed business combination. We cannot assure you that such financing will be available
on acceptable terms, if at all. The current economic environment may make it difficult for companies to obtain acquisition financing.
To the extent that additional financing proves to be unavailable when needed to complete our initial business combination, we would be
compelled to either restructure the transaction or abandon that particular business combination and seek an alternative target business
candidate. If we have not consummated our initial business combination within the required time period, our public shareholders may receive
only approximately $10.00 per public share, or less in certain circumstances, on the liquidation of our trust account and our warrants
will expire worthless. In addition, even if we do not need additional financing to complete our initial business combination, we may require
such financing to fund the operations or growth of the target business. The failure to secure additional financing could have a material
adverse effect on the continued development or growth of the target business. None of our officers, directors, or shareholders is required
to provide any financing to us in connection with or after our initial business combination.
We may amend the
terms of the warrants in a manner that may be adverse to holders of public warrants with the approval by the holders of at least 50% of
the then-outstanding public warrants. As a result, the exercise price of your warrants could be increased, the exercise period could be
shortened, and the number of our Class A ordinary shares purchasable upon exercise of a warrant could be decreased, all without your approval.
Our warrants will be issued in registered form
under a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and us. The warrant agreement provides
that the terms of the warrants may be amended without the consent of any holder for the purpose of (i) curing any ambiguity or correct
any mistake, including to conform the provisions of the warrant agreement to the description of the terms of the warrants and the warrant
agreement set forth in this Report, or defective provision, (ii) amending the provisions relating to cash dividends on ordinary shares
as contemplated by and in accordance with the warrant agreement, or (iii) adding or changing any provisions with respect to matters or
questions arising under the warrant agreement as the parties to the warrant agreement may deem necessary or desirable and that the parties
deem to not adversely affect the rights of the registered holders of the warrants, provided that the approval by the holders of at least
50% of the then-outstanding public warrants is required to make any change that adversely affects the interests of the registered holders
of public warrants. Accordingly, we may amend the terms of the public warrants in a manner adverse to a holder if holders of at least
50% of the then-outstanding public warrants approve of such amendment and, solely with respect to any amendment to the terms of the private
placement warrants or any provision of the warrant agreement with respect to the private placement warrants, 50% of the number of the
then outstanding private placement warrants. Although our ability to amend the terms of the public warrants with the consent of at least
50% of the then-outstanding public warrants is unlimited, examples of such amendments could be amendments to, among other things, increase
the exercise price of the warrants, convert the warrants into cash, shorten the exercise period or decrease the number of Class A ordinary
shares purchasable upon exercise of a warrant.
If our initial business combination is subject to CFIUS jurisdiction,
the initial business combination may not be able to be completed prior to Catcha’s deadline for completing an initial business combination,
or CFIUS could impose conditions on the initial business combination or our investors.
Certain investments that involve the acquisition of, or investment
in, a “U.S. business” by a non-U.S. individual or entity (a “foreign person”) may be subject to review and approval
by the Committee on Foreign Investment in the United States (“CFIUS”). Whether CFIUS has jurisdiction to review an acquisition
or investment transaction depends on the nationality of the buyer or investor, the extent to which the target of the investment or acquisition
is engaged in interstate commerce in the United States, and the nature of the interests and rights afforded to the buyer or investor in
the target entity. For example, transactions that result in “control” of a U.S. business by a foreign person always are subject
to CFIUS jurisdiction. CFIUS also has jurisdiction to review non-control transactions that afford a foreign person certain information
and/or governance rights in a U.S. business that has a qualifying nexus to “critical technologies,” “critical infrastructure,”
and/or “sensitive personal data” (collectively, a “TID U.S. business”) as those terms are defined in the CFIUS
regulations. Certain foreign person investments in TID U.S. businesses may also be subject to mandatory pre-closing CFIUS filing requirements.
Failure to make a required CFIUS filing may subject the transacting parties to significant civil fines.
Crown is unlikely to be a “U.S. business” (i.e., an entity
engaged in interstate commerce in the United States) given its limited nexus to the United States. However, Catcha and its sponsor may
each be regarded as a “foreign person” for CFIUS purposes. The sponsor is managed by non-U.S. persons. Accordingly, because
CFIUS retains broad discretion in determining whether an entity is a “foreign person” and/or a “U.S. business,”
Pubco, Catcha and Crown are unable to assure that the Business Combination would not be subject to CFIUS jurisdiction.
This risk of CFIUS intervention could impede the relevant parties’
ability to complete the Business Combination. CFIUS policies and practices are rapidly evolving, and in the event of a CFIUS review of
a foreign acquisition or investment transaction, there can be no assurances that the foreign buyer or investor will be able to maintain,
or proceed with, such transactions on terms acceptable to the parties. For example, CFIUS could seek to impose limits on purchasing Pubco’s
stock, impose limits on information sharing with foreign person investors, require a voting trust or governance modifications, or force
divestiture by certain investors, among other things. CFIUS may also prohibit the consummation of the Business Combination altogether
should it determine that the transaction presents a significant national security risk. Even if we are able to successfully resolve questions
of CFIUS jurisdiction or of national security risks in a favorable manner, we may be unable to do so prior to Catcha’s deadline
for completion of an initial business combination. This delay may thus force Catcha to wind up and redeem all public shares and completely
liquidate, which would result in shareholders being forced to forgo the investment opportunity in Crown, lose out on potential price appreciation
in the combined company, and lead to the expiration of warrants in connection with the transaction.
Risks Related to our Securities
The securities in
which we invest the proceeds held in the trust account could bear a negative rate of interest, which could reduce the interest income
available for payment of taxes or reduce the value of the assets held in trust such that the per share redemption amount received by shareholders
may be less than $10.00 per share.
The net proceeds of our initial public offering
and certain proceeds from the sale of the private placement warrants, in the amount of $300,000,000, may only be invested in direct the
United States Department of Treasury (“U.S. Treasury”) obligations having a maturity of 185 days or less, or in certain money
market funds that invest only in direct U.S. Treasury obligations. While short-term U.S. Treasury obligations currently yield a positive
rate of interest, they have briefly yielded negative interest rates in recent years. Central banks in Europe and Japan pursued interest
rates below zero in recent years, and the Open Market Committee of the Federal Reserve has not ruled out the possibility that it may in
the future adopt similar policies in the United States. In the event of very low or negative yields, the amount of interest income (which
we may withdraw to pay income taxes, if any) would be reduced. In the event that we are unable to complete our initial business combination,
our public shareholders are entitled to receive their pro-rata share of the proceeds held in the trust account, plus any interest income.
If the balance of the trust account is reduced below $275,000,000 as a result of negative interest rates, the amount of funds in the trust
account available for distribution to our public shareholders may be reduced below $10.00 per share.
If we seek shareholder
approval of our initial business combination and we do not conduct redemptions pursuant to the tender offer rules, and if you or a “group”
of shareholders are deemed to hold in excess of 15% of our Class A ordinary shares, you will lose the ability to redeem all such shares
in excess of 15% of our Class A ordinary shares.
If we seek shareholder approval of our initial
business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer
rules, then, pursuant to our third amended and restated memorandum and articles of association, a public shareholder, together with any
affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined
under Section 13 of the Exchange Act), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the
shares sold in our initial public offering, which we refer to as the “Excess Shares,” without our prior consent. However,
we would not be restricting our shareholders’ ability to vote all of their shares (including Excess Shares) for or against our initial
business combination. Your inability to redeem the Excess Shares will reduce your influence over our ability to complete our initial business
combination and you could suffer a material loss on your investment in us if you sell Excess Shares in open market transactions. Additionally,
you will not receive redemption distributions with respect to the Excess Shares if we complete our initial business combination. And,
as a result, you will continue to hold that number of shares exceeding 15% and, in order to dispose of such shares, would be required
to sell your shares in open market transactions, potentially at a loss.
NYSE American may
delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities
and subject us to additional trading restrictions.
Our ordinary shares are listed on NYSE American.
We cannot assure you that our securities will be, or will continue to be, listed on NYSE American in the future or prior to our initial
business combination. In order to continue listing our securities on NYSE American prior to our initial business combination, we must
maintain certain financial, distribution and share price levels. Generally, we must maintain a minimum market capitalization (generally
$25,000,000) and a minimum number of holders of our securities (generally 300 public holders).
Section 119(b) of the NYSE American Company Guide
requires that a special purpose acquisition company complete one or more business combinations within 36 months of the effectiveness of
its initial public offering registration statement, which, in the case of Catcha, would be February 17, 2024. The extension of Catcha’s
termination date beyond February 17, 2024 exceeds the maximum 36 month period permitted by Section 119(b) of the NYSE American Company
Guide.
On February 20, 2024, the Company received a letter
from the NYSE American LLC (“NYSE American” or the “Exchange”) stating that the staff of NYSE Regulation has determined
to commence proceedings to delist Catcha’s Class A ordinary shares pursuant to Sections 119(b) and 119(f) of the NYSE American Company
Guide because the Company failed to consummate a Business Combination within 36 months of the effectiveness of its Initial Public Offering
registration statement, or such shorter period that the Company specified in its registration statement.
On February 23, 2024, the Company submitted a
written request to NYSE asking for the review of the delisting determination by a Committee of the Board of Directors of the Exchange.
Up to the date the financial statements were issued, the Company’s Class A ordinary shares have not been suspended and will continue
to trade.
The Company has an NYSE appeal hearing scheduled
for July 17, 2024.
If our Class A Ordinary Shares are de-listed,
there may no longer be an active trading market for such Class A Ordinary Shares. In addition, the potential or actual de-listing of the
Catcha Class A Ordinary Shares may also adversely affect our ability to consummate an initial business combination.
If NYSE American delists our securities from
trading on its exchange and we are not able to list our securities on another national securities exchange, we expect such securities
could be quoted on an over-the-counter market. If this were to occur, we could face significant material adverse consequences, including:
| ● | a limited availability of market quotations for our securities; |
| ● | reduced liquidity for our securities; |
| ● | a determination that our Class A ordinary shares are a “penny stock,” which will require brokers
trading in our Class A ordinary shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in
the secondary trading market for our securities; |
| ● | a limited amount of news and analyst coverage; and |
| ● | a decreased ability to issue additional securities or obtain additional financing in the future. |
The National Securities Markets Improvement Act
of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred
to as “covered securities.” Because our ordinary shares are listed on NYSE American, they qualify as covered securities under
the statute. Although the states are preempted from regulating the sale of covered securities, the federal statute does allow the states
to investigate companies if there is a suspicion of fraud, and, if there is a finding of fraudulent activity, then the states can regulate
or bar the sale of covered securities in a particular case. While we are not aware of a state having used these powers to prohibit or
restrict the sale of securities issued by blank check companies, other than the State of Idaho, certain state securities regulators view
blank check companies unfavorably and might use these powers, or threaten to use these powers, to hinder the sale of securities of blank
check companies in their states. Further, if we were no longer listed on NYSE American, our securities would not qualify as covered securities
under the statute and we would be subject to regulation in each state in which we offer our securities.
Provisions in our third amended and restated
memorandum and articles of association may inhibit a takeover of us, which could limit the price investors might be willing to pay in
the future for our Class A ordinary shares and could entrench management.
Our third amended and restated memorandum and
articles of association contain provisions that may discourage unsolicited takeover proposals that shareholders may consider to be in
their best interests. These provisions include a staggered board of directors, the ability of the board of directors to designate the
terms of and issue new series of preference shares, and the fact that prior to the completion of our initial business combination only
holders of our Class B ordinary shares, which have been issued to our sponsor, are entitled to vote on the appointment of directors, which
may make more difficult the removal of management and may discourage transactions that otherwise could involve payment of a premium over
prevailing market prices for our securities.
Our warrant agreement
designates the courts of the State of New York or the United States District Court for the Southern District of New York as the sole and
exclusive forum for certain types of actions and proceedings that may be initiated by holders of our warrants, which could limit the ability
of warrant holders to obtain a favorable judicial forum for disputes with our company.
Our warrant agreement provides that, subject to
applicable law, (i) any action, proceeding or claim against us arising out of or relating in any way to the warrant agreement, including
under the Securities Act, will be brought and enforced in the courts of the State of New York or the United States District Court for
the Southern District of New York, and (ii) that we irrevocably submit to such jurisdiction, which jurisdiction shall be the exclusive
forum for any such action, proceeding or claim. We will waive any objection to such exclusive jurisdiction and that such courts represent
an inconvenient forum.
Notwithstanding the foregoing, these provisions
of the warrant agreement do not apply to suits brought to enforce any liability or duty created by the Securities Act or the Exchange
Act or any other claim for which the federal district courts of the United States of America are the sole and exclusive forum. Accordingly,
our exclusive forum provision does not relieve us of our duties to comply with the federal securities laws and the rules and regulations
thereunder, and holders of our warrants are not deemed to have waived our compliance with these laws, rules and regulations. Any person
or entity purchasing or otherwise acquiring any interest in any of our warrants shall be deemed to have notice of and to have consented
to the forum provisions in our warrant agreement. If any action, the subject matter of which is within the scope the forum provisions
of the warrant agreement, is filed in a court other than a court of the State of New York or the United States District Court for the
Southern District of New York (a “foreign action”) in the name of any holder of our warrants, such holder shall be deemed
to have consented to: (x) the personal jurisdiction of the state and federal courts located in the State of New York in connection with
any action brought in any such court to enforce the forum provisions (an “enforcement action”), and (y) having service of
process made upon such warrant holder in any such enforcement action by service upon such warrant holder’s counsel in the foreign
action as agent for such warrant holder.
This choice-of-forum provision may limit a warrant
holder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with our company, which may discourage
such lawsuits. Alternatively, if a court were to find this provision of our warrant agreement inapplicable or unenforceable with respect
to one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters
in other jurisdictions, which could materially and adversely affect our business, financial condition and results of operations and result
in a diversion of the time and resources of our management and board of directors.
We are not registering
the Class A ordinary shares issuable upon exercise of the warrants under the Securities Act or any state securities laws at this time,
and such registration may not be in place when an investor desires to exercise warrants, thus precluding such investor from being able
to exercise its warrants except on a cashless basis and potentially causing such warrants to expire worthless.
We are not registering the Class A ordinary shares
issuable upon exercise of the warrants under the Securities Act or any state securities laws at this time. However, under the terms of
the warrant agreement, we have agreed that, as soon as practicable, but in no event later than 20 business days after the closing of our
initial business combination, we will use our commercially reasonable efforts to file with the SEC a registration statement covering the
issuance of such shares, and we will use our commercially reasonable efforts to cause the same to become effective within 60 business
days after the closing of our initial business combination and to maintain the effectiveness of such registration statement and a current
prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed. We cannot assure you that we will be able
to do so if, for example, any facts or events arise which represent a fundamental change in the information set forth in the registration
statement or prospectus, the financial statements contained or incorporated by reference therein are not current, complete or correct
or the SEC issues a stop order. If the shares issuable upon exercise of the warrants are not registered under the Securities Act in accordance
with the above requirements, we will be required to permit holders to exercise their warrants on a cashless basis, in which case, the
number of Class A ordinary shares that you will receive upon cashless exercise will be based on a formula subject to a maximum amount
of shares equal to 0.361 Class A ordinary shares per warrant (subject to adjustment). However, no warrant will be exercisable for cash
or on a cashless basis, and we will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance
of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption
from registration is available. Notwithstanding the above, if our Class A ordinary shares are at the time of any exercise of a warrant
not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1)
of the Securities Act, we may, at our option, require holders of public warrants who exercise their warrants to do so on a “cashless
basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event we so elect, we will not be required to file or
maintain in effect a registration statement, but we will use our commercially reasonable efforts to register or qualify the shares under
applicable blue sky laws to the extent an exemption is not available. Exercising the warrants on a cashless basis could have the effect
of reducing the potential “upside” of the holder’s investment in our company because the warrant holder will hold a
smaller number of Class A ordinary shares upon a cashless exercise of the warrants they hold. In no event will we be required to net cash
settle any warrant, or issue securities or other compensation in exchange for the warrants in the event that we are unable to register
or qualify the shares underlying the warrants under applicable state securities laws and no exemption is available. If the issuance of
the shares upon exercise of the warrants is not so registered or qualified or exempt from registration or qualification, the holder of
such warrant shall not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In such event, holders
who acquired their warrants as part of a purchase of units will have paid the full unit purchase price solely for the Class A ordinary
shares included in the units. There may be a circumstance where an exemption from registration exists for holders of our private placement
warrants to exercise their warrants while a corresponding exemption does not exist for holders of the public warrants included as part
of units sold in our initial public offering. In such an instance, our sponsor and its permitted transferees (which may include our officers
and directors) would be able to exercise their warrants and sell the ordinary shares underlying their warrants while holders of our public
warrants would not be able to exercise their warrants and sell the underlying ordinary shares. If and when the warrants become redeemable
by us, we may exercise our redemption right even if we are unable to register or qualify the underlying Class A ordinary shares for sale
under all applicable state securities laws. As a result, we may redeem the warrants as set forth herein even if the holders are otherwise
unable to exercise their warrants.
The warrants may
become exercisable and redeemable for a security other than the Class A ordinary shares, and you will not have any information regarding
such other security at this time.
In certain situations, including if we are not
the surviving entity in our initial business combination, the warrants may become exercisable for a security other than the Class A ordinary
shares. As a result, if the surviving company redeems your warrants for securities pursuant to the warrant agreement, you may receive
a security in a company of which you do not have information at this time. Pursuant to the warrant agreement, the surviving company will
be required to use commercially reasonable efforts to register the issuance of the security underlying the warrants within 20 business
days of the closing of an initial business combination.
We may redeem your
unexpired warrants prior to their exercise at a time that is disadvantageous to you, thereby making your warrants worthless.
We have the ability to redeem the outstanding
public warrants at any time after they become exercisable and prior to their expiration, at a price of $0.01 per warrant, provided that
the closing price of our Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares
issuable upon exercise or the exercise price of a warrant) for any 20 trading days within a 30 trading-day period ending on the third
trading day prior to proper notice of such redemption and provided that certain other conditions are met. If and when the warrants become
redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale
under all applicable state securities laws. As a result, we may redeem the warrants as set forth herein even if the holders are otherwise
unable to exercise the warrants. Redemption of the outstanding warrants could force you to (i) exercise your warrants and pay the exercise
price therefor at a time when it may be disadvantageous for you to do so, (ii) sell your warrants at the then-current market price when
you might otherwise wish to hold your warrants, or (iii) accept the nominal redemption price, which, at the time the outstanding warrants
are called for redemption, we expect would be substantially less than the market value of your warrants.
In addition, we have the ability to redeem the
outstanding public warrants at any time after they become exercisable and prior to their expiration, at a price of $0.10 per warrant upon
a minimum of 30 days’ prior written notice of redemption, provided that the closing price of our Class A ordinary shares equals
or exceeds $10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant)
for any 20 trading days within a 30 trading-day period ending on the third trading day prior to proper notice of such redemption and provided
that certain other conditions are met, including that holders will be able to exercise their warrants prior to redemption for a number
of Class A ordinary shares determined based on the redemption date and the fair market value of our Class A ordinary shares. The value
received upon exercise of the warrants (i) may be less than the value the holders would have received if they had exercised their warrants
at a later time where the underlying share price is higher and (ii) may not compensate the holders for the value of the warrants, including
because the number of ordinary shares received is capped at 0.361 Class A ordinary shares per warrant (subject to adjustment) irrespective
of the remaining life of the warrants.
None of the private placement warrants will be
redeemable by us (except as set forth under Exhibit 4.2 “Description of Registrant’s Securities” filed herewith) so
long as they are held by our sponsor or its permitted transferees.
Our warrants may
have an adverse effect on the market price of our Class A ordinary shares and make it more difficult to effectuate our initial business
combination.
We issued warrants to purchase 10,000,000 of our
Class A ordinary shares as part of the units offered in our initial public offering and, simultaneously with the closing of our initial
public offering, the company consummated a private placement sale of an aggregate of 5,333,333 private placement warrants, each exercisable
to purchase one Class A ordinary share at $11.50 per share, subject to adjustment. In addition, if the sponsor, its affiliates, or a member
of our management team makes any working capital loans, it may convert up to $1,500,000 of such loans into up to an additional 1,000,000
private placement warrants, at the price of $1.50 per warrant.
To the extent we issue ordinary shares for any
reason, including to effectuate a business combination, the potential for the issuance of a substantial number of additional Class A ordinary
shares upon exercise of these warrants could make us a less attractive acquisition vehicle to a target business. Such warrants, when exercised,
will increase the number of issued and outstanding Class A ordinary shares and reduce the value of the Class A ordinary shares issued
to complete the business transaction. Therefore, our warrants may make it more difficult to effectuate a business transaction or increase
the cost of acquiring the target business.
Because each unit
contains one-third of one redeemable warrant and only a whole warrant may be exercised, the units may be worth less than units of other
blank check companies.
Each unit contains one-third of one redeemable
warrant. Pursuant to the warrant agreement, no fractional warrants will be issued upon separation of the units, and only whole units will
trade. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, we will, upon exercise,
round down to the nearest whole number the number of Class A ordinary shares to be issued to the warrant holder. This is different from
other offerings similar to ours whose units include one ordinary share and one whole warrant to purchase one whole share. We have established
the components of the units in this way in order to reduce the dilutive effect of the warrants upon the completion of a business combination
since the warrants will be exercisable in the aggregate for one-third of the number of shares compared to units that each contain a whole
warrant to purchase one whole share, thus making us, we believe, a more attractive merger partner for target businesses. Nevertheless,
this unit structure may cause our units to be worth less than if a unit included a warrant to purchase one whole share.
A provision of our
warrant agreement may make it more difficult for us to consummate an initial business combination.
Unlike most blank check companies, if (i) we issue
additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of our initial
business combination at a Newly Issued Price of less than $9.20 per ordinary share, (ii) the aggregate gross proceeds from such issuances
represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination
on the date of the consummation of our initial business combination (net of redemptions), and (iii) the Market Value is below $9.20 per
share, then the exercise price of the warrants will be adjusted to be equal to 115% of the higher of the Market Value and the Newly Issued
Price, and the $18.00 per share redemption trigger prices will be adjusted (to the nearest cent) to be equal to 180% of the higher of
the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price will be adjusted (to the nearest cent)
to be equal to the higher of the Market Value and the Newly Issued Price. This may make it more difficult for us to consummate an initial
business combination with a target business.
The grant of registration
rights to our sponsor may make it more difficult to complete our initial business combination, and the future exercise of such rights
may adversely affect the market price of our Class A ordinary shares.
Pursuant to a registration and shareholder rights
agreement, our sponsor and its permitted transferees can demand that we register the resale of the Class A ordinary shares into which
founder shares are convertible, the private placement warrants and the Class A ordinary shares issuable upon exercise of the private placement
warrants, and warrants that may be issued upon conversion of working capital loans and the Class A ordinary shares issuable upon conversion
of such warrants. We will bear the cost of registering these securities. The registration and availability of such a significant number
of securities for trading in the public market may have an adverse effect on the market price of our Class A ordinary shares. In addition,
the existence of the registration rights may make our initial business combination more costly or difficult to conclude. This is because
the shareholders of the target business may increase the equity stake they seek in the combined entity or ask for more cash consideration
to offset the negative impact on the market price of our securities that is expected when the securities owned by our sponsor or its permitted
transferees are registered for resale.
Risks Related to Our Sponsor and Management Team
We are dependent
upon our executive officers and directors and their loss could adversely affect our ability to operate.
Our operations are dependent upon a relatively
small group of individuals and, in particular, our executive officers and directors. We believe that our success depends on the continued
service of our executive officers and directors, at least until we have completed our initial business combination. In addition, our executive
officers and directors are not required to commit any specified amount of time to our affairs and, accordingly, will have conflicts of
interest in allocating their time among various business activities, including identifying potential business combinations and monitoring
the related due diligence. We do not have an employment agreement with, or key-man insurance on the life of, any of our executive officers
or directors. The unexpected loss of the services of one or more of our executive officers or directors could have a detrimental effect
on us.
Our ability to successfully
effect our initial business combination and to be successful thereafter will be totally dependent upon the efforts of our key personnel,
some of whom may join us following our initial business combination. The loss of key personnel could negatively impact the operations
and profitability of our post-combination business.
Our ability to successfully effect our initial
business combination is dependent upon the efforts of our key personnel. The role of our key personnel in the target business, however,
cannot presently be ascertained. Although some of our key personnel may remain with the target business in senior management, director
or advisory positions following our initial business combination, it is likely that some or all of the management of the target business
will remain in place. While we intend to closely scrutinize any individuals we engage after our initial business combination, we cannot
assure you that our assessment of these individuals will prove to be correct. These individuals may be unfamiliar with the requirements
of operating a company regulated by the SEC, which could cause us to have to expend time and resources helping them become familiar with
such requirements.
Our key personnel
may negotiate employment or consulting agreements with a target business in connection with a particular business combination, and a particular
business combination may be conditioned on the retention or resignation of such key personnel. These agreements may provide for them to
receive compensation following our initial business combination and, as a result, may cause them to have conflicts of interest in determining
whether a particular business combination is the most advantageous.
Our key personnel may be able to remain with our
company after the completion of our initial business combination only if they are able to negotiate employment or consulting agreements
in connection with the business combination. Such negotiations would take place simultaneously with the negotiation of the business combination
and could provide for such individuals to receive compensation in the form of cash payments and/or our securities for services they would
render to us after the completion of the business combination. Such negotiations also could make such key personnel’s retention
or resignation a condition to any such agreement. The personal and financial interests of such individuals may influence their motivation
in identifying and selecting a target business. In addition, pursuant to a registration and shareholder rights agreement, our sponsor,
upon and following the consummation of an initial business combination, will be entitled to nominate three individuals for appointment
of our board of directors, as long as the sponsor holds any securities covered by the registration and shareholder rights agreement.
The officers and
directors of an acquisition candidate may resign upon the completion of our initial business combination. The loss of a business combination
target’s key personnel could negatively impact the operations and profitability of our post-combination business.
The role of an acquisition candidate’s key
personnel upon the completion of our initial business combination cannot be ascertained at this time. Although we contemplate that certain
members of an acquisition candidate’s management team will remain associated with the acquisition candidate following our initial
business combination, it is possible that members of the management of an acquisition candidate will not wish to remain in place.
Our executive officers
and directors will allocate their time to other businesses thereby causing conflicts of interest in their determination as to how much
time to devote to our affairs. This conflict of interest could have a negative impact on our ability to complete our initial business
combination.
Our executive officers and directors are not required
to, and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between our
operations and our search for a business combination and their other businesses. We do not intend to have any full-time employees prior
to the completion of our initial business combination. Each of our executive officers is engaged in several other business endeavors for
which he may be entitled to substantial compensation, and our executive officers are not obligated to contribute any specific number of
hours per week to our affairs. Our independent directors also serve as officers and board members for other entities. If our executive
officers’ and directors’ other business affairs require them to devote substantial amounts of time to such affairs in excess
of their current commitment levels, it could limit their ability to devote time to our affairs, which may have a negative impact on our
ability to complete our initial business combination.
Our officers and
directors presently have, or may in the future have, fiduciary or contractual obligations to other entities, including another blank check
company, and, accordingly, may have conflicts of interest in determining to which entity a particular business opportunity should be presented.
Until we consummate our initial business combination,
we intend to engage in the business of identifying and combining with one or more businesses or entities. Our officers and directors presently
have, or may in the future have, fiduciary or contractual obligations to other entities pursuant to which such officer or director is
or will be required to present a business combination opportunity to such entity, subject to his or her fiduciary duties under Cayman
Islands law. Accordingly, they may have conflicts of interest in determining to which entity a particular business opportunity should
be presented. These conflicts may not be resolved in our favor and a potential target business may be presented to another entity prior
to its presentation to us, subject to their fiduciary duties under Cayman Islands law.
In addition, our sponsor, officers and directors
presently are, or may in the future become affiliated with other blank check companies that may have acquisition objectives that are similar
to ours. Accordingly, they may have conflicts of interest in determining to which entity a particular business opportunity should be presented.
These conflicts may not be resolved in our favor and a potential target business may be presented to such other blank check companies
prior to its presentation to us, subject to our officers’ and directors’ fiduciary duties under Cayman Islands law. Our third
amended and restated memorandum and articles of association provides that, to the fullest extent permitted by applicable law: (i) no individual
serving as an officer or a director shall have any duty, except and to the extent expressly assumed by contract, to refrain from engaging
directly or indirectly in the same or similar business activities or lines of business as us; and (ii) we renounce any interest or expectancy
in, or in being offered an opportunity to participate in, any potential transaction or matter which may be a corporate opportunity for
any director or officer, on the one hand, and us, on the other hand.
Our executive officers,
directors, security holders and their respective affiliates may have competitive pecuniary interests that conflict with our interests.
We have not adopted a policy that expressly prohibits
our executive officers, directors, security holders, or affiliates from having a direct or indirect pecuniary or financial interest in
any investment to be acquired or disposed of by us or in any transaction to which we are a party or have an interest. In fact, we may
enter into a business combination with a target business that is affiliated with our sponsor, executive officers or directors, although
we do not intend to do so. Nor do we have a policy that expressly prohibits any such persons from engaging for their own account in business
activities of the types conducted by us. Accordingly, such persons or entities may have a conflict between their interests and ours.
The personal and financial interests of our executive
officers and directors may influence their motivation in timely identifying and selecting a target business and completing a business
combination. Consequently, our executive officers’ and directors’ discretion in identifying and selecting a suitable target
business may result in a conflict of interest when determining whether the terms, conditions and timing of a particular business combination
are appropriate and in our shareholders’ best interest. If this were the case, it would be a breach of their fiduciary duties to
us as a matter of Cayman Islands law and we or our shareholders might have a claim against such individuals for infringing on our shareholders’
rights. However, we might not ultimately be successful in any claim we may make against them for such reason.
We may engage in
a business combination with one or more target businesses that have relationships with entities that may be affiliated with our sponsor,
executive officers or directors, which may raise potential conflicts of interest.
In light of the involvement of our sponsor, executive
officers and directors with other entities, we may decide to acquire one or more businesses affiliated with our sponsor, executive officers
or directors. Our directors also serve as executive officers and board members for other entities, including, without limitation, those
described under “Management-Conflicts of Interest.” Our sponsor, executive officers and directors may sponsor, form or participate
in other blank check companies similar to ours during the period in which we are seeking an initial business combination. Such entities
may compete with us for business combination opportunities. Our sponsor, executive officers and directors are not currently aware of any
specific opportunities for us to complete our initial business combination with any entities with which they are affiliated, and there
have been no substantive discussions concerning a business combination with any such entity or entities. Although we will not be specifically
focusing on, or targeting, any transaction with any affiliated entities, we would pursue such a transaction if we determined that such
affiliated entity met our criteria and guidelines for a business combination and such transaction was approved by a majority of our independent
and disinterested directors. Despite our agreement to obtain an opinion from an independent investment banking firm that is a member of
Financial Industry Regulatory Authority (“FINRA”) or another independent entity that commonly renders valuation opinions regarding
the fairness to our company from a financial point of view of a business combination with one or more domestic or international businesses
affiliated with our sponsor, executive officers or directors, potential conflicts of interest still may exist and, as a result, the terms
of the business combination may not be as advantageous to our public shareholders as they would be absent any conflicts of interest.
Our management may
not be able to maintain control of a target business after our initial business combination. Upon the loss of control of a target business,
new management may not possess the skills, qualifications, or abilities necessary to profitably operate such business.
We may structure our initial business combination
so that the post-business combination company in which our public shareholders own shares will own less than 100% of the equity interests
or assets of a target business, but we will only complete such business combination if the post-business combination company owns or acquires
50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient
for us not to be required to register as an investment company under the Investment Company Act. We will not consider any transaction
that does not meet such criteria. Even if the post-business combination company owns 50% or more of the voting securities of the target,
our shareholders prior to our initial business combination may collectively own a minority interest in the post-business combination company,
depending on valuations ascribed to the target and us in the business combination. For example, we could pursue a transaction in which
we issue a substantial number of new Class A ordinary shares in exchange for their shares of stock, shares or other equity interests of
a target. In this case, we would acquire a 100% interest in the target. However, as a result of the issuance of a substantial number of
new Class A ordinary shares, our shareholders immediately prior to such transaction could own less than a majority of our outstanding
Class A ordinary shares subsequent to such transaction. In addition, other minority shareholders may subsequently combine their holdings
resulting in a single person or group obtaining a larger portion of the company’s shares than we initially acquired. Accordingly,
this may make it more likely that our management will not be able to maintain control of the target business.
Since our sponsor,
executive officers and directors will lose their entire investment in us if our initial business combination is not completed (other than
with respect to public shares they have acquired during or may acquire after our initial public offering), a conflict of interest may
arise in determining whether a particular business combination target is appropriate for our initial business combination.
On December 28, 2020, our sponsor paid $25,000,
or approximately $0.003 per share, to cover certain of our offering costs in consideration of 7,187,500 Class B ordinary shares, par value
$0.0001. On February 11, 2021, we effected a share capitalization resulting in our sponsor holding an additional 718,750 Class B ordinary
shares for an aggregate of 7,906,250 of Class B ordinary shares. Prior to the initial investment in the company of $25,000 by the sponsor,
the company had no assets, tangible or intangible. The per share price of the founder shares was determined by dividing the amount contributed
to the company by the number of founder shares issued. The founder shares will be worthless if we do not complete an initial business
combination. In addition, simultaneously with the closing of our initial public offering our sponsor also purchased an aggregate of 5,333,333
private placement warrants at a price of $1.50 per warrant, generating gross proceeds to the Company of $8,000,000, each exercisable to
purchase one Class A ordinary share at $11.50 per share, subject to adjustment. In addition, pursuant to the Convertible Promissory Notes
described below under “Promissory Notes-Related Party,” such loans may, at the Sponsor’s discretion, be converted
into private placement warrants. If we do not consummate an initial business combination within 42 months from the closing of our initial
public offering, the private placement warrants will expire worthless. The personal and financial interests of our executive officers
and directors may influence their motivation in identifying and selecting a target business combination, completing an initial business
combination and influencing the operation of the business following the initial business combination. This risk may become more acute
as the 39-month anniversary of the closing of our initial public offering nears, which is the deadline for our consummation of an initial
business combination subject to further extensions.
General Risk Factors
Past performance
of our management team, Catcha Group or their respective affiliates may not be indicative of future performance of an investment in us.
Information regarding performance is presented
for informational purposes only. Any past experience or performance of our management team, Catcha Group or their respective affiliates
is not a guarantee of either (i) our ability to successfully identify and execute a transaction or (ii) success with respect to any business
combination that we may consummate. You should not rely on the historical record of our management team, Catcha Group or their respective
affiliates as indicative of the future performance of an investment in us or the returns we will, or are likely to, generate going forward.
Our management has no experience in operating special purpose acquisition companies.
Cyber incidents
or attacks directed at us could result in information theft, data corruption, operational disruption, and/or financial loss.
We depend on digital technologies, including information
systems, infrastructure and cloud applications, and services, including those of third parties with which we may deal. Sophisticated and
deliberate attacks on, or security breaches in, our systems or infrastructure, or the systems or infrastructure of third parties or the
cloud, could lead to corruption or misappropriation of our assets, proprietary information and sensitive or confidential data. As an early-stage
company without significant investments in data security protection, we may not be sufficiently protected against such occurrences. We
also lack sufficient resources to adequately protect against, or to investigate and remediate any vulnerability to, cyber incidents. It
is possible that any of these occurrences, or a combination of them, could have material adverse consequences on our business and lead
to financial loss.
Changes in laws
or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, including our ability to negotiate
and complete our initial business combination, and results of operations.
We are subject to laws and regulations enacted
by national, regional, and local governments. In particular, we are required to comply with certain SEC and other legal requirements.
Compliance with, and monitoring of, applicable laws and regulations may be difficult, time consuming and costly. Those laws and regulations
and their interpretation and application may also change from time to time and those changes could have a material adverse effect on our
business, investments, and results of operations. In addition, a failure to comply with applicable laws or regulations, as interpreted
and applied, could have a material adverse effect on our business, including our ability to negotiate and complete our initial business
combination, and results of operations.
We are an emerging
growth company and a smaller reporting company within the meaning of the Securities Act, and if we take advantage of certain exemptions
from disclosure requirements available to “emerging growth companies” or “smaller reporting companies,” which
could make our securities less attractive to investors and may make it more difficult to compare our performance with other public companies.
We are an “emerging growth company”
within the meaning of the Securities Act, as modified by the JOBS Act, and we may take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies that are not “emerging growth companies,” including, but not limited
to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure
obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding
a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
As a result, our shareholders may not have access to certain information they may deem important. We could be an emerging growth company
for up to five years, although circumstances could cause us to lose that status earlier, including if the market value of our Class A
ordinary shares held by non-affiliates equals or exceeds $700 million as of any June 30 before that time, in which case we would no longer
be an emerging growth company as of the following December 31. We cannot predict whether investors will find our securities less attractive
because we will rely on these exemptions. If some investors find our securities less attractive as a result of our reliance on these exemptions,
the trading prices of our securities may be lower than they otherwise would be, there may be a less active trading market for our securities
and the trading prices of our securities may be more volatile.
Further, Section 102(b)(1) of the JOBS Act exempts
emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that
is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company
can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but
any such an election to opt out is irrevocable. We have elected not to opt out of such extended transition period, which means that when
a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company,
can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our
financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted
out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Additionally, we are a “smaller reporting
company” as defined in Rule 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure
obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting
company until the last day of the fiscal year in which (1) the market value of our Class A ordinary shares held by non-affiliates equals
or exceeds $250 million as of the prior June 30 and (2) our annual revenues exceeded $100 million during such completed fiscal year and
the market value of our Class A ordinary shares held by non-affiliates equals or exceeds $700 million as of the prior June 30. To the
extent we take advantage of such reduced disclosure obligations, it may also make comparison of our financial statements with other public
companies difficult or impossible.
Because we are incorporated
under the laws of the Cayman Islands, you may face difficulties in protecting your interests, and your ability to protect your rights
through the U.S. federal courts may be limited.
We are an exempted company incorporated under
the laws of the Cayman Islands. As a result, it may be difficult for investors to effect service of process within the United States upon
our officers or directors, or enforce judgments obtained in the United States courts against our officers or directors.
Our corporate affairs are governed by our third
amended and restated memorandum and articles of association, the Companies Act (as the same may be supplemented or amended from time to
time) and the common law of the Cayman Islands. We are also subject to the federal securities laws of the United States. The rights of
shareholders to take action against the directors, actions by minority shareholders and the fiduciary responsibilities of our directors
to us under Cayman Islands law are to a large extent governed by the common law of the Cayman Islands. The common law of the Cayman Islands
is derived in part from comparatively limited judicial precedent in the Cayman Islands as well as from English common law, the decisions
of whose courts are of persuasive authority but are not binding on a court in the Cayman Islands. The rights of our shareholders and the
fiduciary responsibilities of our directors under Cayman Islands law are different from what they would be under statutes or judicial
precedent in some jurisdictions in the United States. In particular, the Cayman Islands has a different body of securities laws as compared
to the United States, and certain states, such as Delaware, may have more fully developed and judicially interpreted bodies of corporate
law. In addition, Cayman Islands companies may not have standing to initiate a shareholders derivative action in a federal court of the
United States.
We have been advised by Maples and Calder (Hong
Kong) LLP, our Cayman Islands legal counsel, that there is uncertainty as to whether the courts of the Cayman Islands would (i) recognize
or enforce against us judgments of courts of the United States predicated upon the civil liability provisions of the federal securities
laws of the United States or any state; or (ii) entertain original actions brought in the Cayman Islands predicated upon the civil liability
provisions of the federal securities laws of the United States or any state. In those circumstances, although there is no statutory enforcement
in the Cayman Islands of judgments obtained in the United States, the courts of the Cayman Islands will recognize and enforce a foreign
money judgment of a foreign court of competent jurisdiction at common law any re-examination of the merits of the underlying dispute provided
that such judgment (i) is given by a foreign court of competent jurisdiction, (ii) imposes on the judgment debtor a liability to pay a
liquidated sum for which the judgment has been given, (iii) is final, (iv) is not in the nature of taxes, a fine, or a penalty; and (v)
was not obtained in a manner and is not of a kind the enforcement of which is contrary to natural justice or the public policy of the
Cayman Islands. However, there is uncertainty with regard to Cayman Islands law on whether judgments of courts of the United States predicated
upon the civil liability provisions of the securities laws of the United States or any State will be determined by the courts of the Cayman
Islands penal or punitive in nature. If such a determination is made, the courts of the Cayman Islands will not recognize or enforce the
judgment against a Cayman Islands company, such as our company. Because such a determination in relation to judgments obtained from U.S.
courts under civil liability provisions of U.S. securities laws has not yet been made by a court of the Cayman Islands, it is uncertain
whether such judgments would be enforceable in the Cayman Islands. A Cayman Islands Court may stay enforcement proceedings if concurrent
proceedings are being brought elsewhere.
As a result of all of the above, public shareholders
may have more difficulty in protecting their interests in the face of actions taken by management, members of the board of directors or
controlling shareholders than they would as public shareholders of a United States company.
Since only holders
of our founder shares have the right to vote on the appointment of directors NYSE may consider us to be a “controlled company”
within the meaning of the NYSE rules and, as a result, we may qualify for exemptions from certain corporate governance requirements.
Only holders of our founder shares have the right
to vote on the appointment of directors. As a result, NYSE may consider us to be a “controlled company” within the meaning
of the NYSE corporate governance standards. Under the NYSE corporate governance standards, a company of which more than 50% of the voting
power is held by an individual, group or another company is a “controlled company” and may elect not to comply with certain
corporate governance requirements, including the requirements that:
| ● | we have a board that includes a majority of “independent directors,” as defined under the
rules of NYSE; |
| ● | we have a compensation committee of our board that is comprised entirely of independent directors with
a written charter addressing the committee’s purpose and responsibilities; and |
| ● | we have a nominating and corporate governance committee of our board that is comprised entirely of independent
directors with a written charter addressing the committee’s purpose and responsibilities. |
We do not intend to utilize these exemptions and
intend to comply with the corporate governance requirements of NYSE, subject to applicable phase-in rules. However, if we determine in
the future to utilize some or all of these exemptions, you will not have the same protections afforded to shareholders of companies that
are subject to all of the NYSE corporate governance requirements.
We may be a passive
foreign investment company, or “PFIC,” which could result in adverse U.S. federal income tax consequences to U.S. investors.
If we are a PFIC for any taxable year (or portion
thereof) that is included in the holding period of a U.S. Holder of our Class A ordinary shares or warrants, the U.S. Holder may be subject
to adverse U.S. federal income tax consequences and may be subject to additional reporting requirements. Our PFIC status for our current
and subsequent taxable years may depend on whether we qualify for the PFIC start-up exception. Depending on the particular circumstances,
the application of the start-up exception may be subject to uncertainty, and there cannot be any assurance that we will qualify for the
start-up exception. Accordingly, there can be no assurances with respect to our status as a PFIC for our current taxable year or any subsequent
taxable year. Our actual PFIC status for any taxable year, however, will not be determinable until after the end of such taxable year.
Moreover, if we determine we are a PFIC for any taxable year, upon written request, we will endeavor to provide to a U.S. Holder such
information as the Internal Revenue Service (“IRS”) may require, including a PFIC Annual Information Statement, in order to
enable the U.S. Holder to make and maintain a “qualified electing fund” election, but there can be no assurance that we will
timely provide such required information, and such election would be unavailable with respect to our warrants in all cases. We urge U.S.
investors to consult their tax advisors regarding the possible application of the PFIC rules.
We may reincorporate
in another jurisdiction in connection with our initial business combination and such reincorporation may result in taxes imposed on shareholders
or warrant holders.
We may, in connection with our initial business
combination and subject to requisite shareholder approval under the Companies Act, reincorporate in the jurisdiction in which the target
company or business is located or in another jurisdiction. The transaction may require a shareholder or warrant holder to recognize taxable
income in the jurisdiction in which the shareholder or warrant holder is a tax resident or in which its members are resident if it is
a tax transparent entity. We do not intend to make any cash distributions to shareholders or warrant holders to pay such taxes. Shareholders
or warrant holders may be subject to withholding taxes or other taxes with respect to their ownership of us after the reincorporation.
Risks Associated with Acquiring and Operating a Business in Foreign
Countries
If we pursue a target
company with operations or opportunities outside of the United States for our initial business combination, we may face additional burdens
in connection with investigating, agreeing to and completing such initial business combination, and if we effect such initial business
combination, we would be subject to a variety of additional risks that may negatively impact our operations.
If we pursue a target a company with operations
or opportunities outside of the United States for our initial business combination, we would be subject to risks associated with cross-border
business combinations, including in connection with investigating, agreeing to and completing our initial business combination, conducting
due diligence in a foreign jurisdiction, having such transaction approved by any local governments, regulators or agencies and changes
in the purchase price based on fluctuations in foreign exchange rates.
If we effect our initial business combination
with such a company, we would be subject to any special considerations or risks associated with companies operating in an international
setting, including any of the following:
| ● | costs and difficulties inherent in managing cross-border business operations; |
| ● | rules and regulations regarding currency redemption; |
| ● | complex corporate withholding taxes on individuals; |
| ● | laws governing the manner in which future business combinations may be effected; |
| ● | exchange listing and/or delisting requirements; |
| ● | tariffs and trade barriers; |
| ● | regulations related to customs and import/export matters; |
| ● | local or regional economic policies and market conditions; |
| ● | unexpected changes in regulatory requirements; |
| ● | tax issues, such as tax law changes and variations in tax laws as compared to the United States; |
| ● | currency fluctuations and exchange controls; |
| ● | challenges in collecting accounts receivable; |
| ● | cultural and language differences; |
| ● | underdeveloped or unpredictable legal or regulatory systems; |
| ● | protection of intellectual property; |
| ● | social unrest, crime, strikes, riots and civil disturbances; |
| ● | regime changes and political upheaval; |
| ● | terrorist attacks, natural disasters and wars; and |
| ● | deterioration of political relations with the United States. |
We may not be able to adequately address these
additional risks. If we were unable to do so, we may be unable to complete such initial business combination, or, if we complete such
combination, our operations might suffer, either of which may adversely impact our business, financial condition and results of operations.
Corporate governance
standards in Southeast Asian countries may not be as strict or developed as in the United States and such weakness may hide issues and
operational practices that are detrimental to a target business.
General corporate governance standards in Southeast
Asian countries are weaker than those in the United States. This could result in unfavorable related party transactions, over-leveraging,
improper accounting, family company interconnectivity and poor management. Local laws often do not go far enough to prevent improper business
practices. Therefore, shareholders may not be treated impartially and equally as a result of poor management practices, asset shifting,
conglomerate structures that result in preferential treatment to some parts of the overall company, and cronyism. The lack of transparency
and ambiguity in the regulatory process also may result in inadequate credit evaluation and weakness that may precipitate or encourage
financial crisis. In our evaluation of a business combination we will have to evaluate the corporate governance of a target and the business
environment, and in accordance with United States laws for reporting companies take steps to implement practices that will cause compliance
with all applicable rules and accounting practices. Notwithstanding these intended efforts, there may be endemic practices and local laws
that could add risk to an investment we ultimately make and that result in an adverse effect on our operations and financial results.
If the government
of the country in which we effect our initial business combination finds that the agreements we entered into to acquire control of a target
business through contractual arrangements with one or more operating businesses do not comply with local governmental restrictions on
foreign investment, or if these regulations or the interpretation of existing regulations change in the future, we could be subject to
significant penalties or be forced to relinquish our interests in those operations.
Some countries in Asia currently prohibit and/or
restrict foreign ownership in certain “important industries,” including telecommunications, food production, and heavy equipment.
There are uncertainties under certain regulations whether obtaining a majority interest through contractual arrangements will comply with
regulations prohibiting or restricting foreign ownership in certain industries. In addition, there can be restrictions on the foreign
ownership of businesses that are determined from time to time to be in “important industries” that may affect the national
economic security or those having “famous brand names” or “well-established brand names.”
If we or any of our potential future target businesses
are found to be in violation of any existing or future local laws or regulations (for example, if we are deemed to be holding equity interests
in certain of our affiliated entities in which direct foreign ownership is prohibited), the relevant regulatory authorities might have
the discretion to:
revoke the business and operating licenses of
the potential future target business;
| ● | confiscate relevant income and impose fines and other penalties; |
| ● | discontinue or restrict the operations of the potential future target business; |
| ● | require us or the potential future target business to restructure the relevant ownership structure or
operations; |
| ● | restrict or prohibit our use of the proceeds of our initial public offering to finance our businesses
and operations in the relevant jurisdiction; or |
| ● | impose conditions or requirements with which we or the potential future target business may not be able
to comply. |
Many of the economies
in Asia are experiencing substantial inflationary pressures, which may prompt the governments to take action to control the growth of
the economy and inflation that could lead to a significant decrease in our profitability following our initial business combination.
While many of the economies in Asia have experienced
rapid growth over the last two decades, they have also experienced inflationary pressures. As governments take steps to address inflationary
pressures, there may be significant changes in the availability of bank credits, interest rates, limitations on loans, restrictions on
currency conversions and foreign investment. There also may be imposition of price controls. If prices for the products of our ultimate
target business rise at a rate that is insufficient to compensate for the rise in the costs of supplies, it may have an adverse effect
on our profitability. If these or other similar restrictions are imposed by a government to influence the economy, it may lead to a slowing
of economic growth. Because we are not limited to any specific industry, the ultimate industry that we operate in may be affected more
severely by such a slowing of economic growth.
If our management
following our initial business combination is unfamiliar with United States securities laws, they may have to expend time and resources
becoming familiar with such laws, which could lead to various regulatory issues.
Following our initial business combination, our
management may resign from their positions as officers or directors of the company and the management of the target business at the time
of the business combination will remain in place. Management of the target business may not be familiar with United States securities
laws. If new management is unfamiliar with United States securities laws, they may have to expend time and resources becoming familiar
with such laws. This could be expensive and time-consuming and could lead to various regulatory issues that may adversely affect our operations.
After our initial
business combination, substantially all of our assets may be located in a foreign country and substantially all of our revenue may be
derived from our operations in any such country. Accordingly, our results of operations and prospects will be subject, to a significant
extent, to the economic, political, and social conditions and government policies, developments and conditions in the country in which
we operate.
The economic, political, and social conditions,
as well as government policies, of the country in which our operations are located could affect our business. Economic growth could be
uneven, both geographically and among various sectors of the economy, and such growth may not be sustained in the future. If in the future
such country’s economy experiences a downturn or grows at a slower rate than expected, there may be less demand for spending in
certain industries. A decrease in demand for spending in certain industries could materially and adversely affect our ability to find
an attractive target business with which to consummate our initial business combination and if we effect our initial business combination,
the ability of that target business to become profitable.
Exchange rate fluctuations
and currency policies may cause a target business’ ability to succeed in the international markets to be diminished.
In the event we acquire a non-U.S. target, all
revenues and income would likely be received in a foreign currency, and the dollar equivalent of our net assets and distributions, if
any, could be adversely affected by reductions in the value of the local currency. The value of the currencies in our target regions fluctuate
and are affected by, among other things, changes in political and economic conditions. Any change in the relative value of such currency
against our reporting currency may affect the attractiveness of any target business or, following the consummation of our initial business
combination, our financial condition and results of operations. Additionally, if a currency appreciates in value against the dollar prior
to the consummation of our initial business combination, the cost of a target business as measured in dollars will increase, which may
make it less likely that we are able to consummate such transaction.
We may reincorporate
in another jurisdiction in connection with our initial business combination, and the laws of such jurisdiction may govern some or all
of our future material agreements and we may not be able to enforce our legal rights.
In connection with our initial business combination,
we may relocate the home jurisdiction of our business from the Cayman Islands to another jurisdiction. If we determine to do this, the
laws of such jurisdiction may govern some or all of our future material agreements. The system of laws and the enforcement of existing
laws in such jurisdiction may not be as certain in implementation and interpretation as in the United States. The inability to enforce
or obtain a remedy under any of our future agreements could result in a significant loss of business, business opportunities, or capital.
We are subject to
changing laws and regulations regarding regulatory matters, corporate governance and public disclosure, which have increased both our
costs and the risk of non-compliance.
We are subject to laws and regulations by various
governing bodies, including, for example, the SEC, which is charged with the protection of investors and the oversight of companies whose
securities are publicly traded, and to new and evolving regulatory measures under applicable law. Our efforts to comply with new and changing
laws and regulations have resulted in, and are likely to continue to result in, increased general and administrative expenses and a diversion
of management time and attention from seeking a business combination target.
Moreover, because these laws, regulations, and
standards are subject to varying interpretations, their application in practice may evolve over time as new guidance becomes available.
This evolution may result in continuing uncertainty regarding compliance matters and additional costs necessitated by ongoing revisions
to our disclosure and governance practices. If we fail to address and comply with these regulations and any subsequent changes, we may
be subject to penalty and our business may be harmed.
Risks Associated with Our Internal Control over Financial Reporting
We
have identified material weaknesses in our internal control over financial reporting as of December 31, 2023. If we are unable to
maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial
results in a timely manner, which may adversely affect investor confidence in us and materially and adversely affect our business
and operating results
Our management is responsible for establishing
and maintaining adequate internal control over financial reporting designed to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. Our management is likewise
required, on a quarterly basis, to evaluate the effectiveness of our internal controls and to disclose any changes and material weaknesses
identified through such evaluation in those internal controls. A material weakness is a deficiency, or a combination of deficiencies,
in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or
interim financial statements will not be prevented or detected on a timely basis.
As described elsewhere in this Annual Report,
our disclosure controls and procedures were not effective as of December 31, 2023, due to the material weaknesses in our internal control
over financial reporting related to accounting for complex financial instruments. In light of this material weaknesses, we performed additional
analysis as deemed necessary to ensure that our audited financial statements were prepared in accordance with U.S. generally accepted
accounting principles.
Any failure to maintain such internal control
could adversely impact our ability to report our financial position and results from operations on a timely and accurate basis. If our
financial statements are not accurate, investors may not have a complete understanding of our operations. Likewise, if our financial statements
are not filed on a timely basis, we could be subject to sanctions or investigations by the stock exchange on which our ordinary shares
are listed, the SEC or other regulatory authorities. In either case, there could result a material adverse effect on our business. Ineffective
internal controls could also cause investors to lose confidence in our reported financial information, which could have a negative effect
on the trading price of our stock.
We can give no assurance that the measures we
have taken and plan to take in the future will remediate the material weaknesses identified or that any additional material weaknesses
or restatements of financial results will not arise in the future due to a failure to implement and maintain adequate internal control
over financial reporting or circumvention of these controls. In addition, even if we are successful in strengthening our controls and
procedures, in the future those controls and procedures may not be adequate to prevent or identify irregularities or errors or to facilitate
the fair presentation of our financial statements.
Item
1B. Unresolved Staff Comments
None.
Item
1C. Cybersecurity
As a blank check company, we do not have any operations
and our sole business activity has been to search for and consummate an initial business combination. However, because we have investments
in our trust account and bank deposits and we depend on the digital technologies of third parties, we and third parties may be subject
to attacks on or security breaches in our or their systems. Because of our reliance on the technologies of third parties, we also depend
upon the personnel and the processes of third parties to protect against cybersecurity threats, and we have no personnel or processes
of our own for this purpose.
In the event of a cybersecurity incident
impacting us, our management team will report to the Company’s board of directors and provide updates on our management
team’s incident response plan for addressing and mitigating any risks associated with such an incident. As an early-stage
company without significant investments in data security protection, we may not be sufficiently protected against such occurrences.
We also lack sufficient resources to adequately protect against, or to investigate and remediate any vulnerability to, cyber
incidents. It is possible that any of these occurrences, or a combination of them, could have material adverse consequences on our
business and lead to financial loss. For more information about the cybersecurity risks we face, see the risk factor entitled “General
Risk Factors - Cyber incidents or attacks directed at us could result in information theft, data corruption, operational disruption,
and/or financial loss” in Item 1A. Risk Factors. As of the date of this Annual Report, we have not encountered any
cybersecurity incidents since our initial public offering.
Item
2. Properties
We currently maintain our principal executive
offices at 3 Raffles Place #06-01, Bharat Building, Singapore, Singapore 048617. The cost for our use of this space is included in the
$10,000 per month fee we pay to an affiliate of our sponsor for office space and administrative and support services. We consider our
current office space adequate for our current operations.
Item
3. Legal Proceedings
To the knowledge of our management, there is no
litigation currently pending or contemplated against us, any of our officers or directors in their capacity as such or against any of
our property.
Item
4. Mine Safety Disclosures
Not applicable.
PART
II
Item
5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
(a) Market Information
Our units, Class A ordinary shares and warrants
began trading on the NYSE under the symbols “CHAA,” “CHAA.U” and “CHAA WS,” respectively. Our
units commenced public trading on February 12, 2021. Our Class A ordinary shares and warrants began trading on April 5, 2021.
On November 4, 2022, the New York Stock Exchange
(the “NYSE”) notified the Company, and publicly announced, that the NYSE determined to commence proceedings to delist the
Company’s warrants, each whole warrant exercisable for one Class A ordinary share and listed to trade on NYSE under the symbol “CHAA
WS”, from the NYSE and that trading in the Warrants would be suspended immediately, due to “abnormally low” trading
price levels pursuant to Section 802.01D of the NYSE Listed Company Manual. The public warrants began to trade over-the counter (OTC)
since then.
On March 23, 2023, the Company received approval
to transfer the listing of Class A ordinary shares from the NYSE to the NYSE American and on March 28, 2023, the Class A ordinary shares
began trading on the NYSE American under the symbol “CHAA”. In connection with the transfer, effective March 28, 2023, any
remaining units were mandatorily separated into its component parts and the units are no longer traded on the NYSE.
On February 20, 2024, the Company received a letter
from the NYSE American LLC (“NYSE American” or the “Exchange”) stating that the staff of NYSE Regulation has determined
to commence proceedings to delist Catcha’s Class A ordinary shares pursuant to Sections 119(b) and 119(f) of the NYSE American Company
Guide because the Company failed to consummate a Business Combination within 36 months of the effectiveness of its Initial Public Offering
registration statement, or such shorter period that the Company specified in its registration statement.
On February 23, 2024, the Company submitted a
written request to NYSE asking for the review of the delisting determination by a Committee of the Board of Directors of the Exchange.
Up to the date the financial statements were issued, the Company’s Class A ordinary shares have not been suspended and will continue
to trade.
On April 17, 2024, the Company received a written
notice from NYSE American indicating that the Company was not in compliance with NYSE American’s continued listing standards because
the Company did not timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Form 10-K”),
which was due on April 16, 2024.
In accordance with Section 1007 of the NYSE American
Company Guide, the Company will have six months from April 16, 2024 (the “Initial Cure Period”), to file the Form 10-K with
the SEC. If the Company fails to file the Form 10-K during the Initial Cure Period, NYSE American may, in its sole discretion, provide
an additional six-month cure period (the “Additional Cure Period”). The Company can regain compliance with the Exchange’s
continued listing standards at any time during the Initial Cure Period or Additional Cure Period, as applicable, by filing the Form 10-K
and any subsequent delayed filings with the SEC.
The Company has an NYSE appeal hearing scheduled
for July 17, 2024.
(b) Holders
As of June 17, 2024, there were no holders of record of our units,
4 holders of record of our Class A ordinary shares, 215 holders of our Class B ordinary shares, and 2 holders of our warrants.
(c) Dividends
We have not paid any cash dividends on our ordinary
shares to date and do not intend to pay cash dividends prior to the completion of our initial business combination. The payment of cash
dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition
subsequent to completion of our initial business combination. The payment of any cash dividends subsequent to our initial business combination
will be within the discretion of our board of directors at such time. If we increase the size of our initial public offering, we will
effect a share capitalization or other appropriate mechanism immediately prior to the consummation of our initial public offering in such
amount as to maintain the number of founder shares, on an as-converted basis, at 20% of our issued and outstanding ordinary shares (excluding
the private placement shares underlying the private placement units) upon the consummation of our initial public offering. Further, if
we incur any indebtedness in connection with a business combination, our ability to declare dividends may be limited by restrictive covenants
we may agree to in connection therewith.
(d) Securities Authorized for Issuance Under Equity Compensation
Plans
None.
(e) Performance Graph
Not applicable.
(f) Recent Sales of Unregistered Securities; Use of Proceeds from
Registered Offerings.
On February 17, 2021, we consummated our Initial
Public Offering of 30,000,000 Units, inclusive of 2,500,000 Units sold to the underwriters exercising their over-allotment option. The
Units were sold at an offering price of $10.00 per Unit, generating total gross proceeds of $300,000,000. Each Unit consisted of one Class
A ordinary share of the Company, par value $0.0001 per share, and one-third of one redeemable warrant of the Company. J.P. Morgan Securities
LLC acted as book-running manager of the offering. The securities sold in the offering were registered under the Securities Act on a registration
statement on Form S-1 (No. 333-252389). The SEC declared the registration statement effective on February 11, 2021.
Simultaneously with the consummation of the Initial
Public Offering, we consummated a private placement of 5,333,333 Private Placement Warrants to our Sponsor at a price of $1.50 per Private
Placement Warrant, generating total proceeds of $8,000,000. Such securities were issued pursuant to the exemption from registration contained
in Section 4(a)(2) of the Securities Act.
The Private Placement Warrants are the same as
the warrants underlying the Units sold in the Initial Public Offering, except that Private Placement Warrants are not transferable, assignable
or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private
Placement Warrants are exercisable on a cashless basis and are non-redeemable so long as they are held by the initial purchasers or their
permitted transferees.
Of the gross proceeds received from the Initial
Public Offering and the Private Placement Warrants, $300,000,000 was placed in the Trust Account.
We paid a total of $6,000,000 underwriting discounts
and commissions and $531,183 for other costs and expenses related to the Initial Public Offering. On August 10, 2023, J.P. Morgan Securities
LLC, the underwriter in the IPO, waived its entitlement to the payment of $10,500,000 deferred underwriting fee in connection with its
role as underwriter in the Company’s IPO.
In connection with the votes taken at the First Extraordinary General
Meeting, holders of 27,785,141 of our Class A ordinary shares properly exercised their right to redeem their shares for cash at a redemption
price of approximately $10.18 per share, for an aggregate redemption amount of $282,903,643.31. The funds were redeemed from the
Trust Account on February 23, 2023.
In connection with the votes taken at the Second
Extraordinary General Meeting, holders of 641,303 our Class A ordinary shares properly exercised their right to redeem their shares for
cash at a redemption price of approximately $11.29 per share, for an aggregate redemption amount of $7,241,004. The funds were redeemed
from the Trust Account on February 23, 2024.
In connection with the vote taken at the
Third Extraordinary General Meeting, the holders of 208,674 Class A ordinary shares of the Company properly exercised their right to
redeem their shares for cash at a redemption price of approximately $11.52 per share, for an aggregate redemption amount of
$2,403,928.46. The funds were redeemed from the Trust Account on May 20, 2024.
(g) Purchases of Equity Securities by the Issuer and Affiliated
Purchasers
None.
Item
6. Reserved.
Item
7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
References in this report (the “Annual
Report”) to “we,” “us” or the “Company” refer to Catcha Investment Corp. References to our “management”
or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Catcha
Holdings LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read
in conjunction with the audited financial statements and the notes thereto contained elsewhere in this Annual Report. Certain information
contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Overview
We are a blank check company incorporated on December
17, 2020 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase,
reorganization or similar business combination with one or more businesses or entities. We intend to effectuate our initial business combination
using cash from the proceeds (net of any redemptions as discussed under the “Liquidity, Capital Resources and Going Concern”
section below) of the IPO and the sale of the Private Placement Warrants, our shares, debt or a combination of cash, equity and debt.
We expect to incur significant costs in the pursuit
of our acquisition plans. We cannot assure you that our plans to complete a business combination will be successful.
Business Combination Agreement
On August 3, 2023, the Company entered into a
Business Combination Agreement (the “Business Combination Agreement”) with Crown LNG Holding AS, a private limited liability
company incorporated under the laws of Norway (“Crown”), Crown LNG Holdings Limited, a private limited company incorporated
under the laws of Jersey, Channel Islands (“PubCo”), and CGT Merge II Limited, a Cayman Islands exempted company limited by
shares (“Merger Sub”).
Pursuant to the Business Combination Agreement,
subject to the satisfaction or waiver of certain conditions set forth therein, (i) Merger Sub will merge with and into the Company, with
the Company being the surviving company and becoming the wholly owned subsidiary of PubCo, as a result of which (a) each of the Company’s
Class A ordinary share and Class B ordinary share issued and outstanding immediately prior to the effective time of the merger (the “Merger
Effective Time”) shall automatically be cancelled and cease to exist in exchange for the right to receive one newly issued ordinary
share of PubCo, and (b) each Company warrant outstanding immediately prior to the Merger Effective Time shall cease to be a warrant with
respect to the Company Ordinary Shares and be assumed by PubCo and converted into a warrant to purchase one ordinary share of PubCo; and
(ii) subject to the certain procedures and conditions, Crown shareholders will transfer their Crown shares to PubCo in exchange for their
Pro Rata Share of the Exchange Consideration, which is a number of PubCo ordinary shares issued by PubCo equal to (a) a transaction value
of $600 million divided by (b) a per share price of $10.00.
During the seven years following the Closing of
the Business Combination, the persons who are Crown shareholders immediately prior to the Exchange Effective Time and who have participated
in the Exchange shall have the contingent right to receive in the aggregate a number of ordinary shares of PubCo equivalent to 10% of
the issued and outstanding ordinary shares of PubCo as of the Closing (the “Earnout Shares”), which will vest upon achievement
of certain share prices and milestones as provided under the Business Combination Agreement. On October 2, 2023, the Business Combination
Agreement was amended to delete the provisions with regards to the Earnout Shares in their entirety.
On January 31, 2024, the Business Combination
Agreement was further amended to (i) remove the closing condition which would have required the Company to have satisfied the minimum
cash condition of at least US$20,000,000 and (ii) allow for listing of the PubCo ordinary shares on either the NYSE or Nasdaq.
On February 14, 2024, the SEC declared the registration
statement on Form F-4 with respect to the Business Combination effective.
On February 16, 2024, the Business Combination
Agreement was further amended to extend the date on which the Business Combination Agreement may be terminated if the conditions to the
Closing (as defined in the Business Combination Agreement) have not been satisfied or waived from February 17, 2024 (and subsequently extended, see below. In addition, the Company agreed to waive its right under its amended and restated memorandum
and articles of association to withdraw up to $100,000 of the interest earned on the funds held in the Trust Account to pay dissolution
expenses in the event of the liquidation of the Trust Account.
On May 21, 2024, the Business Combination Agreement
was further amended to extend the date on which the Business Combination Agreement may be terminated if the conditions to the Closing
have not been satisfied or waived from May 17, 2024 to June 17, 2024. Also, the parties have agreed that the Business Combination Agreement
may be terminated by Crown in the event that prior to June 17, 2024, the parties do not receive notice from Nasdaq, NYSE American, or
another national securities exchange acceptable to Crown, that the post-business combination public company common stock shall be approved
for listing upon the closing of the Business Combination. The non-solicitation provisions of the Business Combination Agreement were amended
to expire on May 31, 2024, unless Crown has received notice that the post-business combination public company common stock shall be approved
for listing upon the closing of the Business Combination on Nasdaq, NYSE American or another national securities exchange acceptable to
Crown.
Additionally, the Business Combination Agreement
may be terminated under certain customary circumstances at any time prior to the Closing, including, without limitation, (i) upon the
mutual written consent of the Company and Crown, (ii) by the Company, on the one hand, or Crown, on the other hand, as a result of breaches
by the counterparties to the Business Combination Agreement that remain uncured after any applicable cure period, (iii) by either the
Company or Crown, if a governmental authority of competent jurisdiction shall have issued an order or taken any other action permanently
prohibiting the transactions contemplated by the Business Combination Agreement, (iv) by the Company, on the one hand, or Crown, on the
other hand, as a result of the failure by the counterparties to obtain approvals required for the Business Combination, and (v) by the
Company, if there has been a material adverse effect on each of Crown and its direct and indirect subsidiaries.
On June 11, 2024, the Business Combination Agreement was further amended
to extend the date on which the Business Combination Agreement may be terminated by the parties if the conditions to the Closing (as defined
in the Business Combination Agreement) have not been satisfied or waived from June 17, 2024 to June 28, 2024. Also, the parties have agreed
that the Business Combination Agreement may be terminated by Crown in the event that prior to June 28, 2024, the parties do not receive
notice from NASDAQ, NYSE American, or another national securities exchange acceptable to Crown, that the post-business combination public
company common stock shall be approved for listing upon the closing of the Business Combination.
On June 12, 2024, Catcha held its Fourth
Extraordinary General Meeting of shareholders pursuant to which the shareholders of record as of January 16, 2024 approved
Catcha’s previously proposed Business Combination with Crown. In connection with the votes taken at this Extraordinary General
Meeting, Catcha has received elections from certain holders of our Class A ordinary shares to exercise their right to redeem their
shares for cash. As of the date of these financial statements, such elections are still within the time frame when such requests can
be rescinded; thus the final redemption payout has not yet been determined.
Business Combination – Other Agreements
April 2024 Notes
On April 30, 2024, PubCo entered into subscription
agreements with certain investors with respect to convertible promissory notes issuable upon closing of the Business Combination (the
“April 2024 Notes”) with an aggregate original principal amount of $1.05 million for an aggregate purchase price of $1.0 million,
reflecting a 5% original issue discount.
The April
2024 Notes bear interest at an annual rate of 10% and mature on the first anniversary of the issuance of the applicable note (the date
of such issuance, the “Issuance Date”). Interest on the April 2024 Notes is payable in cash or in-kind through the
issuance of additional April 2024 Notes, at the option of PubCo.
The
April 2024 Notes are convertible into PubCo ordinary shares at the option of the holder. The number of ordinary shares issuable upon conversion
of the April 2024 Notes is determined by dividing (x) such Conversion Amount by (y) the Conversion Price (the “Conversion Rate”).
“Conversion Amount” means the sum of (A) the portion of the principal of a note to be converted, redeemed or otherwise
with respect to which this determination is being made, (B) accrued and unpaid interest with respect to such principal of the applicable
note, and (C) any other unpaid amounts, if any. “Conversion Price” means $10.00 initially at the date of issuance of
the April 2024 Notes. The Conversion Price will reset to 95% of the lowest closing volume weighted average price observed over the 5 trading
days immediately preceding the 180th calendar day following the Issuance Date, subject to a minimum price of $2.50 (the “Minimum
Price”).
PubCo
has the option to redeem the April 2024 Notes in full at any time after the Issuance Date and prior to maturity thereof upon 10 Trading
Days’ (as defined in the April 2024 Notes) notice for cash at a redemption price equal to 110% of the aggregate principal amount
thereof, plus accrued and unpaid interest thereon.
PIPE
On May 6, 2024, PubCo and the Company entered
into a subscription agreement (the “PIPE Subscription Agreement”) for a private placement (the “PIPE”) with certain
accredited investor (the “Purchaser”). Pursuant to the PIPE Subscription Agreement, the Purchaser has agreed to purchase an
aggregate of 176,470 PubCo Ordinary Shares, at a price per share of $8.50, representing aggregate gross proceeds of $1.5 million.
On May 14, 2024, PubCo and the Company entered
into additional subscription agreements (together with the PIPE Subscription Agreement above, the “PIPE Subscription Agreements”)
for a private placements with certain accredited investor who are existing shareholders of Crown (the “Existing Shareholder Purchasers”).
Pursuant to the PIPE Subscription Agreement, the Existing Shareholder Purchasers have agreed to purchase an aggregate of 26,393 PubCo
Ordinary Shares (together with the PubCo Ordinary Shares to be purchased by the Purchaser, the “PIPE Shares”), at a price
per share of $10.00, representing aggregate gross proceeds of $263.9 thousand.
Securities Lending Agreement
On May 22, 2024, PubCo entered into a securities
lending agreement (the “Securities Lending Agreement”) with Millennia Capital Partners Limited (the “Lender”)
pursuant to which the Lender agreed to loan PubCo up to $4.0 million (the “Loan”) at fifty-five (55%) Loan to Value of the
current market value of 730,000 shares of Crown pledged to the Lender (“Transferred Collateral”). “Loan to Value”
means the ratio of the Loan to the value of the Transferred Collateral, calculated by dividing the amount borrowed by the fair market
value of the Transferred Collateral. The Loan matures thirty-six (36) months after the Closing Date (as defined in the Securities Lending
Agreement) and bears interest at an annual rate of 6.0% to be paid quarterly.
Securities Purchase Agreement
On June 4, 2024, PubCo entered into a a definitive
securities purchase agreement (the “Securities Purchase Agreement”; together with the April 2024 Notes, the PIPE and the Securities
Lending Agreement, the “Financing Agreements”) with Helena Special Opportunities LLC (the “Investor”), an affiliate
of Helena Partners Inc., a Cayman-Islands based advisor and investor, providing for up to approximately USD$20.7 million in funding through
a private placement for the issuance of convertible notes (the “SPA Notes”).
Results of Operations
We have neither engaged in any operations nor
generated any revenues to date. Our only activities from inception to December 31, 2023 were organizational activities, those necessary
to prepare for the IPO, described below, and after the IPO, identifying a target company for a business combination, the negotiation of
the Business Combination Agreement as described above and subsequent amendments thereto, and the preparation and filing on October 3,
2023 with the SEC of a registration statement on Form F-4 with respect to the Business Combination (the “Form F-4”). We do
not expect to generate any operating revenues until after the completion of our business combination. We may generate non-operating income
in the form of interest income on cash and investments held in the Trust Account and will recognize changes in the fair value of warrant
liability, Convertible Promissory Notes and Capital Contribution Note as other income (expense). We incur expenses as a result of being
a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection
with completing a business combination.
For the year ended December 31, 2023, we
had a net loss of $6,189,645, which consisted of operating expenses of $6,741,998, an unrealized loss on excess of fair value of the Capital
Contribution Note over proceeds at issuance of $1,059,720, an unrealized loss on change in fair value of the Convertible Promissory Notes
of $118,117, an unrealized loss on the change in fair value of the Working Capital Loan of $133,205 an unrealized loss on change in fair
value of the Capital Contribution Note of $840,571, unrealized loss on change in fair value of the warrant liability of $553,309 , an
unrealized loss on the issuance of the Derivative Liability – Note Payable of $1,917,828, an unrealized loss on the change in fair
value of the Derivative Liability — Note Payable of $21,536 and interest expense associated with the note payable, net of original
issuance discount of $750,000, these were partially offset by interest income on cash and investments held in the Trust Account of $2,774,613,
interest income associated with the note receivable, net of original issuance discount of $750,000, an unrealized gain on the issuance
of the Derivative Asset – Note Receivable of $1,917,828, an unrealized gain on the change in fair value of the Derivative Asset
— Note Receivable of $21,536 and other income attributable to the derecognition of deferred underwriting fees allocated to offering
costs of $482,662.
For the year ended December 31, 2022, we
had a net income of $11,616,356, which consisted of an unrealized gain on change in fair value of the warrant liability of $8,841,922,
interest income on investments held in the Trust Account of $4,001,686, offset partially by operating expenses of $1,227,252.
Liquidity, Capital Resources and Going Concern
On February 17, 2021, we consummated the
IPO of 30,000,000 Units, which included the partial exercise by the underwriter of its over-allotment option to purchase an additional
2,500,000 Units, at $10.00 per Unit, generating gross proceeds of $300,000,000. Simultaneously with the closing of the IPO, we consummated
the sale of an aggregate of 5,333,333 Private Placement Warrants to the Sponsor at a price of $1.50 per warrant, generating gross proceeds
of $8,000,000.
Following the IPO, the partial exercise of the
over-allotment option and the sale of the Private Placement Warrants, a total of $300,000,000 was placed in the Trust Account. We incurred
$17,031,183 in transaction costs, including $6,000,000 of underwriting fees, $10,500,000 of deferred underwriting fees and $531,183 of
other offering costs in connection with the IPO and the sale of the Private Placement Warrants.
On August 10, 2023, J.P. Morgan waived its entitlement
to the payment of $10,500,000 deferred underwriting fees in connection with its role as underwriter in the Company’s IPO. Furthermore,
J.P. Morgan had no role in connection with the Business Combination transaction.
For the year ended December 31, 2023, net cash
used in operating activities was $1,424,434. The net loss of $6,189,645 was impacted by an unrealized loss on excess of fair value of
the Capital Contribution Note over proceeds at issuance of $1,059,720, an unrealized loss on change in fair value of the Capital Contribution
Note of $840,571, an unrealized loss on change in fair value of the Convertible Promissory Notes of $118,117, an unrealized loss on the
change in fair value of the Working Capital Loan of $133,205, an unrealized gain on change in fair value of the warrant liability of $553,309
and an unrealized loss on the change in fair value of the Derivative Liability — Note Payable of $21,536 and interest expense associated
with the note payable, net of original issuance discount of $750,000 offset by interest income on cash and investments held in the Trust
Account of $2,774,613, interest income associated with the note receivable, net of original issuance discount of $750,000, an unrealized
gain on the change in fair value of the Derivative Asset — Note Receivable of $21,536 and other income attributable to derecognition
of deferred underwriting fees allocated to offering costs of $482,662 and changes in operating assets and liabilities, which provided
$5,317,564 of cash in operating activities, primarily due to the increase in accounts payable and accrued expenses.
For the year ended December 31, 2022, net
cash used in operating activities was $974,358. The net income of $11,616,356 was impacted by unrealized gain on change in fair value
of the warrant liability of $8,841,922, interest income on investments held in the Trust Account of $4,001,686 and by changes in operating
assets and liabilities, which provided $252,894 of cash from operating activities.
For the year ended December 31, 2023, net cash
provided by investing activities was $281,328,643, consisting of disposal of investments held in Trust Account of $282,903,643, partially
offset by cash deposited in Trust Account of $825,000 and note receivable $750,000.
For the year ended December 31, 2022, net
cash provided by/used in investing activities was $0.
For the year ended December 31, 2023, net cash
used in financing activities was $279,894,065, consisting of redemption of Class A ordinary shares of $282,903,643, partially offset by
proceeds from the issuance of a working capital loan of $1,134,578, proceeds from the issuance of a promissory note to a related party
of $825,000, proceeds from issuance of the Capital Contribution Note of $300,000 and proceeds from issuance of the promissory note to
a third party of $750,000.
For the year ended December 31, 2022, net
cash provided by/used in financing activities was $0.
As of December 31 2023, we had $30,850 in cash
outside of the Trust Account and working capital deficit of $9,345,634. In addition, in order to finance transaction costs in connection
with a business combination, the Sponsor, or an affiliate of the Sponsor, or certain of our officers and directors may, but are not obligated
to, provide us with working capital loans.
On December 13, 2022, we issued the $1.5
Million Convertible Promissory Note (see Note 5 of the Notes to Financial Statements) to the Sponsor, pursuant to which we may
borrow up to $1,500,000 from the Sponsor. As of December 31, 2023, we had borrowed $1,134,578 in principal under such note; the fair value of the note was $675,934 as of December 31, 2024.
As of the date these financial statements were issued, the Company received an aggregate of $1,431,995 in principal for working capital purposes under the $1.5 Million Convertible Promissory Note.
On February 14, 2023, we issued an unsecured convertible
promissory note (the “Extension Note”) to the Sponsor, pursuant to which we may borrow up to $900,000 (the “Extension
Loan”) from the Sponsor. Using these loans received, we deposited twelve tranches of $75,000 into the Trust Account from February
2023 to January 2024, to extend the date by which we must complete a Business Combination to February 14, 2024.
On March 9, 2023, we entered into a subscription agreement (the “March
2023 Subscription Agreement”) with the Sponsor and Polar Multi-Strategy Master Fund (“Polar”), pursuant to which Polar
has agreed to provide $300,000 to us (the “Capital Contribution Note”) as discussed in Note 7 of the Notes to the Financial
Statement. As of December 31, 2023, we had received the entire $300,000 funding under such note (see Note 6 of the Notes to Financial
Statements).
On February 22, 2024, March 21, 2024 and April
19, 2024, using the loans received from 2024 Extension Note No. 1, as described below, we deposited three tranches of $47,207 into the
Trust Account to extend the date by which we have to consummate the Business Combination to May 17, 2024.
On March 27, 2024,
we issued an unsecured convertible promissory note (the “2024 Extension Note No. 1”), dated as of February 17, 2024,
to the Sponsor, pursuant to which we may borrow up to $141,620 (the “2024 Extension Loan No. 1”) from the Sponsor,
consisting of the aggregate amount of the potential extensions of the Business Combination through May 17, 2024. Pursuant to the
2024 Extension Note No. 1, the Sponsor has agreed to deposit into the Trust Account cash in the amount of $47,207 per monthly extension
(or a pro rata portion thereof if less than a month), and we have agreed that the amount of each such deposit shall constitute a loan,
until the earlier of (i) the date of the extraordinary general meeting held in connection with a shareholder vote to approve an initial
business combination, and (ii) the date that $141,620 has been loaned. Such loan may, at the Sponsor’s discretion, be converted
into warrants to purchase our Class A ordinary shares at a conversion price equal to $1.50 per warrant, with each warrant entitling
the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to the same adjustments applicable to the
warrants issued to the Sponsor in the private placement that closed on February 17, 2021 in connection with the initial public offering.
The terms of the warrants will be identical to those of the private placement warrants. The 2024 Extension Loan No. 1 will not bear any
interest, and will be repayable by us to the Sponsor, on a date that is the earlier of the consummation of an initial business combination
and our liquidation. The maturity date of the 2024 Extension Loan No. 1 may be accelerated upon the occurrence of an Event of Default
(as defined under the 2024 Extension Note No. 1).
On March 29, 2024, we issued an unsecured
convertible promissory note (the “2024 Convertible Promissory Note”) to the Sponsor, pursuant to which we may borrow
up to $500,000 from the Sponsor. Such loan may, at the Sponsor’s discretion, be converted into warrants to purchase Class A
ordinary shares at a conversion price equal to $1.50 per warrant, with each warrant entitling the holder to purchase one Class A
ordinary share at a price of $11.50 per share, subject to the same adjustments applicable to the private placement warrants. The terms
of the warrants will be identical to those of the Private Placement Warrants. The loan will not bear any interest, and will be repayable
by us to the Sponsor, on a date that is the earlier of the consummation of an initial business combination and the liquidation of the
Company. The maturity date of the loan may be accelerated upon the occurrence of an Event of Default (as defined under the 2024 Convertible
Promissory Note).
On May 15, 2024, we
issued a promissory note in the principal amount of up to $122,839 (the “2024 Extension Note No. 2”) to the
Sponsor, pursuant to which we may borrow up to $122,839.38 (the “2024 Extension Loan No. 2”) from the Sponsor,
consisting of the aggregate amount of the potential extensions of the Business Combination through August 17, 2024. Pursuant to
the 2024 Extension Note No. 2, the Sponsor has agreed to deposit into our trust account established in connection with its initial
public offering cash in the amount of $40,946.46 per monthly Extension (or a pro rata portion thereof if less than a month), and we
have agreed that the amount of each such deposit shall constitute a loan, until the earlier of (i) the date of the
extraordinary general meeting held in connection with a shareholder vote to approve an initial business combination, and
(ii) the date that $122,839.38 has been loaned. Such loan may, at the Sponsor’s discretion, be converted into warrants to
purchase Class A ordinary shares of the Company at a conversion price equal to $1.50 per warrant, with each warrant entitling
the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to the same adjustments applicable to
the warrants issued to the Sponsor in the private placement that closed on February 17, 2021 in connection with the initial
public offering. The terms of the warrants will be identical to those of the private placement warrants. The 2024 Extension Loan No.
2 will not bear any interest, and will be repayable by us to the Sponsor, on a date that is the earlier of the
consummation of an initial business combination and the liquidation of the Company. The maturity date of the 2024 Extension Loan No.
2 may be accelerated upon the occurrence of an Event of Default (as defined under the 2024 Extension Note No. 2).
On May 24, 2024, using the proceeds received
under the 2024 Extension Note No. 2, the Company deposited $40,946 into our Trust Account to extend the date by which we have to
consummate the Business Combination to June 17, 2024.
In addition, in order to fund working capital
deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of e our officers and directors
or their affiliates may, but are not obligated to, loan us funds as may be required. Management will use these funds for paying existing
accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective
target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating
and consummating a Business Combination. No additional funding has been received under this arrangement. However, management expects us
to continue to incur significant costs in pursuit of the consummation of a Business Combination and current funds, committed or otherwise,
may not be sufficient to operate the Company for at least the 12 months following the issuance of the financial statements contained herein.
If we are unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include,
but not necessarily be limited to, suspending the pursuit of a Business Combination.
In connection with our assessment of going concern
considerations in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Subtopic
(“ASC”) 205-40, “Presentation of Financial Statements – Going Concern,” management has determined that if
we are unable to complete a Business Combination by August 17, 2024 (subject to us making the required monthly deposits of $40,946
to extend the date by which to consummate the Business Combination each month up through August 17, 2024) or such earlier date as is determined
by the Company’s board of directors, then we will cease all operations except for the purpose of liquidating. The mandatory liquidation,
subsequent dissolution and liquidity issues raise substantial doubt about our ability to continue as a going concern one year from the
date that these financial statements are issued. No adjustments have been made to the carrying amounts of assets or liabilities should
the Company be required to liquidate after August 17, 2024 or such earlier date as is determined by the Company’s board of directors.
Off-Balance Sheet Financing Arrangements
We have no obligations, assets or liabilities,
which would be considered off-balance sheet arrangements as of December 31, 2023. We do not participate in transactions that create relationships
with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established
for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements,
established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.
Contractual Obligations
We do not have any long-term debt, capital lease
obligations, operating lease obligations or long-term liabilities, other than as described below.
We have an agreement to pay the sponsor
$10,000 per month for office space, utilities, secretarial and administrative support services provided to members of the
Company’s management team. We began incurring these fees on February 12, 2021 and will continue to incur these fees
monthly until the earlier of the completion of the business combination or our liquidation. For each the years ended December 31,
2023 and 2022, we incurred $120,000 in expenses in connection with such services as reflected in the accompanying
statements of operations and paid an aggregate of $5,065 of these fees during the year ended December 31, 2023. As of December 31,
2023 and 2022, respectively, administrative service fees of $240,935 and $125,625 were unpaid and are included in due to related
party on the accompanying balance sheets.
On March 14, 2023, the Company entered into
an agreement with Chardan Capital Markets, LLC (“Chardan”) for Chardan to act as exclusive capital markets technical
advisor with respect to an event of a stock exchange demand for action by the Company at a time other than the initial closing of a
business combination involving the Company and a target or targets. The agreement calls for Chardan to receive a fee of $175,000 at
the signing of the agreement, a fee of $175,000 no later than 10 calendar days after Chardan informs the Company of the documented
completion of the technical advisory activities and a deferred fee of $275,000 at the earlier of (i) the closing of a Business
Combination from the closing flow-of-funds or (ii) upon the liquidation of the Trust Account if the Company has not consummated a
Business Combination. For the period ended December 31, 2023, the Company recorded $625,000 of such advisory service fees in the
accompanying statements of operations. As of December 31, 2023, the Company had paid an aggregate of $350,000 to Chardan; the total
unpaid balance due to Chardan was $275,000 and is included in accounts payable and accrued expenses in the accompanying balance
sheets.
On March 26, 2023, the Company entered an agreement
with Alumia to act as a non-exclusive transactional and strategic capital markets advisor to the Company assisting with introductions
and with respect to the Company’s potential Business Combination. The agreement calls for Alumia to receive simultaneously with
the Closing of the Business Combination (a) a fee in the amount of $2,500,000 and (b) a fee of 4% multiplied by the dollar amount of any
equity financing transactions which may be entered into by third party investors identified and introduced by Alumia, regardless of whether
the counterparty in the Business Combination was a subject target, payable upon the Closing. Alumia is currently not involved in the Company’s
Business Combination transaction with Crown, and no fee is currently payable under this agreement.
On May 18, 2023, the Company engaged J.V.B.
Financial Group, LLC, acting through its CCM division, to act as its (i) capital markets advisor in connection with the Business
Combination with Crown and (ii) placement agent in connection with a private placement of equity, equity-linked, convertible and/or
debt securities in connection with the Business Combination. The Company shall pay CCM (i) an advisor fee in connection with the
Business Combination in an amount equal to the sum of (I) $2,000,000 paid in full in U.S. dollars simultaneously with the Closing of
the Business Combination and (II) 50,000 Shares of the publicly listed post-business combination company (collectively, the
“Advisor Fee”) and (ii) an Offering Fee in connection with the Offering of an amount equal to 7.0% of the sum of (A) the
gross proceeds raised from investors and received by the Company or Crown simultaneously with or before the closing of the Offering
plus (B) proceeds released from the Trust Account with respect to any shareholder of the Company that (x) entered into a
non-redemption or other similar agreement or (y) did not redeem the Company’s Class A ordinary shares, in each instance to the
extent such investor or shareholder under (A) and (B) above was identified to the Company by CCM, which shall be payable in U.S.
dollars by the Company and due to CCM simultaneously with the closing of the Offering. The Shares shall be fully duly authorized,
validly issued, paid and non-assessable and shall be registered for resale under the Act, or otherwise freely tradeable, as of the
Closing of the Business Combination and will be delivered in book entry form in the name of and delivered to CCM (or its designee)
at the Closing of the Business Combination. As of December 31, 2023, no fees are currently payable under the aforementioned
agreement.
On October 25, 2023, we, the Sponsor and Polar entered into
the October 2023 Subscription Agreement (as defined in Note 8 of Notes to Financial Statements), pursuant to which Polar agreed to fund
a capital contribution of $750,000, without interest, to us and in consideration thereof, we agreed to issue or cause
PubCo to issue 750,000 Class A ordinary shares to Polar at the Closing. Together with the Sponsor, we, jointly and severally, agreed to
promptly repay the $750,000 to Polar within five (5) business days of the Closing. In the event that: (i) the Business Combination Agreement
is terminated or (ii) the Business Combination does not close by February 17, 2024 (or such other date as the parties to the Business
Combination Agreement shall agree) (the “Termination”), the Sponsor and us, jointly and severally, agreed to transfer,
or cause to be transferred to Polar within ten business days of the Termination, (A) $1,750,000 in cash; or (B) solely at the discretion
and election of Polar, $1,000,000 in cash and, a number of shares of Crown’s common equity equal to 1.5% of its outstanding common
equity (on a fully diluted basis) as of the date of Termination (either (A) or (B) above, the “Catcha Termination Payment”).
If a Catcha Termination Payment is not made within ten business days of the Termination, the Sponsor and the Company agreed to transfer,
or cause to be transferred, warrants that entitle Polar to purchase a number of shares of Crown’ common equity equal to 0.30 percent
per annum of the outstanding Crown common equity (on a fully-diluted basis) at exercise, for a price per share of $0.01 (the “Crown
Warrants”), accruing monthly (for each month from the date of the Termination until the time that Polar receives the full amount
of the Catcha Termination Payment, so that for each such month, a Crown Warrant shall be issued to Polar for a number of shares equal
to the total number of shares of outstanding common equity of Crown on a fully diluted basis multiplied by 0.00025). The Crown Warrants
are exercisable pursuant to terms set forth in the October 2023 Subscription Agreement.
On October 27, 2023, we entered into the Promissory
Note with Crown whereby the we agreed to provide a loan in the principal amount of $750,000 to Crown to fund working capital until the Closing.
Crown has agreed to repay the $750,000 to us within ten (10) business days of the Company providing Crown with written notice
of demand after the Closing. In the event the Business Combination Agreement is terminated or the Business Combination does not close
by February 17, 2024 (which was subsequently extended to May 17, 2024), Crown has agreed to transfer, or cause to be transferred to us within ten (10) business days of the termination, (A) $1,750,000 in cash; or (B) solely at our discretion and election, $1,000,000 in cash and a number of shares of Crown’s common equity equal to 1.5% of the outstanding common equity (on a
fully diluted basis) as of the date of the termination. We filed a current report on Form 8-K with the SEC on October 30, 2023,
to disclose the October 2023 Subscription Agreement and the Promissory Note.
On March 27,
2024, the we issued the 2024 Extension Note No. 1 to the Sponsor, pursuant to which we may borrow up to $141,620.04 from the
Sponsor, consisting of the aggregate amount of the potential extensions of the Business Combination through May 17, 2024.
Pursuant to the 2024 Extension Note No. 1, the Sponsor has agreed to deposit into our trust account established in connection with
its initial public offering cash in the amount of $47,206.68 per monthly Extension (or a pro rata portion thereof if less than a
month), and hawse have agreed that the amount of each such deposit shall constitute a loan, until the earlier of (i) the date
of the extraordinary general meeting held in connection with a shareholder vote to approve an initial business combination, and
(ii) the date that $141,620.04 has been loaned. Such loan may, at the Sponsor’s discretion, be converted into warrants to
purchase our Class A ordinary shares at a conversion price equal to $1.50 per warrant, with each warrant
entitling the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to the same adjustments
applicable to the warrants issued to the Sponsor in the private placement that closed on February 17, 2021 in connection with
the initial public offering. The terms of the warrants will be identical to those of the private placement warrants. The 2024
Extension Loan No. 1 will not bear any interest, and will be repayable by us to the Sponsor, on a date that is the earlier
of the consummation of an initial business combination and our liquidation. The maturity date of the 2024
Extension Loan No. 1 may be accelerated upon the occurrence of an Event of Default (as defined under the 2024 Extension Note No.
1).
On March 29, 2024, we issued the
2024 Convertible Promissory Note to our Sponsor, pursuant to which we may borrow up to $500,000 from the Sponsor. Such loan may,
at the Sponsor’s discretion, be converted into warrants to purchase Class A ordinary shares at a conversion price equal to
$1.50 per warrant, with each warrant entitling the holder to purchase one Class A ordinary share at a price of $11.50 per share,
subject to the same adjustments applicable to the private placement warrants. The terms of the warrants will be identical to those of
the Private Placement Warrants. The loan will not bear any interest, and will be repayable by us to the Sponsor, on a date that
is the earlier of the consummation of an initial business combination and the liquidation of the Company. The maturity date of the loan
may be accelerated upon the occurrence of an Event of Default (as defined under the 2024 Convertible Promissory Note).
On
May 15, 2024, we issued a promissory note in the principal amount of up to $122,839 (the “2024 Extension Note No.
2”) to the Sponsor, pursuant to which we may borrow up to $122,839 (the “2024 Extension Loan No. 2”)
from the Sponsor, consisting of the aggregate amount of the potential extensions of the Business Combination through August 17,
2024. Pursuant to the 2024 Extension Note No. 2, the Sponsor has agreed to deposit into our trust account established in connection
with its initial public offering cash in the amount of $40,946.46 per monthly Extension (or a pro rata portion thereof if less than
a month), and hawse have agreed that the amount of each such deposit shall constitute a loan, until the earlier of (i) the date
of the extraordinary general meeting held in connection with a shareholder vote to approve an initial business combination, and
(ii) the date that $122,839.38 has been loaned. Such loan may, at the Sponsor’s discretion, be converted into warrants to
purchase our Class A ordinary shares at a conversion price equal to $1.50 per warrant, with each warrant
entitling the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to the same adjustments
applicable to the warrants issued to the Sponsor in the private placement that closed on February 17, 2021 in connection with
the initial public offering. The terms of the warrants will be identical to those of the private placement warrants. The 2024
Extension Loan No. 2 will not bear any interest, and will be repayable by the Company to the Sponsor, on a date that is the earlier
of the consummation of an initial business combination and our liquidation. The maturity date of the 2024
Extension Loan No. 2 may be accelerated upon the occurrence of an Event of Default (as defined under the 2024 Extension Note No.
2).
Critical Accounting Policies and Estimates
This management’s discussion and analysis
of our financial condition and results of operations is based on our audited financial statements, which have been prepared in accordance
with GAAP. We describe our significant accounting policies in Note 2, of the notes to the audited financial statements included in this
report. The preparation of these audited financial statements requires us to make estimates and judgments that affect the reported amounts
of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in our audited financial statements. On an
ongoing basis, we evaluate our estimates and judgments, including those related to fair value of financial instruments and accrued expenses.
We base our estimates on historical experience, known trends and events and various other factors that we believe to be reasonable under
the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are
not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. The
Company has identified the following critical accounting policies and estimates.
Note Receivable
We analyzed the October 2023 Subscription Agreement
under ASC 320 “Investments – Debt Securities” and concluded that, bifurcation of a single derivative that comprises
all of the fair value of the Termination feature (i.e., derivative instrument) is necessary under ASC 815-15-25. As a result, the Company
recorded a held to maturity asset in the amount of $750,000 which is representative of the amortized cost of the Note Receivable and
recorded a corresponding Derivative Asset – Note Receivable in the amount of $2,667,828. During the subsequent measurement period,
the Company recorded an increase in expense in the amount of $21,536 associated with changes in the fair value of the Derivative Asset
- Note Receivable as of December 31, 2023. Further, the Note Receivable was issued at a discount of $750,000, which was fully accreted
to the Note Receivable balance immediately as it occurred.
To value the Derivative Asset – Note Receivable
upon issuance, the Company used a probability weighted expected return model (“PWER model”) that values the October 2023 Subscription
Agreement based on future projections of the various potential outcomes. The embedded options were valued using a Black Scholes model.
The derivative value was determined on a with and without basis. The key inputs for PWER model include 1) volatility of 35.5%; 2) risk–
free rate of 5.6%; 3) restricted terms of 0.31 year; 4) likelihood of completing a business combination of 60%.
Convertible Promissory Notes
We elected to account for the Convertible Promissory
Notes entered into with the Sponsor pursuant to the fair value option under ASC 825. ASC 825-10-15-4 provides for the “fair value
option” election, to the extent not otherwise prohibited by ASC 825-10-15-5, to be afforded to financial instruments, wherein the
financial instrument is initially measured at its issue-date estimated fair value and subsequently remeasured at estimated fair value
on a recurring basis at each reporting period date. Differences between the face value of the Convertible Promissory Notes and fair value
at issuance are recognized as either an expense in the statement of operations (if issued at a premium) or as a capital contribution
(if issued at a discount). Any material changes in the estimated fair value of the Convertible Promissory Notes are recognized as non-cash
gains or losses in the statements of operations. We believe that the fair value option better reflects the underlying economics of the
Convertible Promissory Notes. As such, the Convertible Promissory Notes were initially measured at $916,114 as of the issue date (including
$542,729 under the $1.5 Million Convertible Promissory Note and $373,385 under the Extension Note). The $1,043,464 excess of proceeds
over fair value at issuance was recorded as additional paid-in capital in the accompanying statement of shareholders’ deficit for
the period ended December 31, 2023. As of December 31, 2023, the fair value of the Convertible Promissory Notes was $491,502 under the
Extension Note and the fair value of the Working Capital Loan under the $1.5 Million Convertible Promissory Note was $675,934. For the
period ended December 31, 2023, the Company recognized an unrealized loss of $118,117 on the change in fair value of the Convertible
Promissory Note and an unrealized loss of $133,205 on the change in fair value of the Working Capital Loan, respectively, in the statements
of operations.
Capital Contribution Note
We elected to account for the Capital Contribution
Note entered into with Polar and the Sponsor (the March 2023 Subscription Agreement) on March 9, 2023, pursuant to the fair value option
under ASC 825. ASC 825-10-15-4 provides for the “fair value option” election, to the extent not otherwise prohibited by ASC
825-10-15-5, to be afforded to financial instruments, wherein the financial instrument is initially measured at its issue-date estimated
fair value and subsequently remeasured at estimated fair value on a recurring basis at each reporting period date. Differences between
the face value of the Capital Contribution Note and fair value at issuance are recognized as either an expense in the statement of operations
(if issued at a premium) or as a capital contribution (if issued at a discount). Any material changes in the estimated fair value of
the Capital Contribution Note are recognized as noncash gains or losses in the statements of operations. The Company believes that the
fair value option better reflects the underlying economics of the Capital Contribution Note. The fair value of the Capital Contribution
Note will include both the fair value of the 300,000 shares in consideration for the Capital Calls as described in Note 7 and the principal
as of each reporting date. As such, the Capital Contribution Note was initially measured at $1,359,720 as of the issue dates. The $1,059,720
excess of fair value of the Capital Contribution Note over proceeds at issuance was recorded in the accompanying statement of operations
for the period ended December 31, 2023. As of December 31, 2023, the fair value of the Capital Contribution Note was $2,200,291. For
the period ended December 31, 2023, we recognized $840,571 of unrealized loss on the change in fair value of the Capital Contribution
Note in the statements of operations.
October 2023 Subscription Agreement
We analyzed the October 2023 Subscription
Agreement under ASC 480 “Distinguishing Liabilities from Equity” and ASC 815, Derivatives and Hedging, and concluded
that, (i) the Subscription Shares issuable under the October 2023 Subscription Agreement are not required to be accounted for as a
liability under ASC 480 or ASC 815, (ii) bifurcation of a single derivative that comprises all of the fair value of the Subscription
Share feature(s) (i.e., derivative instrument) is not necessary under ASC 815-15-25, and (iii) bifurcation of a single derivative
that comprises all of the fair value of the Termination feature (i.e., derivative instrument) is necessary under ASC 815-15-25. As a
result, we analyzed the October 2023 Subscription Agreement under ASC 470 “Debt” and concluded that, the Subscription
Shares are representative of an equity classified freestanding financial instrument issued in a bundled transaction with a SPAC Loan
which is representative of liability classified freestanding financial instrument which contains a derivative instrument which is
required to be bifurcated and classified and accounted for as a derivative liability measured at fair value, on a recurring basis,
with changes in fair value recorded within the accompanying statements of operations. As a result, we recorded the October 2023
Subscription Agreement using the with-and-without method of accounting combined with the relative fair value method of accounting
when allocating the proceeds received under the October 2023 Subscription Agreement, as required under ASC 470. On October 25, 2023,
the date of issuance, the fair value of the Subscription Shares was $4,917,967, the fair value of the Derivative Liability —
Note Payable was $2,667,828, and the fair value of the Derivative Asset – Note Receivable (see Note 6) was $2,667,828. As of
December 31, 2023, we received $750,000 under the October 2023 Subscription Agreement. As of December 31, 2023, the fair value of
the Derivative Liability — Note Payable was $2,689,364; therefore, we recorded an increase in expense in the amount of $21,536
associated with changes in the fair value of the Derivative Liability — Note Payable as of December 31, 2023. Further, the
Note Payable was issued at a discount of $750,000, which was fully accreted to the Note Payable balance immediately as it
occurred.
We used a probability weighted expected return
model (“PWER model”) that values the October 2023 Subscription Agreement based on future projections of the various potential
outcomes. The embedded options were valued using a Black Scholes model. The derivative value was determined on a With and Without basis.
The key inputs for PWER model include 1) volatility of 35.5%; 2) risk– free rate of 5.6%; 3) restricted terms of 0.31 year; 4) likelihood
of completing a business combination of 60%.
Item 7A.
Quantitative and Qualitative Disclosures about Market Risk
We are a Smaller Reporting Company as defined
by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.
Item 8.
Financial Statements and Supplementary Data
This information appears following Item 15 of
this Report and is included herein by reference.
Item 9.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
None.
Item 9A.
Controls and Procedures.
Disclosure controls and procedures are controls
and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the
Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure
controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed
in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive
Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.
Evaluation of Disclosure Controls and Procedures
As required by Rules 13a-15 and 15d-15 under the
Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and
operation of our disclosure controls and procedures. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer
concluded that our disclosure controls and procedures were not effective as of December 31, 2023, due to the material weaknesses
in our internal control over financial reporting related to accounting for complex financial instruments, determining the fair value of
complex financial instruments and lack of controls needed to evaluate contractual agreements for contingent fee arrangements and unrecorded
liabilities to ensure it is accurate and complete. In light of these material weaknesses, we performed additional analysis as deemed necessary
to ensure that our audited financial statements were prepared in accordance with U.S. generally accepted accounting principles. Accordingly,
management believes that the financial statements included in this Annual Report on Form 10-K present fairly in all material respects
our financial position, results of operations and cash flows for the period presented.
We do not expect that our disclosure controls
and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and
operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met.
Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits
must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation
of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances
of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of
future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Management’s Annual Report on Internal Control over Financial
Reporting
As required by SEC rules and regulations implementing
Section 404 of the Sarbanes-Oxley Act, our management is responsible for establishing and maintaining adequate internal control over
financial reporting. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of our financial statements for external reporting purposes in accordance with U.S. GAAP. Our
internal control over financial reporting includes those policies and procedures that:
|
(1) |
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of our company, |
|
(2) |
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors, and |
|
(3) |
provide reasonable assurance regarding prevention
or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial
statements. |
Because of its inherent limitations, internal
control over financial reporting may not prevent or detect errors or misstatements in our financial statements. Also, projections of any
evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions,
or that the degree or compliance with the policies or procedures may deteriorate. Management assessed the effectiveness of our internal
control over financial reporting at December 31, 2023. In making these assessments, management used the criteria set forth by the
Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control—Integrated Framework (2013). Based on
our assessments and those criteria, management determined that our internal control over financial reporting was not effective, due to
the material weaknesses described elsewhere in this Report.
Management has implemented remediation steps to
address the material weaknesses and to improve our internal control over financial reporting. Specifically, we expanded and improved our
review process for complex securities and related accounting standards. We plan to further improve this process by enhancing access to
accounting literature, identification of third-party professionals with whom to consult regarding complex accounting applications and
consideration of additional staff with the requisite experience and training to supplement existing accounting professionals. Notwithstanding
the material weaknesses described above, management has concluded that our audited financial statements included in this Report are fairly
stated in all material respects in accordance with GAAP for each of the periods presented therein. The elements of our remediation plan
can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.
This Report does not include an attestation report
on internal controls from our independent registered public accounting firm due to our status as an emerging growth company under the
JOBS Act.
Changes in Internal Control over Financial
Reporting
There were no changes in our internal control
over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal
quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Item 9B.
Other Information
None.
Item 9C. Disclosure
Regarding Foreign Jurisdictions that Prevent Inspection
None.
Part
III
Item
10. Directors, Executive Officers and Corporate Governance
Directors and Executive Officers
As of the date of this Annual Report on Form 10-K,
our directors and officers are as follows:
Name |
|
Age |
|
Position |
Patrick Grove |
|
48 |
|
Chairman and Executive Officer |
Luke Elliott |
|
47 |
|
Director and President |
Wai Kit Wong |
|
40 |
|
Chief Financial Officer |
James Graf |
|
59 |
|
Independent Director |
Rick Hess |
|
61 |
|
Independent Director |
Yaniv Ghitis |
|
44 |
|
Independent Director |
Patrick Grove has served as our chairman
of the board of directors and our chief executive officer since our inception. Since founding Catcha Group in 1999, Mr. Grove has built
an extensive track record of founding, building, acquiring, listing and growing both private and public Southeast Asian digital businesses.
Today, Mr. Grove is widely recognized as one of the leading entrepreneurs in the region, having founded and taken numerous companies from
start up to initial public offering in Australia and Southeast Asia, including iProperty Group Limited, iCar Asia Limited, and Frontier
Digital Ventures Limited. Mr. Grove has been the recipient of numerous awards, including World Economic Forum Global Leader of Tomorrow,
Bloomberg Business Week Asia’s Best Young Entrepreneur, the Australia Unlimited Global 50 and Asian Entrepreneur of the Year. Mr.
Grove received his Bachelor of Commerce degree with a major in Finance from the University of Sydney.
Luke Elliott has served as our director
and president since our inception. Mr. Elliott co-founded Catcha Group with Mr. Grove in 1999 and has been responsible for the Group’s
corporate finance and operating activities since inception. Over the last 20 years, Mr. Elliott has completed over 70 corporate exercises
including capital raisings, mergers, acquisitions, and public listings and manages the acceleration and scaling of the Group’s portfolio
companies. Mr. Elliott has been in partnership with Mr. Grove for over 20 years, where they have together brought six digital business
from their early stages to a public listing or sale, worth over $1 billion in value.
Wai Kit Wong is our chief financial officer.
Mr. Wong brings significant corporate finance experience from 13 years at Goldman Sachs in Hong Kong, where he was an executive director
in the investment banking division, focusing on coverage of technology, media, and telecommunications companies in the Asia Pacific region.
At Goldman Sachs, Mr. Wong led and executed various large and sophisticated corporate finance transactions across Southeast Asia, China,
Australia, and India, including mergers and acquisitions, de-mergers, initial public offerings and debt offerings. He received a Bachelor
of Arts degree in Economics from the University of California, Berkeley.
James A. Graf is one of our independent directors. Mr. Graf has served as the Interim Chief Financial Officer of NKGen Biotech, Inc. (Nasdaq:
NKGN) since September 2023. Mr. Graf served as the chief executive officer of Graf Acquisition Corp. IV from its inception in January
2021 through the closing of the Business Combination with NKGen Biotech, Inc. in September 2023. Mr. Graf served as the chief executive
officer of Graf Industrial Corp., a blank check company, from June 2018 through its business combination with Velodyne Lidar, Inc. in
September 2020. Mr. Graf served as a director of Graf Industrial Corp. from June 2018 to September 2019 and served as a director of Velodyne
Lidar, Inc. from September 2020 to February 2021. Mr. Graf served as a director of Platinum Eagle Acquisition Corp. from January 2018
through its business combination with Target Logistics Management, LLC and RL Signor Holdings, LLC in March 2019. Mr. Graf served as the
vice president, chief financial officer and treasurer of Double Eagle Acquisition Corp. from its inception in June 2015 through its business
combination with Williams Scotsman, Inc. in November 2017. He served as vice president, chief financial officer, treasurer and secretary
of Silver Eagle Acquisition Corp. from its inception in April 2013 through Silver Eagle’s business combination with Videocon d2h
and he served as vice president, chief financial officer, treasurer and secretary of GEE from its inception in February 2011 to its business
combination with Row 44, Inc. and Advanced Inflight Alliance AG in January 2013. He was vice chairman of Global Entertainment AG, the
German entity holding GEE’s equity in AIA from 2013 to 2014 and special advisor to GEE in 2013. He served as a special advisor to
Videocon d2h from 2015 to 2016. From 2008 to 2011 Mr. Graf served as a managing director of TC Capital Ltd., an investment bank, in Singapore.
From 2007 to 2008, Mr. Graf was engaged as a consultant to provide financial advisory services to Metro- Goldwyn-Mayer, Inc. In 2001,
Mr. Graf founded and became chief executive officer of Praedea Solutions, Inc., an enterprise software company with operations in the
United States, Malaysia and Ukraine. The assets of Praedea Solutions, Inc. were sold in 2006 to a Mergent Inc., a wholly-owned subsidiary
of Xinhua Finance Ltd. and renamed Mergent Data Technology, Inc., where Mr. Graf continued to serve as Chief Executive Officer from 2006
to 2007. Praedea Solutions Inc. was renamed PSI Capital Inc. and currently serves as an investment holding company for Mr. Graf’s
private investments. Mr. Graf continues to be chief executive of PSI Capital Inc. Prior to founding Praedea, Mr. Graf was a managing director
at Merrill Lynch, in Singapore from 1998 to 2000 and a consultant to Merrill Lynch in 2001. From 1996 to 1998, Mr. Graf served as a director
and then managing director and president of Deutsche Bank’s investment banking entity in Hong Kong, Deutsche Morgan Grenfell (Hong
Kong) Ltd. From 1993 to 1996, he was a vice president at Smith Barney in Hong Kong and Los Angeles. From 1987 to 1993, Mr. Graf was an
analyst and then associate at Morgan Stanley in New York, Los Angeles, Hong Kong and Singapore. Mr. Graf received a Bachelor of Arts degree
from The University of Chicago in 1987.
Rick Hess is one of our independent directors.
Mr. Hess is the founder and a Managing Partner of Cobalt Capital Inc. (“Cobalt”). He leads the firm and is responsible for
deal origination and execution, as well as for the management of various Cobalt portfolio company relationships. Mr. Hess founded Evolution
Media Capital (EMC) (“Evolution Media”) in 2008, an investment advisory firm created in partnership with Creative Artists
Agency and served as its Managing Partner. He then formed Evolution Media, the early growth investing vehicle of TPG Growth (“TPG
Growth”), which invested in partnership with TPG Growth from 2012 to 2019. Prior to Evolution Media, Rick created and led the Film
Finance Group at Creative Artists Agency LLC (“CAA”). Under his leadership there, the group packaged, raised financing for,
or sold more than 125 feature films, including Academy Award-winning films Crash, Brokeback Mountain, Goodnight and Good Luck, and The
Tree of Life. Previously, he held executive positions at various film production companies.
Yaniv Ghitis is one of our independent
directors. Mr. Ghitis is an investment specialist in Asia-Pacific with considerable experience in originating, structuring, negotiating
and executing M&A and capital markets transactions across the region, including in Greater China, Southeast Asia, India, Korea, Japan
and Australia. Mr. Ghitis has served as the Chief Investment Officer of Digital Edge, a leading APAC data center platform, since 2021.
Prior to joining Digital Edge, he worked at J.P. Morgan for 17 years from 2004 to 2021 in its Hong Kong, New York, London and Tel Aviv
offices. Most recently he served as Managing Director and Co-Head of J.P. Morgan Technology, Media and Telecom Investment Banking in Asia-Pacific,
where he advised and raised capital for some of the most impactful technology and digital infrastructure companies in the region. Based
in Hong Kong, Yaniv holds a Bachelor of Arts in Management and Economics and a Masters of Arts in Economics, both from Tel Aviv University.
Number and Terms of Office of Officers and Directors
Prior to the completion of an initial business
combination, any vacancy on the board of directors may be filled by a nominee chosen by holders of a majority of our founder shares. In
addition, prior to the completion of an initial business combination, holders of a majority of our founder shares may remove a member
of the board of directors for any reason.
Pursuant to a registration and shareholder rights
agreement entered into concurrently with the issuance and sale of the securities in our initial public offering, our sponsor, upon and
following the consummation of an initial business combination, will be entitled to nominate three individuals for appointment of our board
of directors, as long as the sponsor holds any securities covered by the registration and shareholder rights agreement.
Our officers are appointed by the board of directors
and serve at the discretion of the board of directors, rather than for specific terms of office. Our board of directors is authorized
to appoint persons to the offices set forth in our third amended and restated memorandum and articles of association as it deems appropriate.
Our third amended and restated memorandum and articles of association provides that our officers may consist of one or more chairman of
the board, chief executive officer, president, chief financial officer, vice presidents, secretary, treasurer and such other offices as
may be determined by the board of directors.
Director Independence
NYSE listing standards require that a majority
of our board of directors be independent. Our board of directors has determined that James Graf, Rick Hess and Yaniv Ghitis are “independent
directors” as defined in the NYSE listing standards. Our independent directors will have regularly scheduled meetings at which only
independent directors are present.
Committees of the Board of Directors
Our board of directors has three standing committees:
an audit committee, a nominating & corporate governance committee, and a compensation committee. Subject to phase-in rules and a limited
exception, the rules of NYSE and Rule 10A-3 of the Exchange Act require that the audit committee of a listed company be comprised solely
of independent directors. Subject to phase-in rules and a limited exception, the rules of NYSE require that the compensation committee
and the nominating & corporate governance committee of a listed company be comprised solely of independent directors.
Audit Committee
We have established an audit committee of the
board of directors. James Graf, Rick Hess and Yaniv Ghitis serve as members of our audit committee. Our board of directors has determined
that each of James Graf, Rick Hess and Yaniv Ghitis are independent under the NYSE listing standards and applicable SEC rules. James Graf
serves as the chairman of the audit committee. Each member of the audit committee is financially literate and our board of directors has
determined that James Graf qualifies as an “audit committee financial expert” as defined in applicable SEC rules.
The audit committee is responsible for:
| ● | meeting with our independent registered public accounting firm regarding, among other issues, audits and
the adequacy of our accounting and control systems; |
| ● | monitoring the independence of the independent registered public accounting firm; |
| ● | verifying the rotation of the lead (or coordinating) audit partner having primary responsibility for the
audit and the audit partner responsible for reviewing the audit as required by law; |
| ● | inquiring and discussing with management our compliance with applicable laws and regulations; |
| ● | pre-approving all audit services and permitted non-audit services to be performed by our independent registered
public accounting firm, including the fees and terms of the services to be performed; |
| ● | appointing or replacing the independent registered public accounting firm; |
| ● | determining the compensation and oversight of the work of the independent registered public accounting
firm (including resolution of disagreements between management and the independent registered public accounting firm regarding financial
reporting) for the purpose of preparing or issuing an audit report or related work; |
| ● | establishing procedures for the receipt, retention and treatment of complaints received by us regarding
accounting, internal accounting controls or reports which raise material issues regarding our financial statements or accounting policies; |
| ● | monitoring compliance on a quarterly basis with the terms of our initial public offering and, if any noncompliance
is identified, immediately taking all action necessary to rectify such noncompliance or otherwise causing compliance with the terms of
our initial public offering; and |
| ● | reviewing and approving all payments made to our existing shareholders, officers or directors and their
respective affiliates. Any payments made to members of our audit committee will be reviewed and approved by our board of directors, with
the interested director or directors abstaining from such review and approval. |
Nominating &
Corporate Governance Committee
We have established a nominating & corporate
governance committee of our board of directors. The members of our nominating & corporate governance committee are James Graf, Rick
Hess and Yaniv Ghitis, and Rick Hess serves as chairman of the nominating & corporate governance committee. Our board of directors
has determined that each of James Graf and Rick Hess are independent.
The nominating & corporate governance committee
is responsible for overseeing the appointment of persons to be nominated to serve on our board of directors. The nominating & corporate
governance committee considers persons identified by its members, management, shareholders, investment bankers and others.
The guidelines for selecting nominees, which are
specified in a charter adopted by us, generally provides that persons to be nominated:
| ● | should have demonstrated notable or significant achievements in business, education or public service; |
| ● | should possess the requisite intelligence, education and experience to make a significant contribution
to the board of directors and bring a range of skills, diverse perspectives and backgrounds to its deliberations; and |
| ● | should have the highest ethical standards, a strong sense of professionalism and intense dedication to
serving the interests of the shareholders. |
The nominating & corporate governance committee
will consider a number of qualifications relating to management and leadership experience, background, integrity and professionalism in
evaluating a person’s candidacy for membership on the board of directors. The nominating & corporate governance committee may
require certain skills or attributes, such as financial or accounting experience, to meet specific board needs that arise from time to
time and will also consider the overall experience and makeup of its members to obtain a broad and diverse mix of board members. The nominating
& corporate governance committee does not distinguish among nominees recommended by shareholders and other persons.
Compensation Committee
We have established a compensation committee of
our board of directors. The members of our compensation committee are James Graf, Rick Hess and Yaniv Ghitis, and James Graf serves as
chairman of the compensation committee. Our board of directors has determined that each of James Graf and Rick Hess are independent. We
have adopted a compensation committee charter, which details the principal functions of the compensation committee, including:
| ● | reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chairman’s,
President’s and Chief Executive Officer’s compensation, evaluating our Chairman’s, President’s and Chief Executive
Officer’s performance in light of such goals and objectives, and determining and approving the remuneration (if any) of our Chairman,
President and Chief Executive Officer based on such evaluation; |
| ● | reviewing and approving the compensation of all of our other Section 16 executive officers, if any; |
| ● | reviewing our executive compensation policies and plans; |
| ● | implementing and administering our incentive compensation and equity-based remuneration plans; |
| ● | assisting management in complying with our proxy statement and annual report disclosure requirements; |
| ● | approving all special perquisites, special cash payments and other special compensation and benefit arrangements
for our executive officers and employees; |
| ● | producing a report on executive compensation to be included in our annual proxy statement; and |
| ● | reviewing, evaluating, and recommending changes, if appropriate, to the remuneration for directors. |
The charter also provides that the compensation
committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, legal counsel, or other adviser and will
be directly responsible for the appointment, compensation, and oversight of the work of any such adviser. However, before engaging or
receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee will consider
the independence of each such adviser, including the factors required by NYSE and the SEC.
Compensation Committee
Interlocks and Insider Participation
None of our executive officers currently serves,
and in the past year has not served, as a member of the compensation committee of any entity that has one or more executive officers serving
on our board of directors.
Code of Ethics
We have adopted a code of ethics (“Code
of Ethics”) applicable to our officers, directors, and employees. A copy of the Code of Ethics will be provided without charge upon
request from us. We intend to disclose any amendments to or waivers of certain provisions of our Code of Ethics in a Current Report on
Form 8-K.
Conflicts of Interest
Under Cayman Islands law, officers and directors
owe the following fiduciary duties:
| ● | duty to act in good faith in what the officer or director believes to be in the best interests of the
company as a whole; |
| ● | duty to exercise powers for the purposes for which those powers were conferred and not for a collateral
purpose; |
| ● | directors should not improperly fetter the exercise of future discretion; |
| ● | duty to exercise powers fairly as between different sections of shareholders; |
| ● | duty not to put themselves in a position in which there is a conflict between their duty to the company
and their personal interests; and |
| ● | duty to exercise independent judgment. |
In addition to the above, directors also owe a
duty of care, which is not fiduciary in nature. This duty has been defined as a requirement to act as a reasonably diligent person having
both the general knowledge, skill and experience that may reasonably be expected of a person carrying out the same functions as are carried
out by that director in relation to the company and the general knowledge skill and experience of that director.
As set out above, directors have a duty not to
put themselves in a position of conflict and this includes a duty not to engage in self-dealing, or to otherwise benefit as a result of
their position. However, in some instances, what would otherwise be a breach of this duty can be forgiven and/or authorized in advance
by the shareholders, provided that there is full disclosure by the directors. This can be done by way of permission granted in the third
amended and restated memorandum and articles of association or alternatively by shareholder approval at general meetings.
Our officers and directors presently have, or
may in the future have, fiduciary and contractual duties to other entities. As a result, if any of our officers or directors becomes aware
of a business combination opportunity that is suitable for an entity to which he or she has then-current fiduciary or contractual obligations,
then, subject to their fiduciary duties under Cayman Islands law, he or she will need to honor such fiduciary or contractual obligations
to present such business combination opportunity to such entity, before we can pursue such opportunity. If these other entities decide
to pursue any such opportunity, we may be precluded from pursuing the same. However, we do not expect these duties to materially affect
our ability to complete our initial business combination. Our third amended and restated memorandum and articles of association provides
that, to the fullest extent permitted by applicable law: (i) no individual serving as an officer or a director shall have any duty, except
and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same or similar business activities
or lines of business as us; and (ii) we renounce any interest or expectancy in, or in being offered an opportunity to participate in,
any potential transaction or matter which may be a corporate opportunity for any director or officer, on the one hand, and us, on the
other.
Below is a table summarizing the entities to which
our executive officers and directors currently have fiduciary duties, contractual obligations or other material management relationships:
Individual |
|
Entity |
|
Entity’s Business |
|
Affiliation |
Patrick Grove(1) |
|
Catcha Group |
|
Private Investments |
|
Co-founder, Chairman, and Chief Executive Officer |
Luke Elliott(1) |
|
Catcha Group |
|
Private Investments |
|
Co-founder and Executive Director |
James Graf |
|
PSI Capital Inc. |
|
Venture Capital Investments |
|
Chief Executive Officer |
|
|
NKGen Biotech, Inc. |
|
Clinical stage biotechnology |
|
Interim Chief Financial Officer |
Rick Hess(2) |
|
Cobalt Capital |
|
Venture Capital Investments |
|
Founder and Chief Executive Officer |
Yaniv Ghitis |
|
Digital Edge |
|
Digital infrastructure |
|
Chief Investment Officer |
| (1) | Mr. Grove and Mr. Elliott are directors of portfolio companies
of Catcha Group and its affiliated entities, and may be obligated to show acquisitions to such companies before we may pursue such acquisitions. |
| (2) | Mr. Hess is also a director of certain portfolio companies of
Cobalt Capital and its affiliated entities, and he may be obligated to show acquisitions to such companies before we may pursue such
acquisitions |
Potential investors should also be aware of the
following other potential conflicts of interest:
| ● | Our executive officers and directors are not required to, and will not, commit their full time to our
affairs, which may result in a conflict of interest in allocating their time between our operations and our search for a business combination
and their other businesses. We do not intend to have any full-time employees prior to the completion of our initial business combination.
Each of our executive officers is engaged in, or may in the future engage in, several other business endeavors for which he may be entitled
to substantial compensation, and our executive officers are not obligated to contribute any specific number of hours per week to our affairs. |
| ● | Our sponsor subscribed for founder shares and purchased private placement warrants in a transaction that
closed simultaneously with the closing of our initial public offering. |
|
● |
Our officers and directors have entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to any founder shares and public shares held by them in connection with (i) the completion of our initial business combination and (ii) a shareholder vote to approve an amendment to our third amended and restated memorandum and articles of association (A) that would modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of our initial public offering or during any extension period or (B) with respect to any other provision relating to the rights of holders of our Class A ordinary shares. Additionally, our officers and directors have agreed to waive their rights to liquidating distributions from the trust account with respect to their founder shares if we fail to complete our initial business combination within the prescribed time frame. If we do not complete our initial business combination within the prescribed time frame, the private placement warrants will expire worthless. Except as described herein, our sponsor, directors and executive officers have agreed not to transfer, assign or sell any of their founder shares until the earliest of (A) one year after the completion of our initial business combination and (B) subsequent to our initial business combination, (x) if the closing price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination, or (y) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Except as described herein, the private placement warrants will not be transferable until 30 days following the completion of our initial business combination. Our officers and directors who own ordinary shares or warrants, directly or indirectly may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination. |
| ● | Our officers and directors may have a conflict of interest with respect to evaluating a particular business
combination if the retention or resignation of any such officers and directors is included by a target business as a condition to any
agreement with respect to our initial business combination. In addition, our sponsor, officers and directors may sponsor, form, or participate
in other blank check companies similar to ours during the period in which we are seeking an initial business combination. Any such companies
may present additional conflicts of interest in pursuing an acquisition target, particularly in the event there is overlap among investment
mandates. |
We are not prohibited from pursuing an initial
business combination with a company that is affiliated with our sponsor, officers, or directors. In the event we seek to complete our
initial business combination with a company that is affiliated with our sponsor or any of our officers or directors, we, or a committee
of independent directors, will obtain an opinion from an independent investment banking firm that is a member of FINRA or another independent
entity that commonly renders valuation opinions that such initial business combination is fair to our company from a financial point of
view. We are not required to obtain such an opinion in any other context.
Furthermore, in no event will our sponsor or any
of our existing officers or directors or their respective affiliates be paid by us any finder’s fee, consulting fee or other compensation
prior to, or for any services they render in order to effectuate, the completion of our initial business combination. Further, commencing
on the date our securities are first listed on NYSE, we will also reimburse an affiliate of our sponsor for office space, secretarial
and administrative services provided to us in the amount of $10,000 per month.
We cannot assure you that any of the above mentioned
conflicts will be resolved in our favor.
If we seek shareholder approval, we will complete
our initial business combination only if we obtain the approval of an ordinary resolution under Cayman Islands law, which requires the
affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the company. In such case, our officers
and directors have agreed to vote their founder shares and public shares in favor of our initial business combination.
Limitation on Liability and Indemnification of Officers and Directors
Cayman Islands law does not limit the extent to
which a company’s memorandum and articles of association may provide for indemnification of officers and directors, except to the
extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification
against willful default, willful neglect, civil fraud or the consequences of committing a crime. Our third amended and restated memorandum
and articles of association provides for indemnification of our officers and directors to the maximum extent permitted by law, including
for any liability incurred in their capacities as such, except through their own actual fraud, willful default, or willful neglect. We
entered into indemnity agreements with our officers and directors to provide contractual indemnification in addition to the indemnification
provided for in our third amended and restated memorandum and articles of association. We expect to purchase a policy of officers’
and directors’ liability insurance that insures our officers and directors against the cost of defense, settlement or payment of
a judgment in some circumstances and insures us against our obligations to indemnify our officers and directors.
Our officers and directors have agreed to waive
any right, title, interest or claim of any kind in or to any monies in the trust account, as well as any right, title, interest or claim
of any kind they may have in the future as a result of, or arising out of, any services provided to us, and will not seek recourse against
the trust account for any reason whatsoever (except to the extent they are entitled to funds from the trust account due to their ownership
of public shares). Accordingly, any indemnification provided will only be able to be satisfied by us if (i) we have sufficient funds outside
of the trust account or (ii) we consummate an initial business combination.
Our indemnification obligations may discourage
shareholders from bringing a lawsuit against our officers or directors for breach of their fiduciary duty. These provisions also may have
the effect of reducing the likelihood of derivative litigation against our officers and directors, even though such an action, if successful,
might otherwise benefit us and our shareholders. Furthermore, a shareholder’s investment may be adversely affected to the extent
we pay the costs of settlement and damage awards against our officers and directors pursuant to these indemnification provisions.
We believe that these provisions, the insurance,
and the indemnity agreements are necessary to attract and retain talented and experienced officers and directors.
Item
11. Executive Compensation
Executive Officer and Director Compensation
None of our executive officers or directors have
received any cash compensation for services rendered to us. We pay an affiliate of our sponsor for office space, secretarial and administrative
services provided to us in the amount of $10,000 per month. In addition, our sponsor, executive officers, directors or their respective
affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf, such as identifying
potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly
basis all payments that were made by us to our sponsor, executive officers or directors or their respective affiliates. Any such payments
prior to an initial business combination will be made using funds held outside the trust account. Other than quarterly audit committee
review of such reimbursements, we do not expect to have any additional controls in place governing our reimbursement payments to our executive
officers and directors for their out-of-pocket expenses incurred in connection with our activities on our behalf in connection with identifying
and consummating an initial business combination. Other than these payments and reimbursements, no compensation of any kind, including
finder’s and consulting fees, will be paid by the company to our sponsor, executive officers and directors or their respective affiliates,
prior to completion of our initial business combination.
After the completion of our initial business combination,
directors or members of our management team who remain with us may be paid consulting or management fees from the combined company. All
of these fees will be fully disclosed to shareholders, to the extent then known, in the proxy solicitation materials or tender offer materials
furnished to our shareholders in connection with a proposed business combination. We have not established any limit on the amount of such
fees that may be paid by the combined company to our directors or members of management. It is unlikely the amount of such compensation
will be known at the time of the proposed business combination, because the directors of the post-combination business will be responsible
for determining executive officer and director compensation. Any compensation to be paid to our executive officers will be determined,
or recommended to the board of directors for determination, either by a compensation committee constituted solely by independent directors
or by a majority of the independent directors on our board of directors.
We do not intend to take any action to ensure
that members of our management team maintain their positions with us after the consummation of our initial business combination, although
it is possible that some or all of our executive officers and directors may negotiate employment or consulting arrangements to remain
with us after our initial business combination. The existence or terms of any such employment or consulting arrangements to retain their
positions with us may influence our management’s motivation in identifying or selecting a target business but we do not believe
that the ability of our management to remain with us after the consummation of our initial business combination will be a determining
factor in our decision to proceed with any potential business combination. We are not party to any agreements with our executive officers
and directors that provide for benefits upon termination of employment.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
The following table sets forth information regarding the beneficial
ownership of our ordinary shares as of June 17, 2024 based on information obtained from the persons named below, with respect to the beneficial
ownership of our shares of Class A ordinary shares and Class B ordinary shares, by:
| ● | each
person known by us to be the beneficial owner of more than 5% of our issued and outstanding ordinary shares; |
| ● | each
of our officers and directors that beneficially owns ordinary shares; and |
| ● | all
our officers and directors as a group. |
In the table below, percentage ownership is based on 8,715,232 shares
of Class A ordinary shares, and 149,650 shares of Class B ordinary shares issued and outstanding as of June 17, 2024. Voting power represents
the combined voting power of Class A ordinary shares and Class B ordinary shares owned beneficially by such person. On all matters to
be voted upon, the holders of the Class A ordinary shares and Class B ordinary shares vote together as a single class. The following table
does not reflect record or beneficial ownership of the private placement warrants as these warrants are not exercisable within 60 days
of this report.
| |
Class B ordinary shares | | |
Class A ordinary shares | | |
| |
Name of Beneficial Owners(1) | |
Number of Shares Beneficially Owned | | |
Approximate Percentage of Class | | |
Number of Shares Beneficially Owned | | |
Approximate Percentage of Class | | |
Approximate Percentage of Voting Control | |
Catcha Holdings LLC(2) | |
| | | |
| — | | |
| 7,350,350 | | |
| 84 | % | |
| 84 | %(4) |
Patrick Grove | |
| | | |
| — | | |
| 7,350,350 | | |
| 84 | % | |
| 84 | %(4) |
Luke Elliott | |
| | | |
| — | | |
| 7,350,350 | | |
| 84 | % | |
| 84 | %(4) |
Wai Kit Wong(3) | |
| 625 | | |
| 0.4 | % | |
| — | | |
| — | | |
| — | |
James Graf | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | |
Rick Hess | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | |
Yaniv Ghitis | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | |
All officers and directors as a group (six members) | |
| 625 | | |
| 0.4 | % | |
| 7,350,350 | | |
| 84 | % | |
| 84 | % |
| (1) | Unless otherwise noted, the business address of each of our
shareholders is 3 Raffles Place, #06-01 Bharat Building, Singapore 048617. |
| (2) | Represents 7,350,350 Class A ordinary shares directly held by
our sponsor. |
| (3) | Represents 625 Class B ordinary shares directly held by our
chief financial officer. |
| (4) | Patrick Grove and Luke Elliott share voting and investment control
over the shares held by Catcha Holdings LLC. Mr. Grove and Mr. Elliott disclaim any beneficial ownership of the securities held by Catcha
Holdings LLC other than to the extent of any pecuniary interest they may have therein, directly or indirectly. |
Changes in Control
None.
Item 13. Certain Relationships and Related Transactions, and Director Independence
Founder Shares
On December 28, 2020, the sponsor paid $25,000,
or approximately $0.003 per share, to cover certain offering costs in consideration for 7,187,500 Class B ordinary shares, par value $0.0001.
On February 11, 2021, the company effected a share capitalization resulting in the sponsor holding an additional 718,750 class B ordinary
shares for an aggregate of 7,906,250 class B ordinary shares including up to 1,031,250 founder shares subject to forfeiture by the sponsor
depending on the extent to which the underwriters’ over-allotment option was exercised. On February 17, 2021, the underwriters partially
exercised their over-allotment option, hence, 625,000 founder shares were no longer subject to forfeiture.
The initial shareholders have agreed not to transfer,
assign, or sell any of their founder shares and any Class A ordinary shares issuable upon conversion thereof until the earlier to occur
of: (i) one year after the completion of the initial business combination, or (ii) the date on which the company completes a liquidation,
merger, share exchange or other similar transaction after the initial business combination that results in all of the company’s
shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property; except to certain permitted
transferees and under certain circumstances (the “lock-up”). Notwithstanding the foregoing, if the closing price of Class
A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations
and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial business combination
or (2) if the company consummates a transaction after the initial business combination which results in the company’s shareholders
having the right to exchange their shares for cash, securities or other property, the founder shares will be released from the lock-up.
Private Placement
Warrants
Substantially concurrent with the closing of the
initial public offering, we completed the private placement sale of 5,333,333 Private Placement Warrants at a purchase price of $1.50
per private placement warrant, to the sponsor generating gross proceeds to the company of $8,000,000. The proceeds from the sale of the
Private Placement Warrants were added to the proceeds from the initial public offering held in the trust account. If the company does
not complete a business combination within the relevant period, the private placement warrants will expire worthless.
The private placement warrants (including the
Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable, or salable until
30 days after the completion of the initial business combination and they will not be redeemable by the company so long as they are held
by the sponsor or its permitted transferees. The sponsor, or its permitted transferees, has the option to exercise the private placement
warrants on a cashless basis. If the private placement warrants are held by holders other than the sponsor or its permitted transferees,
the private placement warrants will be redeemable by the company and exercisable by the holders on the same basis as the warrants included
in the units being sold in the initial public offering.
Administrative Service
Fee
We currently maintain our executive offices at
3 Raffles Place #06-01, Bharat Building, Singapore 048617. The cost for our use of this space is included in the $10,000 per month fee
we pay to an affiliate of our sponsor for office space and administrative and support services, commencing on the date that our securities
are first listed on NYSE. Upon the completion of our initial business combination or our liquidation, we will cease paying these monthly
fees.
Due to related party
As of December 31, 2023 and 2022, the amount due
to related party was $241,366 and $125,625, respectively, which mainly consisted of the unpaid portion of the administrative service fee
described below.
Promissory Notes-Related Party
On December 28, 2020, the Company issued an unsecured
promissory note to the Sponsor, pursuant to which the Company was allocated to borrow up to $300,000 to be used for a portion of the expenses
of the IPO. These loans were non-interest bearing, unsecured and were due at the earlier of September 30, 2021 or the closing of the IPO.
On February 22, 2021, the Company repaid $131,259 of amounts borrowed from the Sponsor, the funds of which were used to pay offering costs.
The note was terminated on February 22, 2021.
On February 14, 2023, the Company issued an unsecured
convertible promissory note (the “Extension Note” and, together with the “1.5 Million Convertible Promissory Note”
as described below, the “Convertible Promissory Notes”) to the Sponsor, pursuant to which the Company may borrow up to $900,000
(the “Extension Loan”) from the Sponsor. Pursuant to the Extension Note, from February 17, 2023 to February 17, 2024 or such
earlier date as is determined by the Company’s board of directors, the Sponsor has agreed to deposit into the Company’s Trust
Account the lesser of (i) $75,000 or (ii) $0.0375 for each unredeemed public share, for each month (or a pro rata portion thereof if less
than a month) until the earlier of (i) the date of the extraordinary general meeting held in connection with a shareholder vote to approve
the Business Combination, and (ii) the date that $900,000 has been loaned. Such loan may, at the Sponsor’s discretion, be converted
into warrants (the “Extension Loan Warrants”) to purchase Class A ordinary shares of the Company, par value $0.0001 per share,
at a conversion price equal to $1.50 per warrant, with each warrant entitling the holder to purchase one Class A ordinary share of the
Company at a price of $11.50 per share, subject to the same adjustments applicable to the Private Placement Warrants that were issued
in connection with the IPO. The terms of the Extension Loan Warrants will be identical to those of the Private Placement Warrants. The
Extension Loan will not bear any interest, and will be repayable by the Company to the Sponsor, on a date that is the earlier of (a) the
consummation of the Company’s initial merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization
or similar business combination with one or more businesses or entities and (b) the liquidation of the Company. The maturity date of the
Extension Loan may be accelerated upon the occurrence of an Event of Default (as defined under the Extension Note).
As of December 31, 2023, $825,000 had been withdrawn
under the Extension Note. Up to the date that the financial statements were issued, the Company had received $900,000 for the extension
deposits under the Extension Note.
On March 27, 2024, the Company issued an unsecured convertible promissory note
(the “2024 Extension Note No. 1”), dated as of February 17, 2024, to the Sponsor, pursuant to which the Company may borrow
up to $141,620 (the “2024 Extension Loan No. 1”) from the Sponsor, consisting of the aggregate amount of the potential Extensions
through May 17, 2024. Pursuant to the 2024 Extension Note No. 1, the Sponsor has agreed to deposit into the Company’s trust account
established in connection with its initial public offering cash in the amount of $47,207 per monthly Extension (or a pro rata portion
thereof if less than a month), and the Company has agreed that the amount of each such deposit shall constitute a loan, until the earlier
of (i) the date of the extraordinary general meeting held in connection with a shareholder vote to approve an initial business combination,
and (ii) the date that $141,620 has been loaned. Such loan may, at the Sponsor’s discretion, be converted into warrants (the “2024
Extension Loan No. 1 Warrants”) to purchase Class A ordinary shares of the Company, par value $0.0001 per share (“Class A
Ordinary Shares”), at a conversion price equal to $1.50 per warrant, with each warrant entitling the holder to purchase one Class
A Ordinary Share at a price of $11.50 per share, subject to the same adjustments applicable to the warrants issued to the Sponsor in the
private placement that closed on February 17, 2021 (the “Private Placement Warrants”) in connection with the initial public
offering of the Company’s securities. The terms of the 2024 Extension Loan No. 1 Warrants will be identical to those of the Private
Placement Warrants. The 2024 Extension Loan No. 1 will not bear any interest, and will be repayable by the Company to the Sponsor, on
a date that is the earlier of (a) the consummation of the Company’s initial merger, stock exchange, asset acquisition, stock purchase,
recapitalization, reorganization or similar business combination with one or more businesses or entities and (b) the liquidation of the
Company. The maturity date of the 2024 Extension Loan No. 1 may be accelerated upon the occurrence of an Event of Default (as defined
under the 2024 Extension Note No. 1).
Up to the date that the financial statements were issued, the Company
had received $141,620 for the extension deposits under the 2024 Extension Note No. 1.
Up to the date that the financial statements were
issued, the Company had received $40,946 for the extension deposits under the 2024 Extension Note No. 2.
On May 15, 2024, the Company issued the 2024 Extension
Note No. 2 to the Sponsor, pursuant to which the Company may borrow up to $122,839.38 (the “2024 Extension Loan No. 2”) from
the Sponsor, consisting of the aggregate amount of the potential extensions of the Business Combination through August 17, 2024. Pursuant
to the 2024 Extension Note No. 2, the Sponsor has agreed to deposit into the Company’s trust account established in connection with
its initial public offering cash in the amount of $40,946.46 per monthly Extension (or a pro rata portion thereof if less than a month),
and the Company has agreed that the amount of each such deposit shall constitute a loan, until the earlier of (i) the date of the extraordinary
general meeting held in connection with a shareholder vote to approve an initial business combination, and (ii) the date that $122,839.38
has been loaned. Such loan may, at the Sponsor’s discretion, be converted into warrants to purchase Class A ordinary shares of the
Company at a conversion price equal to $1.50 per warrant, with each warrant entitling the holder to purchase one Class A ordinary share
at a price of $11.50 per share, subject to the same adjustments applicable to the warrants issued to the Sponsor in the private placement
that closed on February 17, 2021 in connection with the initial public offering. The terms of the warrants will be identical to those
of the private placement warrants. The 2024 Extension Loan No. 2 will not bear any interest, and will be repayable by the Company to the
Sponsor, on a date that is the earlier of the consummation of an initial business combination and the liquidation of the Company. The
maturity date of the 2024 Extension Loan No. 2 may be accelerated upon the occurrence of an Event of Default (as defined under the 2024
Extension Note No. 2).
On May 24, 2024, using the proceeds received under
the 2024 Extension Note No. 2, the Company deposited $40,946 into the Trust Account to extend the date by which the Company has to consummate
the Business Combination to June 17, 2024.
Working Capital Loans
In
addition, in order to finance transaction costs in connection with an intended Business Combination, the Sponsor or an affiliate of the
Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required
(“Working Capital Loans”). If the Company completes the initial Business Combination, the Company would repay the Working
Capital Loans. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital
held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working
Capital Loans. A portion of the Working Capital Loans, not to exceed $1,500,000, may be convertible into Private Placement Warrants at
a price of $1.50 per warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants.
On December 13, 2022, the Company issued an unsecured
convertible promissory note under the Working Capital Loans to the Sponsor, pursuant to which the Company may borrow up to $1,500,000
from the Sponsor (the “$1.5 Million Convertible Promissory Note,” and together with the “Extension Note” as described
above, the “Convertible Promissory Notes”). Such loan may, at the Sponsor’s discretion, be converted into Private Placement
Warrants at a price of $1.50 per warrant as described above. The $1.5 Million Convertible Promissory Note will not bear any interest,
and will be repayable by the Company to the Sponsor, on a date that is the earlier of (a) the consummation of the Company’s initial
merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or
more businesses or entities and (b) the liquidation of the Company. The maturity date of the $1.5 Million Convertible Promissory Note
may be accelerated upon the occurrence of an Event of Default (as defined under the $1.5 Million Convertible Promissory Note). As of December
31, 2023 and 2022, $1,134,578 and $0 were outstanding under the $1.5 Million Convertible Promissory Note. Up to the date that the financial
statements were issued, the Company received a total of $1,431,995 for working capital purposes under the $1.5 Million Convertible Promissory
Note.
On March 29, 2024, the Company issued an
unsecured convertible promissory note (the “2024 Convertible Promissory Note”) to the Sponsor, pursuant to which
the Company may borrow up to $500,000.00 (the “Working Capital Loan”) from the Sponsor. Such loan may, at the
Sponsor’s discretion, be converted into warrants (the “Working Capital Loan Warrants”) to purchase Class A
Ordinary Shares, at a conversion price equal to $1.50 per warrant, with each warrant entitling the holder to purchase one Class A
Ordinary Share at a price of $11.50 per share, subject to the same adjustments applicable to the Private Placement Warrants. The
terms of the Working Capital Loan Warrants will be identical to those of the Private Placement Warrants. The Working Capital Loan
will not bear any interest, and will be repayable by the Company to the Sponsor, on a date that is the earlier of (a) the
consummation of the Company’s initial merger, stock exchange, asset acquisition, stock purchase, recapitalization,
reorganization or similar business combination with one or more businesses or entities and (b) the liquidation of the Company. The
maturity date of the Working Capital Loan may be accelerated upon the occurrence of an Event of Default (as defined under the 2024
Convertible Promissory Note). Up to the date that the financial statements were issued, the Company had no borrowings
under the 2024 Convertible Promissory Note. Up to the date that the financial statements were issued, there are no outstanding
amounts under the 2024 Convertible Promissory Note.
Registration and
Shareholders Rights
The holders of the founder shares, private placement
warrants, and any warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon
the exercise of the private placement warrants and warrants that may be issued upon conversion of Working Capital Loans) are entitled
to registration rights pursuant to a registration and shareholder rights agreement. The holders of these securities are entitled to make
up to three demands, excluding short form demands, that the company registers such securities. In addition, the holders have certain “piggy-back”
registration rights with respect to registration statements filed subsequent to the company’s completion of its initial business
combination. However, the registration and shareholder rights agreement provides that the company will not permit any registration statement
filed under the Securities Act to become effective until termination of the applicable lock-up period, which occurs (i) in the case of
the founder shares, and (ii) in the case of the private placement warrants and the respective Class A ordinary shares underlying such
warrants, 30 days after the completion of the initial business combination. The company will bear the expenses incurred in connection
with the filing of any such registration statements
Policy for Approval of Related Party Transactions
The audit committee of our board of directors
adopted a charter that provides for the review, approval, and/or ratification of “related party transactions,” which are those
transactions required to be disclosed pursuant to Item 404 of Regulation S-K as promulgated by the SEC, by the audit committee. At its
meetings, the audit committee shall be provided with the details of each new, existing, or proposed related party transaction, including
the terms of the transaction, any contractual restrictions that the company has already committed to, the business purpose of the transaction,
and the benefits of the transaction to the company and to the relevant related party. Any member of the committee who has an interest
in the related party transaction under review by the committee shall abstain from voting on the approval of the related party transaction,
but may, if so requested by the chairman of the committee, participate in some or all of the committee’s discussions of the related
party transaction. Upon the completion of its review of the related party transaction, the committee may determine to permit or to prohibit
the related party transaction.
Item 14. Principal Accountant
Fees and Services
The following is a summary of fees paid or to
be paid to Marcum LLP, or Marcum, for services rendered during 2023 and 2022.
Audit Fees. Audit fees consist of fees
for professional services rendered for the audit of our year-end financial statements, reviews of our quarterly financial statements and
services that are normally provided by Marcum in connection with regulatory filings. During the years ended December 31, 2023 and
2022, fees for our independent registered public accounting firm were $284,280 and $122,055, respectively.
Audit-Related Fees. Audit-related fees
consist of fees billed for assurance and related services that are reasonably related to performance of the audit or review of our financial
statements and are not reported under “Audit Fees.” These services include attest services that are not required by statute
or regulation and consultations concerning financial accounting and reporting standards. For the years ended December 31, 2023 and
2022 we did not pay Marcum any audit-related fees.
Tax Fees. During the years ended December 31,
2023 and 2022, our independent registered public accounting firm did not render services to us for tax compliance, tax advice and tax
planning.
All Other Fees. During the years ended
December 31, 2023 and 2022, there were no fees billed for products and services provided by our independent registered public accounting
firm other than those set forth above.
Pre-Approval Policy
Our audit committee was formed upon the consummation
of our initial public offering. As a result, the audit committee did not pre-approve all of the foregoing services, although any services
rendered prior to the formation of our audit committee were approved by our board of directors. Since the formation of our audit committee,
and on a going-forward basis, the audit committee has and will pre-approve all auditing services and permitted non-audit services to be
performed for us by our auditors, including the fees and terms thereof (subject to the de minimis exceptions for non-audit services described
in the Exchange Act which are approved by the audit committee prior to the completion of the audit).
PART IV
Item 15. Exhibits, Financial Statement Schedules
|
(a) |
The following documents are filed as part of this Form 10-K: |
|
(1) |
Financial Statements: |
|
(2) |
Financial Statement Schedules: |
None.
We hereby file as part of this Report the
exhibits listed in the attached Exhibit Index. Copies of the exhibits which are incorporated herein by reference can be obtained from
the SEC’s website at www.sec.gov.
Exhibit No. |
|
Description |
2.1 |
|
Business Combination Agreement, dated as of August 3, 2023, by and among Catcha Investment Corp, Crown LNG Holding AS and Catcha Holdings LLC(9) |
2.2 |
|
Amendment No. 2, dated January 31, 2024, by and among Catcha Investment Corp, Crown LNG Holding AS and Catcha Holdings LLC, to the Business Combination Agreement(11) |
2.3 |
|
Amendment No. 3, dated February 16, 2024, by and among Catcha Investment Corp, Crown LNG Holding AS and Catcha Holdings LLC, to the Business Combination Agreement(6) |
2.4 |
|
Amendment No. 4, dated May 21, 2024, by and among Catcha Investment Corp, Crown LNG Holding AS and Catcha Holdings LLC, to the Business Combination Agreement(8) |
2.5 |
|
Amendment No. 5, dated June 11, 2024, by and among Catcha Investment Corp, Crown LNG Holding AS and
Catcha Holdings LLC, to the Business Combination Agreement (12) |
3.1 |
|
Second Amended and Restated Memorandum and Articles of Association (2) |
3.2 |
|
Amendment
to Amended and Restated Memorandum and Articles of Association (5) |
3.3 |
|
Second Amendment to the Amended and Restated Memorandum and Articles of Association of Catcha Investment Corp(6) |
3.4 |
|
Third Amendment to the Amended and Restated Memorandum and Articles of Association of Catcha Investment Corp(8) |
4.1 |
|
Warrant Agreement dated February 11, 2021 between Continental Stock Transfer & Trust Company and the Registrant (2) |
4.2 |
|
Description of Registrant’s Securities (3) |
4.3 |
|
Specimen Unit Certificate (1) |
4.4 |
|
Specimen Class A Ordinary Share Certificate (1) |
4.5 |
|
Specimen Warrant Certificate (1) |
10.1 |
|
Private Placement Warrants dated as of February 11, 2021 Purchase Agreement between the Company and Catcha Holdings LLC (2) |
10.2 |
|
Investment Management Trust Agreement dated as of February 11, 2021 between Continental Stock Transfer & Trust Company and the Company (2) |
10.3 |
|
Amendment No. 1 to Investment Management Trust Agreement dated as of February 14, 2023 between Continental Stock Transfer & Trust Company and the Company (5) |
10.4 |
|
Amendment No. 2 to Investment Management Trust Agreement dated as of February 16, 2024 between Continental Stock Transfer & Trust Company and the Company (6) |
10.5 |
|
Amendment No. 3 to the Investment Management Trust Agreement, dated May 15, 2024, by and between Catcha Investment Corp and Continental Stock Transfer & Trust Company(8) |
10.6 |
|
Registration and Shareholder Rights Agreement dated as of February 11, 2021 among the Company and Catcha Holdings LLC (2) |
10.7 |
|
Letter Agreement dated February 11, 2021 among the Company, and Catcha Holdings LLC and each director and executive officer of the Company (2) |
10.8 |
|
Administrative Services Agreement dated February 11, 2021 between the Company and Catcha Holdings LLC (2) |
10.9 |
|
Indemnity Agreement, dated February 11, 2021, between the Company and Patrick Grove (2) |
10.10 |
|
Indemnity Agreement, dated February 11, 2021, between the Company and Luke Elliott (2) |
10.11 |
|
Indemnity Agreement, dated February 11, 2021, between the Company and Wai Kit Wong (2) |
10.12 |
|
Indemnity Agreement, dated February 11, 2021, between the Company and James Graf (2) |
10.13 |
|
Indemnity Agreement, dated February 11, 2021, between the Company and Rick Hess (2) |
10.14 |
|
Indemnity Agreement, dated February 22, 2022, between the Company and Yaniv Ghitis (4) |
10.15 |
|
Securities Subscription Agreement, dated December 28, 2020, between the Registrant and the Sponsor (1) |
10.16 |
|
Promissory
Note, dated as of February 14, 2023 and issued to Catcha Holdings LLC (5) |
10.17 |
|
Promissory Note, dated October 27, 2023, by and among Crown LNG Holding AS and Catcha Investment Corp(10) |
10.18 |
|
Promissory Note, dated as of February 17, 2024 and issued to Catcha Holdings LLC on March 27, 2024 (7) |
10.19 |
|
Promissory Note, dated as of March 29, 2024 and issued to Catcha Holdings LLC(7) |
10.20 |
|
Promissory Note, dated May 15, 2024, between Catcha Investment Corp and the Sponsor(8) |
10.21 |
|
Exchange and Support Agreement, dated as of August 3, 2023, by and among Catcha, the Company, PubCo and certain Company Shareholders(9) |
10.22 |
|
Form of Registration Rights Agreement(9) |
10.23 |
|
Form of Lock-Up Agreement(9) |
10.24 |
|
Subscription Agreement, dated October 25, 2023, by and among Polar Multi-Strategy Master Fund, Catcha Investment Corp and Catcha Holdings LLC(10) |
14.1 |
|
Code of Ethics (3) |
31.1 |
|
Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) * |
31.2 |
|
Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) * |
32.1 |
|
Certification of the Chief Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350 ** |
32.2 |
|
Certification of the Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350 ** |
99.1 |
|
Form of April 2024 Note(13) |
99.1 |
|
Form of PIPE Subscription Agreement(13) |
99.3 |
|
Securities Lending Agreement, dated as of May 22, 2024, by and between
Crown LNG Holdings Limited and Millenia Capital Partners Limited(13) |
99.4 |
|
Securities Purchase Agreement, dated as of June 4, 2024, by and among between Crown LNG Holdings
Limited and each investor identified on the signature pages thereto(13) |
101.INS* |
|
Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
101.CAL* |
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document |
101.SCH* |
|
Inline XBRL Taxonomy Extension Schema Document |
101.DEF* |
|
Inline XBRL Taxonomy Extension Definition Linkbase Document |
101.LAB* |
|
Inline XBRL Taxonomy Extension Label Linkbase Document |
101.PRE* |
|
Inline XBRL Extension Presentation Linkbase Document |
104* |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
| (1) | Incorporated by reference to the registrant’s Registration
Statement on Form S-1/A, filed with the SEC on February 8, 2021. |
| (2) | Incorporated by reference to the registrant’s Current
Report on Form 8-K, filed with the SEC on February 18, 2021. |
| (3) | Incorporated by reference to the registrant’s Annual Report
on Form 10-K, filed with the SEC on April 15, 2021. |
| (4) | Incorporated by reference to the registrant’s Annual Report
on Form 10-K, filed with the SEC on March 31, 2022. |
| (5) | Incorporated by reference to the registrant’s Current
Report on Form 8-K, filed with the SEC on February 17, 2023. |
| (6) | Incorporated by reference to the registrant’s Current
Report on Form 8-K, filed with the SEC on February 23, 2024. |
| (7) | Incorporated by reference to the registrant’s Current
Report on Form 8-K, filed with the SEC on April 2, 2024. |
(8) |
Incorporated by reference to the registrant’s Current Report on Form 8-K, filed with the SEC on May 21, 2024. |
| (9) | Incorporated by reference to the registrant’s Current
Report on Form 8-K, filed with the SEC on August 3, 2023. |
| (10) | Incorporated by reference to the registrant’s Current
Report on Form 8-K, filed with the SEC on October 30, 2023. |
| (11) | Incorporated by reference to the registrant’s Current
Report on Form 8-K, filed with the SEC on January 31, 2024. |
| (12) | Incorporated by reference to the registrant’s Current
Report on Form 8-K, filed with the SEC on June 12, 2024. |
| (13) | Incorporated
by reference to the registrant’s Current Report on Form 8-K, filed with the SEC on June 7, 2024. |
Item 16. Form 10-K Summary
Not applicable.
SIGNATURES
Pursuant to the requirements of Section 13 or
15(d) of the Securities Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the
undersigned, thereunto duly authorized.
June 17, 2024
CATCHA INVESTMENT CORP |
|
|
|
/s/ Patrick Grove |
|
Name: |
Patrick Grove |
|
Title: |
Chairman and Chief Executive Officer |
|
|
(Principal Executive Officer) |
|
Pursuant to the requirements of the Securities
Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the registrant and in
the capacities and on the dates indicated.
/s/ Patrick Grove |
Chairman and Chief Executive Officer |
|
Patrick Grove |
(Principal Executive Officer) |
June 17, 2024 |
|
|
|
/s/ Luke Elliott |
Director and President |
|
Luke Elliott |
(Principal Financial and Accounting Officer) |
June 17, 2024 |
|
|
|
/s/ Wai Kit Wong |
|
|
Wai Kit Wong |
Chief Financial Officer |
June 17, 2024 |
|
|
|
/s/ James Graf |
|
|
James Graf |
Independent Director |
June 17, 2024 |
|
|
|
/s/ Rick Hess |
|
|
Rick Hess |
Independent Director |
June 17, 2024 |
|
|
|
/s/ Yaniv Ghitis |
|
|
Yaniv Ghitis |
Independent Director |
June 17, 2024 |
CATCHA INVESTMENT CORP
INDEX TO FINANCIAL STATEMENTS
REPORT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM
To the Shareholders and Board of Directors
of
Catcha Investment Corp
Opinion on the Financial Statements
We have audited the accompanying balance sheets
of Catcha Investment Corp (the “Company”) as of December 31, 2023 and 2022, the related statements of operations, changes
in shareholders’ deficit and cash flows for each of the two years in the period ended December 31, 2023, and the related notes
(collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all
material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and
its cash flows for each of the two years in the period ended December 31, 2023, in conformity with accounting principles generally
accepted in the United States of America.
Explanatory Paragraph – Going Concern
The accompanying financial statements have
been prepared assuming that the Company will continue as a going concern. As more fully described in Note 1, the Company’s
business plan is dependent on the completion of the business combination and the Company’s cash and working capital as of
December 31, 2023 are not sufficient to complete its planned activities for a reasonable period of time, which is considered to
be one year from the issuance date of the financial statements. The business combination agreement has a termination date of June
28, 2024. There is no assurance that the Company will be able to complete the business combination by June 28, 2024 or by the
Company's extended liquidation date of August 17, 2024. If the Company does not complete a business combination by August 17, 2024, it will be required to liquidate. These conditions raise substantial doubt about the Company’s ability to continue as a
going concern. Management’s plans in regard to these matters are also described in Note 1. The financial statements do not
include any adjustments that may be necessary should the Company be unable to continue as a going concern.
Basis for Opinion
These financial statements are the responsibility
of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our
audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”)
and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable
rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with
the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the
financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we
engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding
of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s
internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures
to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that
respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial
statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as
evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
/s/ Marcum LLP
Marcum LLP
We have served as the Company’s auditor
since 2020.
New York, NY
June 17, 2024
CATCHA INVESTMENT CORP
BALANCE SHEETS
| |
December 31, 2023 | | |
December 31, 2022 | |
Assets | |
| | |
| |
Cash | |
$ | 30,850 | | |
$ | 20,706 | |
Prepaid expenses | |
| 10,161 | | |
| 33,875 | |
Note receivable, net of original issuance discount | |
| 750,000 | | |
| — | |
Derivative asset — Note Receivable, at fair value | |
| 2,689,364 | | |
| — | |
Total current assets | |
| 3,480,375 | | |
| 54,581 | |
| |
| | | |
| | |
Cash and investments held in Trust Account | |
| 24,782,259 | | |
| 304,086,289 | |
Total Assets | |
$ | 28,262,634 | | |
$ | 304,140,870 | |
| |
| | | |
| | |
Liabilities and Shareholders’ Deficit | |
| | | |
| | |
Accounts payable and accrued expenses | |
$ | 5,777,552 | | |
$ | 599,443 | |
Due to Related Party | |
| 241,366 | | |
| 125,625 | |
Convertible Promissory Note, at fair value | |
| 491,502 | | |
| — | |
Working Capital Loan, at fair value | |
| 675,934 | | |
| — | |
Note payable, net of original issuance discount | |
| 750,000 | | |
| — | |
Derivative Liability — Note Payable, at fair value | |
| 2,689,364 | | |
| — | |
Capital Contribution Note, at fair value | |
| 2,200,291 | | |
| — | |
Total current liabilities | |
| 12,826,009 | | |
| 725,068 | |
| |
| | | |
| | |
Warrant liability | |
| 621,969 | | |
| 68,660 | |
Deferred underwriting fees | |
| — | | |
| 10,500,000 | |
Total liabilities | |
| 13,447,978 | | |
| 11,293,728 | |
| |
| | | |
| | |
Commitments and Contingencies | |
| | | |
| | |
| |
| | | |
| | |
Class A ordinary shares subject to possible redemption, 2,214,859 and 30,000,000 shares at redemption value of $11.19 and $10.14 per share as of December 31, 2023 and 2022, respectively | |
| 24,782,259 | | |
| 304,086,289 | |
| |
| | | |
| | |
Shareholders’ Deficit: | |
| | | |
| | |
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding | |
| — | | |
| — | |
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; no shares issued and outstanding (excluding 2,214,859 and 30,000,000 shares subject to possible redemption, respectively) at December 31, 2023 and 2022, respectively | |
| — | | |
| — | |
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 7,500,000 shares issued and outstanding at December 31, 2023 and 2022, respectively | |
| 750 | | |
| 750 | |
Additional paid-in capital | |
| — | | |
| — | |
Accumulated deficit | |
| (9,968,353 | ) | |
| (11,239,897 | ) |
Total shareholders’ deficit | |
| (9,967,603 | ) | |
| (11,239,147 | ) |
Total Liabilities and Shareholders’ Deficit | |
$ | 28,262,634 | | |
$ | 304,140,870 | |
The accompanying notes are an integral
part of the financial statements.
CATCHA INVESTMENT CORP
STATEMENTS OF OPERATIONS
| |
For the Year Ended December 31, | |
| |
2023 | | |
2022 | |
Formation and operating costs | |
$ | 6,741,998 | | |
$ | 1,227,252 | |
Loss from operations | |
| (6,741,998 | ) | |
| (1,227,252 | ) |
| |
| | | |
| | |
Other income (expenses): | |
| | | |
| | |
Interest income from Trust Account | |
| 2,774,613 | | |
| 4,001,686 | |
Interest income – note receivable, net of original issuance discount | |
| 750,000 | | |
| — | |
Interest expense – note payable, net of original issuance discount | |
| (750,000 | ) | |
| — | |
Excess of fair value of Capital Contribution Note over proceeds at issuance | |
| (1,059,720 | ) | |
| — | |
Change in fair value of Convertible Promissory Note | |
| (118,117 | ) | |
| — | |
Change in fair value of Working Capital Loan | |
| (133,205 | ) | |
| — | |
Change in fair value of Capital Contribution Note | |
| (840,571 | ) | |
| — | |
Other income attributable to derecognition of deferred underwriting fees allocated to offering costs | |
| 482,662 | | |
| — | |
Change in fair value of warrant liability | |
| (553,309 | ) | |
| 8,841,922 | |
Gain on initial recognition of Derivative Asset – Note Receivable | |
| 1,917,828 | | |
| — | |
Change in fair value of Derivative Asset – Note Receivable | |
| 21,536 | | |
| — | |
Loss on initial recognition of fair value of Derivative Asset – Note Payable | |
| (1,917,828 | ) | |
| — | |
Change in fair value of Derivative Liability – Note Payable | |
| (21,536 | ) | |
| — | |
Total other income (expenses), net | |
| 552,353 | | |
| 12,843,608 | |
| |
| | | |
| | |
Net (loss) income | |
$ | (6,189,645 | ) | |
$ | 11,616,356 | |
| |
| | | |
| | |
Basic and diluted weighted average shares outstanding, redeemable Class A ordinary shares, subject to possible redemption | |
| 5,792,672 | | |
| 30,000,000 | |
Basic and diluted net (loss) income per share | |
$ | (0.47 | ) | |
$ | 0.31 | |
| |
| | | |
| | |
Basic and diluted weighted average shares outstanding, non-redeemable Class B ordinary shares | |
| 7,500,000 | | |
| 7,500,000 | |
Basic and diluted net (loss) income per share | |
$ | (0.47 | ) | |
$ | 0.31 | |
The accompanying notes are an integral
part of the financial statements.
CATCHA INVESTMENT CORP
STATEMENTS OF CHANGES IN SHAREHOLDERS’
DEFICIT
FOR THE YEARS ENDED DECEMBER 31, 2023
AND 2022
| |
Class A Ordinary Shares | | |
Class B Ordinary Shares | | |
Additional Paid-in | | |
Accumulated | | |
Total Shareholders’ | |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Capital | | |
Deficit | | |
Deficit | |
Balance as of December 31, 2021 | |
| — | | |
$ | — | | |
| 7,500,000 | | |
$ | 750 | | |
$ | — | | |
$ | (18,854,567 | ) | |
$ | (18,853,817 | ) |
Accretion of interest income to Class A shares subject to possible redemption (Note 2) | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (4,001,686 | ) | |
| (4,001,686 | ) |
Net income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 11,616,356 | | |
| 11,616,356 | |
Balance as of December 31, 2022 | |
| — | | |
| — | | |
| 7,500,000 | | |
| 750 | | |
| — | | |
| (11,239,897 | ) | |
| (11,239,147 | ) |
Excess of proceeds from Convertible Promissory Note and Working Capital Loan over fair value at issuance (Note 5) | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 1,043,464 | | |
| 1,043,464 | |
Accretion of extension deposits to Class A ordinary shares subject to possible redemption (Note 2) | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (825,000 | ) | |
| (825,000 | ) |
Derecognition of deferred underwriting fee (Note 10) | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 10,017,338 | | |
| 10,017,338 | |
Accretion of interest income to Class A shares subject to possible redemption | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (2,774,613 | ) | |
| (2,774,613 | ) |
Net loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (6,189,645 | ) | |
| (6,189,645 | ) |
Balance as of December 31, 2023 | |
| — | | |
$ | — | | |
| 7,500,000 | | |
$ | 750 | | |
$ | — | | |
$ | (9,968,353 | ) | |
$ | (9,967,603 | ) |
The accompanying notes are an integral
part of the financial statements.
CATCHA INVESTMENT CORP
STATEMENTS OF CASH FLOWS
| |
For the Year Ended December 31, | |
| |
2023 | | |
2022 | |
Cash Flows from Operating Activities: | |
| | |
| |
Net (loss) income | |
$ | (6,189,645 | ) | |
$ | 11,616,356 | |
Adjustments to reconcile net (loss) income to net cash used in operating activities: | |
| | | |
| | |
Interest income from Trust Account | |
| (2,774,613 | ) | |
| (4,001,686 | ) |
Interest income - note receivable, net of original issuance discount | |
| (750,000 | ) | |
| — | |
Interest expense - note payable, net of original issuance discount | |
| 750,000 | | |
| — | |
Excess of fair value of Capital Contribution Note over proceeds at issuance | |
| 1,059,720 | | |
| — | |
Change in fair value of warrant liability | |
| 553,309 | | |
| (8,841,922 | ) |
Change in fair value of Convertible Promissory Note | |
| 118,117 | | |
| — | |
Change in fair value of Working Capital Loan | |
| 133,205 | | |
| — | |
Change in fair value of Capital Contribution Note | |
| 840,571 | | |
| — | |
Other income attributable to derecognition of deferred underwriting fee allocated to offering costs | |
| (482,662 | ) | |
| — | |
Change in fair value of Derivative Asset — Note Receivable | |
| (21,536 | ) | |
| — | |
Change in fair value of Derivative Liability — Note Payable | |
| 21,536 | | |
| — | |
Changes in current assets and current liabilities: | |
| | | |
| | |
Prepaid expenses | |
| 23,714 | | |
| 8,080 | |
Accounts payable and accrued expenses | |
| 5,178,109 | | |
| 125,189 | |
Due to related party | |
| 115,741 | | |
| 119,625 | |
Net cash used in operating activities | |
| (1,424,434 | ) | |
| (974,358 | ) |
| |
| | | |
| | |
Cash Flows from Investing Activities: | |
| | | |
| | |
Cash deposited in Trust Account | |
| (825,000 | ) | |
| — | |
Cash withdrawn from Trust Account in connection with redemption | |
| 282,903,643 | | |
| — | |
Advances to Crown under Note Receivable | |
| (750,000 | ) | |
| — | |
Net cash provided by investing activities | |
| 281,328,643 | | |
| — | |
| |
| | | |
| | |
Cash Flows from Financing Activities: | |
| | | |
| | |
Proceeds from issuance of Working Capital Loan ($1.5 Million Convertible Promissory Note as disclosed in Note 1) | |
| 1,134,578 | | |
| — | |
Proceeds from issuance of Convertible Promissory Note (Extension Note as disclosed in Note 5) | |
| 825,000 | | |
| — | |
Proceeds from issuance of Capital Contribution Note (subscription agreement with Polar as disclosed in Note 7) | |
| 300,000 | | |
| — | |
Proceeds from issuance of Note Payable (subscription agreement with Polar as disclosed in Note 8) | |
| 750,000 | | |
| — | |
Payment of class A ordinary shares redemption | |
| (282,903,643 | ) | |
| — | |
Net cash used in financing activities | |
| (279,894,065 | ) | |
| — | |
| |
| | | |
| | |
Net Change in Cash | |
| 10,144 | | |
| (974,358 | ) |
Cash - Beginning | |
| 20,706 | | |
| 995,064 | |
Cash, end of the period | |
$ | 30,850 | | |
$ | 20,706 | |
| |
| | | |
| | |
Supplemental Disclosure of Non-cash Investing and Financing Activities: | |
| | | |
| | |
Excess of proceeds from Convertible Promissory Notes over fair value at issuance (Note 5) | |
$ | 1,043,464 | | |
$ | — | |
Derecognition of deferred underwriting fee (Note 10) | |
$ | 10,017,338 | | |
$ | — | |
Accretion of interest income to Class A shares subject to possible redemption | |
$ | 2,774,613 | | |
$ | 4,001,686 | |
Accretion of extension deposits to Class A ordinary shares subject to possible redemption (Note 2) | |
$ | 825,000 | | |
$ | — | |
Gain on initial recognition of fair value of Derivative Asset - Note Receivable | |
$ | 1,917,828 | | |
$ | — | |
Loss on initial recognition of Derivative Liability - Note Payable | |
$ | (1,917,828 | ) | |
$ | — | |
The accompanying notes are an integral
part of the financial statements.
CATCHA INVESTMENT CORP
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 AND 2022
NOTE 1. ORGANIZATION, BUSINESS OPERATION AND
GOING CONCERN
Organization and General
Catcha Investment Corp (the “Company”)
was incorporated as a Cayman Islands exempted company on December 17, 2020. The Company was incorporated for the purpose of effecting
a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses
or entities (the “Business Combination”).
The Company is an early stage and emerging growth
company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
As of December 31, 2023, the Company had not commenced any operations.
All activity through December 31, 2023 relates to the Company’s formation, the Initial Public Offering (as defined below), and after
the Initial Public Offering, searching for a Business Combination target, the negotiation of the Business Combination Agreement described
below and subsequent amendments thereto, and the preparation and filing on October 3, 2023 with the Securities and Exchange Commission
(the “SEC”) of a registration statement on Form F-4 with respect to the Business Combination ( the “Form F-4”).
The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest.
The Company will generate non-operating income in the form of interest income on cash and investments held in the trust account established
at the consummation of the Initial Public Offering (the “Trust Account”) from the proceeds derived from the Initial Public
Offering and will recognize changes in the fair value of warrant liability, Convertible Promissory Notes, the Capital Contribution Note
and fair value changes of the Derivative Asset – Note Receivable, and Derivative Liability – Note Payable (which are all described
further in Notes 2 and 8) as other income (expense). The Company has selected December 31 as Its fiscal year end.
The Company’s sponsor is Catcha Holdings
LLC, a Cayman Islands limited liability company (the “Sponsor”).
Financing
The registration statement for the Company’s
Initial Public Offering was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on February 11,
2021 (the “Effective Date”). On February 17, 2021, the Company consummated the initial public offering (the “Initial
Public Offering” or “IPO”) of 30,000,000 units (the “Units” and, with respect to the Class A ordinary shares
included in the Units sold, the “Public Shares”), including the issuance of 2,500,000 Units as a result of the underwriter’s
partial exercise of the over-allotment option, at $10.00 per Unit generating gross proceeds of $300,000,000, which is described in Note
3. Each Unit consists of one Class A ordinary share, and one-third of one warrant to purchase one Class A ordinary share. Each whole warrant
will entitle the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. Each whole warrant
will become exercisable on the later of 30 days after the completion of the initial Business Combination or 12 months from the closing
of the IPO (i.e., February 17, 2021), and will expire five years after the completion of the initial Business Combination, or earlier
upon redemption or liquidation (see Note 3).
Simultaneously with the closing of the IPO, the
Company consummated the sale of an aggregate of 5,333,333 warrants (the “Private Placement Warrants”) at a price of $1.50
per warrant in a private placement to the Company’s Sponsor, generating gross proceeds to the Company of $8,000,000, which is described
in Note 4.
Following the closing of the IPO on February 17,
2021, an amount of $300,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private
Placement Warrants was placed in the Trust Account and was invested only in U.S. government treasury obligations with a maturity of 185
days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended
( the “Investment Company Act”), that invests only in direct U.S. government treasury obligations. In March 2023, the Company
liquidated the money market funds held in the Trust Account. The funds in the Trust Account will be maintained in cash in an interest-bearing
demand deposit account at a bank until the earlier of consummation of the initial Business Combination and liquidation. Except with respect
to interest earned on the funds held in the Trust Account that may be released to the Company to pay its income taxes, if any, the Company’s
third amended and restated memorandum and articles of association, and subject to the requirements of law and regulation, provide that
the proceeds from the IPO held in the Trust Account will not be released from the Trust Account (1) to the Company, until the completion
of the initial Business Combination, or (2) to the Company’s public shareholders, until the earliest of (i) the completion of the
initial Business Combination, and then only in connection with those Class A ordinary shares that such shareholders properly elected to
redeem, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the Company’s
third amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation
to provide holders of its Class A ordinary shares the right to have their shares redeemed in connection with the initial Business Combination
or to redeem 100% of the Company’s public shares if the Company does not complete the initial Business Combination within 24 months
from the closing of the IPO (the “Combination Period”) or during any extended time in which the Company has to consummate
a Business Combination beyond the aforementioned period as a result of a shareholder vote to amend the third amended and restated memorandum
and articles of association (an “Extension Period”) or (B) with respect to any other provision relating to the rights of holders
of the Company’s Class A ordinary shares, and (iii) the redemption of the Company’s public shares if the Company has not consummated
its Business Combination within the Combination Period, subject to applicable law. On February 14, 2023, the Company held an extraordinary
general meeting of shareholders, at which the Company’s shareholders approved, among other things, a proposal to amend the Company’s
amended and restated memorandum and articles of association to extend the date by which the Company has to consummate the Business Combination
from February 17, 2023 to February 17, 2024 or such earlier date as is determined by the Company’s board of directors. On February
16, 2024, the parties to the Business Combination Agreement (as defined below) agreed to extend the date on which the Business Combination
Agreement may be terminated by the parties if the conditions to the Closing (as defined in the Business Combination Agreement) have not
been satisfied or waived from February 17, 2024 to May 17, 2024. On May 15, 2024, pursuant to the third extraordinary general meeting
of shareholders, the Company’s amended and restated memorandum and articles of association was amended to provide the Company’s
board of directors the ability to extend the date by which the Company must (1) consummate an initial business combination, (2) cease
its operations except for the purpose of winding up if it fails to complete such business combination, and (3) redeem all of the Company’s
then outstanding Class A ordinary shares included as part of the units sold in the Company’s initial public offering that was consummated
on February 17, 2021 from May 17, 2024 up to three times by one month each to June 17, 2024, July 17, 2024, or August 17, 2024. On May
21, 2024, the parties to the Business Combination Agreement agreed to extend the date on which the Business Combination Agreement may
be terminated by the parties if the conditions to the Closing have not been satisfied or waived from May 17, 2024 to June 17, 2024. On June 11, 2024, the parties to the Business Combination Agreement agreed to extend the date on which the Business Combination Agreement
may be terminated by the parties if the conditions to the Closing have not been satisfied or waived from June 17, 2024 to June 28, 2024
(See Note 12).
Transaction costs related to the IPO amounted
to $17,031,183, consisting of $6,000,000 of underwriting fees, $10,500,000 of deferred underwriting fees (see Note 9), and $531,183 of
other offering costs. Of the $17,031,183 transaction costs, $16,236,137 was charged to additional paid-in capital and $795,046 was allocated
to the public and private warrants and recorded as other income (loss) during the three months ended March 31, 2021.
On August 10, 2023, J.P. Morgan Securities LLC
(“J.P. Morgan”), the underwriter in the IPO, waived its entitlement to payment of the $10,500,000 deferred underwriting fee
in connection with its role as underwriter in the Company’s IPO. As a result, the Company recognized $482,662 of other income attributable
to the derecognition of deferred underwriting fees allocated to offering costs previously expensed and $10,017,338 was recorded to accumulated
deficit in relation to the waiver of the deferred underwriting fees in the accompanying financial statements.
Initial Business Combination
The Company’s management has broad discretion
with respect to the specific application of the net proceeds of the IPO and the Private Placement Warrants, although substantially all
of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company
will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having
an aggregate fair market value of at least 80% of the assets held in the Trust Account (net of amounts disbursed to management for working
capital purposes, if permitted, and excluding the amount of any deferred underwriting discount) at the time of the agreement to enter
into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company
owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires an interest in the target sufficient
for it not to be required to register as an investment company under the Investment Company Act.
The Company will provide its public shareholders
with the opportunity to redeem all or a portion of their Class A ordinary shares upon the completion of the initial Business Combination
either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision
as to whether the Company will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by
the Company, solely in its discretion.
The shareholders will be entitled to redeem their
shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two
business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust
Account and not previously released to the Company to pay its income taxes, if any, divided by the number of then outstanding public shares.
The amount in the Trust Account was initially $10.00 per public share.
If the Company is unable to complete a Business
Combination within the Combination Period, or during the Extension Period, the Company will (i) cease all operations except for the purpose
of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a
per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the
funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any divided by the number of then
outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the
right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject
to the approval of the Company’s remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject
in the case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other
applicable law. On February 14, 2023, the Company held an extraordinary general meeting of shareholders (the “First Extraordinary
General Meeting”), at which the Company’s shareholders approved (i) an amendment to the Company’s amended and restated
memorandum and articles of association to extend the date by which the Company has to consummate the Business Combination from February
17, 2023 to February 17, 2024 or such earlier date as is determined by the Company’s board of directors and (ii) an amendment to
the Company’s investment management trust agreement, dated as of February 11, 2021 (the “IMTA”), by and between the
Company and Continental Stock Transfer & Trust Company (“CST”), to extend the date by which the Company has to consummate
the Business Combination from February 17, 2023 to February 17, 2024 or such earlier date as is determined by the Company’s board
of directors, by extending on a monthly basis. Following such approval by the Company’s shareholders, the Company and CST entered
into the Amendment No. 1 to the IMTA on February 14, 2023.
In connection with the votes taken at the First
Extraordinary General Meeting of shareholders, holders of 27,785,141 Class A ordinary shares of the Company properly exercised their right
to redeem their shares for cash at a redemption price of approximately $10.18 per share, for an aggregate redemption amount of $282,903,643.
The funds were redeemed from the Trust Account on February 23, 2023.
From February 2023 to December 2023, the Company deposited eleven tranches
of $75,000, for an aggregate of $825,000, into the Trust Account, to extend the date that the Company has to consummate the Business Combination
from February 17, 2023 to January 17, 2024. In January 2024, the Company deposited another $75,000 into the Trust Account, to extend the
date that the Company has to consummate the Business Combination to February 17, 2024. All these deposits were made by proceeds received
from the Sponsor under the Extension Note as discussed below.
On February 16, 2024, the Company held another extraordinary general
meeting of shareholders (the “Second Extraordinary General Meeting”), at which the Company’s shareholders approved i)
to extend the date by which the Company has to consummate the Business Combination from February 17, 2024 up to three times by one month
each to March 17, 2024, April 17, 2024, or May 17, 2024, subject to the Sponsor or one or more of its affiliates,
members or third-party designees (the “Lender”), will deposit into the Trust Account for each month $0.03 for each then-outstanding
ordinary share issued in the Company’s initial public offering that is not redeemed, in exchange for one or more non-interest bearing,
unsecured promissory notes issued by the Company to the Lender and (ii) an amendment to the Company’s IMTA to extend the date by
which the Company has to consummate the Business Combination up to three times for one month each from February 17, 2024 to March 17,
2024, April 17, 2024 or May 17, 2024 (the “IMTA Amendment No.2”). On February 16, 2024, Catcha and Continental entered into
the IMTA Amendment No.2.
In connection with the votes taken at the Second
Extraordinary General Meeting of shareholders, holders of an additional 641,303 Class A ordinary shares of the Company properly exercised
their right to redeem their shares for cash at a redemption price of approximately $11.29 per share, for an aggregate redemption amount
of $7,241,004. The funds were redeemed from the Trust Account on February 23, 2024. As a result, 1,573,556 Class A ordinary shares subject
to possible redemption, amounting to approximately $17.8 million were still outstanding after redemption.
On each of February 22, 2024, March 21, 2024 and April 19, 2024, using
the proceeds received under the 2024 Extension Note No. 1, the Company deposited $47,207 into the Trust Account to extend the date by
which the Company has to consummate the Business Combination to May 17, 2024.
On May 15, 2024, the Company held another extraordinary
general meeting of shareholders (the “Third Extraordinary General Meeting”), at which the Company’s shareholders approved
to extend the date by which the Company has to consummate the Business Combination from May 17, 2024 up to three times by one month each
to June 17, 2024, July 17, 2024, or August 17, 2024 (hereinafter, the “Extended Termination Date”), subject to that the Lender
will deposit into the Trust Account for each month $0.03 for each then-outstanding ordinary share issued in the Company’s initial
public offering that is not redeemed, in exchange for one or more non-interest bearing, unsecured promissory notes issued by the Company
to the Lender.
In connection with the votes taken at the Third
Extraordinary General Meeting of shareholders on May 15, 2024, holders of an additional 208,674 Class A ordinary shares of the Company
properly exercised their right to redeem their shares for cash at a redemption price of approximately $11.52 per share, for an aggregate
redemption amount of $2,403,928. The funds were redeemed from the Trust Account on May 20, 2024. As a result, 1,364,882 Class A ordinary
shares subject to possible redemption, amounting to approximately $15.7 million were still outstanding after the redemption.
On May 15, 2024, the Company issued a promissory
note in the principal amount of up to $122,839 (the “2024 Extension Note No. 2”) to the Sponsor. The Note does not
bear interest and matures upon closing of the Business Combination. If the Company completes the proposed Business Combination, it will
repay the amounts loaned under the promissory notes or convert a portion or all of the amounts loaned under such promissory notes into
warrants at a price of $1.50 per warrant, which warrants will be identical to the private placement warrants issued to the Sponsor at
the time of the Company’s initial public offering. If the Company does not complete the proposed Business Combination by the final
applicable Extended Termination Date, such promissory notes will be repaid only from funds held outside of the Trust Account.
On May 24, 2024, using the proceeds received under the 2024 Extension
Note No. 2, the Company deposited $40,946 into the Trust Account to extend the date by which the Company has to consummate the Business
Combination to June 17, 2024.
On May 10, 2024, the Company determined to postpone its extraordinary
general meeting of shareholders relating to shareholder approval of the Company’s entry into a Business Combination Agreement and
a related Merger and Plan of Merger (the “Business Combination Meeting”), from the previously scheduled date of May 15, 2024
to June 12, 2024.
On February 20, 2024, the Company received a letter
from the NYSE American LLC (“NYSE American” or the “Exchange”) stating that the staff of NYSE Regulation has determined
to commence proceedings to delist Catcha’s Class A ordinary shares pursuant to Sections 119(b) and 119(f) of the NYSE American Company
Guide because the Company failed to consummate a Business Combination within 36 months of the effectiveness of its Initial Public Offering
registration statement, or such shorter period that the Company specified in its registration statement.
On February 23, 2024, the Company submitted a
written request to NYSE asking for the review of the delisting determination by a Committee of the Board of Directors of the Exchange.
Up to the date the financial statements were issued, the Company’s Class A ordinary shares have not been suspended and will continue
to trade.
The Company has an NYSE appeal hearing scheduled for July 17, 2024.
The Sponsor and the Company’s officers and
directors have agreed to (i) waive their redemption rights with respect to their Class B ordinary shares (the “Founder Shares”)
and public shares in connection with the completion of the Business Combination, (ii) waive their redemption rights with respect to their
Founder Shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s third amended and
restated memorandum and articles of association (A) that would modify the substance or timing of the Company’s obligation to provide
holders of its Class A ordinary shares the right to have their shares redeemed in connection with the Business Combination or to redeem
100% of its public shares if the Company does not complete the Business Combination within 24 months from the closing of the IPO or during
the Extension Period or (B) with respect to any other provision relating to the rights of holders of its Class A ordinary shares, and
(iii) waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares and public shares they
hold if the Company fails to consummate the Business Combination within the Combination Period or during the Extension Period.
In the event of the liquidation of the Trust Account
upon the failure of the Company to consummate a Business Combination, the Sponsor has agreed that it will be liable to the Company if
and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services
rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction
agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount
per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per public share
due to reductions in the value of the trust assets, in each case net of the interest that may be withdrawn to pay the Company’s
tax obligations, provided that such liability will not apply to any claims by a third party or prospective target business that executed
a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity
of the underwriter of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities
Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently
verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor’s
only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations.
None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation,
claims by vendors and prospective target businesses.
Business Combination Agreement
On August 3, 2023, the Company entered into a
Business Combination Agreement (the “Business Combination Agreement”) with Crown LNG Holding AS, a private limited liability
company incorporated under the laws of Norway (“Crown”), Crown LNG Holdings Limited, a private limited company incorporated
under the laws of Jersey, Channel Islands (“PubCo”), and CGT Merge II Limited, a Cayman Islands exempted company limited by
shares (“Merger Sub”).
Pursuant to the Business Combination Agreement,
subject to the satisfaction or waiver of certain conditions set forth therein, (i) Merger Sub will merge with and into the Company, with
the Company being the surviving company and becoming the wholly owned subsidiary of PubCo, as a result of which (a) each of the Company’s
Class A ordinary share and Class B ordinary share issued and outstanding immediately prior to the effective time of the merger (the “Merger
Effective Time”) shall automatically be cancelled and cease to exist in exchange for the right to receive one newly issued ordinary
share of PubCo, and (b) each Company warrant outstanding immediately prior to the Merger Effective Time shall cease to be a warrant with
respect to the Company’s ordinary shares and be assumed by PubCo and converted into a warrant to purchase one ordinary share of
PubCo; and (ii) subject to the certain procedures and conditions, Crown shareholders will transfer their Crown shares to PubCo in exchange
for their Pro Rata Share (as defined below) of the Exchange Consideration (as defined below). The “Exchange Consideration”
is a number of newly issued ordinary shares of PubCo equal to (a) a transaction value of $600 million divided by (b) a per share price
of $10.00. “Pro Rata Share” means, with respect to each Crown shareholder, a fraction expressed as a percentage equal to (i)
the number of Crown shares held by such Crown shareholder immediately prior to the effective time of the exchange (the “Exchange
Effective Time”), divided by (ii) the total number of issued and outstanding Crown shares immediately prior to the Exchange Effective
Time.
During the seven years following the consummation
of the Business Combination (the “Closing”), the persons who are Crown shareholders immediately prior to the Exchange Effective
Time and who have participated in the Exchange shall have the contingent right to receive in the aggregate a number of ordinary shares
of PubCo equivalent to 10% of the issued and outstanding ordinary shares of PubCo as of the Closing (the “Earnout Shares”),
which will vest upon achievement of certain share prices and milestones as provided under the Business Combination Agreement. On October
2, 2023, the Business Combination Agreement was amended to delete the provisions with regards to the Earnout Shares in their entirety.
On January 31, 2024, the Business Combination
Agreement was amended to (i) remove the closing condition in Section 9.2(f) of the Business Combination Agreement which would have required
the Company to have satisfied the minimum cash condition of at least US$20,000,000 and (ii) allow for listing of the PubCo ordinary shares
on either the NYSE or Nasdaq.
On February 14, 2024, the SEC declared the registration
statement on Form F-4 with respect to the Business Combination effective.
On February 16, 2024, the Business Combination
Agreement was further amended to extend the date on which the Business Combination Agreement may be terminated if the conditions to the
Closing (as defined in the Business Combination Agreement) have not been satisfied or waived from February 17, 2024 to May 17, 2024, In
addition, the Company agreed to waive its right under its amended and restated memorandum and articles of association to withdraw up to
$100,000 of the interest earned on the funds held in the Trust Account to pay dissolution expenses in the event of the liquidation of
the Trust Account.
On May 21, 2024, the Business Combination Agreement was further amended
to extend the date on which the Business Combination Agreement may be terminated if the conditions to the Closing have not been satisfied
or waived from May 17, 2024 to June 17, 2024. Also, the parties have agreed that the Business Combination Agreement may be terminated
by Crown in the event that prior to June 17, 2024, the parties do not receive notice from Nasdaq, NYSE American, or another national securities
exchange acceptable to Crown, that the post-business combination public company common stock shall be approved for listing upon the closing
of the Business Combination. The non-solicitation provisions of the Business Combination Agreement were amended to expire on May 31, 2024,
unless Crown has received notice that the post-business combination public company common stock shall be approved for listing upon the
closing of the Business Combination on Nasdaq, NYSE American or another national securities exchange acceptable to Crown.
On June 11, 2024, the Business Combination Agreement was further amended to extend the date on which the Business Combination Agreement
may be terminated if the conditions to the Closing have not been satisfied or waived from June 17, 2024 to June 28, 2024. Also, the parties
have agreed that the Business Combination Agreement may be terminated by Crown in the event that prior to June 28, 2024, the parties do
not receive notice from Nasdaq, NYSE American, or another national securities exchange acceptable to Crown, that the post-business combination
public company common stock shall be approved for listing upon the closing of the Business Combination.
On June 12, 2024, Catcha held an
extraordinary general meeting of shareholders (the “Fourth Extraordinary General Meeting”) pursuant to which the
shareholders of record as of January 16, 2024 approved Catcha’s previously proposed Business Combination with Crown. In
connection with the votes taken at this Extraordinary General Meeting, Catcha has received elections from certain holders of our
Class A ordinary shares to exercise their right to redeem their shares for cash. As of the date of these financial statements, such
elections are still within the time frame when such requests can be rescinded; thus the final redemption payout has not yet been
determined.
The Business Combination Agreement may be terminated under certain
customary circumstances at any time prior to the Closing, including, without limitation, (i) upon the mutual written consent of the Company
and Crown, (ii) by either the Company or Crown, if any of the conditions to the Closing have not been satisfied or waived by May 17, 2024,
(iii) by the Company, on the one hand, or Crown, on the other hand, as a result of certain material breaches by the counterparties to
the Business Combination Agreement that remain uncured after any applicable cure period, (iv) by either the Company or Crown, if a governmental
authority of competent jurisdiction shall have issued an order or taken any other action permanently prohibiting the transactions contemplated
by the Business Combination Agreement, (v) by the Company, on the one hand, or Crown, on the other hand, as a result of the failure by
the counterparties to obtain approvals required for the Business Combination, and (vi) by the Company, if there has been a material adverse
effect on each of Crown and its direct and indirect subsidiaries.
Liquidity, Capital Resources and Going Concern
As of December 31, 2023, the Company had
$30,850 in cash outside of the Trust Account and working capital deficit of $9,345,634.
On December 13, 2022, the Company issued an
unsecured convertible promissory note (see Note 5) to the Sponsor, pursuant to which the Company may borrow up to $1,500,000 (the
“$1.5 Million Convertible Promissory Note”) from the Sponsor. As of December 31, 2023, the Company had $1,134,578 in
principal outstanding under such note, with a fair value of $675,934. As of the issuance date of these financial statements, the
Company received a total of $1,431,995 principal for working capital purposes under the $1.5 Million Convertible Promissory
Note.
On February 14, 2023, the Company issued an unsecured
convertible promissory note (the “Extension Note”) to the Sponsor, pursuant to which the Company may borrow up to $900,000
(the “Extension Loan”) from the Sponsor. Using these loans received, the Company deposited twelve tranches of $75,000, totaling
$900,000, into the Trust Account from February 2023 to January 2024, to extend the date by which the Company must complete a Business
Combination to February 14, 2024.
On March 9, 2023, the Company entered into a subscription agreement
(the “March 2023 Subscription Agreement”) with the Sponsor and Polar Multi-Strategy Master Fund (“Polar”), pursuant
to which Polar has agreed to provide $300,000 to the Company (the “Capital Contribution Note”) as discussed in Note 7. As
of December 31, 2023, the Company had received the entire $300,000 funding under such note (see Note 6).
On March 27, 2024, the Company issued an unsecured convertible
promissory note (the “2024 Extension Note No. 1”), dated as of February 17, 2024, to the Sponsor, pursuant to which
the Company may borrow up to $141,620.04 (the “2024 Extension Loan No. 1”) from the Sponsor, consisting of the aggregate
amount of the potential extensions of the Business Combination through May 17, 2024. Pursuant to the 2024 Extension Note No. 1, the
Sponsor has agreed to deposit into the Company’s trust account established in connection with its initial public offering cash in
the amount of $47,206.68 per monthly Extension (or a pro rata portion thereof if less than a month), and the Company has agreed that the
amount of each such deposit shall constitute a loan, until the earlier of (i) the date of the extraordinary general meeting held
in connection with a shareholder vote to approve an initial business combination, and (ii) the date that $141,620.04 has been loaned.
Such loan may, at the Sponsor’s discretion, be converted into warrants to purchase Class A ordinary shares of the Company at
a conversion price equal to $1.50 per warrant, with each warrant entitling the holder to purchase one Class A ordinary share at a
price of $11.50 per share, subject to the same adjustments applicable to the warrants issued to the Sponsor in the private placement that
closed on February 17, 2021 in connection with the initial public offering. The terms of the warrants will be identical to those
of the private placement warrants. The 2024 Extension Loan No. 1 will not bear any interest, and will be repayable by the Company to the
Sponsor, on a date that is the earlier of the consummation of an initial business combination and the liquidation of the Company.
The maturity date of the 2024 Extension Loan No. 1 may be accelerated upon the occurrence of an Event of Default (as defined under the
2024 Extension Note No. 1).
On March 29, 2024, the Company issued an unsecured convertible
promissory note (the “2024 Convertible Promissory Note”) to the Sponsor, pursuant to which the Company may borrow up
to $500,000 from the Sponsor for working capital purposes. Such loan may, at the Sponsor’s discretion, be converted into warrants
to purchase Class A ordinary shares at a conversion price equal to $1.50 per warrant, with each warrant entitling the holder to purchase
one Class A ordinary share at a price of $11.50 per share, subject to the same adjustments applicable to the private placement warrants.
The terms of the warrants will be identical to those of the Private Placement Warrants. The loan will not bear any interest, and will
be repayable by the Company to the Sponsor, on a date that is the earlier of the consummation of an initial business combination and the
liquidation of the Company. The maturity date of the loan may be accelerated upon the occurrence of an Event of Default (as defined under
the 2024 Convertible Promissory Note).
On May 15, 2024, the
Company issued the 2024 Extension Note No. 2 to the Sponsor, pursuant to which the Company may borrow up to $122,839.38 (the “2024
Extension Loan No. 2”) from the Sponsor, consisting of the aggregate amount of the potential extensions of the Business Combination
through August 17, 2024. Pursuant to the 2024 Extension Note No. 2, the Sponsor has agreed to deposit into the Company’s trust
account established in connection with its initial public offering cash in the amount of $40,946.46 per monthly Extension (or a pro rata
portion thereof if less than a month), and the Company has agreed that the amount of each such deposit shall constitute a loan, until
the earlier of (i) the date of the extraordinary general meeting held in connection with a shareholder vote to approve an initial
business combination, and (ii) the date that $122,839.38 has been loaned. Such loan may, at the Sponsor’s discretion, be converted
into warrants to purchase Class A ordinary shares of the Company at a conversion price equal to $1.50 per warrant, with each warrant
entitling the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to the same adjustments applicable
to the warrants issued to the Sponsor in the private placement that closed on February 17, 2021 in connection with the initial public
offering. The terms of the warrants will be identical to those of the private placement warrants. The 2024 Extension Loan No. 2 will not
bear any interest, and will be repayable by the Company to the Sponsor, on a date that is the earlier of the consummation of an initial
business combination and the liquidation of the Company. The maturity date of the 2024 Extension Loan No. 2 may be accelerated upon the
occurrence of an Event of Default (as defined under the 2024 Extension Note No. 2).
On February 22, 2024, March 21, 2024 and April
19, 2024, the sponsor deposited three tranches of $47,207 into the Trust Account to extend the date by which the Company has to consummate
the Business Combination to May 17, 2024. On May 23, 2024, the sponsor deposited $40,946 into the Trust Account to extend the date by
which the Company has to consummate the Business Combination to June 17, 2024.
In addition, in order to fund working capital deficiencies or finance
transaction costs in connection with a Business Combination, the Sponsor, or certain of the Company’s officers and directors or
their affiliates may, but are not obligated to, loan the Company additional funds as may be required. Management will use these funds
for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence
on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring,
negotiating and consummating a Business Combination. No additional funding has been received under this arrangement. However, management
expects the Company to continue to incur significant costs in pursuit of the consummation of a Business Combination and current funds,
committed or otherwise, may not be sufficient to operate the Company for at least the 12 months following the issuance of the financial
statements contained herein. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve
liquidity, which could include, but not necessarily be limited to, suspending the pursuit of a Business Combination.
In connection with the Company’s assessment of going concern
considerations in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Subtopic
(“ASC”) 205-40, “Presentation of Financial Statements – Going Concern,” management has determined that if
the Company is unable to complete a Business Combination by August 17, 2024 (subject to the Company making the required monthly deposits
of $40,946 to extend the date by which to consummate the Business Combination each month up through August 17, 2024) or such earlier date
as is determined by the Company’s board of directors, then the Company will cease all operations except for the purpose of liquidating.
The mandatory liquidation, subsequent dissolution and the liquidity issues described above raise substantial doubt about the Company’s
ability to continue as a going concern one year from the date that these financial statements are issued. No adjustments have been made
to the carrying amounts of assets or liabilities should the Company be required to liquidate after August 17, 2024 or such earlier date
as is determined by the Company’s board of directors.
Risks and Uncertainties
Management is currently evaluating the impact
of persistent inflation and rising interest rates, financial market instability, including the recent bank failures, the lingering effects
of the COVID-19 pandemic and certain geopolitical events, including the current wars, and has concluded that while it is reasonably possible
that the risks and uncertainties related to or resulting from these events could have a negative effect on the Company’s financial
position, results of its operations and/or the closing of the Business Combination, the specific impact is not readily determinable as
of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome
of these risks and uncertainties.
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying financial statements are presented
in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules
and regulations of the Securities and Exchange Commission (the “SEC”).
Emerging Growth Company Status
The Company is an “emerging growth company,”
as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012 (the “JOBS Act”),
and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that
are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements
of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and
proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder
approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts
emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that
is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered
under the Securities Exchange Act of 1934, as amended) are required to comply with the new or revised financial accounting standards.
The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply
on on-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended
transition period which means that when a standard is issued or revised and it has different application dates for public or private companies,
the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised
standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging
growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because
of the potential differences in accounting standards used.
Use of Estimates
The preparation of the financial statements in
conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during
the reporting period.
Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments
with an original maturity of three months or less when purchased to be cash equivalents. The Company had $30,850 and $20,706 in cash and
did not have any cash equivalents as of December 31, 2023 and 2022, respectively.
Cash and Investments Held in Trust Account
In March 2023, the Company liquidated the money market funds held in
the Trust Account. The funds in the Trust Account are now maintained in cash in an interest-bearing demand deposit account at a bank until
the earlier of consummation of the initial Business Combination and liquidation. Prior to liquidating the money market funds, the Company’s
portfolio of investments was comprised primarily of U.S. Treasury securities. The Company classified its money market funds as trading
securities in accordance with ASC Topic 320, “Investments-Debt Securities.” Trading securities are presented on the balance
sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities
is included in interest income from Trust Account in the accompanying statements of operations.
As of December 31, 2023 and 2022, respectively,
the assets held in the Trust Account were $24,782,259 and $304,086,289.
Concentration of Credit Risk
Financial instruments
that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at
times, may exceed the Federal Depository Insurance Coverage of $250,000. At December 31, 2023 and 2022, the Company has not experienced
losses on this account and management believes the Company could be exposed to significant risks on the funds held in trust account.
Fair Value Measurements
FASB ASC Topic 820, “Fair Value Measurement”
(“ASC 820”), defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements.
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the
buyer and the seller at the measurement date. In determining fair value, the valuation techniques consistent with the market approach,
income approach and cost approach shall be used to measure fair value. ASC 820 establishes a fair value hierarchy for inputs, which represent
the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are further defined as observable and unobservable
inputs. Observable inputs are those that buyer and seller would use in pricing the asset or liability based on market data obtained from
sources independent of the Company. Unobservable inputs reflect the Company’s assumptions about the inputs that the buyer and seller
would use in pricing the asset or liability developed based on the best information available in the circumstances.
The fair value hierarchy is categorized into three
levels based on the inputs as follows:
|
● |
Level 1 – |
Valuations based on
unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation
adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly
available in an active market, valuation of these securities does not entail a significant degree of judgment. |
|
|
|
|
|
● |
Level 2 – |
Valuations based on
(i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active
for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that
are derived principally from or corroborated by market through correlation or other means. |
|
|
|
|
|
● |
Level 3 – |
Valuations based on
inputs that are unobservable and significant to the overall fair value measurement. |
The fair value of certain of the Company’s
assets and liabilities, which qualify as financial instruments under ASC 820, approximates the carrying amounts represented in the balance
sheets. The fair values of prepaid expenses, accounts payable and accrued expenses, and due to related party are estimated to approximate
the carrying values as of December 31, 2023 and 2022 due to the short maturities of such instruments.
Offering Costs Associated with IPO
The Company complies with the requirements of
the FASB ASC 340-10-S99, “Other Assets and Deferred Costs – SEC Materials,” and SEC Staff Accounting Bulletin (“SAB”)
Topic 5A, “Expenses of Offering”. Offering costs consist principally of underwriting fees, professional fees and registration
fees that are related to the IPO. FASB ASC 470-20, “Debt with Conversion and Other Options,” addresses the allocation of proceeds
from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate IPO proceeds
from the Units between Class A ordinary shares and warrants, using the residual method by allocating IPO proceeds first to fair value
of the warrants and then the Class A ordinary shares.
Offering costs in the aggregate of $16,236,137 were charged to shareholders’
equity (deficit) (consisting of $5,724,193 in underwriting fees, $10,017,338 in deferred underwriting fees, and $494,606 in other offering
costs), and offering costs in the aggregate of $795,046 were recorded as other income (loss) (consisting of $275,807 in underwriting fees,
$482,662 in deferred underwriting fees, and $36,577 in other offering costs) during the three months ended March 31, 2021. On August 10,
2023, the underwriter waived its entitlement to the deferred underwriting fees, see Note 10.
Class A Ordinary Shares Subject to Possible
Redemption
The Company accounts for its Class A ordinary
shares subject to possible redemption in accordance with the guidance in FASB ASC Topic 480, “Distinguishing Liabilities from Equity.”
Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value.
Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within
the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control)
are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s
Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject
to the occurrence of uncertain future events. Accordingly, all ordinary shares subject to possible redemption are presented at redemption
value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets.
In connection with the extraordinary general meeting
of shareholders held on February 14, 2023, holders of 27,785,141 Class A ordinary shares of the Company properly exercised their right
to redeem their shares for cash at a redemption price of approximately $10.18 per share, for an aggregate redemption amount of $282,903,643,
which includes interest of $5,052,233.
At December 31, 2023 and 2022, the Class A ordinary shares reflected
in the balance sheets are reconciled in the following table:
| |
Shares | | |
Amount | |
Class A ordinary shares subject to possible redemption as of December 31, 2021 | |
| 30,000,000 | | |
$ | 300,084,603 | |
Add: Accretion of interest income to Class A ordinary shares subject to redemption | |
| — | | |
| 4,001,686 | |
Class A ordinary shares subject to possible redemption as of December 31, 2022 | |
| 30,000,000 | | |
| 304,086,289 | |
Add: Accretion of interest income to Class A ordinary shares subject to redemption | |
| — | | |
| 2,774,613 | |
Add: Accretion of extension deposit to Class A ordinary shares subject to redemption | |
| — | | |
| 825,000 | |
Less: Class A ordinary shares redeemed, including interest | |
| (27,785,141 | ) | |
| (282,903,643 | ) |
Class A ordinary shares subject to possible redemption as of December 31, 2023 | |
| 2,214,859 | | |
$ | 24,782,259 | |
Convertible Promissory Notes
The Company elected to account for the
Convertible Promissory Notes (which includes the $1.5 Million Convertible Promissory Note and the Extension Note) entered into with
the Sponsor pursuant to the fair value option under ASC 825. ASC 825-10-15-4 provides for the “fair value option”
election, to the extent not otherwise prohibited by ASC 825-10-15-5, to be afforded to financial instruments, wherein the financial
instrument is initially measured at its issue-date estimated fair value and subsequently remeasured at estimated fair value on a
recurring basis at each reporting period date. Differences between the face value of the Convertible Promissory Notes and fair value
at issuance are recognized as either an expense in the statement of operations (if issued at a premium) or as a capital contribution
(if issued at a discount). Any material changes in the estimated fair value of the Convertible Promissory Notes are recognized as
non-cash gains or losses in the statements of operations. The Company believes that the fair value option better reflects the
underlying economics of the Convertible Promissory Notes. As such, the Convertible Promissory Notes were initially measured at
$916,114 as of the issue dates (including $542,729 under the $1.5 Million Convertible Promissory Note and $373,385 under the
Extension Note). For the year ended December 31, 2023, $1,043,464 excess of proceeds over fair value at issuance was recorded as
additional paid-in capital in the accompanying statements of shareholders’ deficit. As of December 31, 2023, the fair value of
the Convertible Promissory Notes was $675,934 under the $1.5 Million Convertible Promissory Note and the fair value of the
convertible promissory note was $491,502 under the Extension Note, respectively. For the year ended December 31, 2023, the Company
recognized an unrealized loss of $118,117 attributable to the change in fair value
of the Convertible Promissory Note and an unrealized loss of $133,205 attributable to the change in fair value of the Working Capital
Loan, respectively, in the statements of operations.
Capital Contribution Note
The Company elected to account for the Capital Contribution Note entered
into with Polar and the Sponsor (the March 2023 Subscription Agreement) on March 9, 2023, pursuant to the fair value option under ASC
825. ASC 825-10-15-4 provides for the “fair value option” election, to the extent not otherwise prohibited by ASC 825-10-15-5,
to be afforded to financial instruments, wherein the financial instrument is initially measured at its issue-date estimated fair value
and subsequently remeasured at estimated fair value on a recurring basis at each reporting period date. Differences between the face value
of the Capital Contribution Note and fair value at issuance are recognized as either an expense in the statement of operations (if issued
at a premium) or as a capital contribution (if issued at a discount). Any material changes in the estimated fair value of the Capital
Contribution Note are recognized as non-cash gains or losses in the statements of operations. The Company believes that the fair value
option better reflects the underlying economics of the Capital Contribution Note. The fair value of the Capital Contribution Note will
include both the fair value of the 300,000 shares in consideration for the Capital Calls as described in Note 7 and the principal as of
each reporting date. As such, the Capital Contribution Note was initially measured at $1,359,720 as of the issue date. The $1,059,720
excess of fair value of Capital Contribution Note over proceeds at issuance was recorded in the accompanying statement of operations for
the year ended December 31, 2023. As of December 31, 2023, the fair value of the Capital Contribution Note was $2,200,291. For the year
ended December 31, 2023, the Company recognized $840,571 unrealized loss on fair value changes of the Capital Contribution Note in the
statements of operations.
October 2023 Subscription Agreement
The Company analyzed the October 2023
Subscription Agreement (as defined in Note 8) under ASC 480 “Distinguishing Liabilities from Equity” and ASC 815,
Derivatives and Hedging, and concluded that, (i) the Subscription Shares (as defined in Note 8) issuable under the October 2023
Subscription Agreement are not required to be accounted for as a liability under ASC 480 or ASC 815, (ii) bifurcation of a single
derivative that comprises all of the fair value of the Subscription Share feature(s) (i.e., derivative instrument) is not necessary
under ASC 815-15-25, and (iii) bifurcation of a single derivative that comprises all of the fair value of the Termination (as
defined in Note 8) feature (i.e., derivative instrument) is necessary under ASC 815-15-25. As a result, the Company analyzed the
October 2023 Subscription Agreement under ASC 470 “Debt” and concluded that, the Subscription Shares are representative
of an equity classified freestanding financial instrument issued in a bundled transaction with a loan which is representative of a
liability classified freestanding financial instrument which contains a derivative instrument which is required to be bifurcated and
classified and accounted for as a derivative liability measured at fair value, on a recurring basis, with changes in fair value
recorded within the accompanying statements of operations. As a result, the Company will record the October 2023 Subscription
Agreement using the with-and-without method of accounting combined with the relative fair value method of accounting when allocating
the proceeds received under the October 2023 Subscription Agreement, as required under ASC 470.
Warrant Liability
The Company evaluates its financial instruments
to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic
815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative
instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the
fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments
should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified
in the balance sheets as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required
within 12 months of the balance sheet date.
The Company accounts for the warrants issued in
connection with the IPO and the private placement in accordance with the guidance contained in ASC 815-40. Such guidance provides that
because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly,
the Company classified each warrant as a liability at its fair value. This liability is subject to re-measurement at each reporting periods.
With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s
statements of operations. As of December 31, 2023 and 2022, there were 15,333,333 public and private warrants outstanding (not including
the 1,306,385 and 0 warrants as of December 31, 2023 and 2022, respectively, that could be issued upon conversion of the Convertible Promissory
Notes).
Net (Loss) Income Per Share
The Company has two classes of shares, which are referred to as Class A
ordinary shares and Class B ordinary shares. Earnings and losses are shared pro rata between the two classes of shares. The 15,333,333
potential ordinary shares for outstanding warrants to purchase the Company’s stock, the 1,306,385 potential ordinary shares for
the warrants that could be issued upon conversion of the Convertible Promissory Notes, to purchase the Company’s stock, the 330,000
potential ordinary shares (including 30,000 shares in consideration of the $300,000 principal amount outstanding under the Capital Contribution
Note, if Polar elects to receive shares at a rate of one Class A ordinary share for each $10.00, and 300,000 shares in consideration of
the Capital Calls as described in Note 7) and the 750,000 Subscription Shares (as defined in Note 8) that will be issued to Polar at the
Closing were excluded from diluted earnings per share for the periods ended December 31, 2023 and 2022 because the warrants and the shares
that will be issued to Polar are contingently exercisable, and the contingencies have not yet been met. As a result, diluted net (loss)
income per share is the same as basic net (loss) income per share for the periods. In addition, any shares subject to forfeiture are not
included in the weighted average shares outstanding until the forfeiture restrictions lapse.
The table below presents a reconciliation of the
numerator and denominator used to compute basic and diluted net (loss) income per share for each class of ordinary shares. Because the
redemption value of the Class A ordinary shares approximates their fair value, remeasurement to redemption value is not impacting
allocable earnings.
| |
For the Year Ended December 31, | |
| |
2023 | | |
2022 | |
| |
Class A | | |
Class B | | |
Class A | | |
Class B | |
Basic and diluted net (loss) income per share: | |
| | |
| | |
| | |
| |
Numerator: | |
| | |
| | |
| | |
| |
Allocation of net (loss) income | |
$ | (2,697,319 | ) | |
$ | (3,492,326 | ) | |
$ | 9,293,085 | | |
$ | 2,323,271 | |
Denominator: | |
| | | |
| | | |
| | | |
| | |
Weighted-average shares outstanding | |
| 5,792,672 | | |
| 7,500,000 | | |
| 30,000,000 | | |
| 7,500,000 | |
Basic and diluted net (loss) income per share | |
$ | (0.47 | ) | |
$ | (0.47 | ) | |
$ | 0.31 | | |
$ | 0.31 | |
Income Taxes
The Company accounts for income taxes under FASB
ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for
both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future
tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established
when it is more likely than not that all or a portion of deferred tax assets will not be realized.
FASB ASC 740 prescribes a recognition threshold
and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in
a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing
authorities. There were no unrecognized tax benefits as of December 31, 2023 and 2022. The Company’s management determined
that the Cayman Islands and Singapore are the Company’s only major tax jurisdictions. The Company recognizes accrued interest and
penalties related to unrecognized tax benefits as income tax expense. As of December 31, 2023 and 2022, there were no unrecognized
tax benefits and no amounts were accrued for the payment of interest and penalties. The Company is currently not aware of any issues under
review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax
examinations by major taxing authorities since inception.
There is currently no taxation imposed on income
by the Government of the Cayman Islands. In accordance with federal income tax regulations, income taxes are not levied on the Company,
but rather on the individual owners. United States (“U.S.”) taxation would occur on the individual owners if certain tax elections
are made by U.S. owners and the Company were treated as a passive foreign investment company. Additionally, U.S. taxation could occur
to the Company itself if the Company is engaged in a U.S. trade or business. The Company is not expected to be treated as engaged in a
U.S. trade or business at this time.
Recent Accounting Pronouncements
In August 2020, the FASB issued ASU 2020-06, “Debt-Debt
with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40):
Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies
accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement
conditions that are required for equity-linked contracts to qualify for scope exception, and it simplifies the diluted earnings per share
calculation in certain areas. ASU 2020-06 is effective January 1, 2024 for fiscal years beginning after December 15, 2023
and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The
Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or
cash flows. The Company will adopt this guidance on January 1, 2024.
In December 2023, the FASB issued ASU 2023-09,
Income Taxes (Topic 740): Improvements to Income Tax Disclosures (ASU 2023-09), which requires disclosure of incremental income tax information
within the rate reconciliation and expanded disclosures of income taxes paid, among other disclosure requirements. ASU 2023-09 is effective
for fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company’s management does not believe the adoption
of ASU 2023-09 will have a material impact on its financial statements and disclosures.
The Company’s management does not believe
that any other recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on these
financial statements.
NOTE 3. INITIAL PUBLIC OFFERING
On February 17, 2021, the Company sold 30,000,000
Units, including the issuance of 2,500,000 Units as a result of the underwriter’s partial exercise of the over-allotment option,
at a purchase price of $10.00 per Unit. The over-allotment option covering an additional 1,625,000 Units expired on March 28, 2021. Each
Unit consists of one Class A ordinary share, and one-third of one warrant to purchase one Class A ordinary share. Each whole warrant will
entitle the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. Each whole warrant will
become exercisable on the later of 30 days after the completion of the initial Business Combination or 12 months from the closing of the
IPO, February 17, 2021, and will expire five years after the completion of the initial Business Combination, or earlier upon redemption
or liquidation.
Following the closing of the IPO on February 17,
2021, an amount of $300,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO and the sale of the Private
Placement Warrants was placed in the Trust Account and was invested only in U.S. government treasury obligations with a maturity of 185
days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act that invests only in
direct U.S. government treasury obligations. In March 2023, the Company liquidated the money market funds held in the Trust Account. The
funds in the Trust Account are now maintained in cash in an interest-bearing demand deposit account at a bank until the earlier of consummation
of the initial Business Combination and liquidation.
Warrants
As of December 31, 2023, there were 10,000,000
public warrants and 5,333,333 Private Placement Warrants outstanding (not including the 1,306,385 warrants that could be issued
upon conversion of the Convertible Promissory Notes). Each whole warrant entitles the holder to purchase one Class A ordinary share at
a price of $11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issues additional Class A ordinary
shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at
an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price
to be determined in good faith by the Company’s board of directors and in the case of any such issuance to the Sponsor or its affiliates,
without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance (the “Newly
Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest
thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination
(net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A ordinary shares during the 20 trading
day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price,
the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to
be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price (discussed
below) will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the
$10.00 per share redemption trigger price (discussed below) will be adjusted (to the nearest cent) to be equal to the higher of the Market
Value and the Newly Issued Price.
The warrants will become exercisable 30 days after
the completion of its initial Business Combination, and will expire five years after the completion of the Company’s initial Business
Combination.
The Company has agreed that as soon as practicable,
but in no event later than 20 business days after the closing of the initial Business Combination, it will use its commercially reasonable
efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable
upon exercise of the warrants. The Company will use its commercially reasonable efforts to cause the same to become effective within 60
business days after the closing of the initial Business Combination, and to maintain the effectiveness of such registration statement
and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant
agreement; provided that, if the Company’s Class A ordinary shares are at the time of any exercise of a warrant not listed on a
national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities
Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a “cashless basis”
in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to
file or maintain in effect a registration statement, but the Company will use its commercially reasonable efforts to register or qualify
the shares under applicable blue sky laws to the extent an exemption is not available. If a registration statement covering the Class
A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial
Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when
the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance
with Section 3(a)(9) of the Securities Act or another exemption, but the Company will use its commercially reasonable efforts to register
or qualify the shares under applicable blue sky laws to the extent an exemption is not available. In such event, each holder would pay
the exercise price by surrendering the warrants for that number of Class A ordinary shares equal to the lesser of (A) the quotient obtained
by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied by the excess of the “fair
market value” (defined below) less the exercise price of the warrants by (y) the fair market value and (B) 0.361. The “fair
market value” as used in this paragraph shall mean the volume weighted average price of the Class A ordinary shares for the 10 trading
days ending on the trading day prior to the date on which the notice of exercise is received by the warrant agent.
Redemption of warrants when the price per Class A
ordinary share equals or exceeds $18.00.
Once the warrants become exercisable, the Company
may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants):
| ● | in whole and not in part; |
| | |
| ● | at a price of $0.01 per warrant; |
| | |
| ● | upon not less than 30 days’ prior written notice of redemption to each warrant holder; and |
| | |
| ● | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders. |
Redemption of warrants when the price per Class A
ordinary share equals or exceeds $10.00.
Once the warrants become exercisable, the Company
may redeem the outstanding warrants:
| ● | in whole and not in part; |
| | |
| ● | at a price of $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption, provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares, based on the redemption date and the “fair market value” of the Company’s Class A ordinary shares; |
| | |
| ● | if, and only if, the closing price of the Company’s Class A ordinary shares equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and |
| | |
| ● | if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants. |
The warrant agreement contains an alternative
issuance provision that if less than 70% of the consideration receivable by the holders of the ordinary shares in the Business Combination
is payable in the form of ordinary shares in the successor entity, and if the holders of the warrants properly exercise the warrants within
thirty days following the public disclosure of the consummation of the Business Combination by the Company, the warrant price shall be
reduced by an amount equal to the difference (but in no event less than zero) of (i) the warrant price in effect prior to such reduction
minus (ii) (A) the Per Share Consideration (as defined below) minus (B) the Black-Scholes Warrant Value (as defined below). The “Black-Scholes
Warrant Value” means the value of a warrant immediately prior to the consummation of the Business Combination based on the Black-Scholes
Warrant Model for a Capped American Call on Bloomberg Financial Markets. “Per Share Consideration” means (i) if the consideration
paid to holders of the ordinary shares consists exclusively of cash, the amount of such cash per ordinary share, and (ii) in all other
cases, the volume weighted average price of the ordinary shares as reported during the ten-trading day period ending on the trading day
prior to the effective date of the Business Combination.
The Company believes that the adjustments to the
exercise price of the warrants is based on a variable that is not an input to the fair value of a “fixed-for-fixed” option
as defined under FASB ASC Topic No. 815–40, and thus the warrants are not eligible for an exception from derivative accounting.
The accounting treatment of derivative financial
instruments requires that the Company record a derivative liability at fair value upon the closing of the IPO. The warrants were allocated
a portion of the proceeds from the issuance of the Units equal to their fair value determined by the Monte Carlo simulation. The Company
will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the
warrants will be reclassified as of the date of the event that causes the reclassification. If no events occurred during the period, the
warrants will not be reclassified. The fair value of the liabilities is re-measured at the end of every reporting period and the change
in fair value is reported in the statements of operations as a gain or loss on derivative financial instruments.
NOTE 4. PRIVATE PLACEMENT
Simultaneously with the closing of the IPO, the
Sponsor purchased an aggregate of 5,333,333 Private Placement Warrants at a purchase price of $1.50 per Private Placement Warrant, generating
gross proceeds to the Company of $8,000,000. The fair value of the warrants as of the IPO was $1.38 per warrant, for a total initial fair
value of $7,375,280. The excess of cash received over the fair value of the Private Placement Warrants was $624,720 and was reflected
in additional paid-in capital on the statements of changes in shareholders’ deficit for the three months ended March 31, 2021. The
proceeds from the sale of the Private Placement Warrants were added to the proceeds from the IPO held in the Trust Account. If the Company
does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless.
The Private Placement Warrants (including the
Class A ordinary shares issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable or salable until
30 days after the completion of the initial Business Combination and they will not be redeemable by the Company so long as they are held
by the Sponsor or its permitted transferees. The Sponsor, or its permitted transferees, has the option to exercise the Private Placement
Warrants on a cashless basis. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees,
the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the warrants included
in the units being sold in the IPO.
NOTE 5. RELATED PARTY TRANSACTIONS
Founder Shares
On December 28, 2020, the Sponsor paid $25,000,
or approximately $0.003 per share, to cover certain offering costs in consideration for 7,187,500 Class B ordinary shares, par value $0.0001.
On February 11, 2021, the Company effected a share capitalization resulting in the Sponsor holding an additional 718,750 Class B ordinary
shares for an aggregate of 7,906,250 Class B ordinary shares including up to 1,031,250 Founder Shares subject to forfeiture by the Sponsor
depending on the extent to which the underwriter’s over-allotment option was exercised. On February 17, 2021, J.P. Morgan partially
exercised its over-allotment option, hence, 625,000 Founder Shares were no longer subject to forfeiture. At March 28, 2021, the over-allotment
option expired, hence the 406,250 Class B ordinary shares were forfeited. As of December 31, 2023 and 2022, there were 7,500,000 Founder
Shares issued and outstanding.
The Sponsor and the Company’s directors
and executive officers have agreed not to transfer, assign or sell any of their Founder Shares (except to certain permitted transferees
and under certain circumstances) until the earlier to occur of: (i) one year after the completion of the initial Business Combination,
or (ii) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction after the initial Business
Combination that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash,
securities or other property (the “lock-up”).
Notwithstanding the foregoing, if the closing
price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations,
recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial
Business Combination or (2) if the Company consummates a transaction after the initial Business Combination which results in the Company’s
shareholders having the right to exchange their shares for cash, securities or other property, the Founder Shares will be released from
the lock-up.
The Sponsor and the Company’s directors
and executive officers have also agreed not to transfer any of their Private Placement Warrants (including the Class A ordinary shares
issuable upon exercise of the Private Placement Warrants) until 30 days after the completion of the initial Business Combination.
Due to Related Party
As of December 31, 2023 and 2022, the amount due
to related party was $241,366 and $125,625, respectively, which mainly consisted of the unpaid portion of the administrative service fee
described below.
Convertible Promissory Notes
On February 14, 2023, the Company issued an unsecured
convertible promissory note (the “Extension Note” and, together with the “1.5 Million Convertible Promissory Note”
as described below, the “Convertible Promissory Notes”) to the Sponsor, pursuant to which the Company may borrow up to $900,000
(the “Extension Note”) from the Sponsor. Pursuant to the Extension Note, from February 17, 2023 to February 17, 2024 or such
earlier date as is determined by the Company’s board of directors, the Sponsor has agreed to deposit into the Company’s Trust
Account the lesser of (i) $75,000 or (ii) $0.0375 for each unredeemed public share, for each month (or a pro rata portion thereof if less
than a month) until the earlier of (i) the date of the extraordinary general meeting held in connection with a shareholder vote to approve
the Business Combination, and (ii) the date that $900,000 has been loaned. Such loan may, at the Sponsor’s discretion, be converted
into warrants (the “Extension Loan Warrants”) to purchase Class A ordinary shares of the Company, par value $0.0001 per share,
at a conversion price equal to $1.50 per warrant, with each warrant entitling the holder to purchase one Class A ordinary share of the
Company at a price of $11.50 per share, subject to the same adjustments applicable to the Private Placement Warrants that were issued
in connection with the IPO. The terms of the Extension Loan Warrants will be identical to those of the Private Placement Warrants. The
Extension Loan will not bear any interest, and will be repayable by the Company to the Sponsor, on a date that is the earlier of (a) the
consummation of the Company’s initial merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization
or similar business combination with one or more businesses or entities and (b) the liquidation of the Company. The maturity date of the
Extension Loan may be accelerated upon the occurrence of an Event of Default (as defined under the Extension Note).
The Extension Note was valued using the fair value method, with the
changes of fair value at each reporting period recorded in the statement of operations. As of December 31, 2023, $825,000 was drawn under
the Extension Note, with an initial fair value of $373,385 at the issuance dates. The difference of $451,615, between the withdrawals
of $825,000 and the fair value at the issuance dates of $373,385, was recorded in additional paid-in capital in the accompanying statement
of changes in shareholders’ deficit for the year ended December 31, 2023. As of December 31, 2023, the Extension Note was presented
at its fair value of $491,502, as Convertible Promissory Note on the accompanying balance sheet (see Note 9). Up to the date that the
financial statements were issued, the Company had received $900,000 for the extension deposits under the Extension Note.
For the year ended December 31, 2023, the Company
recorded $118,117 unrealized loss on fair value changes of the Extension Note in the accompanying statement of operations.
Working Capital Loans
In addition, in order to finance transaction costs
in connection with an intended Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers
and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company
completes the initial Business Combination, the Company would repay the Working Capital Loans. In the event that the initial Business
Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital
Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. A portion of the Working Capital Loans,
not to exceed $1,500,000, may be convertible into Private Placement Warrants at a price of $1.50 per warrant at the option of the lender.
Such warrants would be identical to the Private Placement Warrants.
On December 13, 2022, the Company issued an unsecured
convertible promissory note under the Working Capital Loans to the Sponsor, pursuant to which the Company may borrow up to $1,500,000
from the Sponsor (the “$1.5 Million Convertible Promissory Note,” and together with the “Extension Note” as described
above, the “Convertible Promissory Notes”). Such loan may, at the Sponsor’s discretion, be converted into Private Placement
Warrants at a price of $1.50 per warrant as described above. The $1.5 Million Convertible Promissory Note will not bear any interest,
and will be repayable by the Company to the Sponsor, on a date that is the earlier of (a) the consummation of the Company’s initial
merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or
more businesses or entities and (b) the liquidation of the Company. The maturity date of the $1.5 Million Convertible Promissory Note
may be accelerated upon the occurrence of an Event of Default (as defined under the $1.5 Million Convertible Promissory Note). As of December
31, 2023 and 2022, $1,134,578 and $0 were outstanding under the $1.5 Million Convertible Promissory Note. Up to the date that the financial
statements were issued, the Company received a total of $1,431,995 for working capital purposes under the $1.5 Million Convertible
Promissory Note.
The $1.5 Million Convertible Promissory Note was valued using the fair
value method, with the changes of fair value at each reporting period recorded in statement of operations. As of December 31, 2023, $1,134,578
was drawn down under such loan, with an initial fair value of $542,729 at the issuance dates. The difference of $591,849, between the
withdrawal of $1,134,578 and the fair value at the issuance dates of $542,729, was recorded in additional paid-in capital in the accompanying
statement of changes in shareholders’ deficit. As of December 31, 2023, the $1.5 Million Convertible Promissory Note was presented
at its fair value of $675,934 as a Working Capital Loan on the Company’s accompanying balance sheets. As of December 31, 2022,
the Company had no borrowings under the $1.5 Million Convertible Promissory Note (see Note 9).
For the year ended December 31, 2023, the Company
recorded $133,205 unrealized loss on fair value changes of the $1.5 Million Convertible Promissory Note in the accompanying statement
of operations.
Administrative Service Fee
The Company has agreed, commencing on the
date the securities of the Company were first listed on the NYSE, to pay the Sponsor $10,000 per month for office space,
utilities, secretarial and administrative support services provided to members of the Company’s management team. For each of
the years ended December 31, 2023 and 2022, respectively, the Company incurred $120,000 in expenses in connection with such services
and paid in aggregate of $5,065 of these fees during the year ended December 31, 2023. All such expenses were recorded in the
accompanying statements of operations. As of December 31, 2023 and 2022, respectively, administrative service fees of $240,935 and
$125,625 were unpaid and are included in due to related party on the accompanying balance sheets. Upon completion of the initial Business
Combination or the Company’s liquidation, the Company will cease paying these monthly fees.
NOTE 6. NOTE RECEIVABLE
On October 27, 2023, the Company and Crown entered
into a promissory note (“Promissory Note”) whereby the Company agreed to provide a loan in the principal amount of $750,000
to Crown to fund working capital until the Closing. Crown has agreed to repay the $750,000 to the Company within ten (10) business days
of the Company providing Crown with written notice of demand after the Closing. In the event the Business Combination Agreement is terminated
or the Business Combination does not close by February 17, 2024 (which was subsequently extended to June 17, 2024, and then to June 28,
2024), Crown has agreed to transfer, or cause to be transferred to the Company within ten (10) business days of the termination, (A) $1,750,000
in cash; or (B) solely at the discretion and election of the Company, $1,000,000 in cash and a number of shares of Crown’s common
equity equal to 1.5% of the outstanding common equity (on a fully diluted basis) as of the date of the termination. This agreement was
entered into concurrently with the October 2023 Subscription Agreement (as defined and discussed further in Note 8). On October 30, 2023,
the Company advanced $750,000 to Crown.
The Company analyzed the October 2023
Subscription Agreement under ASC 320 “Investments – Debt Securities” and concluded that, bifurcation of a single
derivative that comprises all of the fair value of the Termination feature (i.e., derivative instrument) is necessary under ASC
815-15-25. As a result, the Company recorded a held to maturity asset in the amount of $750,000 which is representative of the
amortized cost of the Note Receivable and recorded a corresponding Derivative Asset – Note Receivable in the amount of
$2,667,828. During the subsequent measurement period, the Company recorded an increase in expense in the amount of $21,536
associated with changes in the fair value of the Derivative Asset - Note Receivable as of December 31, 2023. Further, the Note
Receivable was issued at a discount of $750,000, which was fully accreted to the Note Receivable balance immediately as it
occurred.
To value the Derivative Asset – Note Receivable
upon issuance, the Company used a probability weighted expected return model (“PWER model”) that values the October 2023 Subscription
Agreement based on future projections of the various potential outcomes. The embedded options were valued using a Black Scholes model.
The derivative value was determined on a with and without basis. The key inputs for PWER model include 1) volatility of 35.5%; 2) risk–
free rate of 5.6%; 3) restricted terms of 0.31 year; 4) likelihood of completing a business combination of 60%.
NOTE 7. CAPITAL CONTRIBUTION NOTE
On March 9, 2023, the Company entered into a subscription agreement
(the “March 2023 Subscription Agreement”) with the Sponsor and Polar Multi-Strategy Master Fund (“Polar”), pursuant
to which the Sponsor sought to raise $1,200,000 to fund the extension and to provide working capital to the Company. The Sponsor committed
to fund $900,000 of this amount through the Extension Note described in Note 5 above and Polar agreed to provide the remaining $300,000
(the “Capital Contribution Note”). The Company will request funds from the Sponsor for working capital purposes (“Drawdown
Request”). Upon at least five (5) calendar days’ prior written notice, the Sponsor may require a drawdown from Polar against
the capital commitment in order to meet 25% of the Sponsor’s commitment to the Company under a Drawdown Request (“Capital
Call”). In consideration of the Capital Call(s) made hereunder, the Company will issue 300,000 Class A ordinary shares to Polar
at the Closing. Any amounts funded by the Sponsor to the Company under a Drawdown Request shall not accrue interest and shall be promptly
repaid by the Company to the Sponsor upon the Closing. Following receipt of such sums from the Company, and in any event within five (5)
business days of the Closing, the Sponsor or the Company shall pay Polar an amount equal to Capital Calls funded under the March 2023
Subscription Agreement (the “Business Combination Payment”). The Company and Sponsor are jointly and severally obligated to
make the Business Combination Payment to Polar. Polar may elect at the Closing to receive such Business Combination Payment in cash or
Class A ordinary shares at a rate of one Class A ordinary share for each $10.00 of the Capital Calls funded under the March 2023 Subscription
Agreement. If the Company liquidates without consummating a Business Combination, any amounts remaining in the Sponsor or the Company’s
cash accounts after paying any outstanding third party invoices (excluding any due to the Sponsor), not including the Company’s
Trust Account, will be paid to Polar within five (5) days of the liquidation.
The Company treated the Capital Contribution Note
as a debt instrument and measured it with fair value method, and records changes of fair value at each reporting period in the statement
of operations. The fair value of the Capital Contribution Note will include both the fair value of the 300,000 shares in consideration
for the Capital Calls and the principal as of each reporting date. As of December 31, 2023, the entire $300,000 funding was received under
the Capital Contribution Note. The initial fair value of the Capital Contribution Note was $1,359,720. The difference of $1,059,720, between
the $300,000 principal and the initial fair value of $1,359,720, was recorded as expenses in the accompanying statement of operations
for the period ended December 31, 2023. As of December 31, 2023, the Capital Contribution Note was presented at its fair value of $2,200,291
on the accompanying balance sheets (see Note 8).
For the year ended December 31, 2023, the Company
recorded $840,571 unrealized loss on fair value changes of the Capital Contribution Note in the accompanying statement of operations.
NOTE 8. SUBSCRIPTION AGREEMENT–- POLAR
On October 25, 2023, the Company, the Sponsor
and Polar entered into an additional (see Note 7) subscription agreement (the “October 2023 Subscription Agreement”), pursuant
to which Polar agreed to fund a capital contribution of $750,000 (the “SPAC Loan”), without interest, to the Company and
in consideration thereof, the Company agreed to issue or cause PubCo to issue 750,000 Class A ordinary shares (the “Subscription
Shares”) to Polar at the Closing. The Sponsor and the Company, jointly and severally, agreed to promptly repay the $750,000 to
Polar within five (5) business days of the Closing. In the event that: (i) the Business Combination Agreement is terminated or (ii) the
Business Combination does not close by February 17, 2024 (or such other date as the parties to the Business Combination Agreement shall
agree) (the “Termination”), the Sponsor and the Company, jointly and severally, agreed to transfer, or cause to be transferred
to Polar within ten business days of the Termination, (A) $1,750,000 in cash; or (B) solely at the discretion and election of Polar,
$1,000,000 in cash and, a number of shares of Crown’s common equity equal to 1.5% of its outstanding common equity (on a fully
diluted basis) as of the date of Termination (either (A) or (B) above, the “Catcha Termination Payment”). If a Catcha Termination
Payment is not made within ten business days of the Termination, the Sponsor and the Company agreed to transfer, or cause to be transferred,
warrants that entitle Polar to purchase a number of shares of Crown’ common equity equal to 0.30 percent per annum of the outstanding
Crown common equity (on a fully-diluted basis) at exercise, for a price per share of $0.01 (the “Crown Warrants”), accruing
monthly (for each month from the date of the Termination until the time that Polar receives the full amount of the Catcha Termination
Payment, so that for each such month, a Crown Warrant shall be issued to Polar for a number of shares equal to the total number of shares
of outstanding common equity of Crown on a fully diluted basis multiplied by 0.00025). The Crown Warrants are exercisable pursuant to
terms set forth in the October 2023 Subscription Agreement.
The Company analyzed the October 2023
Subscription Agreement under ASC 480 “Distinguishing Liabilities from Equity” and ASC 815, Derivatives and
Hedging, and concluded that, (i) the Subscription Shares issuable under the October 2023 Subscription Agreement are not required to
be accounted for as a liability under ASC 480 or ASC 815, (ii) bifurcation of a single derivative that comprises all of the fair
value of the Subscription Share feature(s) (i.e., derivative instrument) is not necessary under ASC 815-15-25, and (iii) bifurcation
of a single derivative that comprises all of the fair value of the Termination feature (i.e., derivative instrument) is necessary
under ASC 815-15-25. As a result, the Company analyzed the October 2023 Subscription Agreement under ASC 470 “Debt” and
concluded that, the Subscription Shares are representative of an equity classified freestanding financial instrument issued in a
bundled transaction with a SPAC Loan which is representative of liability classified freestanding financial instrument which
contains a derivative instrument which is required to be bifurcated and classified and accounted for as a derivative liability
measured at fair value, on a recurring basis, with changes in fair value recorded within the accompanying statements of operations
(hereinafter, the “Derivative Liability – Note Payable”). As a result, the Company recorded the October 2023
Subscription Agreement using the with-and-without method of accounting combined with the relative fair value method of accounting
when allocating the proceeds received under the October 2023 Subscription Agreement, as required under ASC 470. On October 25, 2023,
the date of issuance, the fair value of the Subscription Shares was $4,917,967, the fair value of the Derivative Liability —
Note Payable was $2,667,828, and the fair value of the Derivative Asset – Note Receivable (see Note 6) was $2,667,828. As of
December 31, 2023, the Company received $750,000 under the October 2023 Subscription Agreement. As of December 31, 2023, the fair
value of the Derivative Liability — Note Payable was $2,689,364; therefore, the Company recorded an increase in expense in the
amount of $21,536 associated with changes in the fair value of the Derivative Liability — Note Payable as of December 31,
2023. Further, the Note Payable was issued at a discount of $750,000, which was fully accreted to the Note Payable balance
immediately as it occurred.
To value the Derivative Liability – Note
Payable at issuance date the Company used a probability weighted expected return model (“PWER model”) that values the October
2023 Subscription Agreement based on future projections of the various potential outcomes. The embedded options were valued using a Black
Scholes model. The derivative value was determined on a with and without basis. The key inputs for PWER model include 1) volatility of
35.5%; 2) risk–- free rate of 5.6%; 3) restricted terms of 0.31 year; 4) likelihood of completing a business combination of 60%.
NOTE 9. FAIR VALUE MEASUREMENTS
The following tables presents information about
the Company’s assets and liabilities that were measured at fair value on a recurring basis as of December 31, 2023 and 2022 and
indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.
| |
December 31, 2023 | | |
Quoted Prices In Active Markets (Level 1) | | |
Significant Other Observable Inputs (Level 2) | | |
Significant Other Unobservable Inputs (Level 3) | |
Assets: | |
| | |
| | |
| | |
| |
Derivative Asset — Note Receivable | |
$ | 2,689,364 | | |
| | | |
$ | — | | |
$ | 2,689,364 | |
Liabilities: | |
| | | |
| | | |
| | | |
| | |
Warrant Liability–Public Warrants | |
| 400,000 | | |
$ | — | | |
| 400,000 | | |
| — | |
Warrant Liability–Private Placement Warrants | |
| 221,969 | | |
| — | | |
| 221,969 | | |
| — | |
Working Capital Loans | |
| 675,934 | | |
| — | | |
| — | | |
| 675,934 | |
Promissory Note-Related Party | |
| 491,502 | | |
| — | | |
| — | | |
| 491,502 | |
Capital Contribution Note | |
| 2,200,291 | | |
| — | | |
| — | | |
| 2,200,291 | |
Derivative Liability — Note Payable | |
| 2,689,364 | | |
| — | | |
| — | | |
| 2,689,364 | |
Total | |
$ | 6,679,060 | | |
$ | — | | |
$ | 621,969 | | |
$ | 6,057,091 | |
| |
December 31, 2022 | | |
Quoted Prices In Active Markets (Level 1) | | |
Significant Other Observable Inputs (Level 2) | | |
Significant Other Unobservable Inputs (Level 3) | |
Assets | |
| | |
| | |
| | |
| |
Cash and investments held in Trust Account - Trading Securities | |
$ | 304,086,289 | | |
$ | 304,086,289 | | |
$ | — | | |
$ | — | |
| |
$ | 304,086,289 | | |
$ | 304,086,289 | | |
$ | — | | |
$ | — | |
Liabilities | |
| | | |
| | | |
| | | |
| | |
Warrant Liability – Public Warrants | |
$ | 42,000 | | |
$ | 42,000 | | |
$ | — | | |
$ | — | |
Warrant Liability – Private Placement Warrants | |
| 26,660 | | |
| — | | |
| 26,660 | | |
| — | |
| |
$ | 68,660 | | |
$ | 42,000 | | |
$ | 26,660 | | |
$ | — | |
The warrants,
Working Capital Loans, the Extension Note, the Capital Contribution Note and the October 2023 Subscription Agreement are accounted for
as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities, Working Capital Loans, Convertible
Promissory Note, Capital Contribution Note and Derivative Liability — Note Payable, respectively, in the accompanying balance sheets.
The warrant liabilities, Working Capital Loans, Convertible Promissory Note, Capital Contribution Note and Derivative Liability —
Note Payable are measured at fair value at inception and on a recurring basis, with changes in fair value presented in the statements
of operations. The excess of proceeds over fair value at issuance was recorded as additional paid-in capital in the accompanying statements
of shareholders’ equity. The excess of fair value over proceeds at issuance was recorded as expenses in the accompanying statement
of operations.
Warrant Liability
The Company’s public and private warrant
liabilities were valued using a Monte Carlo simulation at issuance date utilizing management judgment and pricing inputs from the quoted
underlying ordinary shares. Significant deviations from these estimates and inputs could result in a material change in fair value. The
fair value of the public and private warrant liabilities was initially classified as Level 3.
On November 4, 2022, the New York Stock Exchange
(the “NYSE”) notified the Company, and publicly announced, that the NYSE determined to commence proceedings to delist the
Company’s warrants, each whole warrant exercisable for one Class A ordinary share and listed to trade on the NYSE under the symbol
“CHAA WS”, from the NYSE and that trading in the warrants would be suspended immediately, due to “abnormally low”
trading price levels pursuant to Section 802.01D of the NYSE Listed Company Manual. The public warrants began to trade over-the counter
(OTC) since then.
On March 23, 2023, the Company received approval
to transfer the listing of Class A ordinary shares from the NYSE to the NYSE American and on March 28, 2023, the Class A ordinary shares
began trading on the NYSE American under the symbol “CHAA”. In connection with the transfer, effective March 28, 2023, any
remaining units were mandatorily separated into their component parts and the units are no longer traded on the NYSE.
The fair value of the public warrant liability was classified as Level
1 as of December 31, 2022 due to it publicly trading on NYSE. As of December 31, 2023, the fair value of the public warrant liability
was re-classified as Level 2 due to the insufficient trading volume.
As of December 31, 2023 and 2022, the Private
Placement Warrants were valued using a Monte Carlo model using the quoted underlying public warrants. Due to the observable inputs in
the fair value estimation of the Private Placement Warrants, these inputs were classified as Level 2 as of December 31, 2023 and 2022.
The key inputs used in the Monte Carlo simulation for the Private Placement
Warrants as of December 31, 2023 and 2022 were as follows:
Input | |
December 31,
2023 | | |
December 31, 2022 | |
Public Warrant Price | |
| 0.040 | | |
| 0.004 | |
Risk-free interest rate | |
| 5.17 | % | |
| 4.74 | % |
Expected term (years) | |
| 5.13 | | |
| 5.31 | |
Expected volatility | |
| 1.4 | % | |
| 5.4 | % |
Stock price | |
$ | 11.13 | | |
$ | 10.09 | |
Exercise price | |
$ | 11.50 | | |
$ | 11.50 | |
Likelihood of Completing a Business Combination | |
| 60 | % | |
| 50 | % |
Convertible Promissory Notes (Extension Note
and Working Capital Loan)
Valuation of the Convertible Promissory Notes
(which includes the $1.5 Million Convertible Promissory Note and the Extension Note) was determined using a discounted cash flow analysis
based on the estimated timing of the initial business combination and classified as a Level 3 valuation. The key inputs or weighted average
inputs, as applicable, for discounted cash flow analysis at initial draw dates and December 31, 2023 were as follows:
Input |
|
December 31,
2023 |
|
|
Initial Draw
Dates
(February 22,
2023 -
December 28,
2023) |
|
Risk-free interest rate for warrant |
|
|
3.84 |
% |
|
|
3.54-4.89 |
% |
Risk-free interest rate for debt |
|
|
5.54 |
% |
|
|
4.82-5.60 |
% |
Term of Debt Conversion
(years) |
|
|
0.13 |
|
|
|
0.32-0.14 |
|
Term of Warrant
Conversion (years) |
|
|
5.00 |
|
|
|
5.00-5.80 |
|
Expected volatility |
|
|
1.4 |
% |
|
|
0.1-4.1 |
% |
Iterated/Market Stock price |
|
$ |
11.13 |
|
|
$ |
10.20-11.13 |
|
Exercise price of Warrants |
|
$ |
11.5 |
|
|
$ |
11.5 |
|
Strike Price of Debt Conversion |
|
$ |
1.5 |
|
|
$ |
1.5 |
|
Likelihood of Completing a Business Combination |
|
|
60 |
% |
|
|
40-100 |
% |
Activity for the year ended December 31, 2023
for the Convertible Promissory Notes (which include the $1.5 Million Convertible Promissory Note and the Extension Note) was as follows:
| |
Extension Note | | |
Working Capital Loan | |
Cash Proceeds from Convertible Promissory Notes | |
$ | 825,000 | | |
$ | 1,134,578 | |
Excess of proceeds over fair value at issuance | |
| (451,615 | ) | |
| (591,849 | ) |
Change in fair value | |
| 118,117 | | |
| 133,205 | |
Fair value as of December 31, 2023 | |
$ | 491,502 | | |
$ | 675,934 | |
Capital Contribution Note
Valuation of the Capital Contribution Note
was determined using a Probability Weighted Expected Return Method (“PWERM”) and classified as a Level 3 valuation. The
PWERM is a multistep process in which value is estimated based on the probability -weighted present value of various future
outcomes. The key inputs or weighted average inputs, as applicable, for PWERM at December 31, 2023 and the initial draw dates of
March 24, 2023 and May 24, 2023 were as follows:
Input |
|
December 31,
2023 |
|
|
Initial
Draws |
|
Risk-free interest rate |
|
|
5.50 |
% |
|
|
4.6-4.84 |
% |
Estimated Term (years) |
|
|
0.13 |
|
|
|
0.72-1.34 |
|
Expected volatility |
|
|
1.4 |
% |
|
|
2.6-3.4 |
% |
Iterated/Market Stock price |
|
$ |
11.13 |
|
|
$ |
10.23-10.33 |
|
Likelihood of Completing a Business Combination |
|
|
60 |
% |
|
|
40 |
% |
Consideration for the Capital Call(s)- in shares |
|
|
300,000 |
|
|
|
300,000 |
|
Activity for the period ended December 31, 2023 for the Capital Contribution
Note was as follows:
| |
Polar | |
Cash Proceeds from Capital Contribution Note | |
$ | 300,000 | |
Excess of fair value over proceeds at issuance | |
| 1,059,720 | |
Change in fair value | |
| 840,571 | |
Fair value of the Capital Contribution Note as of December 31, 2023 | |
$ | 2,200,291 | |
Derivative Liability — Note Payable
Valuation of the Derivative Liability
— Note Payable was determined using a Black -Scholes model with the remaining term, associated risk -free rate, share price,
comparable guideline company volatility and no expected dividends. The key inputs for Black -Scholes model at the initial draw date
of October 25, 2023 and December 31, 2023 were as follows:
Input | |
December 31, 2023 | | |
October 25, 2023 | |
Risk-free interest rate | |
| 5.50 | % | |
| 5.6 | % |
Estimated Term (years) | |
| 0.13 | | |
| 0.31 | |
Expected volatility | |
| 38.1 | % | |
| 35.5 | % |
Iterated/Market Stock price | |
$ | 11.13 | | |
$ | 10.95 | |
Fair Value of 1.5% Shares of Crown | |
| 6,606,000 | | |
| 6,606,000 | |
Exercise Price | |
$ | 750,000 | | |
$ | 750,000 | |
The fair value of 1.5% Shares of Crown is based on a $600 million equity
value of a 100% interest in Crown. The Company adjusted this value based on a discount of 26.6% for lack of marketability.
Activity for the period ended December 31, 2023 for the Derivative
Liability — Note Payable was as follows:
| |
Polar | |
Fair value of Derivative Liability — Note Payable at initial withdrawal day, October 25, 2023 | |
$ | 2,667,828 | |
Change in fair value | |
| 21,536 | |
Fair value of the Derivative Liability — Note Payable as of December 31, 2023 | |
$ | 2,689,364 | |
NOTE 10. COMMITMENTS AND CONTINGENCIES
Registration Rights
The holders of the Founder Shares, the Class A
ordinary shares that will be issued to Polar at Closing, the Private Placement Warrants and any warrants that may be issued upon conversion
of the Working Capital Loans and the Extension Note (and any Class A ordinary shares issuable upon the exercise of the Private Placement
Warrants and warrants that may be issued upon conversion of the Working Capital Loans and the Extension Note) will be entitled to registration
rights pursuant to a registration and shareholder rights agreement. The holders of these securities are entitled to make up to three demands,
excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back”
registration rights with respect to registration statements filed subsequent to the Company’s completion of its initial Business
Combination. However, the registration and shareholder rights agreement provide that the Company will not permit any registration statement
filed under the Securities Act to become effective until termination of the applicable lock-up period, which occurs (i) in the case of
the Founder Shares, and (ii) in the case of the Private Placement Warrants and the respective Class A ordinary shares underlying such
warrants, 30 days after the completion of the initial Business Combination. The Company will bear the expenses incurred in connection
with the filing of any such registration statements.
Underwriting Agreement
The underwriter of the IPO is entitled to a deferred
underwriting fee of 3.5% of the gross proceeds of the IPO, or $10,500,000, held in the Trust Account upon the completion of the Company’s
initial Business Combination subject to the terms of the underwriting agreement. The deferred underwriting fee was included as a liability
on the balance sheet as of December 31, 2022.
On August 10, 2023, J.P. Morgan waived its entitlement
to the payment of $10,500,000 deferred underwriting fee in connection with its role as underwriter in the Company’s IPO. Furthermore,
J.P. Morgan had no role in connection with the Business Combination. As a result, the Company recognized $482,662 of other income attributable
to the derecognition of deferred underwriting fees allocated to offering costs previously expensed and $10,017,338 was recorded to accumulated
deficit in relation to the waiver of the deferred underwriting fees in the accompanying financial statements.
Advisory Agreements
On March 14, 2023, the Company entered into
an agreement with Chardan Capital Markets, LLC (“Chardan”) for Chardan to act as exclusive capital markets technical
advisor with respect to an event of a stock exchange demand for action by the Company at a time other than the initial closing of a
business combination involving the Company and a target or targets. The agreement calls for Chardan to receive a fee of $175,000 at
the signing of the agreement, a fee of $175,000 no later than 10 calendar days after Chardan informs the Company of the documented
completion of the technical advisory activities and a deferred fee of $275,000 at the earlier of (i) the closing of a Business
Combination from the closing flow-of-funds or (ii) upon the liquidation of the Trust Account if the Company has not consummated a
Business Combination. For the period ended December 31, 2023, the Company recorded $625,000 of such advisory service fee in the
accompanying statement of operations. As of December 31, 2023, the Company had paid $350,000 to Chardan and the total unpaid amounts
to Chardan was $275,000, which was included in accounts payable and accrued expenses on the Company’s accompanying balance
sheet.
On March 26, 2023, the Company entered an agreement
with Alumia SARL (“Alumia”) to act as a non-exclusive transactional and strategic capital markets advisor to the Company assisting
with introductions and with respect to the Company’s potential Business Combination. The agreement calls for Alumia to receive simultaneously
with the Closing of the Business Combination (a) a fee in the amount of $2,500,000 and (b) a fee of 4% multiplied by the dollar amount
of any equity financing transactions which may be entered into by third party investors identified and introduced by Alumia prior to the
Closing, regardless of whether the counterparty in the Business Combination was a subject target, payable upon the Closing. Alumia is
currently not involved in the Company’s Business Combination transaction with Crown, and no fee is currently payable under this
agreement.
On May 18, 2023, the Company engaged J.V.B. Financial
Group, LLC, acting through its Cohen & Company Capital Markets division (“CCM”), to act as its (i) capital markets advisor
in connection with the Business Combination with Crown and (ii) placement agent in connection with a private placement of equity, equity-linked,
convertible and/or debt securities (the “Securities”) or other capital or debt raising transaction (the “Offering”)
in connection with the Business Combination. The Company shall pay CCM (i) an advisor fee in connection with the Business Combination
in an amount equal to the sum of (I) $2,000,000 paid in full in U.S. dollars simultaneously with the Closing of the Business Combination
and (II) 50,000 shares of common stock or equivalent equity (the “Shares”) of the publicly listed post-business combination
company (collectively, the “Advisor Fee”) and (ii) a transaction fee in connection with the Offering of an amount equal to
7.0% of the sum of (A) the gross proceeds raised from investors and received by the Company or Crown simultaneously with or before the
closing of the Offering plus (B) proceeds released from the Trust Account with respect to any shareholder of the Company that (x) entered
into a non-redemption or other similar agreement or (y) did not redeem the Company’s Class A ordinary shares, in each instance to
the extent such investor or shareholder under (A) and (B) above was identified to the Company by CCM, which shall be payable in U.S. dollars
by the Company and due to CCM simultaneously with the closing of the Offering. The Shares shall be fully duly authorized, validly issued,
paid and non-assessable and shall be registered for resale under the Act, or otherwise freely tradeable, as of the Closing of the Business
Combination and will be delivered in book entry form in the name of and delivered to CCM (or its designee) at the Closing of the Business
Combination. As of December 31, 2023, no fees are currently payable under the aforementioned arrangement.
NOTE 11. SHAREHOLDERS’ DEFICIT
Preference shares
The Company is authorized to issue 5,000,000 preference shares
with a par value of $0.0001 and with such designations, voting and other rights and preferences as may be determined from time to
time by the Company’s board of directors. As of December 31, 2023 and 2022, there were no preference shares issued or outstanding
(see Note 12).
Class A ordinary shares
The Company is authorized to issue 500,000,000 Class A
ordinary shares with a par value of $0.0001 per share. At December 31, 2023 and 2022, there were no Class A ordinary shares
issued and outstanding, excluding 2,214,859 and 30,000,000 Class A ordinary shares, respectively, subject to possible redemption.
The Class A ordinary shares that will be issued to Polar at the Closing, including 300,000 shares in consideration of Capital Calls as
described in Note 7 and 30,000 shares (if Polar elects to receive shares at a rate of one Class A ordinary share for each $10.00 at the
Closing) in consideration of the $300,000 withdrawal of the Capital Contribution Note as of December 31, 2023, were not shown as outstanding
as of December 31, 2023 or 2022.
Class B ordinary shares
The Company is authorized to issue a total of 50,000,000 Class B
ordinary shares at par value of $0.0001 per share. At December 31, 2023 and 2022, there were 7,500,000 Class B
ordinary shares issued and outstanding.
Holders of Class A ordinary shares and holders
of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders
except as required by law. Unless specified in the Company’s third amended and restated memorandum and articles of association,
or as required by applicable provisions of the Cayman Islands Companies Act or applicable stock exchange rules, the affirmative vote of
a majority of the Company’s ordinary shares that are voted is required to approve any such matter voted on by its shareholders.
The Class B ordinary shares will automatically
convert into Class A ordinary shares (which such Class A ordinary shares delivered upon conversion will not have redemption rights or
be entitled to liquidating distributions from the Trust Account if the Company does not consummate an initial Business Combination) at
the time of the initial Business Combination or earlier at the option of the holders thereof at a ratio such that the number of Class
A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum
of (i) the total number of ordinary shares issued and outstanding upon the completion of the IPO, plus (ii) the total number of Class
A ordinary shares issued, deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed
issued by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A
ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued or to be
issued to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, its affiliates or any
member of the Company’s management team upon conversion of Working Capital Loans, unless the holders of a majority of the then-outstanding
Class B ordinary shares agree to waive such adjustment with respect to such issuance or deemed issuance at the time thereof. In no event
will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one-to-one.
NOTE 12. SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions
that occurred after the balance sheet date up to the date that the financial statements were issued. Other than as described below or
within these financial statements, the Company did not identify any subsequent events that would have required adjustment or disclosure
in the financial statements.
Business Combination Agreement Amendments
On January 31, 2024, the Business Combination
Agreement was amended to (i) remove the closing condition in Section 9.2(f) of the Business Combination Agreement which would have required
the Company to have satisfied the minimum cash condition of at least US$20,000,000 and (ii) allow for listing of the PubCo ordinary shares
on either the NYSE or Nasdaq.
On February 16, 2024, the Business
Combination Agreement was further amended to extend the date on which the Business Combination Agreement may be terminated if the
conditions to the Closing (as defined in the Business Combination Agreement) have not been satisfied or waived from February 17,
2024 to May 17, 2024 (and subsequently extended as described below). In addition, the Company agreed to waive its right under its
amended and restated memorandum and articles of association to withdraw up to $100,000 of the interest earned on the funds held in
the Trust Account to pay dissolution expenses in the event of the liquidation of the Trust Account.
On February 14, 2024, the
SEC declared the registration statement on Form F-4 with respect to the Business Combination effective.
On May 21, 2024, the Business Combination Agreement was further amended
to extend the date on which the Business Combination Agreement may be terminated if the conditions to the Closing have not been satisfied
or waived from May 17, 2024 to June 17, 2024. Also, the parties have agreed that the Business Combination Agreement may be terminated
by Crown in the event that prior to June 17, 2024, the parties do not receive notice from Nasdaq, NYSE American, or another national securities
exchange acceptable to Crown, that the post-business combination public company common stock shall be approved for listing upon the closing
of the Business Combination. The non-solicitation provisions of the Business Combination Agreement were amended to expire on May 31, 2024,
unless Crown has received notice that the post-business combination public company common stock shall be approved for listing upon the
closing of the Business Combination on Nasdaq, NYSE American or another national securities exchange acceptable to Crown.
On June 11, 2024, the Business Combination Agreement was further amended to extend the date on which the Business Combination Agreement
may be terminated if the conditions to the Closing have not been satisfied or waived from June 17, 2024 to June 28, 2024. Also, the parties
have agreed that the Business Combination Agreement may be terminated by Crown in the event that prior to June 28, 2024, the parties do
not receive notice from Nasdaq, NYSE American, or another national securities exchange acceptable to Crown, that the post-business combination
public company common stock shall be approved for listing upon the closing of the Business Combination.
On June 12, 2024, Catcha held its Fourth
Extraordinary General Meeting of shareholders pursuant to which the shareholders of record as of January 16, 2024 approved
Catcha’s previously proposed Business Combination with Crown. In connection with the votes taken at this Extraordinary General
Meeting, Catcha has received elections from certain holders of our Class A ordinary shares to exercise their right to redeem their
shares for cash. As of the date of these financial statements, such elections are still within the time frame when such requests can
be rescinded; thus the final redemption payout has not yet been determined.
Business Combination – Other Agreements
April 2024 Notes
On April 30, 2024, PubCo entered into subscription
agreements with certain investors with respect to convertible promissory notes issuable upon closing of the Business Combination (the
“April 2024 Notes”) with an aggregate original principal amount of $1.05 million for an aggregate purchase price of $1.0 million,
reflecting a 5% original issue discount.
The April
2024 Notes bear interest at an annual rate of 10% and mature on the first anniversary of the issuance of the applicable note (the date
of such issuance, the “Issuance Date”). Interest on the April 2024 Notes is payable in cash or in-kind through the
issuance of additional April 2024 Notes, at the option of PubCo.
The
April 2024 Notes are convertible into PubCo ordinary shares at the option of the holder. The number of ordinary shares issuable upon conversion
of the April 2024 Notes is determined by dividing (x) such Conversion Amount by (y) the Conversion Price (the “Conversion Rate”).
“Conversion Amount” means the sum of (A) the portion of the principal of a note to be converted, redeemed or otherwise
with respect to which this determination is being made, (B) accrued and unpaid interest with respect to such principal of the applicable
note, and (C) any other unpaid amounts, if any. “Conversion Price” means $10.00 initially at the date of issuance of
the April 2024 Notes. The Conversion Price will reset to 95% of the lowest closing volume weighted average price observed over the 5 trading
days immediately preceding the 180th calendar day following the Issuance Date, subject to a minimum price of $2.50 (the “Minimum
Price”).
PubCo
has the option to redeem the April 2024 Notes in full at any time after the Issuance Date and prior to maturity thereof upon 10 Trading
Days’ (as defined in the April 2024 Notes) notice for cash at a redemption price equal to 110% of the aggregate principal amount
thereof, plus accrued and unpaid interest thereon.
PIPE
On May 6, 2024, PubCo and the Company entered
into a subscription agreement (the “PIPE Subscription Agreement”) for a private placement (the “PIPE”) with certain
accredited investor (the “Purchaser”). Pursuant to the PIPE Subscription Agreement, the Purchaser has agreed to purchase an
aggregate of 176,470 PubCo Ordinary Shares, at a price per share of $8.50, representing aggregate gross proceeds of $1.5 million.
On May 14, 2024, PubCo and the Company entered
into additional subscription agreements (together with the PIPE Subscription Agreement above, the “PIPE Subscription Agreements”)
for a private placements with certain accredited investor who are existing shareholders of Crown (the “Existing Shareholder Purchasers”).
Pursuant to the PIPE Subscription Agreement, the Existing Shareholder Purchasers have agreed to purchase an aggregate of 26,393 PubCo
Ordinary Shares (together with the PubCo Ordinary Shares to be purchased by the Purchaser, the “PIPE Shares”), at a price
per share of $10.00, representing aggregate gross proceeds of $263.9 thousand.
Securities Lending Agreement
On May 22, 2024, PubCo entered into a securities
lending agreement (the “Securities Lending Agreement”) with Millennia Capital Partners Limited (the “Lender”)
pursuant to which the Lender agreed to loan PubCo up to $4.0 million (the “Loan”) at fifty-five (55%) Loan to Value of the
current market value of 730,000 shares of Crown pledged to the Lender (“Transferred Collateral”). “Loan to Value”
means the ratio of the Loan to the value of the Transferred Collateral, calculated by dividing the amount borrowed by the fair market
value of the Transferred Collateral. The Loan matures thirty-six (36) months after the Closing Date (as defined in the Securities Lending
Agreement) and bears interest at an annual rate of 6.0% to be paid quarterly.
Securities Purchase Agreement
On June 4, 2024, PubCo entered into a a definitive
securities purchase agreement (the “Securities Purchase Agreement”; together with the April 2024 Notes, the PIPE and the Securities
Lending Agreement, the “Financing Agreements”) with Helena Special Opportunities LLC (the “Investor”), an affiliate
of Helena Partners Inc., a Cayman-Islands based advisor and investor, providing for up to approximately USD$20.7 million in funding through
a private placement for the issuance of convertible notes (the “SPA Notes”).
Redemptions and Extensions
On February 16, 2024, the Company held an extraordinary general meeting
of shareholders (the “Second Extraordinary General Meeting”), at which the Company’s shareholders approved i) to extend
the date by which the Company has to consummate the Business Combination from February 17, 2024 up to three times by one month each to
March 17, 2024, April 17, 2024, or May 17, 2024, subject to that the Sponsor, or one or more of its affiliates, members
or third-party designees (the “Lender”), will deposit into the Trust Account for each month $0.03 for each then-outstanding
ordinary share issued in the Company’s initial public offering that is not redeemed, in exchange for one or more non-interest bearing,
unsecured promissory notes issued by the Company to the Lender and (ii) an amendment to the Company’s IMTA to extend the date by
which the Company has to consummate the Business Combination up to three times for one month each from February 17, 2024 to March 17,
2024, April 17, 2024 or May 17, 2024 (the “IMTA Amendment No.2”). On February 16, 2024, Catcha and Continental entered into
the IMTA Amendment No.2.
In connection with the votes taken at the Second
Extraordinary General Meeting of shareholders, holders of an additional 641,303 Class A ordinary shares of the Company properly exercised
their right to redeem their shares for cash at a redemption price of approximately $11.29 per share, for an aggregate redemption amount
of $7,241,004. The funds were redeemed from the Trust Account on February 22, 2024.
In January 2024, using the proceeds received under
the Extension Note, the Company deposited another $75,000 into the Trust Account, to extend the date that the Company has to consummate
the Business Combination to February 17, 2024.
On each of February 22, 2024, March 21, 2024 and
April 19, 2024, using the proceeds received under the 2024 Extension Note No. 1, the Company deposited $47,207 into the Trust Account
to extend the date by which the Company has to consummate the Business Combination to May 17, 2024.
On May 15, 2024, the Company held another extraordinary
general meeting of shareholders (the “Third Extraordinary General Meeting”), at which the Company’s shareholders approved
to extend the date by which the Company has to consummate the Business Combination from May 17, 2024 up to three times by one month each
to June 17, 2024, July 17, 2024, or August 17, 2024, subject to that the Lender will deposit into the Trust Account for
each month $0.03 for each then-outstanding ordinary share issued in the Company’s initial public offering that is not redeemed,
in exchange for one or more non-interest bearing, unsecured promissory notes issued by the Company to the Lender.
In connection with the votes taken at the Third
Extraordinary General Meeting of shareholders, holders of an additional 208,674 Class A ordinary shares of the Company properly exercised
their right to redeem their shares for cash at a redemption price of approximately $11.52 per share, for an aggregate redemption amount
of $2,403,928. The funds were redeemed from the Trust Account on May 20, 2024. As a result, 1,364,882 Class A ordinary shares subject
to possible redemption, amounting to approximately $15.7 million are still outstanding after the redemption.
On May 24, 2024, using the proceeds received under
the 2024 Extension Note No. 2, the Company deposited $40,946 into the Trust Account to extend the date by which the Company has to consummate
the Business Combination to June 17, 2024.
On May 10, 2024, the Company determined to postpone its extraordinary
general meeting of shareholders relating to shareholder approval of the Company’s entry into a Business Combination Agreement and
a related Merger and Plan of Merger (the “Business Combination Meeting”), from the previously scheduled date of
May 15, 2024 to June 12, 2024.
Additional Financing
On March 27, 2024, the Company issued an unsecured convertible
promissory note (the “2024 Extension Note No. 1”), dated as of February 17, 2024, to the Sponsor, pursuant to which
the Company may borrow up to $141,620 (the “2024 Extension Loan No. 1”) from the Sponsor, consisting of the aggregate
amount of the potential extensions of the Business Combination through May 17, 2024. Pursuant to the 2024 Extension Note No. 1, the
Sponsor has agreed to deposit into the Company’s trust account established in connection with its initial public offering cash in
the amount of $47,206.68 per monthly Extension (or a pro rata portion thereof if less than a month), and the Company has agreed that the
amount of each such deposit shall constitute a loan, until the earlier of (i) the date of the extraordinary general meeting held
in connection with a shareholder vote to approve an initial business combination, and (ii) the date that $141,620.04 has been loaned.
Such loan may, at the Sponsor’s discretion, be converted into warrants to purchase Class A ordinary shares of the Company at
a conversion price equal to $1.50 per warrant, with each warrant entitling the holder to purchase one Class A ordinary share at a
price of $11.50 per share, subject to the same adjustments applicable to the warrants issued to the Sponsor in the private placement that
closed on February 17, 2021 in connection with the initial public offering. The terms of the warrants will be identical to those
of the private placement warrants. The 2024 Extension Loan No. 1 will not bear any interest, and will be repayable by the Company to the
Sponsor, on a date that is the earlier of the consummation of an initial business combination and the liquidation of the Company.
The maturity date of the 2024 Extension Loan No. 1 may be accelerated upon the occurrence of an Event of Default (as defined under the
2024 Extension Note No. 1).
On March 29, 2024, the Company issued an unsecured convertible
promissory note (the “2024 Convertible Promissory Note”) to the Sponsor, pursuant to which the Company may borrow up
to $500,000 from the Sponsor. Such loan may, at the Sponsor’s discretion, be converted into warrants to purchase Class A ordinary
shares at a conversion price equal to $1.50 per warrant, with each warrant entitling the holder to purchase one Class A ordinary
share at a price of $11.50 per share, subject to the same adjustments applicable to the private placement warrants. The terms of the warrants
will be identical to those of the private placement warrants. The loan will not bear any interest, and will be repayable by the Company
to the Sponsor, on a date that is the earlier of the consummation of an initial business combination and the liquidation of the Company.
The maturity date of the loan may be accelerated upon the occurrence of an Event of Default (as defined under the 2024 Convertible Promissory
Note).
On May 15, 2024, the Company issued a promissory
note in the principal amount of up to $122,839 (the “2024 Extension Note No. 2”) to the Sponsor. The Note does not
bear interest and matures upon closing of the Business Combination. If the Company completes the proposed Business Combination, it will
repay the amounts loaned under the promissory notes or convert a portion or all of the amounts loaned under such promissory notes into
warrants at a price of $1.50 per warrant, which warrants will be identical to the private placement warrants issued to the Sponsor at
the time of the Company’s initial public offering. If the Company does not complete the proposed Business Combination by the final
applicable Extended Termination Date, such promissory notes will be repaid only from funds held outside of the Trust Account.
NYSE Notice
On February 20, 2024, the Company received a letter
from the NYSE American LLC (“NYSE American” or the “Exchange”) stating that the staff of NYSE Regulation has determined
to commence proceedings to delist Catcha’s Class A ordinary shares pursuant to Sections 119(b) and 119(f) of the NYSE American Company
Guide because the Company failed to consummate a Business Combination within 36 months of the effectiveness of its Initial Public Offering
registration statement, or such shorter period that the Company specified in its registration statement.
On February 23, 2024, the Company submitted a
written request to NYSE asking for the review of the delisting determination by a Committee of the Board of Directors of the Exchange.
Up to the date the financial statements were issued, the Company’s Class A ordinary shares have not been suspended and will continue
to trade.
On April 17, 2024, the Company received a written
notice from NYSE American indicating that the Company was not in compliance with NYSE American’s continued listing standards because
the Company did not timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Form 10-K”),
which was due on April 16, 2024.
In accordance with Section 1007 of the NYSE American Company Guide,
the Company will have six months from April 16, 2024 (the “Initial Cure Period”), to file the Form 10-K with the SEC. If the
Company fails to file the Form 10-K during the Initial Cure Period, NYSE American may, in its sole discretion, provide an additional six-month
cure period (the “Additional Cure Period”). The Company can regain compliance with the Exchange’s continued listing
standards at any time during the Initial Cure Period or Additional Cure Period, as applicable, by filing the Form 10-K and any subsequent
delayed filings with the SEC.
The Company has an NYSE appeal hearing scheduled for July 17, 2024.
Class B Ordinary Shares Conversion
On May 13, 2024, the Sponsor delivered notice
of conversion of an aggregate of 7,350,350 Class B Ordinary Shares of the Company, into an equal number of Class A Ordinary Shares of
the Company (the “Conversion”). The 7,350,350 Class B Shares, representing approximately 81% of the total issued and outstanding
Class A Shares after the Conversion, issued in connection with the Conversion are subject to the same restrictions as applied to the
Class B Shares before the Conversion, including, among others, certain transfer restrictions, waiver of redemption rights and the obligation
to vote in favor of an initial business combination as further described in the Company’s definitive merger proxy statement/prospectus
on Schedule 14A filed with the Securities and Exchange Commission on February 15, 2024 (“Definitive Merger Proxy Statement”).
Up to the date of the financial statements were issued, the outstanding Class A ordinary shares and Class B ordinary shares are 8,715,232
and 149,650, respectively. The Company evaluated the effect of the Conversion and concluded that the Conversion has no impact to the
Company’s shareholders’ deficit.
F-30
30000000
5792672
0.31
0.47
7500000
7500000
0.31
0.47
0.31
0.31
0.47
0.47
false
FY
0001838293
0001838293
2023-01-01
2023-12-31
0001838293
2023-06-30
0001838293
us-gaap:CommonClassAMember
2024-06-17
0001838293
us-gaap:CommonClassBMember
2024-06-17
0001838293
2023-12-31
0001838293
2022-12-31
0001838293
us-gaap:RelatedPartyMember
2023-12-31
0001838293
us-gaap:RelatedPartyMember
2022-12-31
0001838293
us-gaap:CommonClassAMember
2023-12-31
0001838293
us-gaap:CommonClassAMember
2022-12-31
0001838293
us-gaap:CommonClassBMember
2023-12-31
0001838293
us-gaap:CommonClassBMember
2022-12-31
0001838293
2022-01-01
2022-12-31
0001838293
chaa:RedeemableOrdinarySharesMember
2023-01-01
2023-12-31
0001838293
chaa:RedeemableOrdinarySharesMember
2022-01-01
2022-12-31
0001838293
chaa:NonRedeemableOrdinarySharesMember
2023-01-01
2023-12-31
0001838293
chaa:NonRedeemableOrdinarySharesMember
2022-01-01
2022-12-31
0001838293
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2021-12-31
0001838293
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2021-12-31
0001838293
us-gaap:AdditionalPaidInCapitalMember
2021-12-31
0001838293
us-gaap:RetainedEarningsMember
2021-12-31
0001838293
2021-12-31
0001838293
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-01-01
2022-12-31
0001838293
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-01-01
2022-12-31
0001838293
us-gaap:AdditionalPaidInCapitalMember
2022-01-01
2022-12-31
0001838293
us-gaap:RetainedEarningsMember
2022-01-01
2022-12-31
0001838293
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2022-12-31
0001838293
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2022-12-31
0001838293
us-gaap:AdditionalPaidInCapitalMember
2022-12-31
0001838293
us-gaap:RetainedEarningsMember
2022-12-31
0001838293
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2023-01-01
2023-12-31
0001838293
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-01-01
2023-12-31
0001838293
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-12-31
0001838293
us-gaap:RetainedEarningsMember
2023-01-01
2023-12-31
0001838293
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2023-12-31
0001838293
us-gaap:CommonClassBMember
us-gaap:CommonStockMember
2023-12-31
0001838293
us-gaap:AdditionalPaidInCapitalMember
2023-12-31
0001838293
us-gaap:RetainedEarningsMember
2023-12-31
0001838293
chaa:ConvertiblePomissoryNotesMember
2023-01-01
2023-12-31
0001838293
chaa:ConvertiblePomissoryNotesMember
2022-01-01
2022-12-31
0001838293
2023-10-01
2023-12-31
0001838293
us-gaap:IPOMember
2021-02-17
2021-02-17
0001838293
us-gaap:OverAllotmentOptionMember
2021-02-17
2021-02-17
0001838293
2021-02-17
0001838293
2021-02-17
2021-02-17
0001838293
us-gaap:CommonClassAMember
us-gaap:IPOMember
2021-02-17
2021-02-17
0001838293
us-gaap:WarrantMember
us-gaap:CommonClassAMember
2021-02-17
2021-02-17
0001838293
us-gaap:WarrantMember
us-gaap:IPOMember
2021-02-17
0001838293
us-gaap:WarrantMember
us-gaap:CommonClassAMember
2021-02-17
0001838293
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2021-02-17
2021-02-17
0001838293
chaa:PrivatePlacementWarrantsMember
2023-12-31
0001838293
chaa:PrivatePlacementWarrantsMember
2023-01-01
2023-12-31
0001838293
us-gaap:IPOMember
2021-02-17
0001838293
chaa:BusinessCombinationMember
2023-03-01
2023-03-31
0001838293
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2023-03-01
2023-03-31
0001838293
us-gaap:IPOMember
2023-12-31
0001838293
2021-03-31
0001838293
2021-01-01
2021-03-31
0001838293
chaa:PublicAndPrivateWarrantsMember
2021-01-01
2021-03-31
0001838293
us-gaap:IPOMember
2023-08-10
0001838293
2023-08-10
2023-08-10
0001838293
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2023-12-31
0001838293
us-gaap:CommonClassAMember
2023-01-01
2023-12-31
0001838293
chaa:TrustAccountMember
us-gaap:CommonClassAMember
2023-12-31
0001838293
us-gaap:SubsequentEventMember
2024-01-31
0001838293
2024-01-31
0001838293
us-gaap:SubsequentEventMember
2024-01-01
0001838293
us-gaap:SubsequentEventMember
2024-02-16
2024-02-16
0001838293
srt:ScenarioForecastMember
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2024-04-19
0001838293
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
us-gaap:SubsequentEventMember
2024-02-22
0001838293
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
us-gaap:SubsequentEventMember
2024-03-21
0001838293
srt:ScenarioForecastMember
2024-05-15
2024-05-15
0001838293
srt:ScenarioForecastMember
us-gaap:CommonClassAMember
2024-05-15
2024-05-15
0001838293
srt:ScenarioForecastMember
us-gaap:CommonClassAMember
us-gaap:CommonStockMember
2024-05-15
0001838293
srt:ScenarioForecastMember
chaa:TrustAccountMember
us-gaap:CommonClassAMember
2024-05-15
0001838293
srt:ScenarioForecastMember
2024-05-15
0001838293
srt:ScenarioForecastMember
us-gaap:WarrantMember
2024-05-15
0001838293
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2023-01-01
2023-12-31
0001838293
chaa:BusinessCombinationMember
2023-01-01
2023-12-31
0001838293
chaa:PubCoMember
2023-12-31
0001838293
chaa:UnsecuredConvertiblePromissoryNoteMember
chaa:SponsorMember
2023-12-31
0001838293
chaa:ConvertiblePromissoryNoteMember
chaa:SponsorMember
2023-12-31
0001838293
chaa:ConvertiblePromissoryNoteMember
2023-01-01
2023-12-31
0001838293
chaa:ConvertiblePromissoryNoteMember
2022-12-13
0001838293
chaa:UnsecuredConvertiblePromissoryNoteMember
chaa:SponsorMember
2023-02-14
0001838293
chaa:FromFebruaryTwoThousandTwentyThreeToJanuaryTwoThousandTwentyFourMember
chaa:SponsorMember
2023-02-14
0001838293
chaa:TrustAccountMember
2023-02-14
0001838293
chaa:PolarMultiStrategyMasterFundMember
chaa:SponsorMember
2023-03-09
2023-03-09
0001838293
chaa:PolarMultiStrategyMasterFundMember
chaa:SponsorMember
2023-12-31
0001838293
chaa:UnsecuredConvertiblePromissoryNoteMember
chaa:SponsorMember
us-gaap:SubsequentEventMember
2024-03-27
0001838293
us-gaap:SubsequentEventMember
2024-03-27
2024-03-27
0001838293
us-gaap:WarrantMember
us-gaap:CommonClassAMember
us-gaap:SubsequentEventMember
2024-03-27
2024-03-27
0001838293
us-gaap:CommonClassAMember
us-gaap:SubsequentEventMember
2024-03-27
0001838293
chaa:UnsecuredConvertiblePromissoryNoteMember
chaa:SponsorMember
us-gaap:SubsequentEventMember
2024-03-29
0001838293
us-gaap:WarrantMember
us-gaap:CommonClassAMember
us-gaap:SubsequentEventMember
2024-03-29
2024-03-29
0001838293
us-gaap:CommonClassAMember
us-gaap:SubsequentEventMember
2024-03-29
0001838293
srt:ScenarioForecastMember
2024-05-21
0001838293
srt:ScenarioForecastMember
2024-05-21
2024-05-21
0001838293
srt:ScenarioForecastMember
chaa:SponsorMember
2024-05-15
2024-05-15
0001838293
srt:ScenarioForecastMember
us-gaap:CommonClassAMember
2024-05-15
0001838293
chaa:SponsorMember
us-gaap:SubsequentEventMember
2024-02-22
0001838293
chaa:SponsorMember
us-gaap:SubsequentEventMember
2024-03-21
0001838293
srt:ScenarioForecastMember
2024-05-23
0001838293
us-gaap:IPOMember
2021-01-01
2021-03-31
0001838293
us-gaap:CommonClassAMember
2023-02-14
0001838293
us-gaap:CommonClassAMember
2023-02-01
2023-02-14
0001838293
2023-02-01
2023-02-14
0001838293
chaa:ConvertiblePromissoryNoteMember
2023-12-31
0001838293
chaa:ConvertiblePomissoryNotesMember
2023-01-01
2023-12-31
0001838293
chaa:ConvertiblePomissoryNotesMember
2023-12-31
0001838293
chaa:CapitalContributionMember
2023-01-01
2023-12-31
0001838293
chaa:PrivatePlacementWarrantsMember
2023-12-31
0001838293
us-gaap:WarrantMember
2023-01-01
2023-12-31
0001838293
chaa:BusinessCombinationMember
2023-12-31
0001838293
chaa:OrdinarySharesSubjectToPossibleRedemptionMember
2021-12-31
0001838293
chaa:OrdinarySharesSubjectToPossibleRedemptionMember
2022-01-01
2022-12-31
0001838293
chaa:OrdinarySharesSubjectToPossibleRedemptionMember
2022-12-31
0001838293
chaa:OrdinarySharesSubjectToPossibleRedemptionMember
2023-01-01
2023-12-31
0001838293
chaa:OrdinarySharesSubjectToPossibleRedemptionMember
2023-12-31
0001838293
us-gaap:CommonClassBMember
2023-01-01
2023-12-31
0001838293
us-gaap:CommonClassAMember
2022-01-01
2022-12-31
0001838293
us-gaap:CommonClassBMember
2022-01-01
2022-12-31
0001838293
us-gaap:CommonClassAMember
us-gaap:OverAllotmentOptionMember
2021-02-17
0001838293
us-gaap:OverAllotmentOptionMember
2021-02-17
0001838293
chaa:PublicWarrantsMember
2023-12-31
0001838293
us-gaap:WarrantMember
2023-12-31
0001838293
us-gaap:WarrantMember
us-gaap:CommonClassAMember
2023-12-31
0001838293
us-gaap:WarrantMember
2023-01-01
2023-12-31
0001838293
chaa:PublicShareMember
2023-12-31
0001838293
us-gaap:WarrantMember
us-gaap:CommonClassAMember
2023-01-01
2023-12-31
0001838293
chaa:PrivatePlacementWarrantsMember
2023-01-01
2023-12-31
0001838293
us-gaap:PrivatePlacementMember
2023-01-01
2023-12-31
0001838293
us-gaap:PrivatePlacementMember
2023-12-31
0001838293
us-gaap:WarrantMember
2023-12-31
0001838293
us-gaap:PrivatePlacementMember
2023-01-01
2023-03-31
0001838293
us-gaap:CommonClassBMember
2020-12-28
2020-12-28
0001838293
us-gaap:CommonClassBMember
2020-12-28
0001838293
us-gaap:CommonClassBMember
2021-02-11
2021-02-11
0001838293
us-gaap:CommonClassBMember
2021-02-11
0001838293
us-gaap:CommonClassBMember
us-gaap:OverAllotmentOptionMember
2021-03-28
0001838293
chaa:FounderSharesMember
2023-12-31
0001838293
chaa:FounderSharesMember
2022-12-31
0001838293
2023-02-14
0001838293
chaa:SponsorMember
2023-02-14
0001838293
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2023-02-14
0001838293
chaa:PromissoryNoteRelatedPartyMember
2023-12-31
0001838293
chaa:PromissoryNoteRelatedPartyMember
2023-01-01
2023-12-31
0001838293
chaa:ExtensionNoteMember
2023-01-01
2023-12-31
0001838293
chaa:PromissoryNoteRelatedPartyMember
us-gaap:AdditionalPaidInCapitalMember
2023-12-31
0001838293
chaa:PromissoryNoteRelatedPartyMember
2023-12-31
0001838293
chaa:WorkingCapitalLoanMember
2023-12-31
0001838293
2022-12-13
0001838293
chaa:SponsorMember
2022-12-13
0001838293
chaa:WorkingCapitalLoanMember
2022-12-13
0001838293
2022-12-13
2022-12-13
0001838293
chaa:ConvertiblePromissoryNoteMember
2022-12-31
0001838293
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
chaa:WorkingCapitalLoanMember
2023-12-31
0001838293
chaa:WorkingCapitalPurposesMember
2023-12-31
0001838293
chaa:ConvertiblePromissoryNoteMember
us-gaap:AdditionalPaidInCapitalMember
2023-12-31
0001838293
chaa:FundWorkingCapitalMember
2023-10-27
0001838293
chaa:FundWorkingCapitalMember
2023-10-27
2023-10-27
0001838293
2023-10-27
0001838293
2023-10-27
2023-10-27
0001838293
2023-10-30
2023-10-30
0001838293
2023-01-01
2023-09-30
0001838293
2023-09-30
0001838293
chaa:PWERModelMember
2023-09-30
0001838293
chaa:SponsorMember
2023-03-09
0001838293
chaa:CapitalContributionNoteMember
2023-01-01
2023-12-31
0001838293
chaa:CapitalCallMember
us-gaap:CommonClassAMember
2023-12-31
0001838293
2023-10-25
2023-10-25
0001838293
us-gaap:CommonClassAMember
2023-10-25
0001838293
chaa:SponsorMember
2023-10-25
2023-10-25
0001838293
chaa:SponsorMember
2023-12-31
0001838293
us-gaap:DerivativeMember
2023-10-25
0001838293
2023-10-25
0001838293
chaa:BusinessCombinationMember
2023-12-31
0001838293
chaa:ConvertiblePromissoryNotesMember
2023-12-31
0001838293
chaa:SPACLoanMember
2023-12-31
0001838293
us-gaap:FairValueInputsLevel2Member
2023-12-31
0001838293
us-gaap:FairValueInputsLevel3Member
2023-12-31
0001838293
chaa:PublicWarrantsMember
us-gaap:FairValueInputsLevel1Member
2023-12-31
0001838293
chaa:PublicWarrantsMember
us-gaap:FairValueInputsLevel2Member
2023-12-31
0001838293
chaa:PublicWarrantsMember
us-gaap:FairValueInputsLevel3Member
2023-12-31
0001838293
chaa:PrivatePlacementWarrantsMember
us-gaap:FairValueInputsLevel1Member
2023-12-31
0001838293
chaa:PrivatePlacementWarrantsMember
us-gaap:FairValueInputsLevel2Member
2023-12-31
0001838293
chaa:PrivatePlacementWarrantsMember
us-gaap:FairValueInputsLevel3Member
2023-12-31
0001838293
chaa:WorkingCapitalLoansMember
2023-12-31
0001838293
chaa:WorkingCapitalLoansMember
us-gaap:FairValueInputsLevel1Member
2023-12-31
0001838293
chaa:WorkingCapitalLoansMember
us-gaap:FairValueInputsLevel2Member
2023-12-31
0001838293
chaa:WorkingCapitalLoansMember
us-gaap:FairValueInputsLevel3Member
2023-12-31
0001838293
chaa:PromissoryNoteRelatedPartyMember
2023-12-31
0001838293
chaa:PromissoryNoteRelatedPartyMember
us-gaap:FairValueInputsLevel1Member
2023-12-31
0001838293
chaa:PromissoryNoteRelatedPartyMember
us-gaap:FairValueInputsLevel2Member
2023-12-31
0001838293
chaa:PromissoryNoteRelatedPartyMember
us-gaap:FairValueInputsLevel3Member
2023-12-31
0001838293
chaa:CapitalContributionNoteMember
2023-12-31
0001838293
chaa:CapitalContributionNoteMember
us-gaap:FairValueInputsLevel1Member
2023-12-31
0001838293
chaa:CapitalContributionNoteMember
us-gaap:FairValueInputsLevel2Member
2023-12-31
0001838293
chaa:CapitalContributionNoteMember
us-gaap:FairValueInputsLevel3Member
2023-12-31
0001838293
chaa:TerminationDerivativeLiabilityMember
2023-12-31
0001838293
chaa:TerminationDerivativeLiabilityMember
us-gaap:FairValueInputsLevel1Member
2023-12-31
0001838293
chaa:TerminationDerivativeLiabilityMember
us-gaap:FairValueInputsLevel2Member
2023-12-31
0001838293
chaa:TerminationDerivativeLiabilityMember
us-gaap:FairValueInputsLevel3Member
2023-12-31
0001838293
chaa:CashAndCashAndInvestmentsHeldInTrustAccountTradingSecuritiesMember
2022-12-31
0001838293
chaa:CashAndCashAndInvestmentsHeldInTrustAccountTradingSecuritiesMember
us-gaap:FairValueInputsLevel1Member
2022-12-31
0001838293
chaa:CashAndCashAndInvestmentsHeldInTrustAccountTradingSecuritiesMember
us-gaap:FairValueInputsLevel2Member
2022-12-31
0001838293
chaa:CashAndCashAndInvestmentsHeldInTrustAccountTradingSecuritiesMember
us-gaap:FairValueInputsLevel3Member
2022-12-31
0001838293
us-gaap:FairValueInputsLevel1Member
2022-12-31
0001838293
us-gaap:FairValueInputsLevel2Member
2022-12-31
0001838293
us-gaap:FairValueInputsLevel3Member
2022-12-31
0001838293
chaa:PublicWarrantsMember
2022-12-31
0001838293
chaa:PublicWarrantsMember
us-gaap:FairValueInputsLevel1Member
2022-12-31
0001838293
chaa:PublicWarrantsMember
us-gaap:FairValueInputsLevel2Member
2022-12-31
0001838293
chaa:PublicWarrantsMember
us-gaap:FairValueInputsLevel3Member
2022-12-31
0001838293
chaa:PrivatePlacementWarrantsMember
2022-12-31
0001838293
chaa:PrivatePlacementWarrantsMember
us-gaap:FairValueInputsLevel1Member
2022-12-31
0001838293
chaa:PrivatePlacementWarrantsMember
us-gaap:FairValueInputsLevel2Member
2022-12-31
0001838293
chaa:PrivatePlacementWarrantsMember
us-gaap:FairValueInputsLevel3Member
2022-12-31
0001838293
chaa:PublicWarrantPriceMember
2023-12-31
0001838293
chaa:PublicWarrantPriceMember
2022-12-31
0001838293
us-gaap:MeasurementInputRiskFreeInterestRateMember
2023-12-31
0001838293
us-gaap:MeasurementInputRiskFreeInterestRateMember
2022-12-31
0001838293
us-gaap:MeasurementInputExpectedTermMember
2023-12-31
0001838293
us-gaap:MeasurementInputExpectedTermMember
2022-12-31
0001838293
us-gaap:MeasurementInputPriceVolatilityMember
2023-12-31
0001838293
us-gaap:MeasurementInputPriceVolatilityMember
2022-12-31
0001838293
us-gaap:MeasurementInputSharePriceMember
2023-12-31
0001838293
us-gaap:MeasurementInputSharePriceMember
2022-12-31
0001838293
us-gaap:MeasurementInputExercisePriceMember
2023-12-31
0001838293
us-gaap:MeasurementInputExercisePriceMember
2022-12-31
0001838293
chaa:LikelihoodOfCompletingABusinessCombinationMember
2023-12-31
0001838293
chaa:LikelihoodOfCompletingABusinessCombinationMember
2022-12-31
0001838293
chaa:RiskfreeInterestRateForWarrantMember
2023-01-01
2023-12-31
0001838293
srt:MinimumMember
chaa:RiskfreeInterestRateForWarrantMember
2023-02-22
2023-12-28
0001838293
srt:MaximumMember
chaa:RiskfreeInterestRateForWarrantMember
2023-02-22
2023-12-28
0001838293
chaa:RiskfreeInterestRateForDebtMember
2023-01-01
2023-12-31
0001838293
srt:MinimumMember
chaa:RiskfreeInterestRateForDebtMember
2023-02-22
2023-12-28
0001838293
srt:MaximumMember
chaa:RiskfreeInterestRateForDebtMember
2023-02-22
2023-12-28
0001838293
chaa:TermOfDebtConversionMember
2023-01-01
2023-12-31
0001838293
srt:MinimumMember
chaa:TermOfDebtConversionMember
2023-02-22
2023-12-28
0001838293
srt:MaximumMember
chaa:TermOfDebtConversionMember
2023-02-22
2023-12-28
0001838293
chaa:TermOfWarrantConversionMember
2023-01-01
2023-12-31
0001838293
srt:MinimumMember
chaa:TermOfWarrantConversionMember
2023-02-22
2023-12-28
0001838293
srt:MaximumMember
chaa:TermOfWarrantConversionMember
2023-02-22
2023-12-28
0001838293
us-gaap:MeasurementInputPriceVolatilityMember
2023-01-01
2023-12-31
0001838293
srt:MinimumMember
us-gaap:MeasurementInputPriceVolatilityMember
2023-02-22
2023-12-28
0001838293
srt:MaximumMember
us-gaap:MeasurementInputPriceVolatilityMember
2023-02-22
2023-12-28
0001838293
chaa:IteratedMarketStockPriceMember
2023-01-01
2023-12-31
0001838293
srt:MinimumMember
chaa:IteratedMarketStockPriceMember
2023-02-22
2023-12-28
0001838293
srt:MaximumMember
chaa:IteratedMarketStockPriceMember
2023-02-22
2023-12-28
0001838293
chaa:ExercisePriceOfWarrantsMember
2023-01-01
2023-12-31
0001838293
chaa:ExercisePriceOfWarrantsMember
2023-02-22
2023-12-28
0001838293
us-gaap:MeasurementInputConversionPriceMember
2023-01-01
2023-12-31
0001838293
us-gaap:MeasurementInputConversionPriceMember
2023-02-22
2023-12-28
0001838293
chaa:LikelihoodOfCompletingABusinessCombinationMember
2023-01-01
2023-12-31
0001838293
srt:MinimumMember
chaa:LikelihoodOfCompletingABusinessCombinationMember
2023-02-22
2023-12-28
0001838293
srt:MaximumMember
chaa:LikelihoodOfCompletingABusinessCombinationMember
2023-02-22
2023-12-28
0001838293
us-gaap:MeasurementInputRiskFreeInterestRateMember
2023-01-01
2023-12-31
0001838293
srt:MinimumMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
2023-02-22
2023-12-28
0001838293
srt:MaximumMember
us-gaap:MeasurementInputRiskFreeInterestRateMember
2023-02-22
2023-12-28
0001838293
chaa:EstimatedTermMember
2023-01-01
2023-12-31
0001838293
srt:MinimumMember
chaa:EstimatedTermMember
2023-02-22
2023-12-28
0001838293
srt:MaximumMember
chaa:EstimatedTermMember
2023-02-22
2023-12-28
0001838293
chaa:LikelihoodOfCompletingABusinessCombinationMember
2023-02-22
2023-12-28
0001838293
chaa:ConsiderationForTheCapitalCallsInSharesMember
2023-01-01
2023-12-31
0001838293
chaa:ConsiderationForTheCapitalCallsInSharesMember
2023-02-22
2023-12-28
0001838293
us-gaap:MeasurementInputRiskFreeInterestRateMember
2023-10-25
2023-10-25
0001838293
chaa:EstimatedTermMember
2023-10-25
2023-10-25
0001838293
us-gaap:MeasurementInputPriceVolatilityMember
2023-10-25
2023-10-25
0001838293
chaa:IteratedMarketStockPriceMember
2023-10-25
2023-10-25
0001838293
chaa:FairValueOfSharesOfCrownMember
2023-01-01
2023-12-31
0001838293
chaa:FairValueOfSharesOfCrownMember
2023-10-25
2023-10-25
0001838293
us-gaap:MeasurementInputExercisePriceMember
2023-01-01
2023-12-31
0001838293
us-gaap:MeasurementInputExercisePriceMember
2023-10-25
2023-10-25
0001838293
chaa:ConvertiblePromissoryNotesMember
chaa:ExtensionNoteMember
2023-01-01
2023-12-31
0001838293
chaa:ConvertiblePromissoryNotesMember
chaa:WorkingCapitalLoanMember
2023-01-01
2023-12-31
0001838293
chaa:ConvertiblePromissoryNotesMember
chaa:ExtensionNoteMember
2023-12-31
0001838293
chaa:ConvertiblePromissoryNotesMember
chaa:WorkingCapitalLoanMember
2023-12-31
0001838293
chaa:CapitalContributionNoteMember
chaa:PolarMember
2023-01-01
2023-12-31
0001838293
chaa:CapitalContributionNoteMember
chaa:PolarMember
2023-12-31
0001838293
chaa:CapitalContributionNoteMember
chaa:PolarMember
2023-10-25
0001838293
chaa:CapitalContributionNoteMember
chaa:PolarMember
2023-10-25
2023-12-31
0001838293
us-gaap:IPOMember
2023-01-01
2023-12-31
0001838293
chaa:JPMorganMember
2023-08-10
0001838293
2023-03-01
2023-03-14
0001838293
2023-03-14
0001838293
2023-03-01
2023-03-26
0001838293
2023-05-01
2023-05-18
0001838293
srt:ScenarioForecastMember
2024-04-30
2024-04-30
0001838293
srt:ScenarioForecastMember
2024-04-30
0001838293
srt:ScenarioForecastMember
2024-05-06
0001838293
srt:ScenarioForecastMember
2024-05-14
0001838293
srt:ScenarioForecastMember
chaa:SecuritiesLendingAgreementMember
2024-05-22
0001838293
srt:ScenarioForecastMember
chaa:SecuritiesLendingAgreementMember
2024-05-22
2024-05-22
0001838293
srt:ScenarioForecastMember
2024-04-04
0001838293
chaa:SponsorMember
us-gaap:SubsequentEventMember
2024-01-01
0001838293
srt:ScenarioForecastMember
2024-05-24
0001838293
chaa:UnsecuredConvertiblePromissoryNoteMember
us-gaap:SubsequentEventMember
2024-03-27
0001838293
srt:ScenarioForecastMember
us-gaap:CommonClassBMember
chaa:SponsorMember
2024-05-13
2024-05-13
0001838293
srt:ScenarioForecastMember
us-gaap:CommonClassBMember
2024-05-13
2024-05-13
0001838293
srt:ScenarioForecastMember
2024-05-13
2024-05-13
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
In connection with the Annual Report of Catcha Investment Corp (the
“Company”) on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission on the
date hereof (the “Report”), I, Patrick Grove, Chairman and Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
(1) the Report fully complies with the requirements of Section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in
all material respects, the financial condition and results of operations of the Company.
In connection with the Annual Report of Catcha Investment Corp (the
“Company”) on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission on the
date hereof (the “Report”), I, Luke Elliott, Director and President of the Company, certify, pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
(1) the Report fully complies with the requirements of Section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in
all material respects, the financial condition and results of operations of the Company.